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 سمه تعالیاب
 
 مهمانان عزیز همکاران گرامی،
 شاریر.  المللری رررنان تار ان شانهرگا  گرامری مری مقدم شما عزیزان را به کنگرر  بر  
و خداوند بزرگ را رپارگزارم که توف قی عنایت فرموش تا برای رال شه. ای  کنگر  برزرگ 
شر کهورها و برای همه زنران  عنوان یک معضل بهداش یه را برگزار کن .  ررنان تا ان ب
جهان مورش عنایت ویژ  وزارت بهداشت، شرمان آموزش تزشکی و به تبع آن شانهگا  علروم 
شر هرر ررال برگرزاری کنگرر   تزشکی شه د بههر ی رررار شارش  شر نری ایر  ش  ررال و 
المللی ررنان تا ان تلاش شد  ارت تا تعم ق علمی ای  ب ماری از رطح مولکول ترا ب  
بدی  ترب ت تارخگوی ن ازهای مرشم عزیزمان بویژ  زنان شر  ل   و جامعه صورت گ رش  وبا
جمهوری ارلامی باش .  شر رال جاری ه. با شرت نظر روی ابعاش مخ لف ب مراری اعر. از 
های مرتبط با تهرخ  و های مدرن تلاش شاری. همه گرو های تایه، بال نی و شرمانبحث
ن .، و به نگرشی جامع مراربت ت مری شر معالهره ب مراران جامره شرمان را شور ه. جمع ک
عمل بپوشان .  تعداش ررنان تا ان هنوز شر ایران به رر. کهورهای صنع ی نرر د  ارت 
کنرد  امرا شرصد هزار زنان که رالانه رریب ش  هزار نفر را مبر لا مری  30و با عدشی معاشل 
باشرد، وعرع ت را شر یردی صد شر رال مری شر 6روند روبه رو رشد ای  ب ماری که رریب 
خطرناک مورش توجه مدیران شانهگا  علوم تزشکی شره د بههر ی رررار شاش  اررت   تقریباً
مرکز تحق قات ررنان شانهگا  با هم ی عالمانه و شلاوزانه شر نول ش  رال گذشر ه همره 
نرد  خوشربخ انه ها را به جان خرید  ارت تا ای  شی  ملی را از روی شانهرگا  اشا ک رخ ی
هرای شر شو رال گذش ه مرا بعنروان اولر   و تنهرا شانهرگا  کهرور مارزول آمروزش شور 
 
 
 رئیس دانشگاهپیام 
 دکتر علی اکبر پیوندی
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ایر. و شر ایر  را  برا ترب رت تخصصری همکراران تخصصی فلوش پ جرایری تار ان شرد 
افهرانی کنرد و کی نورهرای علروم تزشر ام دواری. که ای  نل عره علمری شر همره شانهرگا 
 دمت به مرشم فراه. آورش ای جامع برای ارتقای خشبکه
هرای مردرن شر شانهگا  علوم تزشکی شه د بهه ی به عنوان تر  ررراول علمری شرمران 
و یا شرمان راشیروتراتی یر    )BNLS(ررنان تا ان همانند انهام عقد  لنفاوی ت هاهنگ
و انهام تحق قات مررتبط ایر   )SCB(های م عدش یفظ تا ان و یا جرایی )TROI(عمل 
گ رری از تهرب رات ر را به خوبی انهام شاش  ارت  شر کنگر  شه. ن رز برا بهرر وظ فه خط 
شان . شر نبق اخرلا ارزشمند ارات د شاخل و خارج کهور و همه آنچه را که عل. روز می
کن .  بار شیگر مقدم شما عزیزان را گرامی شاش ه و ام د شارم ره آورش  و به شما تقدی. می
شر ای  شانهگا  رپری فرمائ د  فرصرت را نن مرت شرمرش  و بره روز عط ه و روشمندی را 
 همکرراران. شر مرکررز تحق قررات ررررنان خرردا ررروت م گرروی. و ام رردوارم تررلاش آنهررا 
 مرعی یق تعالی باشد  
 
  
 
 9
 1313ماه  اسفند 6-8
 
 
 
 المللی سرطان پستاندهمین کنگره بین
 
 
 
 
 
 
 
 بسم الله الرحمن الرحیم
 
ش  رال گذشت، ش  بار تلاش ما مر برای بروز ررانی عل. ررنان ر نه شر ایران، خداونرد 
عل . را رپارگزاری. که به مهموعه خاشم   عل. شر مرکز تحق قات ررنان توف رق شاش ترا 
با یمایت همه جانبه همه نهاشهای علمی و تحق قاتی کهرور و تهر  بانی خ رری  عرال. و 
اررفند مرا  ررال  8و  7، 6المللی ررنان تا ان را شر روزهرای شلاوز، شهم   کنگر  ب  
شانهگا  علوم تزشکی شه د بهه ی برگزار کنر .  خردم گزاران  جاری شر تالار امام علی(ع)
هرای رررنان تار ان از انردازی کنگرر شما ی ی یک روز از رال را بدون تلاش بررای را 
شهند تا ای  کنگر  با جامع ت خا خوشش ب واند تاررخگوی ن ازهرای علمری شرت نمی
ررطح جهرانی  ی کنگرر  شر همکاران ما باشد  خوشبخ انه هر رال با ردرت علمری ب هر ر 
انرد  شهمر   کنگرر  های جدیدی از آن یمایت کررش ها و رازمانمعرفی شد  ارت و نهاش
تانل وکنگر  عظر . 30کارگا  عملی، 30رخنرانی، 00المللی ررنان تا ان با برگزاریب  
کند تا اشای شی  جامعی را به نالبران علر. شاشر ه مرشمی شفایاف گان از ررنان تلاش می
هرای هرای علمری، تراز هرای علمری و ررخنرانی های جرایری شر رالرب کارگرا شد  تاز با
 هرای جرانبی از رب رل راشیروتراتی و شر می شرمرانی و عوامرل مرو ر تهخ صری، و شرمران
های معنویرت شرمرانی شر یرد اتی ژن  کی مو ر شر ایهاش ررنان با تعم ق ب ولوژیک یاف ه
ه شد  شر ای  کنگر  خواهرد بروش  شر شهمر   کنگرر  رلول و ژن، چهرهایی از مطالب ارائ
المللی ررنان تا ان، تحق قات ملی ایران ان شر محک مقایاه با شانهرمندان مع برری ب  
گ رش کره منهرر بره ترالای علمری لازم بررای فراگ رران از رایر کهورهای جهان ررار می
 خواهد بوش 
 
 
 کنگرهرئیس پیام 
 مد اسماعیل اکبریدکتر مح
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همران از کهرورهای آمریکرا، اترری ، م10المللی ررنان تا ان م زبان شهم   کنگر  ب  
هرای باشد  که تهرب رات خروش را شر رالرب کارگرا بلژیک، روئ س، ترک ه، ای ال ا،عمان می
های علمی ارائه خواهند کرش  شر کنگر  رال جاری با شعوت از مارزول   عملی و رخنرانی
شر اخ  رار  المللی مدیریت ررنان شر جهران تهرب رات گرانقردری را ما ق . نهاشهای ب  
تواند موجب تحول شگرفی شر افراش شررکت کننرد  و شه . که میکنندگان ررار میشرکت
های روشرنی را بررای ایر  نهاشهرا ارائره یا مدیران اجرائی کهور ایهاش کند و خطی و مهی
شهد  مرکز تحق قات ررنان شانهگا  علوم تزشکی شه د بهه ی مف خر اررت کره شرما را 
المللی ررنان تا ان شر تالار امام علری(ع) شانهرگا  زیرارت کنرد و   شر شهم   کنگر  ب
 همه آنچه را شر توان شارش برای جلب رعایت علمی شما به کار بندش 
 
 خدایا چنان ک  تو تایان کار
 تو خهنوش باشی و ما رر گار
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نیب هرگنک نیمهدناتسپ ناطرس یللملا 
In the Name of God 
 
I am proud to celebrate the beginning of the tenth annual Congress on Breast 
Cancer, the tenth effort to update our understanding of breast cancer in Iran. 
Praise to the Lord for His blessings on the staff in Cancer Research Center to 
host the tenth annual Breast Cancer Congress owing to the sustained efforts of 
scientific and research institutions, and charitable organizations and 
individuals on February 25-27th in Imam Ali conference hall at Shahid 
Beheshti University of Medical Sciences. Not a single day has passed here at 
Cancer Research Center without honest endeavors of the staff to address 
scientific requirements of the medical society in this series of seminars. 
Happily, the seminar has grown stronger every year and has gained more 
support from national and international organizations and institutions.  
The Tenth Congress contains 33 lectures, 20 workshops, 10 panels and a big 
gathering of cancer survivors. Those include the recent findings in cancer 
surgery, diagnosis, adjuvant treatments such as radiation-therapy and 
chemotherapy, epigenetic factors affecting cancer, and the latest biological 
issues of spiritual therapy. It is a comparison benchmark to assess the works of 
Iranian researchers with those of leading scientists from around the world 
resulting in profound understanding of the issues.  
The tenth Congress receives 14 guest speakers from America, Austria, 
Belgium, Switzerland, Turkey, Italy and Oman sharing their valuable 
experiences in form of lectures and workshops. This year’s Congress is also 
graced with the presence of international cancer management authorities to 
provide guidelines for executives in the country and enlighten the participants.  
The Cancer Research Center at Shahis Beheshti University of Medical 
Sciences will be honored to see you all in the 10th Annual Congress on Breast 
Cancer in Imam Ali conference hall.  
 
Chairman 
Mohammad Esmail Akbari 
Prof of Surgical Oncology  
Cancer Research Center 
SBMU. Tehran Iran  
Feb 2015   
 
 
 
 
  
 
 10
 
 
 المللی سرطان پستاندهمین کنگره بین
 
 
 1313ماه  اسفند 6-8
 
 
 
 
 
 
 
 سمه تعالیاب
 
المللری رررنان تار ان، برا کوشر و به لطف و عنایت خداوند م عال شهم   کنگر  ب  
تلاش ارات د مح رم کم  ه علمری و اجرایری و همره همکراران ارجمنرد مرکرز تحق قرات 
 گرشش  ررنان شانهگا  علوم تزشکی شه د بهه ی برگزار می
ررنان تا ان به عنوان شایع ری  ررنان شر بانوان کهور با افزای برروز ررالانه نزشیرک 
خوشبخ انه با م رزان عرلاج  ش  هزار و جمع ت یدوش یکصد هزار نفر مب لا به ای  ب ماری،
شوش  با توجه یکی از مهم ری  ماائل یوز  رلامت محاوب می شر مرایل اول ه، %38-37
های ن از به فعال ت بروز رالانه و هرم رنی به رمت بزرگاالی کهور،به افزای رابل تأمل 
 هورمرونی،  فاک ورهرای شرغلی،  تغذیره،  علمی و کارشناری بررری عوامل الگروی زنردگی، 
های زیات مح طی و     یائز اهم ت ارت  بررای ت هرگ ری و ژن  کی، آلوشگی خانواشگی،
جهت ایهاش زیر راخ ارها و تع    اهردا   ریزی مناربن ازمند برنامه کن رل و شرمان آن،
های تخصصی و گرشهمرایی کوتا  مدت و بلند مدت ن از ارتبانات هر چه ب ه ر تمام رش ه
 نلبد  مه رک هدفمند را می
تخصصری های مخ لف تخصصی و فوقنظر رش های  کنگر  با همت ارات د مهرب و صایب
شارش با ارائه الگوهای چنرد تخصصری زم نره شوش و تلاش شاخل و خارج از کهور برگزار می
ها ب  از ت  فراه. نموش  و عرم  ای را شر شرمان ررنانهمکاری گروهی و ب   رش ه
ارائه تحولات جدید و روشهای تهخ  و شرمان نوی  جهانی مانند راشیوتراتی ی   عمرل 
ق قرات تژوههرگران های جدید بازرازی و یفظ ارگان و    با ارائه ن ایج تحتکن ک جرایی،
، تورر ر،کارگاههای م عردش  noitatneserP dipaRنقاط مخ لف جهان شر رالب ررخنرانی، 
 
 
 کنگره دبیرپیام 
 دکتر حمید رضا میرزایی
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 گرو  تزشرکان عمرومی،  ماایل روانهناخ ی، نب رن ی، و    توجه خاصی را به امر تغذیه،
 شارش  های ترر اری شر تیمراربت
هرای ای انهمر ررای شور المللی و برویژ  رو رعی شارش از یضور محقق   صایب نظر ب  
های علمی بهر  گ رش  به نحوی که صورت رخنرانی و برگزاری کارگا ه ب OMSEو OCSA
با توجه به مهکلات و هزینه با ار زیاش برای اعزام م خصص   بره خرارج از کهرور جهرت 
ش  های لازم شان ازشد و شر ای  کنگر  آموزشهای آموزشی ب وان از اعزام بزرگواران بیشور 
 شوش  
هرا ام دوارم با یضور فعرال همره گررو  کنندگان ارجمند،عم  خوش آمدگویی به شرکت
جهت ارائه به ر خدمت به ب ماران و ملت عزیزمان ردم مناربی برشاش ه شروش  شر تایران از 
همه همکاران گرانقدر و شلاوز مرکز تحق قات ررنان و کم  ه اجرایری کره نری یکارال 
 انرد، زیمات با ار زیاشی برای برگزاری کنگرر  کهر د  لاش ما مر،ها وبا تتحمل رخ ی
 کن.  تهکر و رپارگزاری می
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In the Name of God 
 
By the grace of god, Tenth International Congress of breast cancer, with an 
attempt professors and the Executive Committee and all colleagues venerable 
Shahid Beheshti University of Medical Sciences Cancer Center will be held. 
Breast cancer is the most common cancer in women, with an annual incidence 
of nearly ten thousand and a population of about one hundred thousand people 
with the disease, fortunately, the cure rate in the early stages 70-80% one as the 
most important issues health.Due to the significant increase in the annual 
incidence and reflection of the adult population pyramid, require expert 
scientific and life style factors, nutrition, occupational factors, hormones, 
family, genetic, and environmental pollution and ...... are important. 
This Congress by experienced instructors and Technical experts from various 
fields within inside and outside the country to be held and attempts to model 
multi-disciplinary and interdisciplinary cooperation in the field of cancer 
treatment provided  new developments and methods of diagnosis and treatment, 
including radiation during surgery, new techniques for restoring and 
maintaining the organ with the research results provide researchers around the 
world in the form of lectures, Rapid Presentation, posters, numerous workshops 
and ..... special attention to the nutrition, herbal medicine, psychological issues, 
general physicians, nursing care is sought. 
Tries of the international experts and researchers, particularly heads of ASCO 
and ESMO Forum periodic lectures and workshops will be of interest. 
While welcoming the participants, the almighty, I hope that with the active 
participation of all groups in order to provide better service to our patients and 
our nation has taken the appropriate steps. At the end of all great staff and 
caring Cancer Research Center and the Executive Committee of the hardships 
endured during one year of continuous effort, great efforts of the Congress put, 
thank you so much. 
 
Dr Hamid Reza Mirzaei 
Director of the 10th International Breast Cancer Congress  
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 : برگزار کننده
 مرکز تحقیقات سرطان دانشگاه علوم پزشکی شهید بهشتی  
 : با همکاری
 درمان و آموزش پزشکی وزارت بهداشت، 
 های علوم پزشکی سراسر کشور دانشگاه 
 OHWسازمان بهداشت جهانی  
 OEIانستیتو آنکولوژی اروپا 
 TROISIمللی الانجمن بین 
 AMARUEهای پستان انجمن اروپایی آسیایی بیماری 
 APFNUصندوق جمعیت ملل متحد  
 سازمان بیمه خدمات درمانی نیروهای مسلح 
 دانشکده پرستاری و مامایی 
 مرکز تحقیقات سرطان دانشگاه علوم پزشکی مشهد 
 جامعه جراحان ایران 
 انجمن رادیوتراپی آنکولوژی ایران 
 انانجمن سرطان ایر 
 انجمن جراحان عمومی ایران 
 انجمن رادیولوژی ایران  
 انجمن پاتولوژی ایران 
 انجمن ژنتیک 
 انجمن آموزش پزشکی ایران 
 انجمن پزشکان عمومی ایران 
بلژیک، اتریش،  سوئیس، آلمان، و با شرکت اساتید سخنران از ایران ،آمریکا، انگلستان ، ایتالیا، 
 ترکیه، عمان،...
 1315اسفند ماه  8-6
 ، دانشگاه شهید بهشتی، تالار امام علی (ع)ولنجک
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 للی سرطان پستانالمدهمین کنگره بین ارکان
 
 
 1313ماه  اسفند 6-8
 
 
 تر محمد اسماعیل اکبریرئیس کنگره : دک
 : دکتر حمید رضا میرزايی کنگره علمی دبیر
 : دکتر امیر شهرام يوسفی مدير کنگره
 
                     
 
 اپیدمیولوژی و پزشکی اجتماعی
 (مدير کمیته)دکتر مریم خیام زاده
 دکتر اذن ا... آذرگشب
 دکتر محسن اسدی لاری
 دکتر احورا احمدی
 اهیمیدکتر ماندانا ابر
 دکتر حمید سوری
 دکتر محمد شریعتی
 دکتر شهپر حقیقت
 دکتر فیلیپ دیویس
 دکتر یداله محرابی
 دکتر علی منتظری
 دکتر فرشاد نجفی پور
 دکتر پروین یاوری
 دکتر ژاله محسنی فر
 دکتر محمد موحدی
 
 و آزمايشگاه پاتولوژی
 (مدير کمیته)دکتر هانیه ژام
 دکتر شهلا مسعود 
 دریدکتر مسلم بها
 دکتر حسین برومند
 دکتر آرام تاج الدین
 دکتر محمد رضا جلالی ندوشن
 دکتر عیسی جهانزاد
 دکتر آزاده رخشان
 دکتر علی حسامی
 دکتر محمد رضا رفیعی
 دکتر مریم کدیور
 دکتر مرجان فرزامی
 دکتر رکسانا کریمی نژاد
 دکتر محمد واسعی
 دکتر سیاوش قادری
 محمد تربتی پیماندکتر 
 ین دارآفریندکتر حس
 دکتر سیامک شریعت تربقان
 دکتر بهروز شفقی
 دکتر فرید معین فر
 دکتر محمد فرهادی
 دکتر افشین مرادی
 دکتر ژاله محسنی فر
 دکتر مهرداد ناجی
 دکتر محمد هاشمی
 
 اعضاي کمیته علمی  
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 المللی سرطان پستاندهمین کنگره بین
 پزشکی هسته ای
 (مدير کمیته)دکتر مهستی عمویی
 دکتر محمد افتخاری
 دکتر قاسم رضیعی
 دکتر محمد کاظم شیرودی
 دکتر سید محمد کاظم مدرس مصلی
 دکتر عیسی نشاندار
 دکتر رامین صادقی 
 
 جراحی
 مدير کمیته)(دکتر محمد اسماعیل اکبری
 دکتر ابوالقاسم اباسهل
 دکتر فرزانه ابراهیمی فرد
 دکتر حسین الماسی 
 دکتر عدیل الجراح
 دکتر ابوالفضل افشار فرد
 دکتر جعفر اکبری
 دکتر خسرو ایازی
 ن افتخاریدکتر همایو
 دکتر منصوره اخگری
 دکتر آسیه الفت بخش
 ایتالیا -دکتر ماتیا اینترا
 فرانسه-دکتر جان رمی گاربی
 ایتالیا -دکتر جان پتی
 دکتر محمد رضا بدیعی
 دکتر مهرداد بهلولی
 دکتر پریسا عظیمی نژاد
 دکتر حبیب الله پیروی
 دکترفرشته کمانی 
 دکتر علی اصغر پیوندی
 یدکتر حسن پیوند
 دکتر فاطمه توکلی
 دکتر آزاده جولایی
 دکتر مصطفی حسینی
 دکتر اسماعیل حاج نصر اله
 دکتر مهران حبیبی
 دکتر ایرج حریرچی
 دکتر محسن حجتی
 دکتر مجید حیدری
 دکتر منصور جدلی زاده
 دکتر مصطفی خرمشاهی
 دکتر جلال الدین خوشنویس
 دکتر علیرضا خلج
 دکتر منوچهر دوایی
 یاییدکتر پرویز در 
 دکتر ویلیام دولی
 دکتر کامبیز دولتشاهی
 دکتر بهزاد رحمانی
 دکتر سید محمد ربیع هاشمی
 دکترشهریار رحمانی
 دکتر امیر رزم آور
 دکتر خلیل رستمی
 دکتر استفانو زوریدا
 دکتر فریدون سیرتی
 دکتر علی سیفی
 دکتر ایرج شاملو
 دکتر لیلا شجاعی
 دکتر محمود شفاهی
 دکتر سیاوش صحت
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 تر سهیلا صیاددک
 دکتر مجید صمصامی
 دکتر عبدالرسول طالعی
 دکتر مریم طباطبائی
 دکتر محمد رضا ظفرقندی 
 دکتر علی عبدالهی
 دکتر عبد ا... عزیزیان
 دکتر صدف علیپور
 دکتر ناصر عزتی
 دکتر مرتضی عطری
 دکتر رامش عمرانی پور
 دکتر فرشته عباس وندی
 دکتر علی غفوری
 علویدکتر نسرین السادات 
 دکتر محمد صادق فاضلی
 دکتر ژیان فرهادی
 دکتر محمد جعفر فروهش
 دکتر احمد کاویانی
 دکتر محمد رضا کشتگر
 دکتر محمد رضا کلانتر معتمدی 
 دکتر علیرضا کلانتر معتمدی
 دکتر لعبت گرانپایه
 دکتر بهادیر گل و اغلو
 دکتر محمد رضا میر
 دکتر محمد مظفر
 نیدکتر سید مرتضی موسوی نائی
 دکتر هاشم موذن زاده
 دکتر سید رضا موسوی
 دکتر حبیب اله محمود زاده
 دکتر رامین موسوی
 دکتر شاهین محمد صادقی
 دکتر آرش محمدی توفیق
 دکتر ماندانا معتمدی
 دکتر ناصر ملک پور علمداری
 دکتر عباس میر مالک
 دکتر ناهید نفیسی 
 دکتر محمد رضا نیک شعار
 دکتر ماریزیو ناوا 
 واعظ مهدوی دکتر
 دکتر فهیمه ناظمیان
 دکتر معصومه نجفی
 دکتر عصمت السادات هاشمی
 دکتر علی واحدی
 دکتر محمد هادیزاده
 دکتر عادل یزدانخواه 
 
 روان پزشکی و روانشناسی 
 (مدير کمیته) دکتر طاهره کرمانی رنجبر
 دکتر سپیده امیدواری
 دکتر مهدی بینا
 دکتر محسن بازرگان
 فوبیردکتر پاتریشیا 
 دکتر منیژه فیروزی
 دکتر نرگس بیرقی
 دکتر علیرضا ظهیر الدین
 دکتر احمد علی نور بالا
 دکتر فرح لطفی کاشانی
 دکتر شهرام وزیری
 دکتر علی منتظری
 سید مهدی موسوی
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 المللی سرطان پستاندهمین کنگره بین
 دکتر نجاتی صفا
 راديولوژی
 (مدير کمیته)دکتر مرتضی صانعی طاهری
 دکتر نسرین احمدی نژاد
 ردکتر شهرام اخلاق پو
 دکتر نوشین بهبودی مقدم
 دکتر لیلا بیانی
 دکتر تکتم بهشتیان
 دکتر مارینا پور افکاری
 دکتر هدیه ساغری
 دکتر جلال جلال شکوهی
 دکتر احمد حاجیان
 دکتر حمید رضا حقیقت خواه
 دکتر محمد هادی خرازی
 دکتر کلیفورد هادیس
 دکتر سعید راد
 دکتر سوفیا صبوری
 دکتر دنیا فرخ
 فرزانه دکتر فریور
 دکتر علی اکبر عامری
 دکتر مژگان کلانتری
 دکتر الهام کشاورز
 دکتر ناهید کمانگری
 دکتر معصومه گیتی
 دکتر داریوش هندسی
 دکتر عباس هنر بخش
 دکتر معصومه سلامتی
 دکتر عبدالرسول صداقت
 دکتر ناهید صدیقی
 دکتر خدیجه بخت آور
 دکتر فیروزه احمدی
 دکتر فرزانه فتاحی
 ین قناعتیدکتر حس
 دکتر احمد رضا طهماسب پور
 دکتر طاهره لاریجانی
 دکتر مریم رحمانی
 دکتر مریم نوری
 
 راديوتراپی آنکولوژی
 (مدير کمیته)دکتر امیر شهرام یوسفی
 آمریکا -دکتر فریبا اسراری
 ایتالیا -دکتر روبرتو ارچیا
 دکتر فرناز آموزگار هاشمی
 دکتر سید امیر آل داوود
 مدير کمیته پزشکان عمومی)(بابیدکتر فرشید ار
 دکتر سمیرا ازقندی
 دکتر سعید الماسی
 دکتر رباب انبیایی 
 دکتر شادی بابازاده
 دکتر مارتین پیکارت
 دکتر مینا تجویدی
 دکتر جواد ثعلبیان
 دکتر عطا ا... جهانگیر راد
 دکتر پیمان حداد
 دکتر رضا خدابخشی
 دکتر پرستو حاجیان
 دکتر حمیدرضا دهقان منشاری
 دکتر مهناز رعایایی
 دکتر افشین رخشا
 هلند-دکتر ژاکوب زی
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 دکتر رهام سالک
 دکتر منوچهر سرداری
 دکتر ثریا سلمانیان
 دکتر حجت ا... شهبازیان
 دکتر سودابه شهید ثالث
 دکتر مستانه صانعی
 دکتر سید مرتضی طباطبائی فر
 دکتر احمد عامری
 دکتر مهدی عقیلی
 کتر امیر محمد عارف پورد
 دکتر پدرام فدوی
 دکتر فرشید فرهان
 دکتر حسین فودازی
 دکتر امیر قاسمی جنگجو
 دکتر محمد رضا قوام نصیری
 دکتر گرد فستنر
 دکتر علی کاظمیان
 دکتر عباس گوگی زاده
 دکتر مونا ملک زاده 
 دکتر بهرام مفید
 دکتر احمد مصلایی
 دکتر میر احمد موسوی زاده
 سرو مجیر شیبانیدکتر خ
 دکتر گودرز مزدایی
 دکتر علی قنبری مطلق
 دکتر حمید رضا میرزایی
 دکتر حسین مدنی
 دکتر محمد منصوری
 دکتر سید هادی مولانا
 دکتر الهام مهر آوران
 ایتالیا -دکتر هوگو رائول مارسیگلیا
 دکتر غلامحسین نوفرستی
 دکتر علیرضا نیکو فر
 دکتر فاطمه همایی
 شیاریدکتر محمد هو
 دکتر سیمین همتی
 دکتر سید حسین یحیی زاده
 امریکا-دکتر کلارویک هادیس
 
 زنان و زايمان 
 دکتر لادن آجری
 دکتر مریم افراخته
 دکتر حشمت اله ازهر
 دکتر افسانه آقا زاده نائینی
 دکتر رضوان اعلمی هرندی
 دکتر بلقیس اولادی
 دکتر عصمت باروتی
 دکتر نادره بهتاش
 یدکتر علی حسین
 دکتر فاطمه خشتی
 دکتر زهره شاهوردی
 دکتر ملیحه عرب
 دکتر فرح فرزانه
 دکتر ربابه طاهری پناه
 دکتر معصومه فلاحیان
 دکتر احمد عبالحفیض (مصر)
 دکتر پریچهر کیمیائی
 دکتر میترا مدرس گیلانی
 دکتر شهین دخت مولاوردی
 دکتر مرضیه وحید دستجردی
 دکتر جعفر نصوحی
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 المللی سرطان پستاندهمین کنگره بین
 ژنتیک
 (مدير کمیته) طبرستانی دکتر ساناز
 دکتر سیروس زینعلی
 دکتر ابوالفضل موفق
 دکتر ناصر پارسا
 دکتر حمید خرم خورشید
 دکتر پروین مهدی پور
 دکتر سید حسن مقدم نیا
 دکتر مهرداد نوروزی نیا
 دکتر شرلی هودسن
 دکتر وحید رضا یاسایی
 دکتر ندا منصوری
 دکتر کیوان مجید زاده
 دکتر حسین نجم آبادی
 
 طب فیزيکی و توان بخشی
 دکتر داریوش الیاس پور
 دکتر محمد حسن بهرامی
 دکتر سید منصور رایگانی
 لیلا انگوتی
 
 فیزيک پزشکی
 (مدير کمیته)دکتر سید ربیع مهدوی
 دکتر محمود رضا آقامیری
 دکتر عظیم اربابی
 دکتر محسن بخشنده
 دکتر علی جباری ارفعی
 دکتر حسین قرائتی
 دکتر علی منفرد
 دکتر اصغر مصباح
 دکتر علیرضا شیرازی
 دکتر امین  مصلح شیرازی
 دکتر خدیجه اثنی عشری
 دکتر آته کرباس فروشان
 دکتر احمد مستعار
 دکتر علی جباری
 
 مامايی و پرستاری
 (مدير کمیته)دکتر مریم رسولی
 دکتر فروزان آتش زاده شوریده
 خانم مژگان انصاری
 دکتر مهناز ایلخانی
 اجیاندکتر سپیده ح
 خانم لیلا خانعلی مجن
 خانم طاهره السادات خوب بین خوش نظر
 دکتر ماهرخ دولتیان
 دکتر کاملیا روحانی
 دکتر منصوره زاغری تفرشی
 خانم اعظم شیرین آبادی فراهانی
 دکتر عباس عباس زاده
 خانم فاطمه علایی کرهرودی
 خانم آناهیتا معصوم پور
 دکتر فاطمه ناهیدی
 دیشهناز نعمتی دهکر
 خانم منیژه نوریان
 دکتر لیدا نیک فرید
 دکتر گیتی ازگلی
 دکتر زهرا بهبودی
 دکتر مهرنوش پازارگادی
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 دکتر پریسا پارسا
 دکتر سعادت پرهیزکار
 دکتر صدیقه پاک سرشت
 شهناز ترک زهرانی
 دکتر سپیده حاجیان   
 دکتر عفت السادات خویی  
 شراره جان نثاری 
 محبوبه طباطبایی چهر
 جنتی عطایی پدیده
 ناهید خداکرمی
 دکتر زهره قریشی
 نور السادات کریمیان
 ماهرخ دولتیان
 دکتر مرسده طهماسبی
 دکتر معصومه سیمبر
 صدیقه امیر علی اکبری
 دکتر شهناز کهن
 دکتر افسانه کرامت
 فاطمه ناهیدی
 دکتر خدیجه میرزایی نجم آبادی
 دکتر صدیقه اعظم مقسمی
 دکتر مژگان میرغفوربند
 ه هاشمیسمی
 
 هماتولوژی انکولوژی
 دکتر مجید احسانی
 دکتر محمد مهدی ادیب سرشکی
 دکتر فاطمه اصفهانی
 دکتر فاضل الهی
 دکتر غلامرضا توگه
 دکتر مهدی تبرائی
 دکتر عباس حاج فتحعلی
 دکتر عبدالرحیم حزینی 
 دکتر علی اخوتیان
 دکتر حسن جلائی خو
 دکتر محمد خانی
 دکتر جهانگیر رأفت
 محمد جهانیدکتر 
 دکتر نعمت اله رستمی
 دکتر حمید رضوانی
 دکتر علیرضا سعادت
 دکتر جلال الدین شمس
 دکتر حمید عطاریان
 دکتر مجتبی قدیانی
 دکتر اردشیر قوام زاده
 دکتر چارلز کومبس 
 دکتر منوچهر کیهانی
 دکتر داود منادی زاده
 دکتر علیرضا موسوی
 دکتر علی مقدم
 دکتر صفا نجفی
 ود وکیلیدکتر مسع
 
 تغذيه:
 (مدير کمیته) دکتر سید حسین داوودی
 دکتر مرجان عجمی
 دکتر مرتضی عبدالهی
 دکتر حمید پازوکی طرودی
 دکتر رضا همایونفر
 
 طب سنتی:
 دکتر حسین رضایی زاده
 دکتر ناصر رضایی پور
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 المللی سرطان پستاندهمین کنگره بین
 
 دبیر اجرايی: دکتر محمد هادی زاده
 مدير روابط بین الملل: دکتر ناهید نفیسی
 ، شهرزاد شمیرانیاجرايی :  آزاده خردمند انرمدي
 
 
 
 
 
 حسین اکبری
 زهرا بختیاری
 سید مهدی برازی 
 دکتر افسون تقوی
 پگاه خندان
 الهام رحمانی
 موسی رشیدی
 پور سمیه ذوقی
 الهام سه طاقیان
 شهرزاد شمیرانی
 زینب علیئی
 ساجده علی محمدی
 خاتون کریمی
            دکتر علی اصغر کرامتی نیا
    دکتر گوهر محمدی
 راحله مرادپور
 محمد مرادی جو
 فرهاد مشفق
 دکتر الهه نوشین فر
 اجرایی اعضاي کمیته  
 (به ترتیب حروف الفبا):
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 با تشکر از :
 
 وزارت محترم بهداشت درمان و آموزش پزشکی 
 دفتر تهران – سازمان بهداشت جهانی 
 APFNU  دفتر صندوق جمعیت ملل متحد در ایران 
 وزارت محترم امور خارجه جمهوری اسلامی ایران 
 ست محترم دانشگاه علوم پزشکی شهید بهشتیریا 
 معاونت محترم پژوهشی دانشگاه علوم پزشکی شهید بهشتی 
 معاونت محترم آموزشی دانشگاه علوم پزشکی شهید بهشتی 
 کلیه انجمنهای علمی و سازمانهای مردم نهاد مرتبط با سرطان پستان 
 کی شهید بهشتیالملل و امور سمینارهای دانشگاه علوم پزشدفتر روابط  بین 
 دفتر آموزش مداوم  دانشگاه علوم پزشکی شهید بهشتی 
 حراست محترم دانشگاه علوم پزشکی شهید بهشتی 
 واحد محترم سمعی بصری دانشگاه علوم پزشکی شهید بهشتی 
 امور تدارکات دانشگاه علوم پزشکی شهید بهشتی 
 اندا را همراهی نمودههای دارویی و تجهیزاتی که در این کنگره مکلیه نهادها و شرکت 
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 1313ماه  اسفند 6-8
 
 
 
 ن پستانالمللی سرطادهمین کنگره بین
 نشست اول 3139اسفند ماه  2چهارشنبه  روز اول :
 دهمین کنگره بین المللی سرطان پستان  (سالن اصلی)
کد 
 سخنرانی
 سخنران عنوان سخنرانی ساعت
 سرود جمهوری اسلامی و تلاوت قران مجید ::05-8:05 
 دکتر حمید رضا میرزایی (دبیر همایش)افتتاحیه  8:05-::05 
 افتتاحیه ::05-::05 
رئیس مرکز تحقیقات  ،(استاد دانشگاه
 سرطان و رئیس کنگره)
 دکتر محمد اسماعیل اکبری
 افتتاحیه ::05-::05 
 (رئیس دانشگاه علوم پزشکی شهید بهشتی)
 دکتر علی اصغر پیوندی
 ::05-::05 
 افتتاحیه 
 (وزیر بهداشت، درمان و آموزش پزشکی)
 دکتر حسن قاضی زاده هاشمی
 داشت درمان و آموزش پزشکی)(وزیر به
 دکتر ایرج حریرچی
 قائم مقام وزیر بهداشت درمان و آموزش پزشکی)(
وضعیت سرطان پستان در شرق  ::05-::00 10-1O
 مدیترانه
 دکتر گری لوییس
 )نماینده سازمان ملل درایران(
 دکتر سیاوش صحت ، دکتر منوچهر دوایی، دکتر علی اکبر عامری،  هیأت رئیسه:
 ر جلال جلال شکوهی،دکتر علی عبدالهیدکت
 ::00-::00 20-1O
 recnac  tsaerb fo tcepsA
 ni noitneverp dna gnineercs
 eporuE
 دکتر فیلیپ دیویس
  naeporuE lareneG rotceriD(
 recnaC lacivreC& tsaerB
 )noitaicossA
 spiT lacitcarP : seispoiB tsaerB ::00-::00 30-1O
 seisrevortnoC dna
 هدیه ساغری دکتر
 آمریکا)–(رادیولوژیست 
 ::00-::0:: 40-1O
 sehcaorppa evisavni yllaminiM
 fo tnemtaert dna sisongaid ni
 recnaC tsaerB
 دکتر محمد رضا کشتگر
 انگلستان) -(جراح
 
 ::0::- ::0:: 50-1O
 evitciderp/citsongorp raluceloM
 a :recnac tsaerb ni srotcaf
 weiver lacitirc
 دکترفرید معین فر
 اتریش)-(پاتولوژیست
 سرطان پستان چاقی و ::0::-::0:: 60-1O
 دکتر سیدحسین داودی
 ایران)-(تغذیه
 namO ni recnac tsaerB ::0::-::0:: 70-1O
 عجمیدکتر عدیل ال
 عمان)-(جراح
 hgih ni ygetarts   tnemeganaM ::0::-::0:: 80-1O
 recnaC tsaerb rof tneitap ksir
 دکتر مهران حبیبی
 آمریکا)-(جراح
 استراحت ::0::-::0::
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 نشست دوم 3139اسفند ماه  2چهارشنبه   روز اول :
 دهمین کنگره بین المللی سرطان پستان  (سالن اصلی)
کد 
 سخنرانی
 سخنران عنوان سخنرانی ساعت
 دکتر رامین موسوی،  ،دکتر سید رضا موسوی ،دکتر محمد رضا نیک شعارهیأت رئیسه : 
 دکتر محمد جعفر فروهش دکتر علیرضا شیرازی،
 ::0::-:80:: 10-2O
 dna ssentalf fo tnemssessA
 evitarepoartni fo yrtemmyS
 yb sdleif maeb yparehtoidar
 smlif 2-TBE cimorhc oidar
 دکتر سید ربیع مهدوی
 ایران)-(فیزیست
 :80::-::0:: 20-2O
 evitageN elpirT ni tnavujdaoeN
 recnac tsaerB
 دکترمارتین پیکارت
 بلژیک)-(مدیکال آنکولوژی
 -
 ::0::-::0::
 
 پانل: gnittes tnavujda oen ta allixA fo tnemeganaM
 دکترمحمد رضا کشتگر  گرداننده پانل:
 اعضاء پانل :
 دکترآسیه الفت بخش، دکتر جلالدین خوشنویس،جراح:
 فرزانه ابراهیمی فرد دکتر مهران حبیبی، دکتر
 دکتر محمد رضا قوام نصیری، رادیوتراپی آنکولوژی:
 دکتر حسین فودازی، دکتر مارتین پیکارت
 دکتر معصومه گیتیرادیولوژیست:
 دکتر ژاله محسنی فرپاتولوژیست:
 0دکتر سید قاسم رضیعیپزشکی هسته ای
 دکتر مهدی تبرائی هماتولوژی آنکولوژی:
 نهار ::0::-::0::
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 ن پستانالمللی سرطادهمین کنگره بین
 نشست سوم 3139اسفند ماه  2چهارشنبه   وز اول :ر
 المللی سرطان پستان (سالن اصلی)دهمین کنگره بین
 
کد 
 سخنرانی
 سخنران عنوان سخنرانی ساعت
 ::0::-8:0:: -
  TCB dna esaesid  ertnecitluM :etabeD
 ( رادیوتراپی آنکولوژی)پور دکتر امیر محمد عارفگرداننده:
دکتر مجید حیدری،  ،میرمالکعباس  دکتر دی،دکترژیان فرها جراح:
 دکتر محمد مظفر
 دکترپیمان حداد ، دکتر افشین رخشا رادیوتراپی آنکولوژی :
0 دکتر مجتبی قدیانی،دکتر حمید هماتولوژی آنکولوژی
 0 دکتر ناصر پارسا (آمریکا)ژنتیکعطاریان
 یی،دکتر علیرضا خلج،دکتر محمود شفاهی،دکتر علی سیفی،دکتر پرویز دریاهیات رئیسه: 
 دکتر حسن صدیق ،دکتر مهرداد بهلولی،دکتر مسعود وکیلی
 8:0::-8:08: 10-3O
 tsaerB eht fo dnuosartlU
  dna stnioP lacitcarP
 od ot tahW
 دکتر هدیه ساغری
 آمریکا)–(رادیولوژیست 
 8:08:-8:08: 20-3O
 dezilanosreP sdrawoT
 neg txen gnisu tnemtaert
 ralucelom dna gnicneuqes
  rof recnac tsaerb ni ygolohtap
 میکائیل هرمندکتر  
 )بلژیک_(مولکولار بایولوژی
 8:08:-8:08: 30-3O
 noitcaeR slleC recnaC tsaerB
 dna noitavratS mureS ot
 noitcirtseR dioretS
 
 دکتر مریم  نخجوانی
 ایران)-(داروساز
 8:08:-::00: 40-3O
 fo ecnatropmi ehT
 ni ygolocno laicosohcysp
 recnac retfa efil fo ytilauq
 پاترشیا فوبر
 )آمریکا-(روانپزشک 
 ::00:-::01: 50-3O
 پانل: غربالگری در سرطان پستان
 دکتر محمد اسماعیل اکبری گرداننده:
 دکترر محمرد رضرا واعر  مهردوی، دکترر ایررج حریرچری،  اعضاا:
زاده، ری مطلرق،دکتر مرریم خیرام دکتر فیلیپ دیویس، دکتر علی قنبر 
 دکتر شهپر حقیقت،  سودابه احمد زاده، دکتر مریم طباطبایی
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 نشست اول 3139اسفند ماه  2روز دوم : پنجشنبه 
 دهمین کنگره بین المللی سرطان پستان(سالن اصلی)
 
کد 
 سخنرانی
 سخنران عنوان سخنرانی ساعت
 تولیت،سید محسن  محمد ربیع هاشمی، دکتر  دکتر سید ،دکتر شهریار رحمانیهیات رئیسه : 
 دکتر احمد حاجیان، دکتر سعید الماسی، دکتر سپیده حاجیان، دکتر علیرضا ظهیرالدین،
 دکترمحمد مهدی ادیب سرشکی، دکتر جلاالدین شمس
 ::05-:805 10-4O
 evitisop ni  od ew dluohs  tahw
 ?edon  lenitnes
 دکتر مهران حبیبی
 )آمریکا_(جراح
 :805 -::00 30-4O
 ssol htiw epoc stneitap gnipleH
 eht gnicudortni--lortnoc fo
 enignE gnipoC
 پاتریشیا فوبر
 امریکا)-(روانپزشک
 ::00-::00 40-4O
 2REH-itna fo esu lamitpO
 tsaerb egats ylrae rof stnega
 recnac
 رویک هادیسدکتر کلا
 امریکا)–( مدیکال آنکولوژی 
 / yregruS citsalpocno tsaerB ::00-::00 50-4O
 .ecneirepxe sraey 52 ym
 دکتر ماریزیو ناوا
 ایتالیا)-(جراح
 ::00-::0:: 60-4O
 eht ni stneitap gnirewopmE
 rof ssecorp gnikam noisiced
 :yregruS recnaC tsaerB
 lairT naeporuE ERUTCIP
 دکتر محمد رضا کشتگر
 انگلستان)-(جراح
  پرسش و پاسخ ::0::-::0:: 70-4O
 استراحت ::0:: -::0::
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 ن پستانالمللی سرطادهمین کنگره بین
 نشست دوم 3139اسفند ماه  2روز دوم : پنجشنبه 
 دهمین کنگره بین المللی سرطان پستان(سالن اصلی)
کد 
 سخنرانی
 سخنران عنوان سخنرانی ساعت
 -
 ::0::-::0::
 
 ل:پان
 stneitap gnuoy ni gnitlusnoc ytilitreF dna ymotcetsaM/ evitavresnoc tsaerB
 دکتر محمد هادیزاده(جراح)گرداننده پانل:
 اعضاء پانل:
 0 دکتر خسرو ایازی، دکتر نسرین السادات علویجراح
شهرام یوسفی، دکتر احمد عامری، امیر دکتر رادیوتراپی آنکولوژی:
 دکتر گودرز مزدائی
 دکتر فاضل الهی هماتولوژی آنکولوژی:
 دیدکتر مهسا احپاتولوژیست:
 دکتر مریم نوریرادیولوژیست:
0دکتر مریم کاشانیان، دکترربابه طاهری پناه،  جراح زنان (ناباروری)
 دکتر افسانه محمد زاده
 دکتر  سانازطبرستانیژنتیک:
 دکتر رضا خدابخشی، دکتر منوچهر سرداری، دکتر سید مرتضی موسوی نائینی، هیات رئیسه:
 هدکتر علی واحدی،دکتر منصور جدلی زاد
 rof yparehtomehc evitaillaP ::0::-::0:: 10-5O
 CBNT
 دکتر کلارویک هادیس
 امریکا)–(مدیکال آنکولوژی 
 ::0::-::0:: 20-5O
 evitceffe hcihw yb ssecorp ehT
 smargorp gnineercs dezinagro
 seirtnuoc ni detnemelpmi eb nac
 esu yltnerruc yeht erehw
 evah ro gnineercs citsinutroppo
 ,lla ta gnineercs on
 دکتر فیلیپ دیویس
  naeporuE lareneG rotceriD(
 recnaC lacivreC& tsaerB
 )noitaicossA
 استراحت و نهار ::0::-::0::
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 : نشست سوم3139اسفند ماه  2روز دوم :پنجشنبه 
 المللی سرطان پستان(سالن اصلی)دهمین کنگره بین
کد 
 سخنرانی
 سخنران سخنرانی عنوان ساعت
 ::0::-8:0:: 
 recnaC tsaerB ni tnemtaert cimetsys fo noissimO :etabeD
 دکترمحمد هوشیاریگرداننده:
 دکتر سید حسن یحیی زاده ، دکتر پدرام فدوی  رادیوتراپی آنکولوژی :
 دکتر معصومه نجفی،دکتر عادل یزدان خواهجراح:
 ت، دکتر  فریبرز مکاریاندکتر جهانگیر راف هماتولوژی آنکولوژی :
 0دکتر علی حسامیپاتولوژیست
 8:0::-::08: 
 پانل :گراند راند رادیولوژی
 دکتر نسرین احمدی نژادگرداننده:
 اعضاء پانل :
 دکتر آزاده جولایی، دکتر فریدون سیرتی، دکتر مریم طباطبایی جراح:
هید 0دکتر مژگان کلانتری، دکتر مریم رحمانی، دکتر  نارادیولوژیست
 صدیقی، دکتر افسانه علی خاصی
 دکتر فاطمه همایی، دکتر ثریا سلمانیان رادیوتراپی آنکولوژی:
 دکترحمید رضا رضوانی،دکتر محمد جهانهماتولوژی آنکولوژی:
 دکتر آرش محمدی توفیق، دکتر فرشته کمانیهیات رئیسه: 
 yhpargommaM nortorhcnyS ::08:-::08: 10-6O
 دکتر مرتضی 
 طاهری صانعی
 ایران)-(رادیولوژیست
 ::08:-::00: 20-6O
 noitavonnI weN :gnigamI tsaerB D3
 
 دکتر هدیه ساغری
 آمریکا) -(رادیولوژی
 ::00:-::01: 
 پانل:مسائل روانشناختی در سرطان پستان
 دکتر محمد اسماعیل اکبری گرداننده:
 بوالهری، دکتر احمد علی نوربالا، دکتر جعفر روانپزشک: اعضاء پانل:
دکتر علی منتظری، دکتر طاهره کرمانی رنجبر، دکترسپیده امیدواری، 
 دکتر علی اکبر نجاتی صفا، دکتر پاتریشیا فوبیر 
 دکتر فرح لطفی کاشانی، دکتر شهرام وزیری روانشناس:
 دکتر عصمت السادات هاشمیجراح: 
 دکتر علی اخوتیان، دکتر فریبرز مکاریانهماتولوژی آنکولوژی: 
 دکتر رباب انبیایی ادیوتراپی آنکولوژی:ر
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8-6 دنفسا  هام3131 
 
 
 
نیب هرگنک نیمهداطرس یللملاناتسپ ن 
 هعمج : موس زور2  هام دنفسا9313 لوا تسشن 
)یلصا نلاس(ناتسپ ناطرس یللملا نیب هرگنک نیمهد 
نارنخس ینارنخس ناونع تعاس 
 دک
ینارنخس 
: هسیئر تایه  ،یدنویپ نسح رتکد،نیرفآراد نیسح رتکد ،یتعیرش دمحم رتکد 
کد ،یهاش مرخ یفطصم رتکدیساملا نیسح رتکد،یناهیک رهچونم رتیراختفا نویامه رتکد ، 
رتکد شویراد یسدنه 
تسیژولویدار(-)اکیرمآ 
Screening for breast cancer 
managements plan proposal for 
Iranian social security 
50::-50:: O7-01 
یزورون ریما رتکد Cost saving in Armed forces 
insurance Organization without 
Sacrificing the Quality of Care 
50::-50:: O7-02 
رایزوا سینا 
یژولوکنآ یپارتویدار(-)هیکرت 
The role of intraoperative 
radiotherapy in early stage breast 
cancer". 
50::-50:: O7-03 
نیپلاک نیماینب 
یژولوکنآ یپارتویدار(-)هیکرت 
Accelerated partial Hyper 
fractionated Radiotherapy in 
breast cancer 
00::-50:: 
O7-04 
یبابرا دیشرف رتکد 
یژولوکنآ یپارتویدار(-)ناریا 
chemotherapy for HER-2 
Positive MBC 
00::-00:: O7-05 
ربوف ایشیرتاپ 
کشزپناور(-)اکیرما 
Group therapy with cancer 
patients as an important aspect of 
psychosocial support 
00::-00:: 
O7-06 
ینیدجات زانیآ 
هیذغت(- )ناریا 
Periodic foods in association with 
plasma levels of IGF-1 and 
IGFBP-3 in breast cancer patients 
00::-00:: O7-07 
اوان ویزیرام رتکد 
حارج(-)ایلاتیا 
Conservative Mastectomies ::0::-00:: O7-08 
رادساپ اضریلعرتکد 
کیتنژ(-)ناریا 
Relation between smoking or 
narcotics abuse and the 
recurrence of breast cancer in 
patients referred to an oncology 
clinic in Mashhad 
 
::0::-::0:: O7-09 
تحارتسا ::0::-::0:: 
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 نشست دوم 3139اسفند ماه  2روز سوم : جمعه 
 کنگره بین المللی سرطان پستان(سالن اصلی)دهمین 
 ساعت عنوان سخنرانی سخنران
کد 
 سخنرانی
 recnac tsaerB ni TROI fo elor ehTپانل:
 دکتر ناهید نفیسی گرداننده:
 اعضاءپانل:
دکتر مرتضی عطری،دکتر منصوره جراح:
 اخگری،دکترمحمدرضامیر،دکتر عبدالرسول طالعی
 تربتی، دکتر محمد هاشمی دکتر پیمان محمدپاتولوژیست:
 دکتر ترانه فقیهی لنگرودی رادیولوژیست:
 زادهدکتر مونا ملک دکتر احمد مصلایی،رادیوتراپی آنکولوژی:
 0دکترمهستی عموییپزشکی هسته ای
 دکتر نعمت اله رستمی،دکتر صفا نجفی هماتولوژی آنکولوژی:
 ::0::-::0::
 
 -
 سید ربیع مهدوی،دکتر جعفر اکبری،  دکتر خسرو مجیر شیبانی،دکترهیات رئیسه:
 دکتر ماندانا ابراهیمی
 دکتر فرید معین فر
 اتریش)-(پاتولوژیست
 noitceser fo stnemssessA
 gnivresnoc-tsaerb ni snigram
  yregrus
 10-8O ::0::-8:0::
 دکتر ماریزیو ناوا
 ایتالیا)-(جراح
 dna noitcurtsnoceR
 yparehtoidar
 20-8O 8:0::-::0::
 :etabeD
 جراحی پستان در سرطان پستان با متاستازهای همزمان
 دکتر ابوالفضل افشارفرد(جراح)گرداننده:
 دکتر فاطمه توکلی، دکتر محمد رضا کلانتر معتمدی،جراح: 
دکتر بهزاد رحمانی،دکتر ماندانا معتمدی، دکتراحمدکاویانی، 
 دکتر مصطفی حسینی 
 نه صانعی، دکتر مستارادیوتراپی آنکولوژی : 
 دکتر فرناز آموزگار هاشمی
 0دکتر فاطمه اصفهانی،دکتر علی مقدمهماتولوژی آنکولوژی
 دکترمریم کدیورپاتولوژیست: 
 - ::0::-::0::
  اختتامیه
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Day 1: Wednesday, 25 Feb 2015 
 
Speech 
code 
Time Title speaker 
O1-01 
8:00-8:05 National Anthem & Recitation of Holy Quran 
8:05-8:10 
Opening Remarks 
(Director of Congress) 
Dr.H.R.Mirzaei 
8:10-8:20 
Opening Remarks 
(president of congress) 
Dr.M.E.Akbari 
8:20-8:30 
Opening Remarks 
(chancellor of SBMU) 
D.A.A.Paivandi 
8:30-8:50 
Opening Remarks(Minister of  
Health and Medical 
Education) 
Dr.H.Ghazi zadeh 
hashemi 
Dr.Iraj Harirchi 
8:50-9:00 
Situation of Breast Cancer in 
the Eastern Mediterranean 
Dr. Gary Lewis 
 (UN) 
Chairmen: 
Dr.Siavash Sehat, Dr.M. Davaei, Dr.A. Ameri, Dr.J. Jala Shokohi,Dr.A.Abdolahi 
O1-02 9:00-9:20 
Aspect of breast  cancer 
screening and prevention in 
Europe 
Dr.F.Davis 
(Director General 
European Cervical 
CancerAssociation) 
O1-03 9:20-9:40 
Breast Biopsies : Practical 
Tips and Controversies  
 
Dr.H.Saghari 
(Radiologist-USA) 
O1-04 9:40-10:00 
Minimally invasive 
approaches in diagnosis and 
treatment of Breast Cancer 
Dr.M.R.Keshtgar 
(surgeon - UK) 
O1-05 10:00-10:10 
Molecular 
prognostic/predictive factors 
in breast cancer: a critical 
review  
Dr.F. Moinfar 
(Pathologist-
Austria) 
O1-06 10:10-10:20 
Obesity and Breast Cancer 
 
Dr.S.H.Davoodi 
(Nutritionist-Iran) 
O1-07 10:20-10:30 Breast cancer in Oman 
Dr.A.Alajami 
(surgeon-Oman) 
O1-08 10:30-11:00 
Management  strategy in high 
risk patient for breast Cancer 
Dr.M.Habibi 
(surgeon-USA) 
11:00-11:30 Break and Snak 
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Day 1: Wednesday, 25 Feb 2015 
 
Speech 
code 
Time Title speaker 
Chairmen: 
Dr.M.R.Nikshoar, Dr.S.R.Mosavi , Dr.R.Mosavi,Dr.A.R.Shirazi, Dr.M.J.Forohesh 
 
O2-01 11:30-11:50 
Assessment of flatness and 
Symmetry of intraoperative 
radiotherapy beam fields by radio 
chromic EBT-2 films 
 
Dr.S.R.Mahdavi 
(physisisit-iran) 
O2-02 11:50-12:10 
Neoadjuvant in Triple Negative 
Breast  Cancer 
 Dr.M Piccart 
( Medical Oncology- 
Belgium) 
- 12:30-13:30 
Panel discussion: Management of Axilla at neo 
adjuvant Setting. 
 Director: Dr.M.R.Kheshtgar 
Members: 
 Surgeon:Dr.J.Khoshnevis,Dr.Olfatbakhsh,Dr.M.Habibi, 
Dr.F.Ebrahimifard 
Radiation Oncologist: 
Dr.M.R.Ghavamnasiry,Dr.H.Fodazi, Dr.M Piccart 
Radiologist: Dr.M.Giti 
Nuclear Medicine: Dr.S.Gh.Raziei 
Pathologist: Dr.J.Mohsenifar 
Hematologist Oncologist: Dr.M.Tabaraei 
13:30-14:30 Lunch and Break 
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Day 1: Wednesday, 25 Feb 2015 
 
 
Speech 
code 
Time Title speaker 
 
 
 
- 
 
14:30-14:45 
Debate: Multicentric  disease and BCT 
Director: Dr.A.M.Arefpour 
Surgeon: Dr.J.Farhadi,Dr.A,Mirmalek,Dr.M.heidari, 
Dr.M.Mozafar 
Radiation Oncologist: Dr.A.Rakhasha, Dr.p.Hadad 
Hematologist Oncologist:Dr.M.Ghadyani,Dr.H.Atarian  
Genetics:Dr.N.Parsa (USA) 
Chairmen: 
Dr.M.Shafahi, 
Dr.A.Seifi,Dr.P.Daryaei,Dr.A.Khalaj,Dr.M.Bohloli,Dr.M.Vakili,Dr.H.Sedighi 
O3-01 
14:45-15:05 
Ultrasound of the Breast 
Practical Points and What to 
do 
Dr.H.Saghari 
( Radiologist- USA) 
O3-02 
15:05-15:25 
Towards Personalized 
treatment using next gen 
sequencing and molecular 
pathology in breast cancer  
Dr.M. Herman 
(molecular biology- 
Belgium) 
O3-03 
15:25-15:45 
Breast Cancer Cells Reaction 
to Serum Starvation and 
Steroid Restriction 
Dr.M.Nakhjavani 
(Pharmacist-Iran) 
O3-04 
15:45-16:00 
The importance of 
psychosocial oncology in 
quality of life after cancer 
Dr.P.Fobair 
(Psychiatrics-USA) 
 
 
 
 
O3-05 
16:00-17:00 
Panel discussion: Screening for Breast Cancer 
Director:Dr.M.E.Akbari 
Members: 
 Dr.M.R.Vaezmahdavi,Dr.I.Harirchi,Dr.Ph.Davis, 
Dr.A.Ghanbari Motlagh, Dr.M.Khayamzadeh, 
Dr.SH.Haghighat, 
S.Ahmadzadeh- Dr.M.Tabatabaei 
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Day 2: Thursday 26 Feb 2015 
 
  
Speech 
code 
Time Title speaker 
Chairmen: 
Dr.SH.Rahmani, Dr.S.M.R.Hashemi,Dr.S.M.Toliat, Dr.A.Hajian, 
Dr.A.R.Zahirodin, Dr.S.Almasi, Dr.S.Hajian, Dr.M.M.A.Sereshki,Dr.J.Shams 
O4-01 8:30-8:50 
what  should we do   in positive 
sentinel  node? 
 
Dr.M.Habibi 
(Surgeon-USA) 
O4-02 8:50-9:00 
Helping patients cope with loss 
of control--introducing the 
Coping Engine 
 
Dr.P.Fobair 
(Psychiatrics-USA) 
O4-03 9:00-9:20 
 
Optimal use of anti-HER2 
agents for early stage breast 
cancer 
 
Dr.C.Hudis 
( Medical Oncology 
-USA) 
O4-04 9:20-9:40 
Breast oncoplastic Surgery / my 
25 years experience. 
Dr.M.Nava 
(Surgeon-Italy) 
O4-05 9:40-10:00 
Empowering patients in the 
decision making process for 
Breast Cancer Surgery: 
PICTURE European Trial 
Dr.M.R.Keshtgar 
( Surgeon –UK) 
 
O4-06 10:00-10:20 Questions and Answers 
 
10:20-11:00 Break and Snak 
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Speech 
code 
Time Title speaker 
 
11:00-12:00 
 
Panel discussion: Breast conservative /Mastectomy 
and Fertility consulting in young patients 
Director:M.Hadizadeh (surgeon) 
Members: 
surgeon:Dr.Kh.Ayazi,Dr. Dr.N.S.Alavi 
Radiation Oncologist:Dr.A.Sh.yusefi, 
Dr.A.Ameri.Dr.G.Mazdaei 
Hematologist Oncologist:Dr.F.Elahi 
Pathologist:Dr.M.Ahadi 
Radiologist:Dr.M.Noori 
Female surgeon (Infertility):Dr.M.Kashanian, 
Dr.R.Taheripanah, Dr.A.Mohamdzadeh 
Genetics: Dr.S.Tabarestani 
Chairmen: 
Dr.R.khodabakhshi, Dr.M.Sardari, Dr.S.M.Mosavinaeini,Dr.A.Vahedi, 
Dr.M.Jadalizadeh 
O5-01 12:00-12:20 
Palliative chemotherapy 
for TNBC 
Dr.C.Hudis 
(Medical Oncology -USA) 
O5-02 12:20-12:40 
The process by which 
effective organised 
screening programs can 
be implemented in 
countries where they 
currently use 
opportunistic screening 
or have no screening at 
all 
Dr.F.Davis 
(Director General 
European Cervical 
CancerAssociation) 
12:40-13:30 Lunch and Break 
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Speech 
code 
Time Title speaker 
 
 
 
- 
 
 
 
13:30-14:15 
 Debate: Omission of systemic treatment in 
Breast Cance                    
Director:Dr.M.Hoshyari 
Surgeon:Dr.M.Najafi,Dr.A.Yazdankhah 
Radiation Oncologist: Dr.S.H.Yahyazadeh, 
Dr.F.Mokarian 
Hematologist Oncologist: Dr.J.Rafat, 
Dr.F.Mokarian 
Pathologist:Dr.A.Hesami 
- 14:15-15:30 
Panel discussion: Radiology Grand Rounds 
Director: Dr.N.Ahmadunejad 
Members: 
Surgeon: Dr.A.Jolaei,Dr.F.Seirati,Dr.M.Tabatabaei 
Radiologist:Dr.M.Kalantari, Dr.M.Rahmani, 
Dr.N.Sedighi, Dr.A.Aikhasi 
Radiation 
Oncologist:Dr.F.Homaei,Dr.S.Salmanian 
Hematologist Oncologist: Dr.H.R.Rezvani, 
Dr.M.Jahani 
Chairmen: Dr.A.Mohamadi Tofigh, Dr.F.Kamani 
O6-01 
15:30-15:40 
Synchrotron 
Mammography 
Dr.M.Saneietaheri 
(Radiologis-Iran) 
O6-02 
15:40-16:00 
3D Breast Imaging: New 
Innovation 
 
Dr.Saghari 
(Radiation-USA) 
 
 
 
 
 
 
 
 
 
16:00-17:30 
Panel discussion: Psychological issues in breast 
cancer 
Director: Dr.M.E.Akbari 
Members: 
Psychiatrist:Dr.A.Nourbala, Dr.J.Bolhari, 
Dr.A.Montazeri,  
Dr.S.Omidvari,Dr.A.A.Nejatisafa,Dr.P.Fobair, 
Dr.T.Kermaniranjabar 
 Psychologist :Dr.F.Lotfi Kashani,Dr.Sh.Vaziri 
Surgeon:Dr.E.S.Hashemi 
Radiation Oncologist:Dr.R.Anbiaei  
Hematologist Oncologist: 
Dr.A.Okhovatian,Dr.F.Mokarian 
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Day 3: Friday 27 Feb 2015 
 
speaker Title Time 
Speech 
code 
Chairmen: 
Dr.M.S.hariati, Dr.H.Darafarin, Dr.H.Peyvandi, Dr.M.Khoramshahi, 
Dr.M.Keyhani, Dr.H.Almasi, Dr.H.Eftekhari 
Dr.D.Hendesi 
(Radiologist-USA) 
Screening for breast cancer 
managements plan proposal 
for Iranian social security 
8:00-8:10 
O7-01 
Dr.A.Norozi 
Cost saving in Armed 
forces insurance 
Organization without 
Sacrificing the Quality of 
Care 
8:10-8:20 
O7-02 
Dr.E. Ozyar 
(Radiation 
Oncologi- Turkey) 
The role of intraoperative 
radiotherapy in early stage 
breast cancer 
8:20-8:40 
O7-03 
Dr.B. kalpln  
(Radiation 
Oncologi- Turkey) 
Accelerated partial Hyper 
fractionated Radiotherapy 
in breast cancer 
8:40-9:00 O7-04 
Dr.F.Arbabi 
(Radiation 
Oncologi-Iran) 
chemotherapy for HER-2 
Positive MBC 
9:00-9:10 
O7-05 
Dr.P.Fobair 
(Psychiatrics-USA) 
Group therapy with cancer 
patients as an important 
aspect of psychosocial 
support 
9:10-9:30 
O7-06 
Dr.A.Tagedini 
(Nutritionist-Iran) 
Periodic foods in 
association with plasma 
levels of IGF-1 and IGFBP-
3 in breast cancer 
9:30-9:40 
O7-07 
Dr.M.Nava 
(surgeon-Italy) 
Conservative Mastectomies 9:40-9:10 
O7_08 
Dr.A.R.Pasdar 
(Genetics-Iran) 
Relation between smoking 
or narcotics abuse and the 
recurrence of breast cancer 
in patients referred to an 
oncology clinic in Mashhad 
10:00-10:10 
 
 O7_09 
Break and Snak 10:10-10:30  
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Day 3: Friday 27 Feb 2015 
 
peaker Title Time 
Speech 
code 
Panel discussion: The role of IORT in Breast 
cancer 
Director: Dr.N.Nafisi 
Members: 
Surgeon: Dr.M.Atri, Dr.M.Akhgari, Dr.M.R.Mir, 
Dr.A.R.Talei 
Pathologist: Dr.P.Mohamadtorbati, Dr.M.Hashemi 
Radiologist: Dr.T.Habibi Langrodi  
Radiation Oncologist: Dr.A.Mosalaei, 
Dr.M.Malekzadeh 
Nuclear Medicine:Dr.M.Amouei 
Hematologist Oncologist: 
Dr.N.Rostami,Dr.S.Najafi 
10:30-11:30 
 
- 
Chairmen: 
Dr.Kh.M.Sheibani, Dr.S.R.Madavi, Dr.J.Akbari, Dr.M.Ebrahimi 
Dr.F.Moinfar 
(Pathologist- 
Austria) 
Assessments of resection 
margins in breast-conserving 
surgery 
11:30-11:45 O8-01 
Dr.M.Nava 
(surgeon-Italy) 
Reconstruction and 
radiotherapy 11:45-12:00 O8-02 
Debate: Breast surgery in metastatic breast 
cancer with concurrent 
Director: Dr.A.Afsharfard,  
Members: 
Agrement: Dr.M.Hoseini(surgeon), 
Dr.M.Sanei(Radiation Oncologist) 
Disagrement:Dr.A.Kaviani(surgeon),Dr.F.Amozega
r Hashemi( Radiation Oncologist ) 
Surgeon: Dr.M.R.Kalantar Motamed, Dr.F.Tvakoli, 
Dr.B.Rahmani. Dr.M.Motamedi, Dr.M.Hoseini, 
Dr.A.Kaviani 
Radiation Oncologist: Dr.M.Sanei 
Hematologist 
Oncologist:Dr.F.Esfahani,Dr.A.Moghadam 
Pathologist: Dr.M.Kadivar 
12:00-13:00  
Closing 
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 هنازور همانربRapid Oral Presentation 
 هبنشجنپ : مود زور7 مدنفسا ها3131 
 رتکد ـ یرایشوه دمحم رتکد : هسیئر تأیهیدسا یدهم 
تعاس دک ناونع هدنهد هئارا 
50::- 50::  R2-01 
5 years study of patients with 
lactating adenoma and review of 
the literature 
شخب تفلا هیسآ 
50:0- 50::  R2-02 
Study Prevalence of BRCA1/2 
Common Mutations in East 
Azerbaijan Province, Iranian Breast 
Cancer Patients Using High 
Resolution DNA Melting Analysis 
لصا زپ هروک اویش 
50:0 – 50:0  R2-03 
Developmental competence of 
immature oocytes aspirated from 
antral follicles of ovarian cortex as 
a method for fertility preservation 
نایفاص هتشرف 
50:: – 50:0  R2-04 
Health-Promoting Lifestyle in 
Breast Cancer Survivors: In 
Relation to Depression and Social 
Support 
یزیربت مدقم همطاف 
50:8 – 50::  R2-05 
Correlation of Abortion with the 
Risk of Recurrence and Tumor Size 
in Breast Cancer Patients 
رادساپ اضریلع 
50:5 – 50:8  R2-06 Yoga management of breast cancer-
related lymph edema 
یدیشمج هدنخرف 
50:: – 50:5  R2-07 
Evaluation the Relationship 
Between Serum Levels of 
Malondialdehyde and Breast 
Cancer Risk in Women 
یرگنک اسیرپ 
50:: – 50:: R2-08 
Association study of rs1219648 in 
FGFR2 and rs1042522 in TP53 
with premenopausal breast cancer 
in an Iranian Azeri population 
نایتداعس ارهز 
50:1 – 50:: R2-09 
The effects of hydro alcoholic 
extract of sage (Salvia officinalis 
L.) leaves on cultured mouse breast 
cancer cells 
مدقم یزورهب اراس 
50:: – 50:1  R2-10 
Breast Cancer During Pregnancy 
Can Be Treated as in No pregnant 
Women 
زاسبوچ هتشرف 
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تعاس دک ناونع هدنهد هئارا 
50:: – 50::  R2-11 
Protective impacts of Ziziphus 
Jujube on biochemical and 
hematological factors in NMU-
induced breast cancer in rats 
ققحم هلا حیبذ 
50:0 – 50::  R2-12 
Study of epidemiology of Breast 
Cancer in Maragheh, Iran (2007-
2012) 
ناگداز نیسح نسح 
50:0 – 50:0  R2-13 
Health-Related Quality of Life and 
its related factors among women 
with breast cancer 
هداز نسح دیجم 
50:: -  50:0  R2-14 CK19 expression in the peripheral 
blood of breast cancer patients 
یمیرک نیرسن 
50:8 – 50::  R2-15 
Comparative evaluation of lung 
absorbed dose in different methods 
of radiotherapy after mastectomy 
یریش 
50:5 – 50:8  R2-16 Can Breast Cancer Survival by Risk 
Factors? Machine Learning Models 
یرظتنم ارتیم 
508: – 50:5  R2-17 
Early Detection of Breast Cancer: a 
Study on the Breast Blood 
Variability by the Breast Phantom 
Accompanied by Vessels 
شاتریت یرفعج هدئام 
508: – 508:  R2-18 
Effect of Combine Decongestive 
Therapy and the quality of life in 
breast cancer patients  after 
mastectomy 
یردیح هیضرم 
5081 – 508:  R2-19 
Effect of crab shell extract on the 
viability and morphology of breast 
cancer cells in vitro 
یناخاضر 
00:: – 5081  R2-20 
Effect of Patient_ Care giver 
Education program On Cancer 
Related Self- Efficacy in Breast 
Cancer Patients. 
داژن یکچوک ارهز 
00::- 00::  R2-21 
Eligible women's knowledge about 
the importance of breast self-
examination and education in 
Tabriz health centers in 93 
یراصنا 
00:0 – 00::  R2-22 
Evaluation of the relationship 
between axillary lymph nodes 
involvement 
and Ki67 over expression in Breast 
cancer patients 
ثلاثدیهش هبادوس 
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تعاس دک ناونع هدنهد هئارا 
00:0 – 00:0  R2-23 Dose history of induced abortion 
increases the risk of breast cancer? 
یفاعم شونرف 
00:: – 00:0  R2-24 
Evaluation of the expression of mir-
21 oncomir, new diagnostic and 
prognostic molecular marker in 
tissue and blood of breast cancer 
patients 
روپ نامیلس ههلا 
00:8 – 00::  R2-25 
Designing   and Cloning of 
cytolethal distending toxin B as 
Biological Tool against cancer 
یبوقعی رجاه 
00:5 – 00:8  R2-26 
A New Mathematical Dynamics 
Model to Decipher Cancerous Cell 
Invasion in Breast Cancer Using 
Partial Differential Equations 
یرداق یفطصم 
00:: – 00:5  R2-27 Folate; friendly or enemy nutrient یوسوم اسیرپ هدیسنا  
00:: – 00::  R2-28 
An Investigation into the 
Epidemiological Trend of Breast 
Cancer in the World, particularly in 
Iran 
یدنوارگ مظعا 
00:1 – 00::  R2-29 Homocysteine and Breast Cancer یئاجلم رقابدمحم 
00:: – 00:1  R2-30 
Properties of TGFαL3-SEB fusion 
protein as a ligand targeted 
superantigen in breast tumor-
bearing mice following intravenous 
or intratumoral injection 
یفسوی غورف 
00:: – 00::  R2-31 
Knowledge, attitude and practice of 
female students of Maragheh 
faculty of medical sciences on 
breast cancer 
هبعکرئاز ریما 
00:0 – 00::  R2-32 
The investigation of amount of 
awareness, attitude, and 
performance of women over 20 
years old with a positive breast 
cancer in family history in Markazi 
province 
یخیاشم ایدان 
00:0 – 00:0  R2-33 
The Investigation of Health Belief 
Model in Early Diagnosis of Breast 
Cancer in Patient's families in Arak 
Province 
داژن نسحم اتیزآ 
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تعاس دک ناونع هدنهد هئارا 
00:: – 00:0  R2-34 
Effect of 6 months aerobic training 
on plasma leptin levels as a breast 
cancer risk factor in 
postmenopausal women 
یورسخ میسن 
00:8 – 00::  R2-35 
Design and Characterization of a 
Peptide-Based Nanocarrier, MPG-
H1-iRGD, for Gene Delivery to 
Breast Cancer Cells. 
روپیلع نسحم 
00:5 – 00:8  R2-36 Physical Activity and Breast Cancer 
Prevention 
 داوفعیدوجس  
008: – 00:5  R2-37 
Pregnant women' knowledge, 
attitudes and perceptions towards 
breast cancer prevention: a 
questionnaire study in Besaat 
hospital in Sanandaj 
ییایرکز امس هدیس 
008: – 008:  R2-38 
Using docking procedure and 
molecular dynamic simulation to 
design peptides, drived from 
Herceptin 
ناقهد همجن 
0081 – 008:  R2-39 
Study of Reaction in the Biological 
Components of Breast Exposed to 
Light Source Near-Infrared 
Wavelength 
شاتریت یرفعج هدئام 
::0:: – 0081  R2-40 ncRNA ROR is a good way to 
detect Breast Cancer 
بحاص اضری  
::0:: – ::0::  R2-41 
Evaluation of serum Ischemia 
modified albumin( IMA) levels in 
breast cancer patients 
هداز هلادبع هیمس 
::0:0 – ::0::  R2-42 
The Effect of Breast Feeding and 
Breast Cancer Incidence in Women 
wit Breast Cancer 
یلناضمر هیمس 
::0:0 – 0::0:  R2-43 
The Effect of Training Quality of 
Life and Coping Strategies on 
Functional Scale of Quality of Life 
in Women with Breast Cancer 
یلناضمر هیمس 
::0:: – ::0:0  R2-44 
The Impact of Education on 
Symptomatic Scale of Quality of 
Life in Women with Breast Cancer 
 
 
یلناضمر هیمس 
  
 
32 
8-6 دنفسا  هام3131 
 
 
 
نیب هرگنک نیمهداطرس یللملاناتسپ ن 
تعاس دک ناونع هدنهد هئارا 
::0:8 – ::0::  R2-45 
Uniformity of dose distribution in 
target volume in radiotherapy 
techniques for breast after 
Mastectomy 
یریش 
::0:5 – ::0:8  R2-46 Yoga and psychological health of 
breast cancer 
ینابرق مظعا 
::0:: – ::0:5  R2-47 
Knowledge, attitude and practice 
about breast cancer screening 
among students of Tehran 
University of Medical Sciences,  
in 2010 
لکوت بنیز 
::0:: – ::0::  R2-48 The roles of ω 3-fatty acid in breast 
cancer protection 
یوسوم اسیرپ هدیسنا  
::0:1 – ::0::  R2-49 
Predicting  the  survival  in  breast  
cancer  using  Hidden  Markov  
Model 
هداز یددم نازرف 
::0:: – ::0:1  R2-50 
Bioinformatics analysis of potential 
role of miR-520f in patients with 
breast carcinoma 
تاکشم هیضرم 
::0:: – ::0::  R2-51 
Association between SHBG gene 
polymorphism (rs 5790) and breast 
cancer susceptibility 
درف یبسامهط ارهز 
::0:0 – ::0::  R2-52 
Association of Breast Cancer Risk 
with a Common Functional 
Polymorphisms of fas 1377 and fas 
ligand 844. 
درف یبسامهط ارهز 
::0:0 – ::0:0  R2-53 
Expansion and characterization of 
breast cancer stem cells for the 
development of BCSC targeting 
therapeutic strategies 
 ناقهد هیمس
یناتسهوک 
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 هنازور همانربRapid Oral Presentation 
 زورموس  : هعمج8  هامدنفسا3131 
یودف ماردپ رتکد ـ یزادوف نیسح رتکد : هسیئر تأیه 
تعاس دک ناونع هدنهد هئارا 
::0:: – ::0::  R3-01 
Evaluation of sonographic and 
mammographic appearances of invasive 
lobularcarcinoma in breast cancer 
research center since 1380 to 1392 
نایتشهب متکت 
::0:0 – ::0::  R3-02 
Epidemiological review of the situation 
of Breast cancer that have been 
registered in pathologic labs Under 
coverage Iran University of Medical 
Sciences (IUMS) from 2011- 2013 
هلمک تسود عیطم اتیر 
::0:0 – ::0:0  R3-03 
Evaluation of benzoxaloyl coumarins 
induced cell death in MDA-MB-231 
Triple negative breast cancer cell line 
ینمیا هدیحو 
::0:: – ::0:0  R3-04 
The association between Vitamin D 
status and risk of breast cancer: a case-
control study 
ینیئان یدیشمج 
::0:8 – ::0::  R3-05 
The effectiveness digital 
mammography compared to the analog 
mammography for breast cancer 
diagnostic and screening: systematic 
review 
یدرکز تاداساتیب 
::0:5 – ::0:8  R3-06 
New methods of treatment for breast 
cancer 
نایاش وزرآ 
::08: – ::0:5  R3-07 
Effectiveness of Group Training Based 
on Acceptance and Commitment 
Therapy on Anxiety and Depression of 
Women with Breast Cancer 
وج یدارم دمحم 
::08: – ::08: R3-08 
Heavy Metals Contamination of Milk 
and Dairy Products and Risk of Cancers 
یدواد نیسح دیس 
::081 – ::08: R3-09 
The Six family of homeobox genes and 
related mechanisms in diseases 
یدمص رصان 
::0:: – ::081  R3-10 
The effects of vitamin C administration 
on conventional treatment in patients 
with breast cancer: A review 
یناوضر ادن 
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 1313ماه  اسفند 6-8
 
 
 
 ن پستانالمللی سرطادهمین کنگره بین
 ارائه دهنده عنوان کد ساعت
 11-3R  ::0:: – ::0::
اثربخشی آموزش گروهی ذهن آگاهی و درمان 
مبتنی بر پذیرش و تعهد بر افزایش کیفیت 
 زنان مبتلا به سرطان پستان زندگی
 
 محمد مرادی جو
 21-3R  ::0:: – 0:0::
رفتاری _بررسی اثربخشی درمان شناختی 
ی کش بر بهبود مرحله 5مبتنی بر الگویی 
شناختی زنان مبتلابه تصویر تن و بهزیستی روان
 سرطان پستان
 بیتا باوادی
 31-3R  0:0:: – 0:0::
یری از خودمدیریتی در نوجوانان جهت پیشگ
 سرطان سینه
 فاطمه علایی کرهرودی
 مژگان انصاری به فرزندم درباره سرطان پستان چه بگویم؟ 41-3R  0:0:: – ::0::
 51-3R  ::0:: – 8:0::
تبیین ادراک بیماران مبتلا به سرطان پستان از 
 نیازهای مراقبتی بیماران
 طاهره سادات خوش نظر
 61-3R  8:0:: – 5:0::
ماری در زنان مبتلا به سرطان عدم قطعیت در بی
 پستان و عوامل مرتبط با آن
 موسی سجادی
 الهام ذنوبی ها در سرطان پستان ANRim نقش 71-3R  5:0:: – ::0::
 81-3R  ::0:: – ::0::
 no sPNuA gnitcejni fo tceffE
 tsooBuccA fo ecnamrofrep
 htiw stneitap ni metsys yparehtyhcarb
 etnoM gnisu recnac tsaerb egats-ylrae
 dohtem olraC
 اکبر سرابی اصل
 91-3R  ::0:: – 1:0::
 hrnG htiW peelS nairavO fO eloR
 roF yparehtomehC gniruD sgolanA
 tneitaP gnuoY nI noitavreserP ytilitreF
 tsaerB htiW )sraeY 04 oT pU(
 datsO nI stneitaP 45 fO ydutS(recnaC
 nI cinilC eruO dnA latipsoH basanilA
 )zirbaT
  یعلی کرم هدایتی گودرز
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 هبنشراهچ : لوا زور6  هامدنفسا3131 تعاس ،8:88   تیاغل38:18 
رتسوپ دک ناونع هدنهد هئارا 
P1-01 Effect of patient education on breast cancer وت نیهشیدیح  
P1-02 
The Evaluation of the Educational Plan of Breast 
Self-Examination of Women Referring to Health 
Centers 
مرهج رگراک هیضرم 
P1-03 
Sexuality in women with breast cancer after 
treatment 
دار ینایک امیس 
P1-04 Spiritual Health in Breast Cancer وت نیهشیدیح  
P1-05 
Treatment of hot flashes in women with breast 
cancer 
دار ینایکامیس 
P1-06 
Supportive Care During Treatment of Breast Cancer 
Patients 
مرهج رگراک هیضرم 
P1-07 
Deregulation of microRNA in metastatic breast 
cancer as biomarkers and therapeutic targets 
یتاجن ماهرپ 
P1-08 A new strategy against cancer cells دسا یربنق یلع 
P1-09 Aptamer and breast cancer روپدمحم هثیدح 
P1-10 
Investigation of association between miR-152 
polymorphism with breast cancer in Isfahan 
population 
یناماس هرطق ارهز 
P1-11 
Impact of psychological intervention on stress and 
depression in breast cancer patients 
یلوروپ هیضرم 
P1-12 
Differential Diagnosis of Breast Cancers Using 
Texture Analysis of Magnetic Resonance Imaging 
یملسم لضفلاوبا 
P1-13 Adjuvant Endocrine Therapy and Breast Cancer عراز نینبلا ما 
P1-14 
Evaluation of Shoulder Girdle Strength after 
Modified Radical Mastectomy and Comparison with 
Healthy Participants 
نایکچوکآ هیدهم 
P1-15 
Dendrosomal Nano-Curcumin is inducing apoptosis 
in MCF-7 and T47D breast cancer cell lines via 
down-regulating survivin expression 
یزیخ حبص فراع 
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نیب هرگنک نیمهداطرس یللملاناتسپ ن 
رتسوپ دک ناونع هدنهد هئارا 
P1-16 
Arsenic Trioxide increases paclitaxel-induced 
apoptosis in resistant 
breast cancer cells 
شیاشخب یباقع هبیط 
P1-17 
Targeted Therapy in Triple Negative Breast Cancer 
(TNBC): A Case Series 
داص سیردایق  
P1-18 
Different Presentation of Treatment in Carcinomatous 
Meningitis of Breast Cancer: Report of 3 Cases 
یقداص سیردا 
P1-19 
The association between triple negative breast cancer 
with hormonal and reproductive factors 
شخب تفلا هیسآ 
P1-20 
Assessing the Psychological effect of breast cancer 
on the patients’ quality of life 
یچتروص هفطاع 
P1-21 
Association of Ki67 expression and CK19 detection 
in breast cancer patients 
یمیرک نیرسن 
P1-22 
Knowledge and awareness about breast cancer among 
Zabol medical students 
یزگرس هیلاع 
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اهرتسوپ هنازور همانرب 
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 هبنشراهچ : لوا زور6  هامدنفسا3131 تعاس ،33:88   تیاغل30:88 
رتسوپ دک ناونع هدنهد هئارا 
P2-01 
Effectiveness of cognitive-therapy, stress 
management intervention on anxiety, depression and 
quality of life in women with breast cancer 
یشلاگ انیم 
P2-02 
Barriers to Perform BSE of the Viewpoint of Women 
Nurses Working in Hospitals Asadabad City of 
Hamadan in 2014 
یدمحم ابیز 
P2-03 
Black tea and coffee consumption and breast cancer 
risk, new controversy 
یئاجلم رقابدمحم 
P2-04 
In-silico analysis of rs1836724 and its related 
microRNAs in breast cancer 
یرقاب همطاف 
P2-05 Breast Cancer In Pregnancy(Areview Article) یردیح میرم 
P2-06 
Regulation of expression and/or activity of voltage-
gated sodium channels; a therapeutic target in 
metastatic breast cancer 
ینایاضر هتسیاش 
P2-07 
A pathologic study on breast biopsy in Zabol medical 
university of sciences hospital in 2014 
یزگرس اضریلع 
P2-08 Breast Cancer یدمتعم نارهم 
P2-09 
Clinical utility of positron emission mammography 
for breast cancer screening 
ییایرکز ناملسدیس 
P2-10 
Combination Therapy of siRNA and Chemotherapy 
in Breast Cancer 
یئازخ مساق 
P2-11 
Comparative quantification of target gene expression 
in Breast cancer cells by Real-time PCR method 
ناملس مظعا 
P2-12 
Comparison of Clinicopathologcal Characteristics in 
Metastatic Breast Cancer Patients: At Initial 
Presentation and in the Follow up Time 
 تاداسلا تمصع
یمشاه 
P2-13 
Comparison of cytokeratin19 expression in various 
human breast cancer cell lines 
 یناویک هدیعس
یرصمق 
P2-14 
Study of the expression of apoptotic BAX and Bcl-2 
genes in breast cancer cells treated with dendrosomal 
nanocurcumin 
یرفعج ادن 
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رتسوپ دک ناونع هدنهد هئارا 
P2-15 
Coping Strategies Used in Women with Breast 
Cancer 
یمسیلناضمر ه  
P2-16 
Effect of  hydro alcohlic extract of Citrullus 
colocynthis fruit on caspase 3 gene expression in 
MCF-7 breast cancer cell line 
یداباهب هداز لیعامسا 
P2-17 
Detection of CK19 Marker in the MCF7 and T47D 
Cell Lines by Immunofluorescence Microscopy 
افرع ارهز 
P2-18 
Determining pattern of metastasis and prognostic 
factors in breast cancer using conditional regression 
model (PWP) 
 یراتخم اسیرپ
یراصح 
P2-19 Review on the role of EBV in breast cancer induction ناگداز نیسح نسح 
P2-20 
Effect of hydro alcoholic extract of Nigella sativa on 
Caspase3 gene expression in MCF7 cell line 
ینیئان یرهاظم اتهم 
P2-21 
Evaluation of the relationship between axillary lymph 
nodes involvement and Ki67 over expression in 
Breast cancer patients 
ثلاث دیهش هبادوس 
P2-22 
Comparison of IL-25 and IL-17B in Apoptosis and 
Proliferation induction of breast cancer cell lines 
یهلارکش هیدهم 
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 زورمود  : هبنش جنپ7  هامدنفسا3131  تعاس ،88:88   تیاغل38:18 
رتسوپ دک ناونع د هئاراهدنه  
P3-01 
Development of Novel Molecular Drug 
Candidates Using Molecular Docking 
Techniques in the Context of Breast Cancer 
ناسراف یلضاف هنامسی  
P3-02 
Molecular signaling pathway analysis of 
miR-155 targetome to decipher various 
molecular functions of miR-155 in breast 
cancer with respect to prevalence of vaginal 
candidiasis in patients 
روپ مظاک انیم 
P3-03 
Evaluation of Focal magnification View in the 
assessment of mammographic abnormalities in 
Breast Cancer Research Center 
شخب تفلا هیسآ 
P3-04 
Green tea can be a protection factor for breast 
cancer 
نایوسوم اسیرپ هدیس 
P3-05 Anti-oxidation of Green tea and breast cancer ینابرق مظعا 
P3-06 
Impact of Diet on Breast Cancer Risk: A 
Review study 
یدزیا همیظع 
P3-07 In Vitro Fertilization and Cancer Risk ینبلا ماعراز ن  
P3-08 
Association of Breast Cancer and its Therapy 
with Candida Infection 
یلیقع دیعس دیس 
P3-09 
Knowledge, attitude and practice of female 
students of Maragheh faculty of medical 
sciences on breast cancer 
ناگداز نیسح نسح 
P3-10 
Knowledge and women who are qualified to 
carry out the CBE Clinical breast Examination 
( in Tabriz health centers in 2014) 
راصنا 
P3-11 
Induction of Apoptosis in Human Breast 
Cancer MCF-7 Cell Line by Artesunate 
هدازلامج لایل 
P3-12 Life style and Breast Cancer عراز نینبلا ما 
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نیب هرگنک نیمهداطرس یللملاناتسپ ن 
رتسوپ دک ناونع د هئاراهدنه  
P3-13 
A Quick Review of Long Noncoding RNAs: 
A new paradigm in breast cancer pathogenesis, 
diagnosis, and therapy 
یلام اراس 
P3-14 
Enhances the Effects of Chemotherapeutic 
Agents in Human Breast Cancer Cells with 
Downregulation of XIAP Expression by RNAi 
هداز یلقاقآ یدهم 
P3-15 
Mediterranean Diet; Best Dietary Guideline to 
Fighting Breast cancer 
یئاجلم رقابدمحم 
P3-16 
The role of Peer support on quality of life of 
women with breast cancer 
ینموم میرم 
P3-17 
Estrogen Receptor-α A→G Mutation and the 
Breast Cancer Risk 
یسابع هنیکس 
P3-18 
The association between pancreatic function 
and 
genetic markers of obesity in breast cancer 
هاوخ کین دولوم 
P3-19 
Bioinformatics analysis of potential role of 
miR-662 in breast cancer patients: inhibition of 
cytokine-cytokine receptor pathway 
یحایر نرتسن 
P3-20 
Nuclear Medicine breast imaging: Current 
status and future directions 
ییایرکز ناملس دیس 
P3-21 
Knowledge, attitudes, beliefs and practices of 
the Iranians about cancer: a systematic review 
of the previous studies 
ون نسحمیزور  
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 زورمود  : هبنش جنپ7  هامدنفسا3131  تعاس ،33:88   تیاغل30:88 
رتسوپ دک ناونع هدنهد هئارا 
P4-01 
Performance and attitude towards breast cancer in 
women over 18 years in the city of Shiraz, 1392 
نایاش وزرآ 
P4-02 Quality of life in women with  breast cancer یفجن هتشرف 
P4-03 
Results of Breast Cancer Screening tests in Behbood 
Hospital in Tabriz 
ئافش یتحص همیهفی  
P4-04 
Comparison and Evaluation of Synthesis of Risk 
Factors in Breast Cancer and Provide a Model for 
Determine the Likelihood of Developing Breast 
Cancer Using byEM Algorithm in Data Mining 
Techniques 
قافتا نایسامح یدهم 
P4-05 
In-silico analysis of hsa-mir-196a targetome 
pathway and its SNP function in patients with breast 
cancer: potential association between T allele and 
the risk of metastasis 
ینایک اریمس 
P4-06 Screening and early detection of breast cancer هداز یلعحتف لایهس 
P4-07 
Sexual functioning after mastectomy surgery- A 
qualitative study 
ناینیما هجاوخ هیمهف 
P4-08 
Bioinformatics analysis of functional SNP (A→G) at 
miR-499 in patients with breast cancer: G allele is 
probable poor prognostic factor 
هدازریبک دازرهش 
P4-09 
Silibinin Causes Upregulation of PTEN as One of 
the Cell Cycle Progression Blocker in MCF-7 
Human Breast Cancer Cell Line 
زورفا ناهج هرهز 
P4-10 
Review of Computer-aided detection of breast 
cancer on mammograms 
رگ هضرع زورفا 
P4-11 
An Overview of Breast Cancer Prediction in Early 
Stage with Analyses of Mammographic 
Images Using by Data mining Techniques and 
provide a Novel Solution in Screening 
قافتا نایسامح یدهم 
P4-12 
Investigation of the time and the site of metastases in 
patients with triple negative breast cancer and other 
phenotypes 
دنره یلضفت اده 
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رتسوپ دک ناونع هدنهد هئارا 
P4-13 
Vitamin D and Breast Cancer, Is there any 
association? 
سایوسوم اسیرپ هدین  
P4-14 
Vitamin D Receptor (VDR) gene polymorphism is a 
risk for breast cancer 
یئاجلم رقابدمحم 
P4-15 Walnut and Breast Cancer عراز نیبلا ما 
P4-16 New methods of treatment for breast cancer نایاش وزرآ 
P4-17 
Knowledge, attitude and practice of menopause 
women towards breast cancer 
یدرکهد یسیئر ابیز 
P4-18 
in-silico analysis of hsa-mir-146a targetome pathway 
and its SNP function in patients with breast cancer: 
probable association between alleles and prognosis 
تاکشم هبوبحم 
P4-19 
A comparison of body image and public health 
among breast cancer patients with breast evacuation, 
breast keeping and normal people in Tehran 
 یرایدنفسا ارهز
دیبلاود 
P4-20 
Predicting  the  survival  in  breast  cancer  using  
Hidden  Markov  Model 
هداز یددم نازرف 
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 زورموس  : هعمج8  هامدنفسا3131  تعاس ،88:88   تیاغل38:18 
رتسوپ دک ناونع هدنهد هئارا 
P5-01 
Breast Carcinoma Stages Diagnosis by Expression 
of breast Cancer-Specific Gene1 
یللاه یامنهر انوم 
P5-02 
The Impact of Intraoperative Radiation Therapy in 
the Breast Cancer 
یئابطابط زانرف 
P5-03 
Sunlight exposure, vitamin D, and the prevention of 
breast cancer 
شابلزق امیس 
P5-04 
Psychological interventions and pain control in 
breast cancer patients 
بلزق امیسشا  
P5-05 
Quercetin decrease leptin gene expression in breast 
cancer 
درف یمیحر میرم 
P5-06 
Molecular Mechanisms of Melatonin anti cancer 
activity in breast cancer 
رف نیشون ههلا 
P5-07 Breast Cancer and Spiritual Health 
 یدابع نیریش مظعا
یناهارف 
P5-08 
Stability and thermodynamic investigation of 
embryonic stem cell marker Sox2 in breast cancer 
stem cells by spectroscopic and modeling 
techniques 
درگارحص مظعا 
P5-09 
Breast cancer screening barriers from women’s 
perspective: a systematic review in qualitative 
studies and critical appraisal 
ییولرغصا اخیلز 
P5-10 
The effects of vitamin C administration on 
conventional treatment in patients with breast 
cancer: A review 
یناوضر ادن 
P5-11 
Eligible patients for intraoperative radiotherapy 
(IORT) of early breast cancer: A cohort analysis 
 یفسوی مارهش ریما
یشاک 
P5-12 
Adjuvant radiotherapy of regional lymph nodes in 
breast cancer - a meta-analysis  of randomized trials 
 یفسوی مارهش ریما
یشاک 
P5-13 
Radiation Therapy for Locally Recurrent Breast 
Cancer 
شاک یفسوی مارهش ریمای  
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رتسوپ دک ناونع هدنهد هئارا 
P5-14 
The role of Axillary Dissection for Breast Cancer in 
Old women; A Meta-analysis of Randomized 
Clinical Trials 
 یفسوی مارهش ریما
یشاک 
P5-15 Futures of Breast Cancer in Iran رف نیشون ههلا 
P5-16 
Breast cancer with Acrometastasis Of hands, two 
case reports from Ostad Alinasab Hospital in 
Tabriz(north west of Iran). 
 یتیاده مرک یلع
یزردوگ 
P5-17 
Management of breast cancer during pregnancy and   
review of 23 treated cases in our clinic and Ostad 
alinasab hospital in tabriz (north west of IRAN) . 
 مرک یلع یتیاده
یزردوگ 
P5-18 
Evaluation of statins induced cell death in MDA-
MB-231 triple negative breast cancer cell line 
 یناتسهوک لایهس
ناهربوم 
P5-19 
Molecular Mechanisms of Melatonin anti cancer 
activity in breast cancer 
رف نیشون ههلا 
P5-20 
Comparison of clinicopathologic appearance and 
5years survival of breast cancer in young    
(less than 40years )  and  less young (40-50 years) 
women in  Ostad Aalinasab  Hospital in north west 
of IRAN (TABRIZ ) . 
 یتیاده مرک یلع
یزردوگ 
P5-21 
Evaluation of Silibinin Toxicity on Breast Cancer 
Cell line MCF-7 
یناقرف میسن 
P5-22 
Exercise interventions for patients with breast 
cancer related lymphedema 
ققحم مارهش 
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ناتسپ ناطرس یللملا نیب هرگنک نیمهد 
 زورموس  : هعمج8  هامدنفسا3131  تعاس ،33:88   تیاغل30:88 
رتسوپ دک ناونع هدنهد هئارا 
P6-01 
Induction of apoptosis in human breast cancer cells 
by Britannin, a sesquiterpene lactone from Inula 
aucheriana 
نایحلاف کنارف 
P6-02 
Effect of injecting AuNPs on performance of 
AccuBoost brachytherapy system in patients with 
early-stage breast cancer using Monte Carlo 
method 
لصا یبارس ربکا 
P6-03 Impact of nutrition on breast cancer incidence یرهاط لایل 
P6-04 
Comparison of MRI and Pathologic Findings in 
Patients with Breast Complaints 
شیاب اراس 
P6-05 
Evaluation of anti-cancer activity of new COX-2 
inhibitors in an invivo model of breast Cancer 
بصن یراشفا وهآ 
P6-06 
The role of prolactin and growth hormone in breast 
cancer 
ینیسح هدیعس 
P6-07 
Application of Functional Proteomic in the 
Diagnosis and Treatment of Breast Cancers 
روپدارم هلحار 
P6-08 
Determining pattern of metastasis and prognostic 
factors in breast cancer using conditional regression 
model (PWP) 
یراصح یراتخم اسیرپ 
P6-09 
Sexual functioning after mastectomy surgery- A 
qualitative study 
ناینیما هجاوخ همیهف 
P6-10 ناتسپ ناطرس رطخ و یهام فرصم طابترا یسررب تمکح هجیدخ 
P6-11 
 لسکات یلکاپ ییوراد سکلپمک درکلمع یسررب- لپی نلیتا
لولس گرم رد لوکیلاگسپ ناطرس یامونیسراکوندآ یاهنات  
یدیمح نارهم 
P6-12 تسپ ناطرس اب یراگزاس و هلباقم یاهراکهار دنم ماظن رورمنا  نایجاح هدیپس 
P6-13 سپ ناطرس هب لاتبم نانز رد هحناس زا سپ دشر و تیونعمنات  یبارت هزئاف 
P6-14 ناتسپ ناطرس و تیونعم تشرس کین همطاف 
P6-15 
لاتبم دارفا یگدنز تیفیک یاقترارب یونعم تملاس ایآ هب 
؟دراد ریثات ناتسپ ناطرس 
داژن یدابع ارهز 
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8-6 دنفسا  هام3131 
 
 
 
نیب هرگنک نیمهداطرس یللملاناتسپ ن 
رتسوپ دک ناونع هدنهد هئارا 
P6-16 
بم ناوج نانز یارب لزنم رد یراتسرپ تبقارمطرس هب لات نا
ک شیازفا رد یراتسرپ رثوم یژتارتسا ناونع هب ناتسپ تیفی
هداوناخ و رامیب یگدنز 
نبیس یعیمس همطافی  
P6-17 
Breast Cancer Survivor’s Experiences: A 
Qualitative Study 
یزیربت مدقم همطاف 
P6-18 Futures of Breast Cancer in Iran یوقت نوسفا 
P6-19 
The relationship between involved side and 
recurrence and metastasis of breast cancer in 
patients referred to a private oncologic clinic in 
Mashhad 
رادساپ اضریلع 
P6-20 
Histopathologic Characteristics of Breast Cancer in 
Patients Treated in a Private Oncologic Clinic in 
Mashhad 
رادساپ اضریلع 
P6-21 
Evaluating the effect of Femara and Tamoxifen on 
serum lipids in early postmenopausal breast cancer 
patients. 
یهلادبع یلع 
P6-22 
Perceived social support evaluation in breast cancer 
patients: a case-control study 
ادبع یلعیهل  
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 المللی سرطان پستانبرنامه روزانه دهمین کنگره بین
 
 
 1313ماه  اسفند 6-8
 
 هابرنامه ارائه کارگاه
 )TROIعنوان :رادیوتراپی حین عمل (
 مسئول کارگاه : دکتر محمد هادیزاده
 81:83لغایت  81:63 – 13/13/78تاریخ و زمان برگزاری : 
 
 ***
 
 سمینار مراقبت های پرستاری در بیماران مبتلا به کانسر پستان
 
 علوم پزشکی شهید بهشتی  مرکز تحقیقات سرطان دانشگاه برگزار کنندگان:
 دانشکده پرستاری و مامایی دانشگاه علوم پزشکی شهید بهشتی   : با همکاری
 8:/::تا  5؛ :0::اسفندماه  5 زمان:
 دانشکده پزشکی دانشگاه علوم پزشکی شهید بهشتی مکان:
 شرود ترین نوع سرطان در زنان در کشورهای صنعتی محسروب مری کانسر پستان، شایع معرفی: 
های سرطان و به تبع آن افزایش میزان بقرای ناشری های پزشکی و توسعه درمانعلیرغم پیشرفت
از سرطان، بیماران مبتلا هم چنان از طیف وسیعی از علایم و عوارض جانبی مربوط به بیمراری و 
 تراثیر های مربوط به آن، در ابعاد جسمی، معنوی، روانی و اجتماعی رنج می برند که سربب درمان
  شود ها میآن یزندگر رتیفیبرر ک یمنفر
باشرد، آشرنایی ایرن با توجه به این که بخش اعظم مراقبت از بیماران مبتلا بر عهده پرستاران می
های مرسوم و مبانی مراقبت از بیماران مبرتلا بره کانسرر پسرتان بره منظرور ارایره گروه با درمان
گیری از پیامدهای منفی بیماری و ارتقای کیفیت های پرستاری با کیفیت به بیماران، پیشمراقبت
 شود ها، یک ضرورت تلقی میزندگی بیماران و خانواده آن
 
 اهداف جزئی: 
 فراگیران پس از پایان دوره قادر خواهند بود0
های اولیه از بیماری را که به ترازگی اپیدمیولوژی کانسر پستان را توضیح داده و مراقبت  :
 گذاشته شده، شرح دهند  تشخیص بیماری برای او
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 1313ماه  اسفند 6-8
 
 
 
 ن پستانالمللی سرطادهمین کنگره بین
های معمول درمانی در کانسر پستان را نام برده و ضمن توضیح توجهرات ضرروری رژیم  :
 های پرستاری مرتبط با آن بحث کنند در هنگام بکارگیری این داروها، درباره مراقبت
 ضرورت استفاده از پورت و نقاط قوت و ضعف بکارگیری آن در بیماران را شرح دهند   :
ص رادیوتراپی در بیماران مبتلا به کانسر پستان و مردیریت عروارض آن اظهرار در خصو  :
 نظر نمایند 
تررین اصول مدیریت علایم در بیماران مبتلا به کانسر پستان را نام برده و دربراره شرایع   8
 علایمی که در بیماران  مبتلا نیاز به توجهات پرستاری دارد، بحث کنند  
مراقبت های حمایتی و تسکینی و لزوم آشنایی پرسرتاران  تعریف، مبانی و ضرورت ارایه  0
 با این مبانی را توضیح دهند 
 سخنرانی، پرسش و پاسخ روش برگزاری:
پرستاران و به ویژه، پرستاران شاغل در بخش های انکولوژی، هماتولوژی و پیوند مغرز  مخاطبین:
 استخوان
  
 
 32
 
 
 المللی سرطان پستانبرنامه روزانه دهمین کنگره بین
 
 
 1313ماه  اسفند 6-8
 
 عنوان : همایش پرستاری
 سولی مسئول کارگاه : دکتر مریم ر
 13لغایت  81:8– 13/13/88تاریخ و زمان برگزاری : 
 سخنران موضوع برنامه ساعت
 - تلاوت آیاتی چند از قرآن کریم و سرود جمهوری اسلامی ::05-8:05
 - خیر مقدم 8:05-::00
 دکتر محمد هادیزاده اپیدمیولوژی کانسر پستان ::00-::00
 ازقندیدکتر سمیرا  اصول شیمی درمانی ::00-8:00
 دکتر اربابی رژیم های درمانی و طبقه بندی داروها در کانسر پستان 8:00-8800
 خانم پروین پیغمبرلو مراقبت های پرستاری در بکارگیری داروهای شایع 8800-8:0::
 8:0::-8:0::
 مدیریت عوارض شیمی درمانی
 صیادی نیا
 خانم مهیندخت
 
 - استراحت و پذیرایی 8:0::-::0::
 پانل پورت و مراقبت از آن ::0::-::0::
 دکتر مجید صمصامی
 خانم لیلا صابونچی
 خانم انسیه فتح اله زاده 
 خانم بهناز حبیب پناه
 دکتر کامبیز نوین اصول رادیوتراپی در کانسر پستان ::0::-::0::
 خانم شبنم جودکی مراقبت های پرستاری در رادیوتراپی ::0::-::0::
 
 
 
 
 
 
  
 
 22
 1313ماه  اسفند 6-8
 
 
 
 ن پستانالمللی سرطادهمین کنگره بین
  9ان عمومی عنوان : پزشک
 مسئول کارگاه : دکتر فرشید اربابی
 83لغایت  63 – 13/13/68تاریخ و زمان برگزاری : 
 تخصص سخنران عنوان سخنرانی ساعت
 کلینیکال انکولوژیست دکتر نوین چهره سرطان در دنیا و ایران ::00: – ::00:
تشخیص اولیه سرطان پستان در زنان بدون  ::00: – ::00:
 علامت
 رادیولوژیست هادیزاده دکتر
آنچه پزشک عمومی باید از رادیولوژی  ::00: – ::01:
 پستان بداند
 رادیولوژیست دکتر ایمانی
جراح فلوشیب جراحی  دکتر نفیسی نقش پزشکان عمومی در برخورد اولیه ::01: – ::01:
 پستان
 انکولوژیستکلینیکال  دکتر مقدم سرطان پستان چگونه درمان می شود؟ ::01: – ::05:
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 المللی سرطان پستانبرنامه روزانه دهمین کنگره بین
 
 
 1313ماه  اسفند 6-8
 
 5عنوان : پزشکان عمومی 
 مسئول کارگاه : دکتر فرشید اربابی
 83لغایت  63 – 13/13/78تاریخ و زمان برگزاری : 
 ساعت عنوان سخنرانی  سخنران تخصص
 دکتر طاهری پناه کلینیکال انکولوژیست
 چرا شیمی درمانی 
 (اندیکاسیون ها و عوارض)
 ::00: – ::00:
 ::00: – :800: اصول و روشهای رادیوتراپی دکتر مریم میرزایی ژیستکلینیکال انکولو
 :800: – 8:01: هورمون درمانی دکتر ازقندی کلینیکال انکولوژیست
 دکتر مافی کلینیکال انکولوژیست
نقش پزشک عمومی در پی گیری 
 سرطان پستان، سهل و ممتنع
 8:01: – 8:01:
 8:01: – 8:01: خورد با نجات یافتگان سرطانبر دکتر ملک زاده کلینیکال انکولوژیست
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 ن پستانالمللی سرطادهمین کنگره بین
 عنوان : تغذیه
 مسئول کارگاه: دکتر سید حسین داودی 
 81:13لغایت  81:33 – 13/13/68تاریخ و زمان برگزاری : 
 ساعت عنوان سخنرانی سخنران تخصص 
 تغذیه
 دکتر سید حسین داوودی
 دکتر مرجان عجمی
تازه های تغذیه از پیشگیری تا کنترل 
 سرطان پستان
 ::0:: – :80::
 دکتر مرجان عجمی تغذیه
ها ها و فتوکیمیکالبررسی نقش ریز مغذی
 در پیشگیری از سرطان پستان
 :80:: -::0::
 دکتر حمید پازوکی طرودی تغذیه
 مکانیسم اپیژنیک پلی فنول ها، 
 های رژیم غذایی در پلی فنول
 پیشگیری از سرطان
 ::0:: -::0::
 سید حسین داوودیدکتر  تغذیه
 
 ::0:: – :80:: ای در بیماران سرطانیمراقبت تغذیه
 :80:: – ::08: شیر مادر و سرطان پستان مهندس رقیه شهبازی -
 مهندس سعیده اسماعیلی -
ارتباط باقیمانده فلزات سنگین در مواد 
 راهکارها)-غذایی با سرطان پستان (اثرات
 ::08: – ::08:
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 المللی سرطان پستانبرنامه روزانه دهمین کنگره بین
 
 
 1313ماه  اسفند 6-8
 
 ازی سینهعنوان :جراحی بازس
 دکتر ماریزیو ناوا -مسئولین کارگاه : دکتر ناهید نفیسی 
 81:83لغایت  8 – 13/13/88تاریخ و زمان برگزاری : 
 
 تخصص سخنران عنوان سخنرانی
 tsaerb a tahW ro tsaerB desaB tnalpmI
 a ot timmoC ot sah yregruS tnemecnahne
 gninrael gniogno sraey 52 ym /4102 ni tneitaP
 evruc
 جراح دکتر ماریزیوناوا
 جراح دکتر ناهید نفیسی palF MART
 جراح دکتر سهیلا صیاد noitcurtsnocer rof palF isroD  sumsitta
 citsalpocno ni ypareht tnemecalper eussiT
 yregrus
 جراح دکتر محمد هادیزاده
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 ن پستانالمللی سرطادهمین کنگره بین
 عنوان :جراحی آنکوپلاستی
 دکتر ماریزیو ناوا -ید نفیسی مسئولین کارگاه : دکتر ناه
 81:63لغایت  03 – 13/13/78تاریخ و زمان برگزاری : 
 
 عنوان سخنرانی سخنران تخصص
 yspoiB edoN lenitneS دکتر مجید صمصامی جراح
 yregrus citsalpocno ni epyt noisicnI دکتر علی عبدالهی جراح
 دکتر پریسا عظیمی نژاد جراح
 ymotcetsam laitrap fo noitacifissalC
 noitpo tnemtaert & tcefed
 ymotcetsam gniraps CAN دکتر ماریزیوناوا جراح
 دکتر ناهید نفیسی جراح
 gnicuder nikS suoenatucbuS
 etaidemmi ymotcetsam
 noitcurtsnocer
 ymotcetsaM & TCB ni refsnart taF دکتر هاشمیان جراح
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 المللی سرطان پستانبرنامه روزانه دهمین کنگره بین
 
 
 1313ماه  اسفند 6-8
 
 عنوان : رادیو تراپی 
 دکتر پرستو حاجیان –ندگان : دکتر گودرز مزدایی گردان
 3 لغایت 33 – 13/13/78تاریخ و زمان برگزاری : 
 ساعت  عنوان سخنرانی  سخنران تخصص
 htiw TR tsaerB .L آقای دکتر گودرز مزدایی رادیوتراپی انکولوژی
 ot esod gniziminim
 traeh eht
 ::00 – ::0::
 ::0:: – ::0:: تر پرستو حاجیانخانم دک رادیوتراپی انکولوژی
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 ن پستانالمللی سرطادهمین کنگره بین
 عنوان : رادیولوژی
 : دکتر مژگان کلانتری ـ دکتر آزاده جولایی  مسئولین کارگاه
 3لغایت  8ـ   13/13/78تاریخ و زمان برگزاری : 
 تخصص  سخنران عنوان سخنرانی  ساعت
 sdariB weN 8830- 8:30
 دکتر مژگان کلانتری
 دکتر آزاده جولایی
 رادیولوژی
 جراحی عمومی
 IRM tsaerB 8:30 – 8830
 دکتر پرتو حسنی زاده
 دکتر مریم نوری
 رادیو لوژی
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نیب هرگنک نیمهد هنازور همانربناتسپ ناطرس یللملا 
 
 
8-6 دنفسا  هام3131 
 
Workshops program 
 
 8-10 10-12 2-4 
93/12/6 
Supportive-
expressive group 
therapy   
Supportive-
expressive group 
therapy 
Existential therapy 
in cancer 
SPEAKERS 
DR.PATRICIA 
FOBAIR 
DR.PATRICIA 
FOBAIR 
DR.BAHMAN 
BAHMANI 
93/12/7   
Grief therapy in 
cancer 
SPEAKERS   
DR.TAHEREH 
KERMANY 
RANJBAR 
93/12/8 
Sexual rehabilitation 
in breast cancer 
Breaking bad news  
SPEAKERS 
DR.MARYAM 
ALAMDAR 
DR.ARVIN 
HEDAYATI 
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 ن پستانالمللی سرطادهمین کنگره بین
 اه طب سنتی و مکمل جایگ عنوان :
 در کمک به درمان سرطان و افزایش کیفیت زندگی
 مسئول کارگاه: دکتر حسین رضایی زاده 
 81:83لغایت  81:13 – 13/13/68تاریخ و زمان برگزاری : 
 
 
 
 
 
 
 
 
 
 تخصص  سخنران عنوان سخنرانی ساعت
 – 88311
 8:381
 طب تلفیقی و سرطان
 )ygolocnO evitargetnI (
 
 زادهدکتر حسین رضایی 
 
 طب سنتی
 -8:311
 88311
 تغذیه در بیماران سرطانی از دیدگاه 
 طب ایرانی
 
 دکتر حسین رضایی زاده
 
-8:331
 8:311
تداخلات داروهای طبیعی و گیاهی با 
 شیمی درمانی
 
 دکتر طیبه طاهری پناه
 
 رادیو تراپی انکولوژی
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 المللی سرطان پستانبرنامه روزانه دهمین کنگره بین
 
 
 1313ماه  اسفند 6-8
 
 های جانبیبرنامه کارگاه
 سرطان پستان المللیدهمین کنگره بین
 (روز اول)
 1313/13/6 چهارشنبه 
 ردیف عنوان کارگاه گرداننده کارگاه ساعت کارگاه مکان کارگاه
سالن امام علی (ع) 
 2کارگاه شماره
 ::00 – ::0::
 دکتر پاتریشیا فوبیرخانم 
 (روانپزشک از امریکا)
 روانشناسی در سرطان
 عنوان کارگاه0
 
 evisserpxe-evitroppuS
 puorg
 yparehT
 
 1
سالن امام علی (ع) 
 1کارگاه شماره
 ::0::-::0::
 جناب آقای دکتر رضایی زاده
 (متخصص طب سنتی)
 2 طب سنتی و سرطان
سالن امام علی (ع) 
 2کارگاه شماره
 ::0:: – ::0::
 خانم دکتر پاتریشیا فوبیر
 (روانپزشک از امریکا)
 روانشناسی در سرطان
 عنوان کارگاه0
 
 evisserpxe-evitroppuS
 puorg
 yparehT
 3
سالن امام علی (ع) 
 1کارگاه شماره
 :::::0::-8:
 
 داوودی آقای دکترسید حسین
 (متخصص تغذیه)
 4 تغذیه در سرطان
سالن امام علی (ع) 
 2کارگاه شماره
 ::0:: – ::00:
 آقای دکتر بهمن بهمنی
 (روانشناس و مشاور خانواده)
 
 روانشناسی در سرطان
 عنوان کارگاه0
 ni ypareht laitnetsixE
 recnac
 5
سالن امام علی (ع) 
 1کارگاه شماره
 ::00: – ::05:
 آقای دکتر اربابی
 )آنکولوژیست-رادیوتراپیست(
 6 کارگاه پزشکان عمومی
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 ن پستانالمللی سرطادهمین کنگره بین
 برنامه کارگاه های جانبی
 المللی سرطان پستاندهمین کنگره بین
 (روزدوم)
 1313/13/7 پنجشنبه
 ردیف عنوان کارگاه گرداننده کارگاه ساعت کارگاه مکان کارگاه
سالن امام علی (ع) 
 1کارگاه شماره
 larO dipaR سخنرانان 8830-10381
 noitatneserP
 1
سالن امام علی (ع) 
 3کارگاه شماره
 8830 – 8830
 دکتر مژگان کلانتری
 (رادیولوژیست)
 دکتر آزاده جولایی
 (جراح)
 کارگاه رادیولوژی
 عنوان کارگاه3
 sdariB weN
 
 6
سالن امام علی (ع) 
 1کارگاه شماره
 10381-883:1
 آقای علی قنبری مطلق
(ریاست محترم اداره سرطان 
 وزارت بهداشت)
 ni elbaT dnuoR
 recnaC tsaerB
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O1-02 
 
Implementation of 3D imaging with synthesized 2D 
images (C-View™) 
 
Dr saghari 
A brief overview of implementation of digital breast tomosynthesis in the screening setting will 
be presented.  
 
The aim of this review is to provide an overview of digital breast 
tomosynthesis in the screening population. The audience will learn how to 
identify and confidently diagnosis benign pathology on screening breast 
tomosynthesis without need for additional imaging. In addition they will be 
able to recognize suspicious and malignant features on screening breast 
tomosynthesis and learn how to tailor a more focal diagnostic workup based 
on tomosynthesis findings (e.g., additional mammographic imaging versus 
breast ultrasound).  
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O1-04 
Minimally Invasive Approaches in Diagnosis and Treatment 
of Breast Cancer 
 
Mohammed R S Keshtgar BSc, FRCSI, FRCS (Gen), PhD 
Professor of Cancer Surgery and Surgical Oncology university College London, Royal Free Hospital 
london, United Kingdom 
 
Breast cancer is the most common cancer in women worldwide.  We are 
getting better in diagosing and treating the disease using multi-modality 
treatment.   
In my presentation , I will highlight the latest advances in the minimally 
invasive techniques in diagnosis and treatment of breast cancer with empahsis 
on the research that is undergoing in my Institution.  These will include use of 
Breast PET, intra-operative diagnosis of sentinel node, intra-operative 
radiotherapy, intra-operative surgical margin determination and photodynamic 
therapy. 
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O1-06 
Obesity as an Important Risk Factor for Certain Types of 
Cancer (Such as Breast Cancer) 
 
Hossain Davoodi*1, Saeideh Esmaeili2, Roghayeh Shahbazi3,  
Talieh Malek-Shahabi4 
 
1-Department of Clinical Nutrition and Dietetics, National Nutrition and Food Technology Research 
Institute, Faculty of Nutrition Sciences, Food Science and Technology, Shahid Beheshti University of 
Medical Sciences, P.O. Box 19395-4741, Tehran, Iran 
2-Department of Food Technology Research, National Nutrition and Food Technology Research Institute, 
Faculty of Nutrition Sciences, Food Science and Technology, Shahid Beheshti University of Medical 
Sciences, P.O. Box 19395-4741, Tehran, Iran. 
3-Department of Nutrition, Boali Sina teaching Hospital, Qazvin University of Medical Sciences, Qazvin, 
Iran. 
4-Department of Molecular genetic, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 
 
Cancer is the uncontrolled and unrestricted growth of malignant cells in the 
body. It is a multifactorial disease which either heredity or environmental 
factors (such as nutrition, physical inactivity, alcohol, obesity, exposure to 
sun, environmental pollutants, infections) contribute to the incidence of 
cancer. In recent years, several lines of research have focused on obesity as a 
potent risk factor of cancer. Scientific evidence suggests obesity is associated 
with increased risk for a number of different types of cancer. The evidence is 
most consistent for endometrial cancer, breast cancer in postmenopausal 
women, and renal cell cancer. More contradictory results have been reported 
for colorectal, prostate, and pancreatic cancer. In despite of numerous studies 
in regard to the link between obesity and cancer, The molecular mechanisms 
in which obesity increase the risk of cancer have been poorly understood. In 
this article, the association between obesity and cancer risk and its underlying 
mechanisms are reviewed.  
Key words: Cancer, Obesity, Adipocyte, Adipokine, Leptin, Adiponectin, 
Signaling  
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O1-08 
There  have    been    more    controversies    about    the    management    of    
the    axilla    during    the    past    three 
 
Mehran Habibi 
 
years  than    ever    in    the    past.    
Management  of    the    axilla    in    breast    cancer    patients    has    evolved    from    routine    axi
llary    lymph    node    dissection    (ALND)    for    all    patients    to    a    highly    selective    approa
ch    based    on    the    assessment    of    the    sentinel    lymph    nodes    (SLNs)    as    well    as    tumor
    and    patient    characteristics.    Although    ALND    continues    to    have    an    important    rol
e    in    staging    and    regional    control    for    many    breast    cancer    patients,    recent    trial    res
ults    question    the    need    for    routine    ALND    in    patients    who    have    positive    SLNs.    A
pproximately    40    percent    of    patients    with    a    positive    sentinel    lymph    node    (SLN)    
will    be    found    to    have    residual    disease    in    the    axilla    
  Categorization  of    SLN    Metastases    
The  size    of    the    largest    tumor    deposit    is    used    in    classification    of    SLN    metastases 
Isolated  tumor    cells    (ITC)- 
-‐     Small    clusters    of    cells    not    greater    than    0.2    mm,    or    nonconfluent    or    nearly    conf
luent    clusters    of    cells    not    exceeding    200    cells    in    a    single    histologic    lymph    node    
cross    section.    ITCs    are    considered    prognostically    similar    to    node    negative    patie
nts.    Malignant    cells    in    regional    lymph    node(s)    no    greater    than    0.2    mm    are    desig
nated    as    pN0(i+).    Isolated    tumor    cells    are    not    considered    an    indication    for    furthe
r    axillary    surgery,    radiation    treatment,    or    adjuvant    systemic    therapy.       
    Micrometastases  -
-‐ A    separate    designation    of    pN1mi    (>0.2    mm    and    no    greater    than    2.0    mm)    to    indi
cate    micrometastases    alone.    Although    patients    with    micrometastases    are    conside
red    node    positive    and    it    seems    intuitive    that    the    finding    of    axillary    micrometasta
ses    should    worsen    prognosis,    most    studies    show    no    change    or    only    a    small    redu
ction    in    patient    survival    compared    with    those    without    micrometastases.    Howeve
r,    some    analyses    suggest    a    negative    impact    of    micrometastases    on    breast    cancer    
outcomes,    including    regional    recurrence    rate.    
    Macrometastases   
    The    2005    American    Society    of    Clinical    Oncology    (ASCO)    guidelines    and    2010  
  National    Comprehensive    Cancer    Network    (NCCN)    guidelines    recommend    that    
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routine    completion    ALND    be    carried    out    for    patients    with    SLND    macrometastas
es    (≥2    mm).    However,    the    indications    for    a    completion    ALND    in    patients    with    
<3    positive    sentinel    nodes    is    the    subject    of    controversy.    This    is    discussed    in    deta
il    below.       
Completion  axillary    dissection    with    BCT    
    The    need    for    completion    axillary    lymph    node    dissection    (ALND)    in    women    wit
h    clinically    node    negative    T1    or    T2    tumors    is    dependent    upon    the    SLND    finding
s.    The    indications    for    a    completion    axillary    dissection    are    evolving.    
There  is    general    acceptance    for    the    following    approaches:    
For  patients    with    a    negative    sentinel    lymph    node    biopsy    (SLND),    completion    A
LND    is    not    indicated.  
Patients  with    a    SLND    showing    isolated    tumor    cells    only    are    considered    node    ne
gative    for    prognostic  purposes    and    completion    ALND    is    not    indicated.    
For  patients    with    a    positive    SLND    showing    micrometastases    or    macrometastase
s    in    three    or    more    nodes,    detected    with    standard    hematoxylin    and    eosin    (H&E)  
  examination,    completion    ALND    is    recommended    for    staging    purposes    and    to    ensure 
.local  control.    The    timing    of    the    procedure    (ie,    immediate    [one    operation]    versu
s    delayed    [two    separate    operations])    does    not    seem    to    affect    the    total    lymph    nod
e    yield    or    the    rate  of    long-‐ term    complications    (particularly    lymphedema).    The    n
eed    for    a    completion    ALND    in    patients    with    a    positive    SLND    showing    microme
tastases    or    macrometastases    in    less    than    three    nodes    has    been    questioned.     
The    SLN    is    the    sole    tumor- ‐ bearing  node   in   up  to   60  percent  of    cases  overall,    and   
in   almost   90   percent  of    patients  who    harbor    only  micrometastatic    disease.    These   
observations    have    led    to    speculation    that    completion    ALND    may    not    be    necessa
ry    in    selected    patients    with    a    positive    SLND    in    less    than    three    nodes    because    the
    need    for    systemic    therapy    is    established    and    the    risk    of    an    axillary    recurrence    a
ppears    to    be    low.       
However,  a    retrospective    review    of    17    studies    (randomized    control    trials,    prosp
ective  studies)  with  at  least  two  years  of  follow--‐ up  supports   performing    a    complete  
axillary node    dissection   in    select    patients   that    meet    the    followingcriteria:    
•   Palpable  or    needle--‐ biopsy--‐ proven    axillary    metastasis    
•   Positive  sentinel    node    undergoing    a    mastectomy    without    radiation    therapy    
•   Three  or    more    positive    sentinel    nodes    
Patients  who    undergo    an    ALND    are    at    a    higher    risk    of    complications,    such    as    ly
mphedema,    arm    pain    or    numbness,    or    reduced    quality    of    life,    in    comparison    wit
h    women    who    undergo    a    SLND    only.    
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    NCCN  —
    The    National    Comprehensive    Cancer    Network    (NCCN)    has    not    changed    their    g
uidelines    and    continues    to    recommend    completion    ALND    for    all    women    with    p
ositive    sentinel    nodes    until    additional    randomized    trial    results    are    available.    Ho
wever,    a    distinction    can    be    made    between    isolated    tumor    cells,    micrometastases, 
   and    macrometastases,    in    terms    of    clinical    management,    especially    because    at    le
ast    22    percent    misclassification    of    sentinel    node    metastases    has    been    demonstrat
ed.    In    light    of    this,    omission    of    the    ALND    can    be    considered    if    the    tumor    burde
n    appears    low    (eg,    in    cases    with    isolated    tumor    cells    or    micrometastases)    when    
whole    breast    radiation    with    high    axillary    tangents    is    planned.    Additional    results    
are    pending    from    two    
ongoing  randomized    trials    studying    the    benefit    of    ALND    for    clinically    node    ne
gative    women    with    
positive  SLNs:    the    EORTC    10981--‐ 22023    AMAROS    trial;    and    Trial    23-
-‐ 01    of    the    International    Breast    Cancer    Study    Group    (IBCSG)    
    ASCO  2014    guidelines  
   For    patients    with    <3    positive    sentinel    lymph    nodes    (with    or    macro    metastases    f
ound    by    sentinel    node    biopsy),    ASCO    2014    guidelines    advise    a    completion    axill
ary    node    dissection    should    not    be    performed    if    there    is    no    evidence    of    bulky    met
astatic    disease    or    gross    extra    capsular    extension    and    the    patient    is    treated    with    w
hole    breast    irradiation.    
    Age  >65    years  
 A    positive    SLND    followed    by    a    completion    ALND    did    not    improve    all-
-‐ cause    or    breast--‐ cancer--‐ specific    survival    in    women    over    65    years    of    age.       
     Mastectomy  and    completion    ALND   
  —    Management    of    a    negative    and    positive    SLN    identified    in    
conjunction  with    a    mastectomy    is    discussed    separately.    
    SLND  IN    SPECIAL    CIRCUMSTANCES  
Sentinel    lymph    node    dissection    (SLND)    is    evolving    in 
selected  clinical    settings.    
    Locally  advanced    and    inflammatory    breast    cancer    
    Most    studies    have    restricted    SLND    to    T1    or    T2    breast    cancers    <5    cm    in    size,    si
nce    larger    tumors    have    a    higher    likelihood    of    positive    axillary    nodes.    However,    
some    studies    have    shown    that    SLND    is    accurate    in    patients    with    T3    tumors    and    
clinically    negative    axillae.    Thus,    many    clinicians    do    not    recognize    large    breast    t
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umors    as    a    contraindication    to    SLN    dissection,    as    long    as    the    axilla    is    clinically    
negative.    However,    patients    with    T4    tumors    (locally    advanced)    or    inflammatory   
 breast    cancer    are    not    considered    candidates    for    SLND.    The    false    negative    rate    is 
   high    in    patients    with    inflammatory    breast    cancer,    presumably    because    of    the    pr
esence    of    partially    obstructed,    functionally    abnormal    subdermal    lymphatics.    
The  2005    ASCO    guidelines    on    SLND    did    not    recommend    the    routine    use    of    SL
ND    in    patients    with    locally    advanced    or    inflammatory    breast    cancer    for    whom    
ALND    was    recommended    to    ensure    locoregional    control.    Consensus    recommen
dations    from    an    International    Expert    Panel    published  in    2010    considered    inflam
matory    breast    cancer    to    be    the    one    of    the    few    absolute    contraindications  to    SLN
D.    In    addition,    SLND    was    not    recommended    for    T4    tumors.    
    Neoadjuvant  chemotherapy   
    Many    women    with    large    primary    breast    tumors    are    offered    neoadjuvant    chemot
herapy    prior    to    definitive    locoregional    therapy.    The    optimal    timing    for    sentinel    l
ymph    node    biopsy    (SLND)    in    patients    receiving    neoadjuvant    therapy    has    been    d
ebated,    as    some    have    reported    a    higher    false    negative    rate    for    SLND    performed    
after    induction    therapy,    while    others    have    not.          
    Multicentric  disease  
    Studies    that    evaluated    the    functional    anatomy    of    lymphatic    drainage    support    th
e    theory    that    all    quadrants    of    the    breast    drain    into    the    same    lymph    node(s).    Thus
,    subareolar    and    intradermal    (rather    than    peritumoral)    injection    of    radiolabeled    c
olloid    or    blue    dye    render    SLND    feasible    for    patients    with    multicentric    disease.    
    Ductal  carcinoma    in    situ  
   Most    women    with    ductal    carcinoma    in    situ    (DCIS)    do    not    require    assessment    of 
   the    axillary    nodes,    particularly    if    they    are    undergoing    breast-
-‐ conserving    therapy.    However,    women    with    DCIS    may    be    candidates    for    SLN    
mapping    if    they    are    undergoing    mastectomy,    because    the    performance    of    SLND  
  will    be    impossible    at    a    later    time    if    invasive    disease    is    found.    An    intact    breast    w
ith    its    lymphatic    plexus    is    necessary    for    injection    of    both    the    blue    dye    and    the    ra
dioisotope    tracers.    
Some  recommend    that    SLND    be    considered    in    patients    who    are    undergoing    bre
ast    conserving    therapy    or    mastectomy    for    DCIS    only    if    the    risk    of    node    metastas
es    is    increased,    as    with    extensive    high--‐ grade    DCIS,    a  strong    suspicion   
of    invasive    disease    based    upon    ancillary    imaging,    or    documented    microinvasive   
 disease    in    the    core    biopsy.    However,    if    a    partial    mastectomy    is    performed    and    i
  
 
 
78 
 
 
ینارنخس هدیکچیاه نیب هرگنک نیمهدناتسپ ناطرس یللملا 
 
 
8-6 دنفسا  هام3131 
 
nvasive    disease    is    identified,    a    SLND    can    be    done    as    a    separate    operation.    This    
approach    can    minimize    unnecessary    morbidity,    since    SLND    can    be    associated    
with    complications.    SLND    is    generally    performed    if    microinvasion    is    found    in    t
he    breast    biopsy    or    if    mastectomy    is    required    for    extensive    or    multifocal    DCIS,    
where    the    risk    of    an    occult    invasive    component    is    increased.    If    metastases    are    fo
und    on    SLND,    the    disease    stage    would    change    accordingly. 
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O2-01 
Assessment of flatness and Symmetry of intraoperative 
radiotherapy beam fields by radio chromic EBT-2 films 
 
Zahra Rahimzadeh Yekta1, Seied rabi Mehdi Mahdavi2 ,  
Hamidreza Mirzaie3,Mohammad Esmaeil Akbari3, Nahid Nafisi3 , 
Hamid Baghani4, Mostafa Robatjazi 5  
1-Sciences and Research Branch of Tehran, Islamic Azad University, Tehran, Iran 
2-Department of Medical Physics, Iran University of Medical Sciences, Tehran, Iran 
3-Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran 
4-Department of Radiation Medicine, Shahid Beheshti University, Tehran, Iran 
5-Department of Medical Physics, Tehran University of medical Science, Tehran, Iran 
 
Introduction: Symmetry and flatness tests should be done by using suitable 
3D motorized water phantom or appropriate radio chromic films and slab 
phantoms. The aim of this work is to check symmetry and flatness of 
Intraoperative Radiotherapy (IORT) fields by using EBT-2 films and beam 
profiles at 6,8,10 and 12 MeV. 
Methods and materials: Four pieces of EBT-2 films cut into 10×12.5 cm2 
.Then films were scanned before and after irradiation. EBT-2 films put in 
reference condition (applicator 10 cm and 00 angel) and between vertical slab 
systems. Then, films irradiated in four energies 6, 8, 10, 12 MeV, separately. 
After irradiation, by using MATLAB software and selection of appropriate 
pixels can draw profiles. Flatness aria is in 80% filed size. Flatness and 
symmetry were obtained by special formulas. For assessment of flatness, 
maximum and minimum dose must be achieved and for analyzing symmetry, 
dose in corresponding points in central axis in profile should be measured.  
Results: Flatness for 6, 8, 10,12MeV energies were measured 3.6, 3.2, 1.7 and 
2.9, respectively. Also, symmetry measurement in order for above energies 
were obtained 1, 1, 0.9, and 0.9.  
Conclusion:  absorbed dose variation inside the 80% of the field size (50% 
isodose) must be less than 3%. In our results, flatness was acceptable for all 
energies (just for 6, 8 MeV a little is bigger than 3%).  Also, maximum 
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absorbed dose between points equidistant from central beam axis, inside the 
80% of field size must be less or equal 3% and our measurements of 
symmetries were equal or under 1%.  Symmetry and flatness of IORT beam 
fields seems acceptable and reliable for all energies and it is appropriate for 
treatment condition. 
Key words: symmetry, flatness, intraoperative radiotherapy, radio chromic 
EBT-2 films. 
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O3-02 
Breast Ultrasound: Benign or Malignant, What to do? 
 
Dr saghari 
 
Breast ultrasound plays a significant role in woman’s imaging and identifying 
malignances. There are many lesions that may appear benign but warrant 
intervention or close follow up. At the end of this lecture the audience will be 
able to identify these lesion. In addition to appropriate imaging approach to 
common symptoms such as pain, breast lumps (in various ages) and abnormal 
breast exam will be reviewed.   
Hands on Ultrasound Guided Breast Biopsy with Vacuum Assisted Needles 
Workshop Completely hands on approach to perform an ultrasound guided 
breast biopsy.  
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O3-04 
Breast Cancer Cells Reaction to Serum Starvation and Steroid 
Restriction 
 
Maryam Nakhjavani1, Farshad H. Shirazi1, David J. Stewart2 
1-Toxico/Pharmacology, Shahid Beheshti University of Medical Sciences, Tehran, IR 
2-Medical Oncology, University of Ottawa Faculty of Medicine, Ottawa, CA 
 
Breast cancer is still one of the most deadly diseases in women. Beyond 
synthesizing new anticancer agents, a proper cancer treatment needs a better 
understanding about the biology of the cancer, to provide a better view on 
newer chemotherapeutics. The cells at the center of a tumor bear metabolic 
stress and suboptimal growth conditions and following chemotherapy and 
tumor shrinkage they face favorable growth conditions. In the current study, 
the reactions of human breast adenocarcinoma cell line, MCF-7, in harsh 
metabolic stress conditions was studied. In this regards, the cells in culture 
plates were exposed to different serum concentrations (10%, 0.5%, 0.25% and 
0%) with/out steroids for up to 6 days. At 24-hour intervals, cell morphology 
(inverted light microscopy), Cell cycle (flow cytometry), mitochondrial 
content (MTT assay) and protein content (SRB and Biorad protein assay) were 
analyzed. In addition, in each day, the cells were released in media containing 
10% serum and the cells were analyzed with the above-mentioned tests. The 
results of this study showed that serum starvation could cause a delayed G1-S 
transition and re-stimulation with serum could facilitate this transition. 
Furthermore, sub-G1 population of the cells does not increase dramatically 
along with starvation. Serum starvation did not decrease cell proliferation; 
rather increased cell proliferation was observed, accompanied by decreased 
cell size. In this status, intracellular content of cells mitochondria and protein 
was also increased. However, when steroid restriction was also exerted, 
besides reduced growth rate and proliferation, cells protein content was also 
reduced, while mitochondrial content of the cells was not decreased. Releasing 
the cells in 10% serum led to increased foci formation (as a marker of cell 
aggressiveness), cell size, protein and mitochondrial content. These results 
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along with the evidences of low cell death in the form of apoptosis or 
autophagy, confirmed that MCF-7 is a relatively resistant cell line to harsh 
metabolic stress, and even after a long period of 6-day starvation, re-exposing 
the cells to optimal environmental conditions can facilitate their reentry to 
normal cell life again. 
Keywords; MCF-7, Serum Starvation, Steroid 
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O3-05 
Trends in the distribution of breast cancer in the Sultanate of 
Oman and the modalities of treatment 
 
Dr.A.Alajami 
 
Breast cancer represents the highest cancer in terms of incidence in females in 
Oman. Females with breast cancer in Oman tend to be younger than Western 
counterpart, Majority of patients present in advanced stage and tumours 
display aggressive features. 
Ddescription of clinico-pathological features of the disease in Oman with 
analysis of prognostic factors and survival.Small proportion of patients have 
breast conserving surgery, majority received pre-operative chemotherapy 
compared to the past ad this is due to  locally advanced nature of disease. The 
survival and disease free survival to other Asian and Arab Countries. 
The advanced presentation explain in part the inferior survival figures to 
white-American and European females. The following are strongly 
recommended to improve morbidity and mortality: 
1) Increase breast cancer awareness. 
2) Introduction of breast screening programs. 
3) Multi-disciplinary approach in the management. 
4) Molecular biology and genetic research to further explore breast cancer in 
Oman 
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O4-06 
Empowering patients in Decision Making Process in breast 
cancer surgery: PICTURE European Trial 
 
Mohammed R S Keshtgar BSc, FRCSI, FRCS (Gen), PhD 
Professor of Cancer Surgery and Surgical Oncology university College London, Royal Free Hospital 
london, United Kingdom 
 
Breast cancer is the most common cancer affecting women worldwide. It has 
become an increasingly treatable disease with a 10-year survival rate 
exceeding 80%. It is usually treated with surgery, often in conjunction with 
radiotherapy and systemic treatments. Two types of surgery are available: 
 breast-conserving surgery (also known as lumpectomy)     or 
 mastectomy (i.e. the partial or complete removal of the breast). 
However, even breast-conserving surgery can affect the appearance of the 
breast, a prospect that can cause a great deal of stress. Therefore, a good 
aesthetic outcome is an important consideration in breast cancer therapies and 
is closely linked to the patient’s psychological recovery and self-image after 
treatment. Yet for an estimated 30% of women treated with breast-conserving 
surgery, the result is less than ideal aesthetically . Unfortunately, to date there 
is no objective way to assess or predict the aesthetic outcome of breast cancer 
treatment. 
We are developing tools to enable the patient's aesthetic appearance after 
treatment to be objectively evaluated. Current techniques use subjective 
methods, such as assessment by an expert panel, or computer analysis of two-
dimensional photography to estimate, for instance, breast asymmetry. By 
adopting recent developments in low cost three-dimensional photography and 
depth sensing technology, we are developing a standardised, reproducible 
analysis tool which bases the aesthetic outcome evaluation on both the three-
dimensional shape of the reconstructed breast and its volume. This will 
establish standardised quality assurance and evaluation procedures, enabling 
institutions across Europe to be compared and factors that have a positive or 
negative impact on surgical outcome to be identified. 
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I will present the European funded project “Patient Information Combined for 
the Assessment of Specific Surgical Outcomes in Breast Cancer” (PICTURE. 
The goal of the project is to create, validate, and demonstrate a system for the 
patient-specific planning, evaluation, prediction, and quantification of the 
outcome of breast-conserving surgery. The PICTURE demonstrator will 
support surgeons in surgical planning prior to the operation. It is also designed 
to aid patient-clinician communication by visualizing the foreseen outcome, 
and thereby empowers patients to take an active role in a Shared Decision 
Making process.  
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O4-07 
Outcome of Different Timings of Radiotherapy in Implant-
Based Breast Reconstructions 
 
Maurizio B. Nava, M.D.Angela E. Pennati, M.D.Laura Lozza, M.D.Andrea 
Spano, M.D. Milvia Zambetti, M.D.Giuseppe Catanuto, M.D. 
Milan, Italy 
 
Background: The therapeutic role of postmastectomy radiation therapy has 
been demonstrated both in locally advanced breast cancer and in other high-
risk conditions. Implant-based breast reconstruction for irradiated patients can 
generate higher complication rates. In this study, the authors observed the 
effects of radiation on temporary expanders and permanent implants. The 
estimate of the totally failed reconstruction rate was the principal endpoint of 
this study. 
Capsular contracture rates and patients’ and surgeons’ subjective evaluations 
were the secondary endpoints. 
Methods: Two hundred fifty-seven patients were consecutively involved in 
this study. The population was stratified into two groups: group 1, 
postmastectomy radiation therapy on permanent implants (n ! 109 patients); 
and group 2, postmastectomy radiation therapy on tissue expanders (n ! 50 
patients). A nonirradiated control group made up of 98 patients was selected 
randomly. All patients underwent a two-stage immediate breast reconstruction 
with subpectoral temporary expanders and permanent implants. 
Results: The totally failed reconstruction rate was significantly higher in 
group 2, with 40 percent of unsuccessful reconstructions compared with 6.4 
percent in group 1 and 2.3 percent in the control group (p " 0.0001). The 
capsular contracture rate was significantly higher for groups 1 and 2 compared 
with the control group. The shape and symmetry assessment and the patients’ 
opinions demonstrated a higher incidence of good results in group 1 in 
comparison with group 2. The best scores were always obtained by the control 
group. 
Conclusion: This study demonstrated that radiotherapy during tissue 
expansion may compromise the outcome of implant-based breast 
reconstruction. (Plast. Reconstr. Surg. 128: 353, 2011.) 
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O4-07 
CLINICAL QUESTION/LEVEL OF EVIDENCE: 
Therapeutic, II. Skin-Reducing Mastectomy 
 
Maurizio B. Nava 
M.D.Umberto Cortinovis, M.D.Joseph Ottolenghi, M.D.Egidio Riggio, M.D. 
Angela Pennati, M.D.Giuseppe Catanuto, M.D.Marco Greco, M.D.Guidubaldo Querci della 
Rovere, M.D. 
Milan, Italy; and London, United Kingdom 
 
Background: The authors propose a combined flap technique to reconstruct 
large and medium-sized ptotic breasts in a single-stage operation by use of 
anatomical permanent implants. 
Methods: The authors enrolled 28 patients fulfilling criteria for skin-sparing 
mastectomy and presenting with ptotic breasts whose areola-to-inframammary 
fold distance was more than 8 cm. All reconstructions were performed as a 
single-stage procedure. After preoperative planning, a large area in the lower 
half of the breast was deepithelialized according to the conventional Wise 
pattern. Mastectomy was then carried out. To perform reconstructions, the 
infer medial fibers of the pectoralis major muscle were dissected and sutured 
to the superior border of the inferior dermal flap. An anatomical implant was 
then inserted into the pouch, which was closed laterally with the previously 
harvested serratus anterior fascia. Skin flaps were finally closed down to the 
inframammary fold. 
Results: The authors performed 30 procedures on 28 patients. The medium 
size anatomical implants was 433 cc. Twelve women achieved symmetrization 
in a single stage ending in a symmetric inverted-T scar. The overall 
complication rate was 20 percent, with four cases (13 percent) complicated by 
severe, extensive necrosis of the skin flaps requiring implant removal. 
Conclusions: Breast cancer treatment must nowadays optimize cosmetic 
results. This can be accomplished in selected cases by means of a single-stage 
operation that the authors call “skin-reducing mastectomy.” The final scars 
imitate those of cosmetic surgery. Careful patient selection and improvement 
in the learning curve may reduce the complication rate. (Plast. Reconstr. Surg. 
118: 603, 2006.) 
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O4-06 
Optimal use of anti-HER2 agents for early stage breast cancer 
 
Clifford Hudis, M.D. 
Attending and Chief, Breast Medicine Service, MSKCC 
Professor of Medicine, Weill Cornell Medical College 
 
Breast cancers that overexpress HER2 or have amplification of the gene that 
encodes this progein are called “HER2 positive” and are sensitive to anti-
HER2 therapies such as trastuzumab. Several pivotal trials demonstrated that 
the use of one year of trastuzumab, beginning with the taxane portion of 
adjuvant therapy, is likely superior to other approaches.  Pertuzumab, which 
binds a distinctly different region of the extra-cellular domain of HER2 is 
known to further improve outcomes in the metastatic setting and do increase 
the rate of pathologic response when given pre-operatively. Whether it will 
become standard in the conventional adjuvant setting remains to be 
determined although a large randomized trial addressing this issue is 
completed. For low risk patients, paclitaxel and trastuzumab may be 
considered based on very low event rates in a non-randomized trial but it is 
possible that newer and less toxic approaches, such as the trastuzumab-DM1 
linked agent, could be useful here. The impact of hormone receptor status on 
these decisions is also being explored at present.  
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O5-02 
Palliative Therapy for TNBC 
 
Clifford Hudis, M.D. 
Attending and Chief, Breast Medicine Service, MSKCC 
Professor of Medicine, Weill Cornell Medical College 
 
Breast cancers that do not express the estrogen and progesterone receptors and 
also do not overexpress HER2 are collected together and labeled “triple 
negative”. These tumors are not defined by a single molecular defect or target 
but some of them share deficient BRCA protein function, a basal genetic or 
phenotypic profile while others have unique attributes (such as expression of 
the androgen receptor). These tumors have recently been seen to represent a 
special challenge because on the one hand they may be especially sensitive to 
optimization of conventional adjuvant chemotherapy regimens, but on the 
other, they have not been effectively treated with less toxic targeted therapies. 
The latter challenge may be resolved through the growing recognition that 
these tumors are not a single entity but instead represent several or many 
distinct subtypes such that progress will be made through further dissection of 
their relevant biology. Recent advances building on this approach include the 
demonstration that platinum salts may be more active in TNBC when BRCA 
mutations are present, activity for PARP inhibitors in both mutation carriers 
and also in patients given specific chemotherapy agents, and demonstration of 
activity for a range of single agents in selected patients such as those with 
expression of the androgen receptor positive treated with anti-Androgens.  
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O6-04 
Breast Biopsy: New , Old and Pitfalls 
 
Dr saghari 
 
Overview of stereotactic biopsy of the breast old fashion way and with the 
new AFFIRM 3D device. The course covers the techniques, roles and 
fundamentals of stereotactic guided biopsy with AFFIRM. The audience will 
learn the pitfalls of breast biopsy including sampling, hard to see lesions and 
the controversies regarding benign surgical lesion. They will be able to refer 
the appropriate patients to the surgery and the predictors of upgrading a lesion.  
  
 
 
888 
 
 
ینارنخس هدیکچیاه نیب هرگنک نیمهدناتسپ ناطرس یللملا 
 
 
8-6 دنفسا  هام3131 
 
O7-01 
PROPOSAL: Screening for breast cancer managements plan 
proposal for Iranian social security, Ministry of Welfare and 
Social Security (Iran) , Planning and understand the cost of 
preventive medicine comparing to the cost of treatment. 
 
Dr.D Hendesi 
 
Subject: the existing program from  Social Security Organization , were the 
medical services are provided directly through 73 hospitals and 270 medical 
clinics owned by the Social Security Organization.and find out the number of 
the breast cancer was treated and diagnosed from beginning to end and during 
last 5 years, This will allow Us to recommends biennial screening 
mammography for women 50-74 years. And analysis an individual one and 
take patient context into account, including the patient's values regarding 
specific benefits and harms to Conclude from those data and making screening 
managements plan for the next 5 years by reducing and substitute the cost of 
breast cancer treatments by prevention with triple screening plan  including 
the Clinical , mammography and ultrasound  managements plans . The 
Screening mammography can help reduce the number of deaths from breast 
cancer among women ages 50 to 74. The Potential limitations of screening 
mammography include false-positive results, overdiagnosis and overtreatment, 
false-negative results, and radiation exposure. In surgery, for example, value 
depends on not only the surgeon but also the anesthesiologist, the nurses, the 
radiologist, the skilled technicians, and others, all performing well. Yet no 
matter how skilled the surgical team, the overall care cycle is crucial. Unless 
the patient's problem is accurately diagnosed, the patient is properly prepared, 
and recovery and rehabilitation are managed well, patient results will suffer. 
Indeed, the impact of the cycle of care is even broader. Value may be 
enhanced by not performing the surgery at all, and treating the case in a 
different way. Value may be still greater if preventive care and advice is 
provided over time so that little or no treatment is needed at all. The Women’s 
are Doing breast cancer screening one time a years after age of 40 years, The 
triples screening start -first at age of 20 years by inspection and palpations 
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both breasts himself,-Second clinical examination with physician every 3 
years between 20 to 39 years, and one time after 40.  
Because in order to making choices for triples screening the economic 
justification is necessary facing the selective prevention Vs regular treatments 
plans. Also by educating the peoples eating conveniently, advise to doing the 
sport regularly, and stop smoking, reducing fatty foods, and using high fiber 
foods, the Breast cancer triples screening managements plan are seen with the 
respect to the patient risk factors including the Gender, GENETICS Family 
history, BODY Obesity, Not having children, High breast density, certain 
breast changes, and Menstrual history, LIFESTYLE : A sedentary lifestyle, 
Heavy drinking, PREVIOUS TREATMENTS:  Birth control pills, Combined 
post-menopausal hormone therapy (PHT), Diethylstilbestrol exposure (DES), 
Radiation exposure, In order to make a meaningful survival analysis, basic 
cancer and patient characteristics such as  age at initial diagnosis ,year of 
initial diagnosis, in additional Cancer stages, cancer primary sites, and gender 
are necessary, the health care system to deliver care that is both more 
affordable and of higher quality. Then how we can learn from the social 
security practices during last past 5 years data, making it’s the farther used for 
screening breast cancer, and highly likely for others cancers prevention 
managing plans as well. The Diagnostic mammography takes longer than 
screening mammography because more x-rays are needed to obtain views of 
the breast from several angles and used for women’s between 40-74 years  
The Australian Breast Screen Program was launched, The Australia agreed to 
fund the national mammography program. Today, there are 550 locations via 
fixed, relocatabe or mobile screening units in the country. Breast Cancer: 
Screening Release Date: November 2009 the Women, Age 50-74 Years. in 
USA The USPSTF recommends biennial screening mammography for women 
50-74 years. For Women, Before the Age of 50 Years, The decision to start 
regular, biennial screening mammography before the age of 50 years should 
be an individual one and take patient context into account, including the 
patient's values regarding specific benefits and harms.  
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O7-02 
Cost saving in Armed forces insurance Organization without 
Sacrificing the Quality of Care 
 
Dr Farshad Najafipour* Dr Amir Norouzi** 
*CEO of Islamic republic of Iran Armed forces insurance organization 
** Head of Health insurance research center, Islamic republic of Iran Armed forces insurance organization 
 
Introduction: Due to insurance coverage for cancer patient in armed forces 
insurance organization, the mentioned organization has endeavored a great 
deal of financial burden on itself. Regarding to its mission which is" Higher 
quality of care with Lower prices", armed forces insurance organization have 
turned to Strategic Purchasing for cares, drugs and equipment. 
Method: This qualitative study designed based on content thematic analysis 
method. In first step, a stakeholder analysis was performed to detect experts 
with prior experiences in these fields which can help us in this issue. Semi- 
structural interviews were performed, afterward thematic analysis was 
performed and solutions were categorized in five main categories.  
Result: The selected solutions were as follow; Establishment of a cancer 
center for managing cancer among covered population, Cancer guideline 
adaptation under supervision of medical universities, hold contract with 
medical facilities which can offer their care due the guidelines and enter our 
patients data in a pre-designed information system, reorganization of costly 
drugs and care and involve them in strategic purchasing cycle. 
Conclusion: The best way to cut costs in an insurance organization is to 
provide an effective management system without cutting back the covered 
services.  
Key words: Insurance, company, cancer, Strategic purchasing 
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O7-07 
Prebiotic foods in association with plasma levels of IGF-1 and 
IGFBP-3 in breast cancer patients 
 
Saeed Pirouzpanah1, Aynaz Tajaddini2*, Ali Pourzand3, Zohre Sanaat4, 
Mohammad Asghari-Jafrabadi5 
1-Assistant professor, Department of Biochemistry and Dietetics, Nutrition Faculty, Tabriz University of 
Medical Sciences, Tabriz, Iran  
2-PhD student, Student’s Research Committee, Nutrition Faculty, Tabriz University of Medical Sciences, 
Tabriz, Iran.  
3-Full professor, Department of general Surgery, Faculty of Medicine, Tabriz University of Medical 
Sciences, Tabriz, Iran  
4-Associate professor, Hematology and Oncology Research Center, Tabriz University of Medical Sciences, 
Tabriz, Iran  
5-Assistant professor, Department of Statistics and Epidemiology, Faculty of Health, Tabriz University of 
Medical Sciences, Tabriz, Iran  
 
High insulin like growth factor-I (IGF-I) levels, has been notice to be 
contributed in the malignant cells proliferation. It is well known that IGF-I 
associates inversely with the circulation level of IGF-binding protein-3 
(IGFBP-3). However, few studies have denoted to the association of dietary 
factors on concerning biomarkers. Therefore, we aimed to investigate the 
relation between dietary intakes of prebiotics and plasma concentrations of 
IGF-1 and IGFBP-3 among Iranian women with breast cancer (BC) residing in 
North-West of Iran.  A validated, food frequency questionnaire (FFQ) was 
completed by 170 women with BC (aged 25 to 65 years). Plasma 
concentrations of biomarkers were measured by enzyme-linked 
immunosorbent assays (ELISA). Multivariate logistic regression models were 
performed. Our results showed that the higher amount of raw onion and garlic 
intakes were related to lower IGF-1 levels at ORs of 0.45(95%CI: 0.20-1.04) 
and 0.53(95%CI: 0.25-1.13), respectively. There was a positive trend of 
IGFBP-3 concentrations across the increasing intake tertiles of total and raw 
onion with ORs equal to 2.47(95%CI: 1.02-5.99) and 2.15(95%CI: 0.96-4.80), 
respectively. Additionally, we observed a statistically positive significant 
relation between average intakes of whole-wheat bread and IGFBP-3 levels 
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(P< 0.001). Our findings suggested that certain dietary prebiotics; in particular 
onion, garlic and whole-wheat bread intakes were in association with plasma 
IGF-1 and IGFBP-3 concentrations among BC patients. 
Key Words: Breast cancer, Prebiotics, IGF-1, IGFBP-3 
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O7-08 
Effects of the Magnetic Resonance Field on Breast 
TissueExpanders 
 
Maurizio B. Nava, M.D 
Milan, Italy 
 
Background Tissue expansion for breast reconstruction after mastectomy is a 
safe and effective procedure. A magnetic resonance imaging (MRI) scan can 
be requested for patients with a breast expander to evaluate concurrent 
diseases. The electromagnetic field of the MR can interfere with biomedical 
devices, resulting in potential hazards, compromising the diagnosis, or 
creation of artifacts. Methods Four tissue expanders with an integrated 
magnetic valve were tested. The temperature increase was measured using an 
infrared camera in the MR scanner. The expanders were tested (half-full and 
full of saline solution) both free in air and immersed in a phantom. The 
ferromagnetic properties of the devices were assessed using the deflection 
angle method. To evidence artifacts due to the presence of the expander, MR 
images were acquired for expanders tested in air and in the phantom. A valve 
localization test was performed after MRI analysis. 
Results A slight increase in temperature was demonstrated, without any 
clinical significance. The deflection angle due to the magnetic field depends 
on the distance from the bore of the magnet. The angle is higher when the 
device is closer to the bore. The presence of the magnetic valve influences the 
MRI signal, creating artifacts on the acquired images, even far from the valve 
itself. The valve localization test allowed verification of correct valve 
functioning for all the expanders after the MRI analysis. Conclusions Under 
selected conditions, MRI scans can be feasible. Heating is not expected to be a 
major concern, whereas valve displacement could happen in certain clinical 
conditions. The presence of artifacts is almost unavoidable. Level of Evidence 
III This journal requires that authors assign a level of evidence to each article. 
For a full description of these Evidence-Based Medicine ratings, please refer 
to the Table of Contents or the online Instructions to Authors. 
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O7-09 
Relation between smoking or narcotics abuse and the 
recurrence of breast cancer in patients referred to an oncology 
clinic in Mashhad 
 
Fateme Homaei Shandiz1, Fahime Afzaljavan2,3, Mahdi Rivandi2,3,  
Sahar Ardalan2, Alireza Pasdar2,4* 
1-Department of Oncology Radiotherapy, Faculty of Medicine , Omid and Qaem Hospital, Mashhad 
University of Medical Sciences, Mashhad, Iran  
2-Department of Modern Sciences & Technologies, Faculty of Medicine, Mashhad University of Medical 
Sciences, Mashhad, Iran 
3-Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, 
Iran 
4-Departments of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, 
Mashhad, Iran 
 
Breast cancer is the most common malignancy among women in the world 
with different risk factors including smoking. The purpose of this study was to 
investigate the association between smoking or narcotics abuse and recurrence 
in breast cancer patients referred to an oncology clinic in Mashhad. 
Medical records of 840 breast cancer patients (F=827 & M=13), whom 
referred to an oncology clinic in Mashhad were studied and data on age, sex, 
type of cancer, tumour size, recurrence and use of narcotics and smoking 
status were collected and  analysed using SPSS version 21 software. 
The mean age of patients was 49.73±0.425 y. The most frequent type was 
Invasive ductal carcinoma (94%) and the least frequent (0.1%) was high grade 
large cell lymphoma. 13.8% of the patients were smokers (11.2% cigarettes, 
49.1% tobacco) and 39.6% had also addiction to narcotics. The statistical 
analysis indicated an association between smoking and disease recurrence 
(p<0.024) but there was no association between smoking and tumour size and 
also between smoking and lymph node involvement (p=0.176 ،p=0.413 
respectively). According to our results, appropriate interventions and proper 
education seemed to be essential for reduction of exposure to these 
compounds in breast cancer patients. This may, in turn, cause a reduction in 
breast cancer recurrence.  
Key words: breast cancer, addiction, smoking, recurrence. 
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O8-01 
Expander and Implant Reconstruction 
 
M. B. Nava 
Milan, Italy 
 
Breast reconstruction is an extremely sophisticated subject and the 
reconstruction strategies differ a lot between so-called “reference centres” and 
between each specialist. It is often thought that the application of the 
autologous flaps is the wisest solution. In our centre we use them, nevertheless 
principally to the high-risk patients, undergoing radiotherapy. I such cases 
only the flap based operations are advisable; in our institution we prefer to 
perform the least invalidating DIEP flaps that allow muscle preservation, 
avoiding alterations of body biomechanics. 
If the radiation therapy hasn’t been neither performed, nor planned, it is 
possible to reconstruct a female breast with a use of an implant. A skin-
sparing mastectomy leaves the opportunity to a big variety of reconstructive 
strategies, including: reduction, augmentation, both often with a contralateral 
breast treatment. In those cases a careful planning, together with modern 
implants and new surgical techniques lead to the achievement of very high 
aesthetic results, comparable with a look of natural breasts or these after the 
aesthetic surgery. 
To perform a successful reconstruction, a first thing is to choose an adequate 
type of the incision during a skin sparing mastectomy: large and ptotic breast 
may request an inverted T incision, but if the ptose is more moderate a 
transverse access or even periareolar in case of smaller breasts should become 
enough. 
The second step consists in the proper planning of the reconstruction strategy. 
In reference to breast size and patient’s wish a breast may be augmented or 
reduced. Small breasts may permit a one-stage-reconstruction, but usually a 
previous expander insertion is needed.  In breasts with a moderate grade of 
ptosis we use autoprostheses in addiction to the implant and in larger we 
perform the inferior pedicle breast reduction. Breast implants have been 
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designed for the aesthetic purposes. Since the first application in 1962, by 
Dow Corning, six following generation have been designed and released on 
the market, including the most recent one, released in 2004 by Inamed: the 
style 510 dual gel. Its posterior part is filled with the standard cohesive 
silicone gel like the one of the Style 410; the anterior part is filled with a 
special, high-cohesive gel. This feature provides more projection and support 
of the nipple-areola area. Even with use of those modern products the 
achievement of the projection in the reconstructed breast is not an easy task. In 
order to establish a fullness of the upper pole of the breast, we have started to 
inject an autologous fat. It has dramatically improved the surgery outcome. 
Our late experience consists of Two-hundred-thirty-four women with a mean 
age of 47 years (range 19-67 years) who underwent extra-projection based 
reconstructions. Two-hundred-thirty-eight were inserted (four bilateral 
procedures). The mean follow-up time was 18 months (range 12-45 months). 
A peculiarity of our study was that a total of 197 (84%) patients received 
contra-lateral procedures, including 82 augmentations, 55 mastopexies, and 60 
breast reductions. In our experience we haven’t found any malignancies in the 
contra-lateral specimen. The rest of patients (10%) had no symmetrisation on 
the contra-lateral breast as a personal request. The highest rate of positive 
opinion is reported in patients who underwent  augmentation (74%) and the 
highest rate of bad opinion in those who received a mastopexy (10.4%).  
The final results should resemble those of a cosmetic surgery with implants; 
the highest satisfaction rates are reported for patients treated by contra-lateral 
augmentation while ptotic breast on the healthy side, when reshaped without 
prosthetic devices, tend to recur with the highest level of bad ratings. 
Therefore we may confirm that a breast-reconstructive surgery should no 
longer be a procedure leading to just compelling results. Due to our modern 
techniques, especially the fat injection to the upper pole, the result can be 
easily compared with the aesthetic surgery outcomes.   
  
 
 109
 1313ماه  اسفند 6-8
 
 
 
 المللی سرطان پستاندهمین کنگره بین
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 فهرست تفصیلی
 مقالات پذیرفته شده
 `
 
    
 المللی دهمین کنگره بین
 سرطان پستان
 
  
 
 099
 
 
 المللی سرطان پستانفهرست تفصیلی مقالات پذیرفته شده دهمین کنگره بین
 
 
 1313ماه  اسفند 6-8
 
  
 
999 
8-6 دنفسا  هام3131 
 
 
 
نیب هرگنک نیمهدناتسپ ناطرس یللملا 
 Rapid Presentation 
 
R2 - 01 
5 years study of patients with lactating adenoma and review of the literature 
Asiie Olfatbakhsh*1, Zahra Gholizadeh2, Parisa Hoeinpour3 
R2 - 02 
Study Prevalence of BRCA1/2 Common Mutations in East Azerbaijan 
Province, Iranian Breast Cancer Patients Using High Resolution DNA 
Melting Analysis 
Shiva Koorehpaz Asl1*, Majid Farshdousti Hagh2, Laya Farzadi3 
R2 - 03 
Developmental competence of immature oocytes aspirated from antral 
follicles of ovarian cortex as a method for fertility preservation 
Fereshteh Safian1MSc, Mohammad Ali Khalili1,2 *PhD , Mojgan Karimi Zarchi3 
M.D. , Mehdi Mohsenzadeh2 MSc. 
R2 - 04 
Health-Promoting Lifestyle in Breast Cancer Survivors: In Relation to 
Depression and Social Support 
Fatemeh Moghaddam Tabrizi1, Marzieh Ebrahimi2, Elham Sadeghi3 
R2 - 05 
Correlation of Abortion with the Risk of Recurrence and Tumor Size in 
Breast Cancer Patients 
Fatemeh Homaei Shandiz1, Sahar Ardalan2, Mahdi Rivandi2,3, Fahime Afzal 
Javan2,3, Alireza Pasdar2,4* 
R2 - 06 
Yoga management of breast cancer-related lymphoedema 
Farkhondeh jamshidi1*, Arezoo shayan2, Zahra maasumi3 
R2 - 07 
Evaluation the Relationship Between Serum Levels of Malondialdehyde and 
Breast Cancer Risk in Women 
Parisa Kangari1*, Somaiye Ebadollah zade1, Soltan Ali Mahboob2,   
Ali Reza Nourazarian3, Amir Mansour Vatankhah4, Abdolrasool Safaiyan5,  
Vahid Montazeri6 
R2 - 08 
Association study of rs1219648 in FGFR2 and rs1042522 in TP53 with 
premenopausal breast cancer in an Iranian Azeri population 
Zahra Saadatian1&2, Jalal Gharesouran1, Morteza Ghojazadeh1, Sahar Ghohari-
Lasaki1, Najime Tarkesh-Esfahani3, Seyyed Mojtaba Mohaddes Ardebili1* 
  
 
991 
 
 
نیب هرگنک نیمهد هدش هتفریذپ تلااقم یلیصفت تسرهفناتسپ ناطرس یللملا 
 
 
8-6 دنفسا  هام3131 
 
R2 - 09 
The effects of hydro alcoholic extract of sage (Salvia officinalis L.) leaves on               
cultured mouse breast cancer cells 
Sara Behroozi Moghaddam1* , Malihe Monsefi2 , Rahele Masoudi2 
R2 -10 
Breast Cacer During Pregnancy Can Be Treated as in Nonpregnant Women 
fereshteh choobsaz 
R2 - 11 
Protective impacts of Ziziphus Jujube on biochemical and hematological 
factors in NMU-induced breast cancer in rats 
Dr. Reyhane Hoshyar1, Zabihollah Mohaghegh2, Nihad Torabi3, Aliyeh 
Abolghasemi2, Iman Nakhei1 
R2 - 12 
Study of epidemiology of Breast Cancer in Maragheh, Iran (2007-2012) 
Atefeh Keyvani*1  , Hasan Hosainzadegan2 
R2 - 13 
Health-Related Quality of Life and its related factors among women with 
breast cancer 
Majid Hassan zadeh1* , Ali khalafi2 , Zohreh zandi3 
R2 - 14 
CK19 expression in the peripheral blood of breast cancer patients 
Nasrin Karimi*1, Mana Oloomi2, Zahra Orafa3 
R2 - 15 
Comparative evaluation of lung absorbed dose in different methods of 
radiotherapy after mastectomy 
Shayesteh .S (Phd)1, Eivazi. M.T(Phd)2,Amirifard.N (MD)3, Shiri.I (MSc)1* 
R2 - 16 
Can Breast Cancer Survival by Risk Factors? Machine Learning Models 
Mitra Montazeri 1, 2, Mohadeseh Montazeri 3, Mahdieh Montazeri 4,*,  
Abbas Bahrampour 5 
R2 - 17 
Early Detection of Breast Cancer: a Study on the Breast Blood Variability by 
the Breast Phantom Accompanied by Vessels 
Parinaz Mehnati1, Maede Jafari Tirtash2*, Mohammad Sadegh Zakerhamidi3 
 
 
  
 
991 
8-6 دنفسا  هام3131 
 
 
 
نیب هرگنک نیمهدناتسپ ناطرس یللملا 
R2 - 18 
Effect of Combine Decongestive Therapy and the quality of life in breast 
cancer patients  after mastectomy 
Marzeih heidari 
R2 - 19 
Effect of crab shell extract on the viability and morphology of breast cancer 
cells in vitro 
Rezakhani L1, Mirzapur p1, Khazaei M1, Khazaei MR1 
R2 - 20 
Effect of Patient_ Care giver Education program On Cancer Related Self- 
Efficacy in Breast Cancer Patients. 
Zahra Kochaki Nejad 1, Alireza Mohajjel Aghdam 2, Hadi Hassankhani 3,  
Zohreh Sanaat 4  
R2 - 21 
Eligible women's knowledge about the importance of breast self-examination 
and education in Tabriz health centers in 93 
*1M. Ansari,2F. Mohammadi,3Minoo baradaran,4Azizeh  behruzi ,5doctor Nasser 
rahbari farzoo 
R2 - 22 
Evaluation of the relationship between axillary lymph nodes involvement  
and Ki67 over expression in Breast cancer patients 
Soodabeh shahidsales1, Mehdi Asadi2*, Seyed Amir Aledavood1, Kazem Anvari1 , 
Marjaneh Mirsadraee3 , Maryam Nemati4 
R2 - 23 
Dose history of induced abortion increases the risk of breast cancer? 
Farnoosh Moafi1*, Fatemeh Samiei Siboni2, Marzieh khatooni3, Hamide Hajnasiri4 
R2 - 24 
Evaluation of the expression of mir-21 oncomir, new diagnostic and 
prognostic molecular marker in tissue and blood of breast cancer patients 
Elaheh soleimanpour1, Mohamad-ali hosseinpour feizi1*, Esmaeil Babaei1 
R2 - 25 
Designing and Cloning of cytolethal distending toxin B as Biological Tool 
against cancer 
Hajar Yaghobi1, Mojgan Banhehpour2*, Bahram Kazemi3, Ali Ghanbari Asad 4 
 
 
  
 
991 
 
 
نیب هرگنک نیمهد هدش هتفریذپ تلااقم یلیصفت تسرهفناتسپ ناطرس یللملا 
 
 
8-6 دنفسا  هام3131 
 
R2 - 26 
Development of Novel Molecular Drug Candidates Using Molecular Docking 
Techniques in the Context of Breast Cancer 
Nedasadat Vaghefi nezhad1, Samaneh Fazeli Farsani*2, Seyedeh Nooshin Zaker3, 
Mostafa Ghaderi-Zefrehei4 
R2 -27 
Folate; friendly or enemy nutrient 
Seyedeh Parisa Moosavian1 
R2 - 28 
An Investigation into the Epidemiological Trend of Breast Cancer in the 
World, particularly in Iran 
Azam Garavandi1, Sheida Sepahi2, Dr. Nahid Khademi3 
R2 - 29 
Homocysteine and Breast Cancer 
Mohammad Bagher Maljaie1 
R2 - 30 
Properties of TGFαL3-SEB fusion protein as a ligand targeted superantigen 
in breast tumor-bearing mice following intravenous or intratumoral injection 
Forough Yousefi*1, Seyed Fazloallah Mousavi2, Seyed Davar Siadat3, Abbas Ali 
Imani-Fooladi4, Mohammad Mehdi Aslani5, Omid Nasiri6 
R2 - 31 
Knowledge, attitude and practice of female students of Maragheh faculty of 
medical sciences on breast cancer 
Hasan Hosainzadegan1, Nader Mahdavi2, Hadi Naghdian3, Amir Zayerekabeh3*, 
Farzaneh Jafarzadeh3,  Ghazal Davarpanah3 
R2 - 32 
The investigation of amount of awareness, attitude, and performance of 
women over 20 years old with a positive breast cancer in family history in 
Markazi province 
Nadia Mashayekhi1* , Azita Mohsennejad2, Bahar ShahMohammadi3, 
FatemehZakeri4 
R2 - 33 
The Investigation of Health Belief Model in Early Diagnosis of Breast Cancer 
in Patient's families in Arak Province 
Azita Mohsennejad1*, Nadia Mashayekhi2, Nahid Sharahi3, Parvin Mashayekhi4, 
Rozita Ayazi5 
  
 
991 
8-6 دنفسا  هام3131 
 
 
 
نیب هرگنک نیمهدناتسپ ناطرس یللملا 
R2 - 34 
Effect of 6 months aerobic training on plasma leptin levels as a breast cancer 
risk factor in postmenopausal women 
Nasim Khosravi 1*, Azam Abdollah-pour 2, Zohreh Eskandari 3,  
Shahpar Haghighat 4 
R2 - 35 
Design and Characterization of a Peptide-Based Nanocarrier, MPG-H1-
iRGD, for Gene Delivery to Breast Cancer Cells. 
Mohsen Alipoor1, Saman Hosseinkhani*2, Reza Sheikhnejad3, Asia Majidi1 
R2 - 36 
Physical Activity and Breast Cancer Prevention 
Foad Asjodi
1 
,  Azimeh Izadi
2
 
R2 - 37 
Pregnant women' knowledge, attitudes and perceptions towards breast 
cancer prevention: a questionnaire study in Besaat hospital in Sanandaj. 
Seyedeh Soma Zakariaee1, Seyed Salman Zakariaee2*. 
R2 -38 
Using docking procedure and molecular dynamic simulation to design 
peptides, drived from Herceptin 
*2
ghanhDe emNaj ,
1
aatinimeN Negin ,
1
lekuS Paniz 
R2 - 39 
Study of Reaction in the Biological Components of Breast Exposed to Light 
Source Near-Infrared Wavelength 
Maede Jafari Tirtash1*, Parinaz Mehnati2, Mohammad Sadegh Zakerhamidi3, 
Karim Shamsasenjan4 
R2 - 40 
lncRNA ROR is a good way to detect Breast Cancer 
Reza Sahebi 
R2 - 41 
Evaluation of serum Ischemia modified albumin )IMA) levels in breast 
cancer patients 
Somayeh ebadollahzadeh1*, parisa kangari1,  Sultan ali mahboob2, Ali reza 
nourazarian3, amir mansoor vatankhah4, Abdol rasol safaeian5, Vahid montazeri6. 
 
 
 
  
 
991 
 
 
نیب هرگنک نیمهد هدش هتفریذپ تلااقم یلیصفت تسرهفناتسپ ناطرس یللملا 
 
 
8-6 دنفسا  هام3131 
 
R2 - 42 
The Effect of Breast Feeding and Breast Cancer Incidence in Women with 
Breast Cancer 
Somayeh Ramezanli1* , Fatemeh Hashemi2, Marzieh Kargar Jahromi3 
R2 - 43 
The Effect of Training Quality of Life and Coping Strategies on Functional 
Scale of Quality of Life in Women with Breast Cancer 
Somayeh Ramezanli1* , Fatemeh Hashemi2 
R2 - 44 
The Impact of Education on Symptomatic Scale of Quality of Life in Women 
with Breast Cancer 
Somayeh Ramezanli1* , Fatemeh Hashemi2 
R2 -45 
Uniformity of dose distribution in target volume in radiotherapy techniques 
for breast after Mastectomy 
Shayesteh .S (MSc)1, Eivazi. M.T(Phd)2,Amirifard.N (MD)3, Shiri.I (MSc)1* 
R2 -46 
Yoga and psychological health of breast cancer  
Sima Ghezelbash 1, Azam Ghorbani2*, Sahar Ghezelbash3 
R2 -47 
Knowledge, attitude and practice about breast cancer screening among 
students of Tehran University of Medical Sciences, in 2010 
Zeinab Tavakol1 , Seyede Zahra Banihosseini2 , Asieh Mansouri3 
R2 -48 
The roles of ω 3-fatty acid in breast cancer protection 
Seyedeh Parisa Moosavian1 
R2 -49 
Predicting the survival in breast cancer using Hidden Markov Model   
Madadizadeh Farzan1 ,  Montazeri Mitra2,3 , Bahrampour Abbas4* 
 
R2 -50 
Bioinformatics analysis of potential role of miR-520f in patients with breast 
carcinoma 
Marzieh Mehskat1, Kamran Ghaedi2*, Hamzeh Mesrian Tanha2, Mansoureh 
Azadeh34, Mahboobeh Meshkat1 
 
 
  
 
991 
8-6 دنفسا  هام3131 
 
 
 
نیب هرگنک نیمهدناتسپ ناطرس یللملا 
R2 -51 
Association between SHBG gene polymorphism (rs 5790) and breast cancer 
susceptibility 
Nastaran Haghighi 1, Zahra Tahmasebifard* 2, Nahid Nafisi 3 
R2 -52 
Association of Breast Cancer Risk with a Common Functional 
Polymorphisms of fas 1377 and fas ligand 844. 
Zahra Tahmasebi Fard1*, Nahid Nafisi 2Afsoon Taghavi3 
R2 -53 
Expansion and characterization of breast cancer stem cells for the 
development of BCSC targeting therapeutic strategies 
Dehghan Kouhestani Somayeh1, Forouzandeh Moghadam Mehdi1* 
R3 -01 
Evaluation of sonographic and mammographic appearances of invasive 
lobularcarcinoma in breast cancer research center since 1380 to 1392 
Toktam Beheshtian1*,AsiieOlfatbakhsh2 ,Zahra Gholizade3 
R3 -02 
Epidemiological review of the situation of Breast cancer that have been 
registered in pathologic labs Under coverage Iran University of Medical 
Sciences (IUMS) from 2011- 2013 
  Rita Motidost Komleh1* – manochehre karimi2 - Ali Golmohammady3 
R3 -03 
Evaluation of benzoxaloyl coumarins induced cell death in MDA-MB-231 
Triple negative breast cancer cell line 
Vahideh Imeni1، Soheila Koohestanimobarhan2، 
Farahnaz Nourmohammadian3،Siamak Salami4* 
R3 -04 
The association between Vitamin D status and risk of breast cancer: a case-
control study 
Jamshidi Naeini Y1, Abdollahi M2, Ajami M3, Akbari ME4, Davoodi H5 
R3 -05 
The effectiveness digital mammography compared to the analog 
mammography for breast cancer diagnostic and screening: systematic review 
Bita Sadat Zegordi1, Ali Akbari Sari2,Payam Haghighat-Fard3,  Mohammad 
Moradi-joo4, Banafsheh Darvishi3, Aidin Aryan Khesal4* 
 
  
 
991 
 
 
نیب هرگنک نیمهد هدش هتفریذپ تلااقم یلیصفت تسرهفناتسپ ناطرس یللملا 
 
 
8-6 دنفسا  هام3131 
 
R3 -06 
New methods of treatment for breast cancer 
Arezoo shayan1*, Farkhondeh jamshidi2 , Maryam asadi 3, Sima kiani rad4 , 
Shahin tohidi5  
R3 -07 
Effectiveness of Group Training Based on Acceptance and Commitment 
Therapy on Anxiety and Depression of Women with Breast Cancer 
Sahar Mohabat-Bahar1, Fatemeh Maleki-Rizi2, Mohammad Esmaiel Akbari 3, 
Mohammad Moradi-joo 3 
R3 -08 
Heavy Metals Contamination of Milk and Dairy Products and Risk of 
Cancers 
S. Esmaeili1,2, H. Davoodi*2,3  
R3 -09 
The Six family of homeobox genes and related mechanisms in diseases 
Marzieh Armat1, 2, Taiebeh Oghabi Bakhshaiesh1, 2, Mohammad Saied Hejazi3, 
Nasser Samadi 4* 
R3 -10 
The effects of vitamin C administration on conventional treatment in patients 
with breast cancer: A review 
Neda Rezvani1*, Saeed Pirouzpanah2 
R3 -11 
 یگدنز تیفیک شیازفا رب دهعت و شریذپ رب ینتبم نامرد و یهاگآ نهذ یهورگ شزومآ یشخبرثا
ناتسپ ناطرس هب لاتبم نانز 
وج یدارم دمحم ،یربکا لیعامسا دمحم رتکد ،یکلم همطاف ،راهب تبحم رحس 
R3 -12 
 یتخانش نامرد یشخبرثا یسررب_ ییوگلا رب ینتبم یراتفر8 هلحرم و نت ریوصت دوبهب رب شک ی
ناور یتسیزهب ناتسپ ناطرس هبلاتبم نانز یتخانش 
یداواب اتیب1یفیرشروپ دیمح ،2یناشاک یفطل حرف ،3 
R3 -13 
هنیس ناطرس زا یریگشیپ تهج ناناوجون رد یتیریدمدوخ 
یدورهرک ییلاع همطاف 
 
  
 
991 
8-6 دنفسا  هام3131 
 
 
 
نیب هرگنک نیمهدناتسپ ناطرس یللملا 
R3 -14 
س هرابرد مدنزرف هب؟میوگب هچ ناتسپ ناطر 
یراصنا ناگژم 
R3 -15 
نارامیب یتبقارم یاهزاین زا ناتسپ ناطرس هب لاتبم نارامیب کاردا نییبت 
رظن شوخ تاداسلا هرهاط1یلوسر میرم ،2 یربکا لیعامسا دمحم ،3یناشاک یفطل حرف ،4هداز نموم سوریس ،5  
یداجس یسوم6 
R3 -16 
م نانز رد یرامیب رد تیعطق مدعنآ اب طبترم لماوع و ناتسپ ناطرس هب لاتب 
یداجس یسوم1یلوسر میرم ،*2هداز سابع سابع ،3دجم یولع دیمح ،4 
R3 -17 
شقن miRNA ناتسپ ناطرس رد اه 
 یبونذ ماهلا1 شنمهب دادرهم ،* 
R3 -18 
Effect of injecting AuNPs on performance of AccuBoost brachytherapy 
system in patients with early-stage breast cancer using Monte Carlo method 
4Sarabiasl , Akbar3Mohammadi, Parivash 2semi, Habibeh Gha1Hossein Pourbeygi 
R3 -19 
Role Of Ovarian Sleep With Gnrh Analogs During Chemotherapy For 
Fertility Preservation In Young Patient (Up To 40 Years) With Breast 
Cancer(Study Of 54 Patients In Ostad Alinasab Hospital And Oure Clinic In 
Tabriz)   
  Alikaram Hedayati Godarzi ,Fatemeh Hedayati , Zahra Mokarram Ghazani. Amir 
Mohammad Hedayati 
R3 -20 
Properties of TGFαL3-SEB fusion protein as a ligand targeted superantigen 
in breast tumor-bearing mice following intravenous or intratumoral injection 
Forough Yousefi*1, Seyed Fazloallah Mousavi2, Seyed Davar Siadat3, Abbas Ali 
Imani-Fooladi4, Mohammad Mehdi Aslani5, Omid Nasiri6 
  
 
910 
 
 
نیب هرگنک نیمهد هدش هتفریذپ تلااقم یلیصفت تسرهفناتسپ ناطرس یللملا 
 
 
8-6 دنفسا  هام3131 
 
 یاهرتسوپ 
نیب هرگنک نیمهدناتسپ ناطرس یللملا 
P1-01 
Effect of patient education on breast cancer 
Shahin tohidi1*, Arezoo shayan2 , Zahra maasumi3 
P1-02 
The Evaluation of the Educational Plan of Breast Self-Examination of 
Women Referring to Health Centers 
Zahra Dariush1*, Marzieh Kargar Jahromi2, Mahnaz Kargar Jahromi3 
P1-03 
Sexuality in women with breast cancer after treatment 
Sima Kiani rad ¹*, Solmaz Kiani rad ², Maryam Asadi ³, Arezo Shayan 4 
P1-04 
Spiritual Health in Breast Cancer 
Shahin Tohidi1*, Arezoo Shayan2 
P1-05 
Treatment of hot flashes in women with breast cancer 
Sedighe Frouhari ¹, Sima Kiani rad ²*, Maryam Asadi ³, Arezzo Shayan4,  
Solmaz  Kiani rad5 
P1-06 
Supportive Care During Treatment of Breast Cancer Patients 
Zahra Dariush1*,Marzieh Kargar Jahromi2,Mahnaz Kargar Jahromi3 
P1-07 
Deregulation of microRNA in metastatic breast cancer as biomarkers and 
therapeutic targets 
Parham nejati1*, Shayesteh rezayani2, Ghasem khazai1 
P1-08 
A new strategy against cancer cells 
Ali Ghanbari Asad1, Bahram Kazemi2*, Mojgan Banhehpour3, Hajar Yaghobi4 
P1-09 
Aptamer and breast cancer 
Hadiseh mohamadpour1*, Sara danesh2 
P1-10 
Investigation of association between miR-152 polymorphism with breast 
cancer in Isfahan population 
Zahra Ghatreh Samani1*, Majid Motovali-bashi2 
  
 
919 
8-6 دنفسا  هام3131 
 
 
 
نیب هرگنک نیمهدناتسپ ناطرس یللملا 
P1-11 
Impact of psychological intervention on stress and depression in breast 
cancer patients 
Marziah Pourvali.1, Ania Ahani Azari.2* 
P1-12 
Differential Diagnosis of Breast Cancers Using Texture Analysis of Magnetic 
Resonance Imaging 
Abolfazl Moslemi1*, Abolnaser Rostami2 
P1-13 
Adjuvant Endocrine Therapy and Breast Cancer 
Zare ommolbanin 
P1-14 
Evaluation of Shoulder Girdle Strength after Modified Radical Mastectomy 
and Comparison with Healthy Participants 
Mahdie Akoochakian1*, Mohammad Hossein Alizadeh2, Nader Rahnama3, 
Bahareh Mahmoudieh4, 
P1-15 
Dendrosomal Nano-Curcumin is inducing apoptosis in MCF-7 and T47D 
breast cancer cell lines via down-regulating survivin expression 
Aref Sobhkhizy1*, Esmail Babaei2, Neda Jafari3 
P1-16 
Arsenic Trioxide increases paclitaxel-induced apoptosis in resistant breast 
cancer cells 
Tayebeh Oghabi Bakhshaiesh1,2, Marzie Armat1,2, Behzad Baradaran3, 
Mohammad SaeedHejazi1,4, Nasser Samadi1,5* 
P1-17 
Targeted Therapy in Triple Negative Breast Cancer (TNBC): A Case Series. 
Mehrdad Payandeh1, Fariba Falsafi2, Masoud Sadeghi3, Edris Sadeghi4* 
P1-18 
Different Presentation of Treatment in Carcinomatous Meningitis of Breast 
Cancer: Report of 3 Cases  
Mehrdad Payandeh1, Edris Sadeghi2*, Masoud Sadeghi3, Mostafa Hossaini4 
P1-19 
The association between triple negative breast cancer with hormonal and 
reproductive factors  
Tafazzoli- Harandi H1, Olfatbakhsh A*1, Mokhtari Hesari P1, Hashemi E1, Alavi N1  
  
 
911 
 
 
نیب هرگنک نیمهد هدش هتفریذپ تلااقم یلیصفت تسرهفناتسپ ناطرس یللملا 
 
 
8-6 دنفسا  هام3131 
 
P1-20 
Assessing the Psychological effect of breast cancer on the patients’ quality of 
life 
Sourtiji atefe1*, Zare Ommolbanin 2 
P1-21 
Association of Ki67 expression and CK19 detection in breast cancer patients 
Nasrin Karimi1*, Mana Oloomi2, Mahmood Dehgani Ashkezary3,  
Seyed Mahdi Kalantar4, Zahra 
P1-22 
Knowledge and awareness about breast cancer among Zabol medical 
students 
Aliyeh Sargazi1*, Alireza Sargazi2, Zahra Sepehri3, Fatemeh Sepehri4, Morteza 
Salarzaee5, Fateme Sargazi6 
P2-01 
Effectiveness of cognitive-therapy, stress management intervention on 
anxiety, depression and quality of life in women with breast cancer 
Mina Galeshi1 
P2-02 
Barriers to Perform BSE of the Viewpoint of Women Nurses Working in 
Hospitals Asadabad City of Hamadan in 2014 
Nasrin Heidari1, Ziba Mohammadi2* 
P2-03 
Black tea and coffee consumption and breast cancer risk, new controversy 
Mohammad Bagher Maljaie1, Seyedeh Parisa Moosavian1 
P2-04 
In-silico analysis of rs1836724 and its related microRNAs in breast cancer 
Fatemeh bagheri1, Mansooreh Azadeh23, Kamran Ghaedi4*, Hossein Tabatabaeian5 
P2-05 
Breast Cancer in Pregnancy (Areview Article) 
Maryam Haydari    
P2-06 
Regulation of expression and/or activity of voltage-gated sodium channels; a 
therapeutic target in metastatic breast cancer 
Shayesteh Rezayani*1, Parham Nejati2, Ghasem Khazai2 
 
 
  
 
911 
8-6 دنفسا  هام3131 
 
 
 
نیب هرگنک نیمهدناتسپ ناطرس یللملا 
P2-07 
A pathologic study on breast biopsy in Zabol medical university of sciences 
hospital in 2014 
Alireza Sargazi1*, Aliyeh Sargazi2, Zahra Sepehri3, Fatemeh Sepehri4, Morteza 
Salarzaee5, Fateme Sargazi6, fateme allahi7 
P2-08 
Breast Cancer 
Mehran Motamedi،1 Fatemeh ghasemi، 1SAMAN REZAEE2 ، Maryam Emami3 
P2-09 
Clinical utility of positron emission mammography for breast cancer 
screening 
Seyed Salman Zakariaee1*, Shima Golbarg2, Seyedeh Soma Zakariaee3. 
P2-10 
Combination Therapy of siRNA and Chemotherapy in Breast Cancer 
Ghasem Khazaei 1⃰, Parham Nejati 1, Shayesteh Rezayani 2 
P2-11 
Comparative quantification of target gene expression in Breast cancer cells 
byReal-time PCR method 
Azam Salmani1*, Zahra Orafa2, Mana Oloomi3, Reza Mahdian4,  
Sepide Arbabi Bidgoli5 
P2-12 
Comparison of Clinicopathologcal Characteristics in Metastatic Breast 
Cancer Patients: At Initial Presentation and in the Follow up Time 
Esmat Alsadat Hashemi1*, Hoda Tafazzoli2, AsiieOlfatbakhsh1, Parisa Mokhtari3  
P2-13 
Comparison of cytokeratin19 expression in various human breast cancer cell 
lines 
Saeideh Keyvani-Ghamsari1*, Mana Oloomi 2, Zahra Orafa3, Azam 
Salmani4, Iraj Mehregan5 
P2-14 
Study of the expression of apoptotic BAX and Bcl-2 genes in breast cancer 
cells treated with dendrosomal nanocurcumin 
Neda Jafari1, Esmaeil Babaei2*, Aref Sobhkhizy3 
 
 
 
  
 
911 
 
 
نیب هرگنک نیمهد هدش هتفریذپ تلااقم یلیصفت تسرهفناتسپ ناطرس یللملا 
 
 
8-6 دنفسا  هام3131 
 
P2-15 
Coping Strategies Used in Women with Breast Cancer 
Somayeh Ramezanli1*, Fatemeh Hashemi2 
P2-16 
Effect of  hydro alcohlic extract of Citrullus colocynthis fruit on caspase 3 
gene expression in MCF-7 breast cancer cell line 
Roghayeh Davoudi 1, Esmaeilzadeh Bahabadi S2*, Najafi Sh2, Mahta Mazaheri3 
P2-17 
Detection of CK19 Marker in the MCF7 and T47D Cell Lines by 
Immunofluorescence MicroscopyZahra Orafa1*, Mana Oloomi2, Saeideh Keyvani3, 
Nasrin Karimi4, Sepideh Arbabi Bidgoli5 
P2-18 
Determining pattern of metastasis and prognostic factors in breast cancer 
using conditional regression model (PWP) 
Mahmood Reza Gohari*1, Parisa Mokhtari Hesari2, Zeinab Moghadami Fard3, 
Reza khodabakhshi4 
P2-19 
Review on the role of EBV in breast cancer induction 
Hasan Hosainzadegan1, Reza Parvan2 
P2-20 
Effect of hydro alcoholic extract of Nigella sativa on Caspase3 gene 
expression in MCF7 cell line 
Fathemeh Moshtaghi 1, Sedigheh Esmaeilzadeh Bahabadi2, Mahta Mazaheri 
Naeini3*, Shahla Najafi 4, Fatemeh Dahmarde 5 
P2-21 
Evaluation of the relationship between axillary lymph nodes involvement  
And Ki67 over expression in Breast cancer patients 
Soodabeh shahidsales1, Mehdi Asadi2*, Seyed Amir Aledavood1, Kazem Anvari1, 
Marjaneh Mirsadraee3, Maryam Nemati4 
P2-22 
Comparison of IL-25 and IL-17B in Apoptosis and Proliferation induction of 
breast cancer cell lines 
Mahdieh Shokrollahi Barough1, 2,*, Parviz Kokhaei1, 3, Fatemeh Pak1, Mehdi 
Barati1, Ehsan Manuchehri1, 2 
 
 
  
 
911 
8-6 دنفسا  هام3131 
 
 
 
نیب هرگنک نیمهدناتسپ ناطرس یللملا 
 
P3-01 
Development of Novel Molecular Drug Candidates Using Molecular Docking 
Techniques in the Context of Breast Cancer 
Nedasadat Vaghefi nezhad1, Samaneh Fazeli Farsani*2, Seyedeh Nooshin Zaker3, 
Mostafa Ghaderi-Zefrehei4 
P3-02 
Molecular signaling pathway analysis of MiR-155 targetome to decipher 
various molecular functions of miR-155 in breast cancer with respect to 
prevalence of vaginal candidiasis in patients 
Mina Kazempour1*, Kamran Ghaedi2, Mahboobeh Madani3 
P3-03 
Evaluation of Focal magnification View in the assessment of mammographic 
abnormalities in Breast Cancer Research Center 
Asiie Olfatbakhsh1*,Toktam Beheshtian2,Zahra Gholizadeh3,Parisa Mokhtari4, 
Mandana Ebrahimi5 
P3-04 
Green tea can be a protection factor for breast cancer 
Seyedeh Parisa Moosavian1 
P3-05 
Anti-oxidation of Green tea and breast cancer 
Azam Ghorbani, Sima Ghezelbash 1*, Sahar Ghezelbash2 
P3-06 
Impact of Diet on Breast Cancer Risk: A Review study 
Azimeh Izadi1
 
, Foad Asjodi2 
P3-07 
In Vitro Fertilization and Cancer Risk 
Zare ommolbanin 
P3-08 
Association of Breast Cancer and its Therapy with Candida Infection 
Seyyed Saeed Aghili1, Seyed Reza Aghili2*, Bahar Salmanian3 
P3-09 
Knowledge, attitude and practice of female students of Maragheh faculty of 
medical sciences on breast cancer 
Hasan Hosainzadegan1, Nader Mahdavi2, Hadi Naghdian3, Amir Zayerekabeh3*, 
Farzaneh Jafarzadeh3, Ghazal Davarpanah3. 
  
 
911 
 
 
نیب هرگنک نیمهد هدش هتفریذپ تلااقم یلیصفت تسرهفناتسپ ناطرس یللملا 
 
 
8-6 دنفسا  هام3131 
 
 
P3-10 
Knowledge and women who are qualified to carry out the CBE 
 Clinical breast Examination  ( in Tabriz health centers in 2014 
M. Ansari, F. Mohammadi, doctor N.rahbari  , doctor F. Sadeghi, Minoo Bardaran 
P3-11 
Induction of Apoptosis in Human Breast Cancer MCF-7 Cell Line by 
Artesunate 
Leila Jamalzadeh1*, Reyhaneh Sariri2, Hosein Ghafoori3, Hale Hasani 4 
P3-12 
Life style and Breast Cancer 
Zare ommolbanin 
P3-13 
A Quick Review of Long Noncoding RNAs: A new paradigm in breast 
cancer pathogenesis, diagnosis, and therapy 
Sara Malih1, Massoud Saidijam2 *, Narges Malih3 
P3-14 
Enhances the Effects of Chemotherapeutic Agents in Human Breast Cancer 
Cells with Downregulation of XIAP Expression by RNAi 
Mehdi Agha Gholizadeh 
P3-15 
Mediterranean Diet; Best Dietary Guideline to Fighting Breast cancer 
Mohammad Bagher Maljaie1, Seyedeh Parisa Moosavian1 
P3-16 
The role of Peer support on quality of life of women with breast cancer 
Maryam Momeni*1, Fatemeh Hasan dost1, Fatemeh samiei siboni1,  
Marziyeh Khatoni1 
P3-17 
Estrogen Receptor-α A→G Mutation and the Breast Cancer Risk 
Sakineh Abbasi1*, Mina Rasouli2, Samira Kalbasi3 
P3-18 
The association between pancreatic function and genetic markers of 
obesity in breast cancer 
Molood Nikkhah1*, Elahe Abdollahi2 
 
  
 
911 
8-6 دنفسا  هام3131 
 
 
 
نیب هرگنک نیمهدناتسپ ناطرس یللملا 
 
P3-19 
Bioinformatics analysis of potential role of miR-662 in breast cancer patients: 
inhibition of cytokine-cytokine receptor pathway 
Nastaran Riahi1, Mansoureh Azadeh23, Kamran Ghaedi4*, Hamzeh Mesrian 
Tanha4, HosseinSanati1 
P3-20 
Nuclear Medicine breast imaging: Current status and future directions 
Seyed Salman Zakariaee1*, Shima Golbarg2, Seyedeh Soma Zakariaee3. 
P3-21 
Knowledge, attitudes, beliefs and practices of the Iranians about cancer:  
a systematic review of the previous studies 
Mohsen Norouzi1*, Sajad Norouzi2, Alireza eyshi3, Sadra Ansaripour4 
P4-01 
Performance and attitude towards breast cancer in women over 18 years in 
the city of Shiraz, 1392 
Arezoo shayan1*,Shahin Tohidi2,Maryam Asadi3,Sima Kiani rad4, 
Farkhondeh Jamshidi5 
P4-02 
Quality of life in women with breast cancer 
Fereshteh Najafi 1*, Saharnaz Nedjat1 
P4-03 
Results of Breast Cancer Screening tests in Behbood Hospital in Tabriz 
Fahimeh Sehhatie Shafaie1*, Parvin Hadizadeh2, Somayeh Nagizadeh3,  
Soosan Valizadeh4, Bahman Zijah5 
P4-04 
Comparison and Evaluation of Synthesis of Risk Factors in Breast Cancer 
and Provide a Model for Determine the Likelihood of Developing Breast 
Cancer Using by EM Algorithm in Data Mining Techniques 
Mahdi Hemmasian-Ettefagh1*, Mohammad-hossein Nadimi-Shahraki2 Mahnaz 
Etehad-Tavakol3, Maede Behbahani4 
P4-05 
In-silico analysis of hsa-mir-196a targetome pathway and its SNP function in 
patients with breast cancer: potential association between T allele and the 
risk of metastasis 
Samira Kiani1, Hamzeh Mesrian Tanha2, Kamran Ghaedi2*, Mansoureh Azadeh34 
  
 
911 
 
 
نیب هرگنک نیمهد هدش هتفریذپ تلااقم یلیصفت تسرهفناتسپ ناطرس یللملا 
 
 
8-6 دنفسا  هام3131 
 
 
P4-06 
Screening and early detection of breast cancer 
Soheila fathalizadeh, mahnaz chahipour 
P4-07 
Sexual functioning after mastectomy surgery- A qualitative study 
Mandana Ebrahimi1, Fahimeh Khajehaminian2*, Mohammad Kamali3,  
Behrouz Dolatshahi4, Seyd Jalal Younesi5 
P4-08 
Bioinformatics analysis of functional SNP (A→G) at miR-499 in patients with 
breast cancer: G allele is probable poor prognostic factor 
Shahrzad Kabirizadeh1, Hamzeh Mesrian Tanha2, Kamran Ghaedi2*,  
Mansoureh Azadeh34 
P4-09 
Silibinin Causes Upregulation of PTEN as One of the Cell Cycle Progression 
Blocker in MCF-7 Human Breast Cancer Cell Line 
Zohreh Jahanafrooz1٭, Nasrin Motamed2 
P4-10 
Review of Computer-aided detection of breast cancer on mammograms 
Afrooz Arzehgar1*, Mohammad Mahdi Khalilzadeh2, Fatemeh Varshoei3 
P4-11 
An Overview of Breast Cancer Prediction in Early Stage with Analyses of 
Mammographic  
Images Using by Data mining Techniques and provide a Novel Solution in 
Screening  
Mahdi Hemmasian-Ettefagh1*, Mohammad-hossein Nadimi-Shahraki2, 
Mahnaz Etehad-tavakol3 
P4-12 
Investigation of the time and the site of metastases in patients with triple 
negative breast cancer and other phenotypes 
Hoda Tafazzoli-Harandi1, Asiye Olfatbakhsh1*, Parisa Mokhtari Hesari1,  
Safa Najafi1, Esmatosadat Hashemi1 
P4-13 
Vitamin D and Breast Cancer, Is there any association? 
Seyedeh Parisa Moosavian1 
 
  
 
911 
8-6 دنفسا  هام3131 
 
 
 
نیب هرگنک نیمهدناتسپ ناطرس یللملا 
 
P4-14 
Vitamin D Receptor (VDR) gene polymorphism is a risk for breast cancer 
Mohammad Bagher Maljaie1 
P4-15 
Walnut and Breast Cancer  
Zare ommolbanin 
P4-16 
New methods of treatment for breast cancer 
Arezoo shayan1*, Farkhondeh jamshidi2 , Maryam asadi 3, Sima kiani rad4, 
Shahin tohidi5  
P4-17 
Knowledge, attitude and practice of menopause women towards breast 
cancer 
Ziba Raisi Dehkordi 
P4-18 
in-silico analysis of hsa-mir-146a targetome pathway and its SNP function in 
patients with breast cancer: probable association between alleles and 
prognosis 
Mahboobeh Meshkat1, Hamzeh Mesrian Tanha2, Kamran Ghaedi2*,  
Mansoureh Azadeh34, Marzieh Meshkat1 
P4-19 
A comparison of body image and public health among breast cancer patients 
with breast evacuation, breast keeping and normal people in Tehran 
Zahra Esfandiari Dolabid, Azadeh Jolaei 
P4-20 
Predicting the survival in breast cancer using Hidden Markov Model   
Madadizadeh Farzan1 ,  Montazeri Mitra2,3 , Bahrampour Abbas4* 
P5-01 
Breast Carcinoma Stages Diagnosis by Expression of breast Cancer-Specific 
Gene1 
Mona Rahnemay Helali1*, Seyed Ali Rahmani2, Majid Farshdosti Hagh3 
P5-02 
The Impact of Intraoperative Radiation Therapy in the Breast Cancer 
Farnaz Tabatabaie 1, Hamidreza Mirzaei 2, Seied Rabi Mahdavi 3,  
Mohammad Esmaeil Akbari 4 
  
 
910 
 
 
نیب هرگنک نیمهد هدش هتفریذپ تلااقم یلیصفت تسرهفناتسپ ناطرس یللملا 
 
 
8-6 دنفسا  هام3131 
 
 
P5-03 
Sunlight exposure, vitamin D, and the prevention of breast cancer 
Sima Ghezelbash1*, Azam Ghorbani2, Sepehr Shekarchian3, Sahar Ghezelbash4 
P5-04 
Psychological interventions and pain control in breast cancer patients 
Sima Ghezelbash1*, Sepehr Shekarchian2, Azam Ghorbani3, Sahar Ghezelbash4 
P5-05 
Quercetin decrease leptin gene expression in breast cancer 
Maryam Rahimifard1, Faegeh Sadeghi1**, Kazem Nejati-koshki2 
P5-06 
Molecular Mechanisms of Melatonin anti cancer activity in breast cancer 
mini review article 
Elaheh Nooshinfar , Mohamad Esmail Akbari 
P5-07 
Breast Cancer and Spiritual Health 
Azam –Shirinabadi Farahani, PhD Candidate in Nursing, Lecturer, Nursing & 
Midwifery School, Shahid  Beheshti University of Medical Sciences 
P5-08 
Stability and thermodynamic investigation of embryonic stem cell marker 
Sox2 in breast cancer stem cells by spectroscopic and modeling techniques 
Azam Sahragard avval1,*‚ Mohammad-Reza Saberi2‚ Ghasem Hosseini Salekdeh3‚  
Jamshidkhan Chamani4 
P5-09 
Breast cancer screening barriers from women’s perspective: a systematic 
review in qualitative studies and critical appraisal 
Zoleykha Asgarlou1,Saber Azami2,Mohammad Arzanlou3 
P5-10 
The effects of vitamin C administration on conventional treatment in patients 
with breast cancer: A review 
Neda Rezvani1*, Saeed Pirouzpanah2 
P5-11 
Eligible patients for intraoperative radiotherapy (IORT) of early breast cancer: A 
cohort analysis 
Yousefi Kashi A.SH1,,Mofid B1, Rakhsha A1, Hoshyari M1 
 
  
 
919 
8-6 دنفسا  هام3131 
 
 
 
نیب هرگنک نیمهدناتسپ ناطرس یللملا 
 
P5-12 
Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis  of 
randomized trials 
Yousefi Kashi A.SH1,,Mofid B1, Rakhsha A1, Hoshyari M1 
P5-13 
Radiation Therapy for Locally Recurrent Breast Cancer 
Yousefi Kashi A.SH1, Mofid B1, Rakhsha A1, Hoshyari M1 
P5-14 
The role of Axillary Dissection for Breast Cancer in Old Women; A 
Meta-analysis of Randomized Clinical Trials 
Yousefi Kashi A.SH1,,Mofid B1, Rakhsha A1, Hoshyari M1 
P5-15 
Futures of Breast Cancer in Iran 
Afsoon Taghavi*,Nahid Nafissi*, Elaheh Nooshinfar* 
P5-16 
Breast cancer with Acrometastasis Of hands, two case reports from Ostad 
Alinasab Hospital in Tabriz(north west of Iran).   
Alikaram Hedayati Godarzi ,Fatemeh Hedayati , Zahra Mokarram Ghazani.  
Amir Mohammad Hedayati 
P5-17 
Management of breast cancer during pregnancy and   review of 23 treated 
cases in our clinic and Ostad alinasab hospital in tabriz (north west of IRAN). 
Alikaram Hedayati Godarzi ,Fatemeh Hedayati , Zahra Mokarram Ghazani. Amir 
Mohammad Hedayati. 
P5-18 
Evaluation of statins induced cell death in MDA-MB-231 triple negative 
breast cancer cell line 
Soheila Koohestanimobarhan1, Vahide Imeni2, Masoud Hashemiarab3,  
Siamak Salami4* 
P5-19 
Molecular Mechanisms of Melatonin anti cancer activity in breast cancer 
mini review article 
Elaheh Nooshinfar* , Mohamad Esmail Akbari 
 
 
  
 
911 
 
 
نیب هرگنک نیمهد هدش هتفریذپ تلااقم یلیصفت تسرهفناتسپ ناطرس یللملا 
 
 
8-6 دنفسا  هام3131 
 
 
P5-20 
Comparison of clinicopathologic appearance and 5years survival of breast 
cancer in young   (less than 40years )  and  less young (40-50 years) women in  
Ostad Aalinasab  Hospital in north west of IRAN (TABRIZ )  
Alikaram Hedayati Godarzi ,Fatemeh Hedayati , Zahra Mokarram Ghazani. Amir 
Mohammad Hedayati.   
P5-21 
Evaluation of Silibinin Toxicity on Breast Cancer Cell line MCF-7 
Nasim forghani1*, Hossain faramarzi 2, Arash forghani3 
P6-01 
Exercise interventions for patients with breast cancer related lymphedema   
Shahram Mohaghegh, Soori Mohsen, Maryam Hajian 
P6-02 
Induction of apoptosis in human breast cancer cells by Britannin, a 
sesquiterpene lactone from Inula aucheriana 
Faranak Fallahian1*, Maryam Hamzeloo-Moghadam2,3, Mahmoud Aghaei4, 
Mohammad Hossein Abdolmohammadi1 
P6-03 
Effect of injecting AuNPs on performance of AccuBoost brachytherapy 
system in patients with early-stage breast cancer using Monte Carlo method 
Poorbaygi, Hosein1; Habibeh Ghasemi Gharneh2; Mohammadi, parivash3; 
Sarabiasl, Akbar4* 
P6-04 
Impact of nutrition on breast cancer incidence 
Leila taheri 1, Marzeiah Kargar Jahromi2, malihe talebizadeh3 
P6-05 
Comparison of MRI and Pathologic Findings in Patients with Breast 
Complaints 
Elham Neshan1, Sara Bayesh2, Reza Najibpour2, Atieh Alimohammadi2, Nooshin 
Rahimi2, Ali farshad 2,Farzad Tahmasebi-Arashloo2 
P6-06 
Evaluation of anti-cancer activity of new COX-2 inhibitors in an invivo model 
of breast Cancer 
Ahoo Afsharinasaba , Khadijeh Moradi b, Seyyedeh Zahra Moosavi a,  
Hamideh Heidarnezhad c and Mona Salimi d,* 
  
 
911 
8-6 دنفسا  هام3131 
 
 
 
نیب هرگنک نیمهدناتسپ ناطرس یللملا 
 
P6-07 
The role of prolactin and growth hormone in breast cancer. 
saeedeh hosseini 
P6-08 
Application of Functional Proteomic in the Diagnosis and Treatment of 
Breast Cancers 
Raheleh Moradpoor 
P6-09 
Determining pattern of metastasis and prognostic factors in breast cancer 
using conditional regression model (PWP) 
Mahmood Reza Gohari*1, Parisa Mokhtari Hesari2, Zeinab Moghadami Fard3, 
Reza khodabakhshi4 
P6-10 
Sexual functioning after mastectomy surgery- A qualitative study 
Mandana Ebrahimi1, Fahimeh Khajehaminian2*, Mohammad Kamali3,  
Behrouz Dolatshahi4, Seyd Jalal Younesi5  
P6-11 
یسررب طابترا فرصم یهام و رطخ ناطرس ناتسپ 
هجیدخ لایل ،*یراصنا هیمس ،*تمکح مزر **ءارآ 
P6-12 
 لسکات یلکاپ ییوراد سکلپمک درکلمع یسررب- یلپلولس گرم رد لوکیلاگ نلیتا یاه
ناتسپ ناطرس یامونیسراکوندآ 
یدیمح نارهم1داژن فصآ هدازآ ،2یئاضر اضریلع ،1یجار دمحا دمحم ،1 
P6-13 
ناتسپ ناطرس اب یراگزاس و هلباقم یاهراکهار دنم ماظن رورم 
 یبارهم تمصع1 نایجاح هدیپس رتکد ،2 *هموصعم رتکد ،  ربمیس3 یرایشوه دمحم رتکد ،4یریاز دیرف رتکد ،5 
P6-14 
ناتسپ ناطرس هب لاتبم نانز رد هحناس زا سپ دشر و تیونعم 
یبارت هزئاف 
P6-15 
اطرس و تیونعمناتسپ ن 
تشرس کین همطاف 
  
 
911 
 
 
نیب هرگنک نیمهد هدش هتفریذپ تلااقم یلیصفت تسرهفناتسپ ناطرس یللملا 
 
 
8-6 دنفسا  هام3131 
 
 
P6-16 
؟دراد ریثات ناتسپ ناطرس هب لاتبم دارفا یگدنز تیفیک یاقترارب یونعم تملاس ایآ 
داژن یدابع ارهز 
P6-17 
 رثوم یژتارتسا ناونع هب ناتسپ ناطرس هب لاتبم ناوج نانز یارب لزنم رد یراتسرپ تبقارم
وناخ و رامیب یگدنز تیفیک شیازفا رد یراتسرپهدا 
یرافغ یفاعم شونرف ، یدارمیلع بنیز ،ینوتاخ هیضرم ،ینبیس یعیمس همطاف 
P6-18 
Breast Cancer Survivor’s Experiences: A Qualitative Study 
Fatemeh Moghaddam Tabrizi 
P6-19 
Futures of Breast Cancer in Iran 
Afsoon Taghavi*,Nahid Nafissi*, Elaheh Nooshinfar* 
P6-20 
The relationship between involved side and recurrence and metastasis of 
breast cancer in patients referred to a private oncologic clinic in Mashhad 
Fatemeh Homaei Shandiz1, Mahdi Rivandi2&3, Fahime Afzal Javan2&3,  
Sahar Ardalan2, Alireza Pasdar2&4* 
P6-21 
Histopathologic Characteristics of Breast Cancer in Patients Treated in a 
Private Oncologic Clinic in Mashhad 
Fatemeh Homaei Shandiz1, Mahdi Rivandi2&3, Fahime Afzal Javan2&3,  
Sahar Ardalan2, Alireza  
P6-22 
Evaluating the effect of Femara and Tamoxifen on serum lipids in early 
postmenopausal breast cancer patients. 
Ali Abdolahi *, hamid rezvani **, Hamid reza mirzaei**, Maryam Mohsenikia 
***, Ehsan Jangholi ***. 
P6-23 
Perceived social support evaluation in breast cancer patients: a case-control 
study. 
Ali Abdolahi *, hamid rezvani **, Hamid reza mirzaei**,  
Maryam Mohsenikia ***. 
 
  
 
 119
 1313ماه  اسفند 6-8
 
 
 
 المللی سرطان پستاندهمین کنگره بین
  .......................................................................................................................................... یادداشت :
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
 .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  
 
 119
 المللی سرطان پستاندهمین کنگره بین
 
 
 1313ماه  اسفند 6-8
 
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
 .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  .............................................................................................................................................................
  137
 
  
 
 پوسترهای ارائه شده
 ه سرطان پستانردهمین کنگره بین المللی کنگ
این بخش از طریق  یبدیهی است در صورت تمایل به جستجو در مورد پوسترها 
 می گردد. رامکان دسترسی میس F+lrrCکلیدهای ترکیبی 
 731 
 
P1-01 
 
Effect of patient education on breast cancer 
Shahin tohidi1*, Arezoo shayan2, Zahra maasumi3 
1 Instructor of Nursing, Department Medical-Surgical Nursing, School of Nursing and Midwifery, 
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Background: Breast cancer is the most common cancer in women. The purpose of this study is 
overview of studies conducted in the fields of education and prevention of breast cancer. 
Materials and Methods: The science direct، google scholar،SID databases were searched. Finally, 31 
article were available was examined for review in the present study. 
Result: Based on the results, prevention behavior was improved with Interactive computer programs, 
print media and lecture. The impact of computer-based training has been more than a counselor. Video 
instruction, increasing frequency in performing BSE. An interactive computer and interface 
improvement in breast cancer prevention knowledge. The computer-based patient education programs 
which are nowadays easy to install or use through the Internet. Education Causing reduce stress, 
systolic blood pressure and cortisol levels. Increase patient satisfaction, positive attitudes, subjective 
norms, perceived behavioral control and psychological factors, perceived sensitivity, screening and 
treatment of patients. Education spouses of women with breast cancer supportive care needs were 
reduced. 
Conclusion: Training in different ways on prevention, quality of life, reduces of pain and pleasure of 
the experiences of patients with cancer of the breast.  
Keywords: Patient education, breast cancer, prevention, education methods. 
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Abstract: 
Introduction: Breast cancer is one of the most common malignancies in women worldwide especially 
in the developing countries. Existing methods such as mammography screening and breast self-
examination(BSE) provides the possibility of early detection and can reduce mortality up to 25% .Since 
the prognosis in advanced stages of this disease is very bad, it is important to note high attention 
because women as wife or mother have great role . This study determined to study the effect of BSE 
education on women's knowledge and performances. 
Method: This is an experimental research in which 50 women were randomly selected and put into 
case (n=25) and control (n=25) groups. At first, demographic information, knowledge and performance 
collected by observation and interview. Then, experimental group received two training sessions. 
Result: The results showed that before the intervention no statistically significant difference was found 
between the two groups (Knowledge: p= 0.08, performance: p=0.7). One month after training course 
the experimental group members showed a significant difference from the other group. (Knowledge: 
p<0.001 performance: p<0.001). It seems that BSE is effective in women. 
Conclusion: It is useful to integrate the individual elements and social context in the design of a BSE 
program. Humans do such activities specifically for survival, healthy performance, continuous 
development and feeling good. It is hoped that the findings result in educational programs for women 
and help reduce breast cancer mortality. We suggest that future research should focus more on the 
understanding of how women weigh the risks and benefits concerning the personal and social factors, 
before they deny the efficacy of practicing BSE. 
Key word: education, breast self-examination, females 
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Abstract: 
Background: breast cancer is one of the most common cancer in women. Screening and treatments of 
breast cancer have led to increasing rate of survival. So pay attention to the quality of life of these 
patients is important. Sexual function is an important element of quality of life. Therefore the aim of 
this study was review the changes in sexual function in women with breast cancer after treatment.  
Methods: The following data sources were searched for relevant studies that were published in the 
English language by entering  keywords” Breast cancer”,” sexuality” and  “Sexual functioning”,  
between 1998 to 2014  
Results: disturbances to sexual functioning reported following the diagnosis and treatment of breast 
cancer Include:  dyspareunia, vaginal dryness, decreased libido and sexual arousal, difficulty achieving 
orgasm, decreased sexual activity, sexual dissatisfaction. Chemotherapy is associated with problem of 
arousal, lubrication, orgasm, vaginal dryness and dyspareunia. And evidence showed the negative 
relationship between sexual function and use of tamoxifen. Women treated with tamoxifen reported 
pain, burning or discomfort with intercourse, vaginal tightness, hot flashes and negative feelings during 
the sexual intercourse. Women who have had a mastectomy experience negative emotional changes 
such as negative body image, lack of attractiveness, loss of femininity and fertility, anxiety and 
depression, and that changes aggravated sexual problems. It should be noted that the factor predictive 
of sexual health in women after treatment is the quality of their relationship with the partner. 
Conclusions: Breast cancer can have an impact on woman’s sexuality, both psychologically and 
physically. Health care providers can play an important role in counseling and treatment patients with 
sexual problem. 
Keywords: breast cancer, sexual dysfunction, treatment 
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Background: Breast cancer is the second leading cause of death. In addition to the medical, social and 
cultural dimensions as well. The purpose of this study is overview on breast cancer and spirituality. 
Materials and Methods: The science direct، google scholar، SID and pubmed databases were 
searched. Finally, 21 article were examined for review in the present study. 
Result: Based on the results, of cognitive behavior therapy with spiritual treatment method is better 
than cognitive behavior therapy mere. And the amount of hope, sleep, physical activity, depression, 
cortisol and cytokineth1 levels and quality of life in women with breast cancer was improved. spiritual 
perspectives correlated with recovery after illness. Cancer diagnosis leads to Becomes spiritual crisis. 
spiritual health disorder causes depression and spiritual health promotion Becomes to increase 
compatibility. Spiritual identity, strengthen coping techniques. And patients often utilize of spiritual 
beliefs as a way to get a sense during illness. And to deal and cope with the death rely on it. 
Conclusion: Spirituality makes a positive impact on overall health and quality of life. The holistic care 
for patients with breast cancer with emphasis on Spiritual health is recommended. 
Keywords: Spirituality, breast cancer, quality of life, Health. 
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Abstract: 
Background: breast cancer treatments are very effective but may induce adverse events such as 
premature menopause. Most patient experience menopausal symptoms such as hot flashes. This 
symptom is the major complaint during treatment. Given that hormone therapy is contraindicated in 
these patients, and the use of non-hormonal therapies is recommended for these patients. Therefore the 
aim of this study was review the treatment of hot flashes in breast cancer patients. 
Methods: To get the purpose of this study, we investigation  related articles in pubmed, science direct 
and google scholar by entering  keywords,” hot flash”,” vasomotor symptoms”, “treatment” and “ 
breast cancer “ separately and combined. And related articles have been reviewed and evaluated.  
Results: The studies showed that serotonin reuptake inhibitors, serotonin norepinephrine reuptake 
inhibitors, antihypertensives and anticonvulsants significantly reduced the number and severity of hot 
flashes in this patient. 
Conclusion: Medications such as venlafaxine, paroxetine, citalopram, clonidine, gabapentin and 
Pregabalin can be used for treatment of hot flashes in women with breast cancer. It should be noted, the 
use of Fluoxetine and Paroxetine in patient being treated with Tamoxifen is not recommended, because 
reduce the efficacy of Tamoxifen. Black cohosh and phytoestrogens and sertraline will have little 
impact for treatment of hot flashes in these patients. 
Keywords: hot flashes, breast cancer 
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ABSTRACT: 
 
Introduction: Breast cancer patients may have unmet supportive care needs during treatment, 
including symptom management of treatment-related toxicities, and educational, psychosocial, and 
spiritual needs.  
Method: This study is written by review of the new library and internet articles. 
Result: Delivery of supportive care is often a low priority in health-care settings, and is also dependent 
on resources available. This consensus statement describes twelve key recommendations for supportive 
care during treatment in many countries, identified by an expert international panel as part of the 5th 
Breast Health Global Initiative (BHGI) Global Summit for Supportive Care. Panel recommendations 
are presented in a 4-tier resource-stratified table to illustrate how health systems can provide supportive 
care services during treatment to breast cancer patients, starting at a basic level of resource allocation 
and incrementally adding program resources as they become available. These recommendations 
include: health professional and patient and family education; management of treatment related 
toxicities, management of treatment-related symptoms of fatigue, insomnia and non-specific pain, and 
management of psychosocial and spiritual issues related to breast cancer treatment.  
Conclusion: Establishing supportive care during breast cancer treatment will help ensure that breast 
cancer patients receive comprehensive care that can help 1) improve adherence to treatment 
recommendations, 2) manage treatment-related toxicities and other treatment related symptoms, and 3) 
address the psychosocial and spiritual aspects of breast cancer and breast cancer treatments. 
Key words: supportive care, treatment, breast cancer, patients 
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Abstract: 
Metastasis is the major reason for breast cancer-related death. A microRNA is a small non-coding RNA 
molecule, which known to be aberrantly expressed in cancer, with some functioning as tumor 
suppressors and others acting as oncogenes. they are potential biomarkers for disease diagnosis. 
According to published paper that compared the expression profile of miRNAs in breast cancer tissues 
and peripheral blood versus in control sample, proved that some miRNAs were up-regulated in breast 
cancer as oncomir but data have proven that some of these up-regulated miRNAs (miR-10b, miR-373 
and miR-520c), exert their effects only in the metastatic cascade by influencing cancer cell adherence, 
migration, invasion. So according to this up-regulation and the role of these miRNA in metastatic 
processes, we can use mir-10b, mir -373, mir -520c as biomarkers. Emerging evidence indicates that 
the deregulation of miRs might play a crucial role in stimulation of cancer cell migration by regulation 
of gene expression, and identifies them as obvious novel candidate diagnostic and prognostic 
biomarkers, so represent a new class of therapeutics targets based on silencing of miRNA with the anti-
miRNA oligonucleotides to hinder metastasis. Subsequently we can decrease the progression of 
metastasis and cancer mortality by using anti-mir-10b, anti-mir-373, and anti-mir-520c. 
 
Keyword: breast cancer, metastasis, miRNA, Biomarker 
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Abstract 
for minimizing the suicide gene therapy side effects, we need to confine the lethal gene expression just 
to the cancerous target tissue. Hypoxia is present in the microenvironment of solid tumors such as 
breast tumors. The hypoxia-inducible factor (HIF) activates gene transcription via binding to the highly 
variable hypoxia responsive elements (HREs) in HRE-included genes. Consequently, pro-apoptotic 
gene Bax expression is increased and as a result will eliminate cancer cells. we want to use HRE 
element and BAX gene to make a new contract for killing cancer cells.  
we were amplified BAX gene by PCR using specific primers with appropriate restriction enzyme sites 
in their ends and clone this gene in pcDNA3.1 (+) vector. After that, we were amplified HRE element 
from PGK gene and cloned in 3' of BAX gene that cloned before in PcDNA3.1 (+). 
The construct was confirmed by colony PCR, restriction analysis and sequencing. Also HRE element 
amplified and colon in pcDNA3.1/BAX and confirmed by sequencing. 
We make new construct for gene therapy. It is noteworthy that the use of HRE elements and suicide 
genes together can target cancer cells such as breast cancer cells and kill cancer cell without any side 
effects. 
Keywords:Gene therapy,Bax,Hypoxi,HRE 
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Background: Cancer is one of the death reason in the world. Breast Cancer is the most common 
malignancy in the world. In almost 20-30percent of Breast Cancer ,we can see the over expression of 
HER2.The drug delivery to target tumor cells is performed by Aptamer (DNA or RNA oligonucleotide) 
that can bind to wide target molecules like drugs and proteins. This process is related to the increase of 
the effectiveness of chemotherapy and the decrease of toxicity of cell .Antibodies identify their own 
target cells. But Aptamer identify the large amount of molecules. By SELEX method (isolating 
systematic of Ligand by Expotential enrichment), Aptamer can be isolated for proteins, drug, or 
chemical structure.  
Material and Method: studies of reviewed article in 2010 _ 2013 
 Results: complex formed Aptamer _doxorubician .To consider the feasibility of this method, Apt_Dox 
was used as drug delivery system to the Breast Cancer Cells .And in HER2negative, Apt_Dox causes to 
decrease the toxicity in Breast Cancer Cells and it was compared in HER2possitive with cytotoxic free 
apt_dox and Dox that causes selective delivery. 
Discussion;Aptamers can bind to the target cell  by their own high affinity and special specificity, and 
can be used for targeting the Ligand in selective drug delivery. 
Key word: Aptamer, Breast Cancer, HER2 
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Abstract 
Breast cancer is most common cancer among women in the world. Unlike many other diseases which 
have a single cause, breast cancer does consequence of the interaction between numerous factors 
comprise both genetic characteristics and lifestyle factors. Lately, researchers have begun to notice the 
role of miRNA and their polymorphisms in breast cancer. miRNAs are small, single stranded, and  non-
coding RNAs. The miRNAs deregulation in breast cancer was ﬁrst reported in 2005. One of the causes 
of this dysregulation of miRNA expression is single nucleotide polymorphisms in those genes. This 
study aimed to investigate the possible relationship of the rs12940701 polymorphism in miR-152 gene 
and breast cancer, by the method based on RFLP-PCR for genotyping 200 cases and 100 controls. By 
using the SGD data base, DdeI enzyme was recognized suitable for identification of this polymorphism. 
By using the NCBI website the desired gene sequence was gotten and Oligo7 software was used for 
designing primers. The length and Tm of primers was studied by Oligo7 software, To evaluate the 
specificity of  primers and its lack of  binding to other parts of the genome  Blast program was used  
and RFLP-PCR can be optimized for investigation of this polymorphism. 
Key words: Breast cancer, miR-152, RFLP-PCR 
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Introduction 
Cancer is one of the diseases that make a lot of changes in the process of life and social activities of 
people. Cancer patients usually have some degree of stress and depression. The usefulness of 
psychological intervention to improve the psychological symptoms in much research has proven. The 
present study was performed to evaluate the impact of training programs on the rate of psychological 
stress and depression of patients with breast cancer. 
Material and Methods 
This aim of this study is a review for the latest findings about the impact of training programs on the 
rate of stress and depression in breast cancer patients. To approach the appropriate studies and articles 
websites search was performed and 20 articles in the field were studied. 
Results 
In most studies it has been reported that 60-66.4% of breast cancer patients suffer mild to severe 
depression and psychological interventions have greatly reduced the levels of stress and depression of 
these patients . 
Discussion and Conclusion 
Due to the positive impact of psychological interventions on reducing the rate of stress and depression 
among cancer patients’ psychological interventions as a successful approach are offered. As well as 
establishment and strengthen the supporting centers for compatibility with this disease is very 
influential. Of course, more attention of Ministry of health, treatment and medical education on 
psychological training programs in hospitals is also necessary.  
Keywords: Breast cancer, Stress, Depression, psychological intervention. 
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Abstract 
The purpose of this study was the differential diagnosis between the two types of invasive breast cancer 
(Lobular and Ductal) using MRI images in MATLAB software. In this perspective study ,20 patients 
with pathological confirmed  invasive breast cancer (10 lobular carcinoma and 10 ductal carcinoma) 
were examined. The images that analyzed included T1-w before and after contrast injection then these 
two sets of images were subtracted, after that these subtraction images were imported to MATLAB 
software for expected texture analysis. 10 gray level co-occurrence matrix texture features were 
obtained from each lesion. These features were compared in two types of breast cancers by statistical 
analysis. The data of these patients were categorized in two subgroups included ductal and lobular 
carcinoma (mean age: 52.6 ±9.5). The two groups were matched for age and sex with each other. The 
texture analysis based on co-occurrence matrix of two types of breast cancers showed significant 
differences (p=0.05).The results of this study indicated that texture analysis of MRI images can 
distinguish between two types of breast cancers. By using these results, we can assess breast lesions 
decision more accurately. Thereby texture analysis of breast lesions offering a new tool for radiological 
analysis of breast MRI. 
Keywords: Breast cancer, MRI, MATLAB, Co-occurrence matrix 
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Abstract 
BACKGROUND and OBJECTIVE: 
Approximately 60% of breast cancers among premenopausal women express the nuclear estrogen 
receptor (ER+). Adjuvant endocrine therapy is an integral component of care for ER+ breast cancer , 
exerting its effect by reducing the availability of estrogen to micrometastatic tumor cells. 
MATERIAL and METHOD:  
To present this review article, researcher used Adjuvant endocrine therapy and breast cancer as key 
words and searched the google scholar, Cochrane library ,Up-to-date and Pub-med sites, and the result 
was 10 articles, that after study all of them carefully we selected 5 of them, and use their data in this 
article.  
Findings: 
Tamoxifen is currently the standard of care for premenopausal women with hormone receptor- positive 
early breast cancers. However , endocrine strategies in premenopausal women include not only 
estrogen receptor blockade with tamoxifen but also temporary suppression of ovarian estrogen 
synthesis by luteinizing hormone- releasing hormone (LHRH) agonists, or permanent interruption of 
ovarian estrogen synthesis with oophorectomy or radiotherapy. To prevent premature ovarian filure 
(POF) , high risk, premenopausal women with early breast cancer were given a luteinizing hormone- 
releasing hormone analogue during adjuvant chemotherapy. 
 Discussion and Conclusions: 
These data showed that , in premenopausal patients with early breast cancer , the addition of an LH-RH 
analogue to adjuvant chemotherapy was well tolerated , prevented POF ,and was associated with 
excellent disease free survival and overall survival rates. 
Key words: Adjuvant EndocrineTherapy and Breast Cancer. 
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Abstract 
Introduction: The purpose of this study was to compare shoulder strength between women with breast 
cancer and healthy, matched controls. Comparison with healthy subjects specifies whether the upper 
disorders due to cancer and subsequent treatment or due to the natural process of aging. 
Method: Thirty-three postmenopausal women (51±6.46 years old) with breast cancer, on average, five 
years ago, the modified radical mastectomy surgery  with axillary node dissection was completed, 
received chemotherapy and radiation therapy and thirty healthy postmenopausal women (53.26±5.05 
years old) were selected. Shoulder strength was measured using a hand held dynamometer. Data were 
analyzed by MANOVA (P≤ 0/05).  
Results: The findings indicate significant differences between groups for 6 of the shoulder girdle 
strength measure (shoulder flexion, internal rotation, external rotation, horizontal adduction, scapular 
abduction and upward rotation, scapular depression and adduction) and respectively %74/1, %65/3, 
%75/5, % 63/9, %61/3, %74/8 strength reduction in patients compared to healthy controls. 
Discussion: The results indicate the importance of evaluating the shoulder girdle strength in women 
with breast cancer. Since, based on research findings, years after treatment, decreased shoulder girdle 
strength have been found in this patient, during the treatment and designing of training programs and 
rehabilitation for women with breast cancer, health care professionals need to be focused on special 
shoulder girdle strength factors. 
Keywords: Breast Neoplasms, Axillary Node Dissection, Menopause, Shoulder Girdle Function. 
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Abstract  
Breast cancer is one of the most common cancers among women but despite to the recent advances in 
cancer treatment, the lack of new treatment strategy with less side effect, is evident. On the other hand, 
common treatments have unwanted side effects. Nowadays refocusing on traditional medicine, not only for the 
safety of natural products but because of their rich complex chemicals with anticancer effects, is impressive. 
However, hydrophobic nature of phytochemicals prevent their absorption. Recent researches show that new 
form of curcumin called Dendrosomal Nano-Curcumin (DNC) has more anticancer effects and induces the 
apoptosis much more effective in compare to its free form. Therefore, in this study we have evaluated anti-
cancer effect of DNC on down-regulating survivin and its variants as an anti-apoptotic oncogene in MCF-7 and 
T47D cell lines. 
For this aim, toxicity effect of DNC (IC50) was estimated using MTT assay and respectively cells were treated in 
time and dose titration. Then, the expression of survivin and its variants evaluated using Real-Time PCR 
technique. Primary results suggest significant decreases in survivin and its variants expression. Overall, our 
results confirm the strong apoptotic effect of DNC which is associated with significant decrease in anti-
apoptotic activity of Survivin.  
 
Keywords: Breast cancer, Dendrosomal Nano-Curcumin, apoptosis, survivin, MCF-7, T47D 
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Abstract: 
A partial response or resistance to chemotherapeutic agents is considered as a main obstacle in 
treatment of patients with breast cancer. Refining taxan based treatment procedure using adjuvant 
or combination treatment is a novel strategy to increase the efficiency of chemotherapy. PPM1D 
expression was recently reported to modulate the recruitment of DNA repair molecules. In this study 
we examined the impact of arsenic trioxide on efficacy of paclitaxel-induced apoptosis in paclitaxel-
resistant MCF-7 cells. We investigated the expression of PPM1D and P53 in response to this 
combination treatment. Resistant cells were developed from the parent MCF-7 cell line by applying 
increasing concentration of paclitaxel. MTT assay applied to determine the rate of cell survival. DAPI 
staining using fluorescent microscopic technique was applied to study apoptotic bodies. Real-time RT-
PCR analysis was also applied to determine PPM1D and p53 mRNA levels. Our results revealed that 
combination of arsenic trioxide and paclitaxel has a synergetic effect on MCF-7/PAC resistant cells 
by decreasing the IC50 value from 500 to 250 ± 0.11nM. Applying arsenic trioxide also caused a 
significant decreases in PPM1D mRNA level (p< 0.05). Our findings suggest that arsenic trioxide 
Increases paclitaxel-induced apoptosis by down regulation of PPM1D expression. PPM1D-
dependent signaling pathway can be considered as a novel target to improve the efficacy of 
chemotherapeutic agents in resistant breast cancer cells. 
KEY WORDS: Combination therapy, arsenic trioxide, resistant breast cancer, taxan. 
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ABSTRACT 
Background: At least 20% of breast cancers are characterized by triple-negative receptor status 
(negative for estrogen receptor (ER), progesterone receptor (PR), and HER2. Human epidermal growth 
factor receptor (EGFR) is a member of the EGFR/ErbB/HER family of Type I transmembrane tyrosine 
kinas receptors.  
Patients and Methods: Nine patients had TN-EGFR-positive with MBC. EGFR positivity was defined 
as staining in >10% of tumor cells by Immunohistochemistry. In total, nine patients was enrolled that 
the mean age was 46.7 years. All patients been from kurdish ethnicity in west of Iran. Patients received 
erlotinib 150mg daily.  
Conclusion: This suggests there may be a subset of TN, EGFR- positive MBC for whom EGFR-
directed therapy may be suitable or that the natural history of their disease was indolent. Future studies 
to determine molecular and clinical profiles of patients likely to benefit from EGFR-TKI therapy. 
Keywords: Breast Cancer, Erlotinib, Targeted Therapy, Triple Negative  
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Abstract 
Background: Leptomeningeal metastasis refers to the multifocal seeding of the leptomeninges by 
malignant cells. Carcinomatous Meningitis (CM) occurs in approximately 5% of patients with breast 
cancer. Herein, we suggest that IT can use in treatment of breast cancer patients with CM before of any 
treatment until can prevent of going patient to debilitating phase of this disease.  
Patients and Methods: Three patients with high risk breast cancer with leptomeningeal metastasis: A 
62 year-old Kurdish woman with a history of lung tuberculosis. Her cerebrospinal fluid was positive for 
malignant cells. She treated with intrathecal chemotherapy and died 3 months after diagnosis of CM. In 
cerebrospinal fluid (CSF) analysis with diagnosis of CM treated with brain irradiation and multiple 
courses of intrathecal chemotherapy. After six months she is well still and in follow up now. She 
treated with intrathecal chemotherapy and she is alive yet.  
Conclusion: According to the poor prognosis of this disease it is better that in high risk breast cancer 
patients like NHL high risk patients IT prophylaxis was done for these high risk because by this way, 
we can prevent of going patient to debilitating phase of this disease. 
Key Words: Breast Cancer, Carcinomatous Meningitis, Intrathecal Chemotherapy 
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Background: Breast cancer is the most common malignancy in women. Triple negative breast cancer 
(TNBC) (the genes for estrogen receptor, progesterone receptor and Her2neu does not express) account 
for around 15 to 25 percent of all breast cancer cases. This type of cancer consists of highly aggressive 
tumors with poor prognosis that occur in women younger than age 50. The tumors are initially very 
sensitive to chemotherapy but their molecular subtypes are significantly more aggressive than other 
types of tumors. The patients with TNBC have worse prognosis than patients with Estrogen Receptors 
positive (ER+) breast cancer. The aim of this study is to investigate the relationship between hormonal 
and reproductive factors in patients with TNBC.  
Methods: The present study is a comparison study that was conducted at the Breast Cancer Research 
Center of ACECR. 160 patients with TNBC were compared with 708 ER+ patients with respect to their 
diagnosis age, menstrual and reproductive history, lactation and oral contraceptive use. The analysis 
was done by SPSS 16 and t-test and chi-square were used to analysis the results.  
Results: The mean age of patients was 47.64±11.25. The results showed that there was no significant 
difference between the two groups in terms of age at menarche, menopausal status , history of 
pregnancy , history of menstrual cycles and lactation status (p-value>0.05). However there was a 
significant difference between two variables including the age of first pregnancy (p-value: 0.014), and 
duration of oral contraceptive use (p-value<0.001).  
Conclusion: Results of this study showed that there is a significant difference between triple negative 
group and ER+ group with respect to two variables including age of first pregnancy and duration of oral 
contraceptive use. It is recommended to conduct further studies to determine the exact mechanism 
involved in the process and to investigate also effects of other hormonal factors associated with triple 
negative breast cancer.  
Keywords: Breast cancer, Triple negative, Reproductive factor. 
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Introduction: A cancer diagnosis has tremendous consequences for most persons who experience it. In 
the case of breast cancer the treatment usually consists of surgery, radiotherapy, chemotherapy, and 
hormonal treatment. All these factors may, impact the patients quality of life. It has been shown that 
assessing QOL in cancer patients could contribute to improved treatment and could even be as 
prognostic as medical factors. This study reviews psychosocial implications in breast cancer patients 
and its association with QOL.  
Material and methods: We searched the PubMed, Google Scholar, BMC journal, Cochrane library, 
and Uptodate databases and the keywords were breast cancer, quality of life, Psychological distress and 
treatment. 
Results: Women with breast cancer may experience distinct psychosocial related concerns, anxiety, 
depression,  low emotional functioning, weight gain, physical inactivity, and unhappiness with 
appearance, feeling less useful in life, uncertainty about the future, psychological distress related to 
family distress, diagnosis, treatment, and necessity for regular aftercare visits, negative feelings, social 
avoidance, distress about the family's future,  infertility, premature menopause, diagnosis of disease, 
fears of death, suffering,  disease recurrence, sense of aloneness, social concerns included interference 
with activities at home, employment, and financial burden, concerns regarding payment for the 
healthcare costs,  impairment of body image, alteration of femininity, sexuality ,  attractiveness,  
difficulties in occupational tasks, organizing leisure time activities, and pursuing their hobbies are 
factors that can cause unexpected psychological distress even years after diagnosis and treatment. 
Psychological factors also were found to predict subsequent quality of life or even overall survival in 
breast cancer patients. Supportive care:  interventions such as counseling,  providing social support and 
exercise could improve quality of life. Short-term positive changes in fatigue, trait anxiety, depression, 
and QoL was seen following cognitive behavioral therapy for insomnia in Breast Cancer Survivours. 
Physical Activity had beneficial effects on health, physical strength, sexuality, relationships, and social 
functioning.  For many survivors, pregnancy and parenthood can represent normalcy, happiness and life 
fulfillment. 
Conclusions: More attention to Psychological factors could improve QOL in women with breast 
cancer. 
Key words: breast cancer, quality of life, treatment, Psychological distress 
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Abstract 
Background: Cytokeratin19 (CK19) is a part of the cytoskeleton which abundantly expressed in the 
majority of epithelial tumor cells and is used as a tumor marker in cancer. Ki67 is a cellular 
proliferation marker as well as a cancer antigen that is found in growing and dividing cells. This 
characteristic makes Ki67 a good tumor marker.  
Methods: In the present study, 25 patients and 25 healthy women as control were evaluated. Total 
RNA was extracted from blood. RT-PCR technique was applied to the extracted RNA, using specific 
primers. RT-PCR assay was used for detection of CK19 tumor marker and Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) as an internal control.  
Results: In this study, CK19 was detected in 32% of breast cancer patients but CK19 was not positive 
in the healthy controls. The CK19 gene expression in blood was assessed and compared with Ki67 gene 
expression; pathologic characteristic of patients. The association of the CK19 and Ki67 gene expression 
was statistically significant with P value =0.000. 
Conclusion: It was shown that CK19 gene expression is potentially related to the Ki67 expression and 
it could be involved in the pathogenesis of breast cancer. 
 Key word: Ki67, RT-PCR, CK19  
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Abstract 
 Breast cancer is the top cancer in women in developed and developing countries. Social awareness 
about breast cancer and its symptoms is one of the main substantial factors guide to early detection. The 
purpose of this research is to evaluate knowledge and awareness about breast cancer among Zabol 
medical students. A questionnaire with “Cancer Research UK breast cancer awareness Measure” 
criteria was given to 148 medical students to determine their knowledge about breast cancer symptoms, 
age-related risk, confidence to notice a breast change, anticipated delay in presentation and frequency 
of breast checking. Data analyzed using SPSS22 software statistics tests. Respondents mean age was 
22.01±3.43. Out of 148 respondents, 63 (43%) were male and 85 (57%) were female. Out of all, 32 
(22%), 72(48%) and 44(30%) respondents were with poor, average and good knowledge and awareness 
about breast cancer respectively. The study points to insufficient knowledge about breast cancer among 
Zabol medical students. We recommend more programs targeting medical student awareness about 
breast cancer. We are estimating poor knowledge about breast cancer in society. Therefore we are 
strongly suggesting health providers to lead programs in order to increase social awareness about breast 
cancer to decrease its complications. 
Keyword: Breast cancer, knowledge, medical students. 
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Background: Cancer is a wide range of diseases, whose etiology, treatment and prognosis are special. 
After cancer, cardiovascular disease is the second leading cause of death in human breast cancer is the 
most common and most lethal and the most emotional and psychological impact of cancer. 
In general, breast cancer detection and treatment of emotional problems, emotional, and psychological 
deep in the patient's health is negatively affected. 
Cognitive-behavioral .drman complex mixture of some important aspects such as behavior 
modification, cognitive therapy, according to the Social Cognition and facilities-individual reality. 
Materials and methods: This review has been performed by many new articles about the role of 
religion in the elderly has been the site of a valid use of google scholar, cochrane library, pubmed, 
alternative medicin, iran medex 
Findimg: efficacy results of research conducted stress management cognitive-therapy for women with 
breast cancer, anxiety and depression. Improving Quality of Life effectively. 
Results: Studies have shown that due to the fact that cancer is a problem of psycho-neuro-cognitive 
And psychological factors play a significant role in cancer formation And diagnosis and treatment of 
cancer, as well as significant psychological consequences such as anxiety, depression and stress to 
follow.  
Keywords: Cognitive-behavioral interventions for anxiety, depression, stress, breast cancer 
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Abstract 
Background: Breast cancer is a major health concern and a cause of deaths in women worldwide. 
Although BSE have a significant role in reducing morbidity and promote early diagnosis of breast 
cancer among women, but the percentage of women refrain from doing it . Therefore, the present study 
was performed to investigate the barriers to perform BSE Of the Viewpoint of women nurses working 
in hospitals Asadabad city of Hamadan in 2014 
Materials and Methods: In this descriptive study, all nurses (n = 100) employed in Asadabad city 
hospitals were studied.The data collection tool was a valid and reliable questionnaire. To analyze the 
data, spss statistical software (version 16) and descriptive statistics (simple and relative frequency, 
mean and standard deviation) was used . 
Results: The response rate of 74 % (74 patients). The mean age of the sample was 29.3±5.67. 49.6% 
nurses were single and 70 % were less than 10 years of experience. Nearly half of the sample (47.3%) 
did not perform breast self-examination and 75 % (n = 55) did not go to a doctor for a breast exam 
annually. Some of the barriers  to perform BSE include lack of awareness(8.1%) ,  lack of time (8.1% ) 
, lack of belief tothe BSE (6.8%) , forget (6.8% )  and fear of finding a tumor (2.7% ) respectively. 
Conclusion: According to results of the study and given a prominent role of breast self-examination in 
reducing morbidity and mortality from breast cancer is necessary performing person and non -person 
training courses in order to changing perspectives of nurses about breast self-examination. 
Keywords: breast cancer, breast self-examination, nurses, Barriers 
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Background: Breast cancer is by far the most common cancer among women globally and about 1.2 
million women suffer from breast cancer in the world every year. Black tea is a commonly consumed 
beverage in the world, comprising approximately 80% of all tea consumed. Coffee and black 
teas contain a mixture of compounds that have the potential to influence breast cancer risk and survival. 
However, epidemiologic data on the relation between coffee and black tea consumption and breast 
cancer survival are sparse. The aim of this study is investigation effects of black tea and coffee on 
breast cancer. 
Method: We studied recently published (2009-2014) and reviewed articles regarding Black Tea, 
Coffee and Breast Cancer. 
Results: 27 studies were found. Coffee may influence risk and progression through the inhibition of 
DNA methylation, influences on tumor differentiation or alterations in sex hormone levels. Black tea 
has also been shown to alter sex hormone levels and the flavonoids it contains may have antioxidant 
effects. Caffeine is found in both coffee and black tea, and in rodents has been shown to increase 
mammary cell differentiation and decrease tumor incidence. Conversely, caffeine has also been 
associated with increased mammary tumors in animal models. Coffee consumption and breast cancer 
risk have been extensively studied with conflicting results. However, to our knowledge, only one 
observational study has examined coffee consumption and survival following breast cancer diagnosis 
and no studies have examined black tea or caffeine. 
Conclusion: Our findings suggest that coffee, black tea, and caffeine consumption before breast cancer 
diagnosis do not influence breast cancer-specific and overall survival. 
Keywords: Black Tea - Coffee - Breast Cancer. 
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Abstract 
Background: Breast cancer is the most common cause of cancer death among women worldwide. 
Aberration in signal transduction pathway of ErbB family in human tumors is a common phenomenon. 
ErbB4 as an oncogene and also tumor suppressor is one of the members of ErbB family. ErbB4 
overexpression has been observed in approximately 50% of breast cancer cases. miRNAs are the large 
subgroup of noncoding RNAs with 18-25 nucleotides inhibiting the expression of target genes by 
means of binding to their 3’UTR. They also can play role as an oncogene and/or tumor suppressor. In 
recent years, the association of some SNPs located in either miRNA seeds or 3’UTR of their target 
genes with the risk of breast cancer have been proved in some populations. 
Material and method: miRNASNP database was used to identify the miRNAs with the ability to bind to 
the 3’UTR of ErbB4 transcripts. In next step, miRTarBase and DAVID databases were used to 
investigate the function and the related signaling pathways of obtained miRNAs.  
Results: In silico investigation of SNPs in the 3’UTR of ErbB4 gene showed that rs1836724 could alter 
the binding properties of miR-665, miR-708 and miR-335. Due to rs1836724, the binding activity of 
miR-335 (as an oncomiRNA) and miR-665 (as a tumor suppressor) undergoes gain and loss 
respectively; consequently, this SNP could act as a poor-prognostic factor.  On the other hand, the 
binding affinity of miR-708 (as an oncomiRNA) alleviates as a result of rs1836724; therefore, 
rs1836724 could also acts as good-prognostic factor. 
Conclusion: Bioinformatically, rs1836724 could have association with breast cancer, especially with 
prognosis of patients. 
Keywords: Breast Cancer, ErbB4, microRNA, Prognosis, rs1836724. 
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Intrudaction:Breast cancer in pregnancy is nott  common but  it is a diffrentioal  clinical situstion for 
patient and physition. 
Studies has shown that maximum diagnostic and therapetoic strategies for breast cancer in pregnancy is 
nessesery. The aimof this 
 study was assesment  of diagnostic sterategy,,therapetoic methods and prognos of breast cancer in 
pregnancy. 
Methods:Articles  have chosen in pup med  and English language that analysed by author.   
Results:In some of studeis Mammography wase  used for diagnos and applied Radical mastectomy or 
Nidle aspiration  biopsy 
for treatment. In any of them didn’t Radio thraphy but Chemothraphy and  Tamoxifen after first 
trimsester  was common in 
pregnant wemon . 
Conclusion: Although breast cancer in pregnancy isn’t common but it need to exactly  study for  
ditection high or low risk and  
staging for applay  treatment methods  in first pregnancy  visit that due to promotion of  mothers health. 
Keywords:Breast cancer,Pregnancy,Diagnos ,Treatment 
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Abstract 
Breast cancer is the most common cancer in women both in the developed and developing countries. It 
is estimated that worldwide over 508,000 women died in 2011 due to breast cancer Although breast 
cancer is thought to be a disease of the developed countries, almost 50% of breast cancer cases and 
58% of deaths occur in developing countries. The purpose of this research was to study pathologic 
features of Patients with breast cancer in Zabol medical university hospital in 2014. In this cross-
sectional study, pathologic reports of breast biopsies were collected from pathology department of 
Zabol medical university  in 2014. Final information examined by descriptive statistics tests using 
SPSS22 software for analysis. The mean age of the patients at diagnosis was 37.45years (range,18-
80years). Out of 20 breast biopsies obtained in 2014, 40% reported as fibroadenoma, 10% reported as 
gynecomastia, 10% reported as lipoma, 10% reported as invasive ductal carcinoma(ICD-O 
C:50.9/M:8500/3)and 5%reported as medullary carcinoma(ICD-O C:50.9 E:8510/3). The future 
worldwide breast cancer burden will be strongly influenced by large predicted rises in incidence 
throughout parts of Asia due to an increasingly “westernised” lifestyle. Efforts are underway to reduce 
the global disparities in survival for women with breast cancer using cost-effective interventions. 
Keyword: Pathologic study, breast biopsy 
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Introduction 
     Is one of the most prevalent kind of cancer amorg women .according to statistics,from each and 
women ,one of them was stricken to this cancer .what is important here?reserching and delibration 
about it ,because by it is reason and regenerator identification,we are able to have an exact planing for it 
is prevention on reedy women So in this article we try to study ways of it is prevention the method of 
performance  
We obtained this article by checking ,delibration and studing some websites and different another 
articies Like.to bian ,rasekhoon ,google  scolar ,iron medxand etc.. Totally we studied 14diffrent 
articles,and results are here conciusions             has specified causes which by acquaintance and 
introducing them ,it is possible to prevent ready women from suffering from cancer  
As respects this kind of cancer is one of the most incident cancer among females and generaly its 
recognizable in end and rampant levels so it is important and possible for us to prevent suffering in 
ready woman by public training of prevention ways like  ,riddle ,primery and early discretion morns of 
it.                                                                         
We can enumerate regenerator reason from hereditary reason like family <records>and persond 
<records>to acquired and environment causes .like drinking alcoholic,smoking and etc.which by 
stoping these dangerous habitos and waening from  these habits we can prevent suffering to that. 
Keywords:breast،cancer،treatment 
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Abstract 
Introduction: Breast cancer could be considered as a significant cause of morbidity and mortality in 
women. Conventional mammography has high sensitivity and moderate specificity in breast tumors 
detection. Recently, positron emission mammography (PEM) has become available for breast imaging. 
PEM was developed to overcome the limitations of PET in breast screening. In this study, the 
feasibility of utilizing the PEM method for breast cancer screening is investigated. 
Methods: In December 2014, PubMed and science direct were searched using the exact phrases 
‘Positron emission mammography’ and ‘breast cancer screening’ in title and/or abstract fields. Of the 
records articles, the full-text of relevant papers was selected to be reviewed. 
Result and Discussion: In many studies a promising results were reported for breast cancer screening 
by PEM method. In the Berg et al study, the sensitivity and specificity of PEM was 93% and 85%, 
respectively, for index lesions and 90% and 86%, respectively, for index and incidental lesions. They 
also reported that adding PEM to conventional mammography and ultrasound yielded sensitivity and 
specificity of 98% and 41%, respectively.  
Conclusion: Despite the limitations of PEM method, it could be a promising technique for breast 
screening in hybrid imaging or as a single imaging method. 
Key Words: Breast screening; Breast cancer; Positron emission mammography. 
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Abstract 
Breast cancer is a worldwide leading cause of death. The treatment modalities for breast cancer are 
surgery, hormone therapy, radiotherapy, chemotherapy and antisense therapy (include siRNA).The poor 
results obtained with single siRNA delivery have encouraged the development of concomitant 
strategies by use single siRNA with other therapeutic agents like Doxorubicin. Association and synergy 
between siRNA and doxorubicin also reduce toxicity of doxorubicin because of use in combination 
with siRNA, that allowing the use a lower dose of doxorubicin, cause improve their therapeutic effect 
on breast cancer. This method could overcome potential drug resistance by combining agents with 
different mechanism of action. Combination therapy successfully applied in the treatment of many 
types of cancer specially breast cancer. In addition, it will also assess these synergistic effects on other 
types of cancer and in combination with other drugs. 
Key words: Breast cancer,  siRNA, Combination therapy, Doxorubicin 
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Abstrct: 
Background: The purpose of this research was to develop a quantitative real-time PCR for CK19 
(Cytokeratin 19) - mRNA and evaluate its potential for the molecular detection of breast cancer cell 
lines. 
Methods: The method is based on real-time PCR (Polymerase Chain Reaction) by fluorescent SYBR 
green. RNA was prepared from MCF7, MDA-MB-231, SKBR3 and T47D breast carcinoma cells and 
cervical cancer cell line (HeLa) as a negative control. This RNA was screened for mRNA of CK19 
and Glyceraldehyde 3-phosphate Dehyrogenase (GAPDH) by real-time PCR and the results validated 
by Electrophoresis. The average ∆Ct of CK19 and GAPDH was calculated in each cell line as well as 
the ∆Ct 
of GAPDH from different cell lines. Quantitative CK19 expression was calculated using the ∆∆Ct 
method. 
Results: Variable degrees of expression of CK19 was detected in MCF7, T47D and SKBR3 cell lines 
while MDA-MB-231 cell line was not expressed CK19 by this method. 
Conclusions:   Real-time PCR technique is sensitive, accurate and reliable method which can be 
used for high throughput comparative quantification oftrnnor marker studies. 
Keyword: Breast cancer, cell line, CK19, Real-time PCR 
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Abstract 
In this cross sectional study, we tried to investigate the difference of clinicopathological characteristics 
of tumor between metastatic breast cancer patients at initial presentation and patients with metastatic 
breast carcinoma (MBC) in the follow up time. 
Medical records of 290 patients with MBC at initial presentation (n=115) group I or in follow up time 
(n=175) group II between 1997 and 2012 were retrospectively evaluated.  
The mean age of the patients at diagnosis in group I was 48.2 years and in group II was 50.6 years. 
Compared to de novo metastatic disease, MBC tumors in the follow up time were more likely to be 
grade 3 (34.4 % vs. 28.4 %), estrogen receptor (ER) positive (60.8 vs. 72.9 %), progesterone receptor 
(PR) positive (54.3 % vs. 66.7 %), and HER2-positive (37.6 % vs. 41.2 %), tumor size greater than 5 
centimeter (T3) (31.6 % vs. 52.6 %), axillary lymph node positive ( 13.2 % vs. 35.5 %).The results 
indicate that there is a meaningful correlation between tumor size and positive axillary lymph node 
(P=0.002 & P=0.001 respectively) and the presence of metastatic breast cancer at initial presentation 
compare to metastases in the follow up time.  
Our study showed that tumor size and axillary lymph node involvement are independent variables in 
metastatic breast cancer to predict the probability of metastasis at initial presentation. 
Key words: breast cancer, tumor characteristics, metastases 
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Abstract 
Cytokeratin19 (CK19) is the intermediate filament protein and describes as a marker for mammary 
carcinoma cells. On the other hand, breast cancer cell lines are excellent experimental models for 
cancer research. The purpose of this study is to investigate the expression of CK19 marker in different 
human breast cancer cell lines by RT-PCR and Western blot analysis. 
The human breast cancer cell lines MCF7, T47D, MDA-MB-231, SK-BR-3 and cervical cancer cell 
line (HeLa), as a negative control, were used. After extraction of RNA and proteins from cells, 
Extracted RNA from each cell line was analyzed for CK19 gene expression by using specific primers. 
Extracted proteins were analyzed by using mouse monoclonal anti-human CK19. 
In this study, overexpression of CK19 was detected, respectively, in MCF7, T47D and SK-BR-3 by 
RT-PCR. Using Western blot technique, most of CK19 expression was detected in SK-BR-3. CK19 
expression was not detected in MDA-MB-231 by the two methods. 
Expression of CK19 could be different by RT-PCR and Western blot analysis in breast cancer cell 
lines. CK19 expression can be related to the HER-2 and ER markers. However, regarding important 
role of cell lines in the investigation of cancer biology, different expression of markers in breast cancer 
cell lines and sensitivity of the used techniques should be more considered. 
Keyword: Breast Cancer, CK19, Cell Lines, RT-PCR, Western blot. 
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Abstract 
 
An urgent need in cancer control today is to develop effective and affordable approaches to the treatment of 
breast cancer. In order to achieve this goal, producing drugs with high efficiency and low side effects is 
essential.There is no doubt that diet plays an important role in cancer prevention. Getting advantages of natural 
products and their therapeutic potential in nanotechnoloy is one of the prominent accomplishments of this field. 
Curcumin is the flavoring agent of turmeric with various therapeutic effects especially anti-tumor activity. 
Applying nanopartcals have improved these properties and turned dendrosomal curcumin to an effective agent in 
cancer treatment. Following the pervious researches we studied the apoptotic effect of this agent through 
evaluating the expression of BAX and BCL-2 genes in MCF-7 and T47D breast cancer cell lines. MCF-7 and 
T47D cell lines were cultured, cell viability was measured by MTT assay, the cells were treated with both void 
and dendrosomal curcumin  and the expression of BAX and BCL-2 genes were measured by semi quantitative 
RT-PCR. Toxicity assay shows that dendrosomal curcumin significantly suppresses proliferation of MCF-7 and 
T47D cancerous cell lines. Also DNC affected significantly the expression of apoptotic BAX and BCL-2 genes. 
Keywords: Breast cancer, dendrosomal nanocurcumin, apoptosis 
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Background: Women diagnosed with breast cancer may experience  great emotional distress and 
develop a variety of psychological problems including insomnia, loss of appetite, suicidal thoughts, fear 
of cancer recurrence and fear of death. Using the strategies cause individual’s health improvement and 
coping. All these concerns can create psychosocial adjustment disturbances, including anxiety, 
depression other affects or coping disabilities. The aim of this study was to determine coping strategies 
used in women with breast cancer in Shiraz.  
Methods: In this study, 50 patients with breast cancer participated. Their adjuvant treatments had been 
completed. To measure coping strategies, was used Jalowiec coping strategies questionnaire. The 
results were analyzed by using spss.v.16. 
  Results: The mean age of participants was 48.48 ± 8/53. 92% of the participants were married, 42% 
educated diploma and 70% housewife. Average of problem-oriented coping strategies score was 
(41.68± 10.29) and the average emotion-focused coping strategies scores was (81.56±11.27).  
Conclusion: Given that most women with breast cancer have used emotion-focused strategies. It is 
essential that the patient care team should pay attention to support and the necessary training related to 
problem-oriented strategy to women with breast cancer. Thus, it is suggested to be considered as a part 
of treatment program in these patients. 
 
Keywords: Breast cancer, Coping Strategies 
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Abstract 
Breast cancer is one of the most common diseases in worldwide. Clinical efficiency of chemotherapy 
because of side effects, toxicity and drug resistance is limited. Thus, there is interest for using plants as 
a promising source of anti-cancer drugs with more efficient. Citrullus colocynthis fruit has cytotoxic 
effects against cancer. In this study, the effect of hydro alcohlic extract of Citrullus colocynthis fruit on 
the expression of caspase-3, one of the factors contributing in induction of apoptosis was studied.This 
study was performed on MCF-7 cell line. Citrullus colocynthis fruit extract was prepared using 70% 
ethanol. Then cells were treated by concentrations of 200 and 400 µg/ml and harvested on 24, 48 and 
72 h after treatment. The expression of caspase-3 was studied by Real-time PCR.The results showed the 
level of gene expression of caspase-3 increased significantly with increasing concentration and time 
compare to control. It seems that Citrullus colocynthis fruit extract cause death of cancer cell by 
induction of apoptosis. 
Keywords: breast cancer, Citrullus colocynthis, caspase-3 
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Abstract 
Background: Cytokeratin19 (CK19) is a part of the cytoskeleton of epithelial cells. It is a sensitive and 
specific marker of epithelial cells that expressed in breast cancer cells. Immunofluorescence microscopy is a 
powerful technique that is widely used to assess both the localization and expression levels of proteins. On 
the other hand, T47D and MCF7 are two human hormone-dependent breast cancer cell lines, which are 
widely used as experimental models for breast cancer studies. 
Materials and methods: breast cancer cell lines (MCF7, T47D) were cultured in RPMI 1640 containing 
10% fetal bovine serum (FBS) and penicillin-streptomycin antibiotic. Then, cells were fixed with 4% 
paraformaldehyde and permeabilized with ice-cold 100% methanol. The cells were blocked with 1% BSA 
and were stained with CK19 antibody. Finally, CK19 expression was elevated by immunofluorescence 
microscopy. 
Results: Immunofluorescence microscopy was used to detect the CK19 expression in T47D and MCF7 
cells. The result showed that T47D and MCF7 cells were CK19-immunoreactive cells and CK19 was 
mainly located in the cytoplasm of these cells. 
Conclusion: T47D and MCF7 cell lines belonged to luminal A subtype of breast cancer that CK19 
expression correlated whit ER (Estrogen) marker. Expression of CK19 in the estrogen positive (ER+) breast 
cancer cell lines suggest that these cells have originated from luminal epithelial cells.CK19 is an epithelial 
marker that estrogen regulated its expression in luminal A subtype of breast cancer cell lines. 
Keywords: CK19, MCF7, T47D, Luminal A 
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ABSTRACT  
Introduction: identifying the risk factors for metastasis is major concern for treatment processes of 
cancer patients. Metastasis makes patients frail and increase hazard of death. It also decreases physical 
and psychological quality of life of patients. Aim of this study is determining of prognostic factors for 
metastasis of breast cancer using conditional regression model. 
Materials and Methods: in this survival study, hospital records of 246 women with breast cancer who 
underwent surgery and treatment at hospital Fayyazbakhsh were used. Patients were followed and their 
final situations recorded until 2012 May. Metastasis free survival estimated with Kaplan-Myier method. 
To determine the prognostic factors, a conditional regression model called PWP fitted. All statistical 
analysis was conducted with R software. 
Results: 202 patients (82.1%) were alive until follow up and 44 patients (17.9%) died.54patients 
experience metastasis. 11 patients (4.7%) had two metastases. Most of metastases were shown in bone, 
liver, lung and brain. Median metastasis free survival (MFS) estimated 64 month. One, two and three 
year MFS were 88%, 80.1% and 76.6%, respectively. Lymph node involvement and HER2 were shown 
as prognostic factors for metastasis. Age, Estrogen Receptor, Progesterone Receptor, Grade and tumor 
size variables were not significant (P> 0.05). 
Conclusions: number of lymph nodes involvement as a prognostic factor involve more nodes and 
increase risk of metastasis and death. Thus prognosis and treatment of cancer in early stages increase 
survival of patients.   
 
Keywords: Breast cancer, Metastasis, Metastasis free survival, Conditional model. 
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Introduction: 
Increasing rate of different cancers all over the world in spite of decreasing most known cancer 
inducing factors indicates that very important neglected factors are acting as etiologic cause of cancer. 
Many scientists and pathologists from the past century have been proposed an etiologic role of 
microbes in cancer induction and an infectious entity for tumors. The aim of this review was to research 
on the role of Epstein-Barr virus (EBV) in the breast cancer. Methods: 
All of the review, systematic review and other original studies of Pubmed, Cochrane library and 
internet based related records in the time course of 2004-2014 years were collected and studied in this 
research.  
Findings: 
EBV is one of the common viral infections of humans with more than 95% of population affliction 
which have been proposed as a probable cause of breast cancer. Important studies have been done on 
the elucidation of relationships of EBV proteins (including EBNA-1, LMP-1, and EBER) and viral 
sequences in breast cancer cells.in laboratory studies transfection of p31 fragment of EBV DNA has 
immortalized epithelial cells including mammary epithelial cells.The etiologic role of virus was 
strongly discussed in induction of subtypes of Hodgkin’s and non-Hodgkin’s lymphomas (especially 
Burkitt’s lymphoma), HIV/AIDS lymphomas, nasopharyngeal carcinoma and gastric carcinoma, 
primary invasive breast cancer (PIBC). 
Discussion and Conclusion: 
Although in many of the studies the etiologic relation have not been confirmed definitly, but presence 
of viral gene sequence  in tumor cells and poor prognosis of patients carrying viral gene or proteins in 
the serum have proposed a strong role for EBV as inducing breast cancer in addition of other genetic 
and environmental factors. Some intrinsic characteristics of EBV such as immunodeficiency induction 
in patients, similar to other microbes are among pivotal factors of cancer induction processes.   
Key Words: Breast cancer, EBV, etiology 
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ABSTRACT  
There are problems such as treatment failure, drug resistance, heavy costs and other problems 
related to cancer treatment, which cause the plants to attract the interest of many researchers, 
because they have no side effects. In this study effect of Nigella Sativa on, caspase-3 gene expression, 
one of genes inducing of apapotosis was studied. First Nigella sativa was extracted by 70% ethanol 
and concentrations of 200 and 400 µg/ml were prepared and MCF-7 cell lines treated by extractions. 
Then cells harvested on 24, 48 and 72 hours after treatment. Expression of caspase-3 was evaluated 
by Real-time PCR .The results showed that caspase-3 gene expression in MCF-7 cells was not changed 
significantly by Nigella sativa extract. As the concentrations of extract used in this study had no effect 
on caspase-3 gene, it seems that other concentrations of Nigella sativa was effective or other genes in 
apoptosis pathway were affected.   
Keywords: Breast cancer, Nigella sativa, Drug resistance 
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Abstract    
 Background: Breast cancer is the most common malignancy between women in the world and Iran. 
KI67 is a biological marker that is activated in cell proliferation process. In this study we wanted to 
evaluate of the relationship between axillary lymph nodes involvement and Ki67 over expression in 
Breast cancer patients 
Method: In this study, Breast cancer patients admitted to our oncology department , during 2002-2012 
,were evaluated. The Ki67 correlated with age, menopausal status, histologic tumor type, disease stage, 
tumor size, lymph node involvement, hormon receptor (ER, PR), Her2, distant metastasis and the 
overall survival were studied.  
Results: In this study of 2723 cases of female patients with breast cancer were studied, of whom data 
were available for KI67 in 449 of the records. Patients divided into two group as follows: High KI67 
(>=14% ) and Low KI67(<14%). The mean age was 49.3. The most common stag at presentation was 
stage II( 46.8%). In assessing lymph node involvement, 37.9% of patients were N0; 29.3%on N1, 23.1 
on N2 and 9.7on N3. In 66.2% of N0 patients, the 70.9% of N1, 61.7% of N2 and 64.7% of N3; KI67 
rate was high. Although lymph node involvement is associated with KI67, and the relationship of the 
group N1 is the highest, but in this study there is not statistically significant relationship (P-value = 
0.623) in patients with  Her2 positive, patients with high KI67 is significantly more than another group( 
Low KI67) (PV=0.03). On survival analysis performed in patients with Ki67 less than 14% clearly have 
a higher survival rate compared to others. (PV = 0.02). 
Conclusion: The results of this investigation indicate that higher value of KI67 does not accompany 
with the high probability of involving lymph nodes, but due to high level of this factor with decreased 
survival period, we conclude independently to its influence on lymph nodes involvment, this factor can 
play as a prognostic factor and seems determining it at the time of diagnosis, will be helpful for 
decision of appropriate treatment. 
Keywords: Breast Cancer, lymph node involvement, KI67  
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Introduction: Cytokines are one of the major components of tumor microenvironment. IL-25(IL-17E) 
and IL-17B are two members of IL-17 family which both of them bind to a unique receptor (IL-17RB). 
Sincethereceptoris widelyexpressedinbreast cancertissue, so the role of these cytokines in the tumor fate 
can be important. 
Materials and Method: MCF-7 (Estrogen positive) and MDA-MB231 (Estrogen negative) as breast 
cancer cell lines were treated by human recombinant cytokines (rhIL-25/IL-17E) and rhIL-17B from 
R&D system). Apoptosis test was performed using Annexin V and PI staining and analyzed by flow 
cytometry. Proliferation rate was evaluated by MTT proliferation assay. 
Results: According to our results apoptosis rate in IL-25 treated cells was more than control cells and 
proliferation rate in IL-17B treated cells was increased. To evaluate cytokines competition, different 
ratios of cytokines were used. The results showed that in some ratios these cytokines had inhibitory 
and/or a synergistic effect on each other.  
Conclusion: Biochemical component of the tumor microenvironment in different circumstances change 
and cytokines play an important role in tumor cell behavior. It seems these cytokines (IL 17E and IL-
17B) competed with each other and the balance is very important on the fate of breast cancer cells.  
Key words: Breast cancer, IL-17B, IL-25, MCF-7, apoptosis 
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Abstract 
The most common cancer among women in the world is breast cancer. In Iran, the incidence of breast 
cancer is increasingly rising and it is among the five most common cancers. Many of natural 
compounds have high chemo-preventive potential which could be sought to be used in drug discovery. 
Many studies have shown the incidence rate of cancers such as breast, colon, and prostate are decreased 
in communities if they would consume cruciferous vegetable.  Sulforaphane is one of the 
isothiocyanates-derived compounds from cruciferous vegetables which bears up such characteristic. 
Sulforaphane is an electrophile compound which has high tendency to react with sulfhydryl. The target 
of this compound is sought to be residues of cysteine of many proteins which control the regulatory 
process of cancer in the cells. The mechanism of sulforaphane is to modify cysteine residues in Keap1 
(kelch-like ECH-associated protein 1) in such way to stabilize Nrf2 (Nuclear factor (erythroid-derived 
2)-like 2). This stabilization would culminate in activating antioxidant response element (ARE) of 
phase 2 enzymes. In this study, the structure of protein of interest, Keap1, and highly similar analogues 
(90%) from PDB and Pubchem websites were respectively downloaded. Then molecular simulation and 
calculation of docking energy (ligand-protein) by Autodock 4.2 was performed to reach sulforaphane-
similar compounds. In this way, a figurative library with around 300 molecules was generated. Finally 
we identified CID: 52666086, CID: 5076735 and CID: 13352380 with the lowest docking energy. The 
aforementioned molecules could be assumed as breast cancer drug candidates. 
Key words: Cancer, Sulforaphane, Drug Design, Molecular Docking 
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Abstract 
Background: Breast cancer is the most common malignancy in women. Recently, studies have shown 
upregulation of miR-155 in various cancers explaining its oncogenic role. This study aims to estimate 
miR-155 expression and its targetome analysis for deciphering the molecular functions of miR-155 in 
breast cancer. 
Material and Methods: In silico analyses of miR-155 targetome in breast cancer using Unigene 
database was examined. DAVID database was recruited to conduct molecular pathways analyses. RT-
qPCR was implemented for analysis of miR-155 expression in 40 breast cancer samples. Incidence of 
vaginal candidiasis was testified in these patients by means of mycology experiments. 
Results: KEGG signaling pathways were revealed as the most statistically relevant pathways with miR-
155 targetome such as “pathway in cancer (P-Value=2.4E-6)”, “cell cycle (p-value=5.3E-2)”, 
“apoptosis (P-Value=7.6E-2)” and “wnt signaling pathway (p-value=7.0E-2)”. miR-155 can perform 
several tasks during first phases of tumorigenesis of breast cancer such as prevention of 
apoptosis/angiogenesis and induction of cell survival/proliferation. We observed miR-155 was 
upregulated in patients. The isolated Candida from these patients were C.glabrata, C.tropicalis and 
C.krusei. 
Conclusion: miR-155 could exert an oncogenic function through targeting several tumor suppressor 
proteins expressed in breast tissues. There is a relation between incidence of breast cancer and candida 
infection. 
Keywords: Breast cancer, miR-155, signaling pathway, candida. 
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Introduction: Focal Compression Magnification View (FCMV) is a complementary diagnostic 
modality in cases of equivocal mammographic lesions .The aim of this study was to evaluate the 
improvement in mammographic specificity by these special views and to define the circumstances in 
which they were more beneficial. 
Materials and Methods: During a cross-sectional study, all patients for whom FCMV were requested 
at the imaging center of Breast Cancer Research Center, were included. Clinical, Imaging and 
histological data were extracted of their medical papers and follow up was performed. Data were 
analyzed by SPSS version 20 software. 
Results: Between March and February 2012, 5143 women were presented for mammography to this 
center,491 of them Conducted FCMV(9.55%). Mean age of patients was 47.6+8. The most frequent 
reasons for requesting FCMV was focal density( 74.6%) .Radiologist recommendation after reporting 
FCMV were : short follow up in 55.7% ,routine follow up in 24.4%, biopsy in 9% and dependent to 
MRI or ultrasound in 11% of patients. FCMV led to definite diagnosis in 34.4% and all others need 
another imaging .FCMV led to definite diagnosis in 28.7% of focal densities in comparison to 40.5% of 
microcalcifications (p=0.015). 
Conclusion: This study showed that although the most frequent indication for requesting FCMV was 
focal density in mammography, but this special view led to definite diagnosis in less than one third of 
patients. With respect to excess radiation, cost and anxiety related to additional views, FCMV should be 
requested in more appropriate situations such as microcalcification or mass lesions. 
Keywords: Mammography, Focal Compression Magnification View, Focal Density, Microcalcification 
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Background: Green tea is one of common drinks in the worldwide. Also many of women are using of 
green tea for prevention of breast cancer and cardiovascular disease. Although this is a thesis but some 
of researchers accede this. The target of this review article is investigated effect of green tea in 
incidence and recurrence of breast cancer. 
Method: This review article is with investigated of last studies with searching in PUBMED and ISI 
web of sciences searching motors with keywords include “Green Tea” and “Breast Cancer” between 
2008 and 2014. After filtration and separation, 12 articles are selected.   
Results: Some propose mechanisms are including: 
Anti-oxidant effect: There is polyphenol compound in green tea that can have anti-oxidant effect to 
inhibit carcinogens and prevention of breast cancer. 
Cell grows inhibitor: some compound in green tea can modulation of cell signaling that this effect can 
inhibit cell grows. 
Apoptosis adjustment: One of component in green tea is Catechin that can induce apoptosis with 
redox regulation. 
Regulation of potential oncogenes and tumor suppress genes in microRNA of MCF-7 in breast cancer 
cells: Last studies are shown that Polyphenols induced modification of the breast cancer microRNA 
expression profile. The resulting decrease in carcinogenesis is further supported by the altered 
microRNA of MCF-7 regulation of potential oncogenes and tumor-suppressor genes. 
Conclusion: Cell grows unlimited and apoptosis inhibition is known mechanism in cancers. Also many 
of drugs and chemical therapy doing for cell grows inhibition, angiogenesis and apoptosis regulation. 
Green tea can replace drugs. Epidemiologic studies are shown consumption of 5 cups of green tea can 
have a anti-cancer effect.  
Keywords: green tea – breast cancer 
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Abstract 
Background 
Tea is the second most consumed beverage worldwide after water. Tea is a mixture of a large number 
of bioactive compounds, including catechins (Epigallocatechin-3-gallate (EGCG) flavonols, lignans, 
and phenolic acids, which have many cancer chemo preventive attributes including anti-oxidation, anti-
inflammatory, antiproliferative, and anti-angiogenic. 
Methods 
This study was a comprehensive literature review performed through searches in databases such as 
Medline, PubMed, Science Direct, Scopus, and Google Scholar using the terms “Cancer, green tea, 
anti-oxidant, and breast cancer". 
Findings 
Extensive laboratory studies in multiple animal models have consistently shown the inhibitory activities 
of green tea polyphenols against tumorigenesis at different organ sites. Green tea’s estrogen reduction 
activity may result from tea polyphenols inhibiting aromatase, the key enzyme converting androgens to 
estrone or estradiol 21. Evidence from animal models provides convincing risk reduction effects of 
green tea against mammary tumors. Statistically significant association between green tea and breast 
cancer risk reduction. However, supportive evidence from prospective cohort studies is lacking. 
Conclusions 
Although many in vitro and animal studies have demonstrated a protective effect of green tea against 
breast cancer, findings from epidemiological studies have been inconsistent. 
Key words: Breast Cancer, green tea, anti- oxidation. 
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Abstract : 
Background:  Breast  cancer  is  the  most  common  neoplasm  and  major  cause  of  cancer-related  
deaths  in  women, worldwide. Breast cancer is caused by the interaction of genetic and environmental 
factors. Among the latter, since diet is a modifiable risk factor, it offers an opportunity to design 
preventive strategies. Regarding the increasing incidence of breast cancer worldwide, the aim of this 
paper was to review the studies regarding diet and breast cancer prevention. Methods: Eligible studies 
were identified by searching the following databases: PubMed, Google scholar, Science direct and 
Scopus. The search terms used are Diet،Nutrition،Breast Cancer ،Chemoprevention. 
Findings: Initial scientific evidence suggesting that diet might play a crucial role in breast cancer 
development.  Although the nature of the relationship between specific nutrient exposures and breast 
cancer risk is unclear, the optimal intake of micronutrients may lower the risk of breast cancer. 
Deficiencies in the consumption of such compounds could account, 
for the known relationship between those diets traditionally poorest in fruits and vegetables and 
breast cancer incidence. These chemopreventive agents influence through modulating the expression 
and activity of relevant proteins, for example chemopreventive agents in fruits and vegetable exert 
their effects by modulating transcription factors - NF-kB, green tea by the blocking of antiapoptotic 
proteins such as Bcl-2 and Bcl-XL and curcumin stimulates the apoptotic intrinsic pathway via 
cytochrome C release from the mitochondria. 
Conclusion: overall, the evidences indicate that diet plays a crucial role in breast cancer risk. Future 
research  are needed to provide more clarity regarding the type, intensity, and timing of activity that 
relate to breast cancer risk reduction and the effects of physical activity on  proposed biomarkers to 
breast cancer risk. Research into gene-nutrients interactions will provide more clarity regarding the 
involved mechanisms in breast cancer prevention, and offering an opportunity to develop effective 
recommendations for prevention and new treatments against breast cancer. 
Key Words: Diet،Nutrition،Breast Cancer ،Chemoprevention 
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Abstract 
BACKGROUND and OBJECTIVE: 
Long –term effects of ovarian stimulation for In vitro fertilization (IVF) on the risk of cancers are 
unkoown. 
MATERIAL and METHOD:  
To present this review article, researcher used In vitro fertilization (IVF) and Cancer risk as key 
words and searched the google scholar, Cochrane library ,Up-to-date and Pub-med sites, and the result 
was 10 articles, that after study all of them carefully we selected 5 of them, and use their data in this 
article.  
Findings: 
Studies suggest no significant relationships of IVF exposures to the risks of breast, endometrial, or 
ovarian cancers. Results regarding long-term effects were largely reassuring but women receiving IVF 
should continue to be monitored given that the procedures involve potent ovulation stimulators and 
repeated ovarian punctures. 
 Discussion and Conclusions: 
Studies of high methodological quality with larger population and longer follow up are required to 
provide more evidences for a better understanding of the association.  
Key words: In vitro fertilization and cancer risk. 
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Abstract 
Some studies have shown evidence of Candida infection co-existing with malignancy and 
immunosuppressant disease due to debilitating diseases and nosocomial causes. Oncologists give 
patients drugs or undergoing radio or chemotherapy which make their yeast infections worse. In this 
retrospective study, the authors did an extensive literature review of published studies about association 
of breast cancer and candida infection during recent 50 years. Studies showed Candida thrives in a low 
oxygen environment and produce toxin and stimulate breast cancer. Some researchers demonstrated the 
relationship between renal candidiasis and breast cancer. Severe suppression of the immune system and 
inflammation in the body in breast cancer patients lead to an increased risk of Candidal infection in 
their cavities. Candida can cause blood sugar imbalances which are associated with cancers due to 
immune system suppression. On the other hand, deep tissue fungal growth in breast may be commonly 
diagnosed as cancer. Candida can ferment sugar and cancer cells rapidly proliferate in the presence of 
fermented sugar. Candida can be phagocytized by breast cancer cells. Estrogen and corticosteroid drugs 
reduce function of Thymic gland and promote Candidal growth. However, some studies show 
Tamoxifen and Sodium bicarbonate given to prevent breast cancer from returning have anti-candida 
properties. Some studies supported the idea that candida species associate with breast cancer; however, 
they have presented problems with experimental settings. More effort to assess the role of candida in 
carcinogenesis is needed. We propose preventing and treating candida infections may possibly stop or 
even eliminate certain types of cancers. 
Key Words: Breast Cancer, Candida Infection, Candidiasis, Immune Deficiency. 
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Introduction: Breast cancer is one of the most frequent cancers, and it is the second leading cause of 
cancer deaths in women. Since knowledge, early detection and prevention of breast cancer have had 
important role in reducing the burden of disease, this study aimed to assess the knowledge, attitude and 
practice of female students at the Maragheh faculty of medical sciences on breast cancer.  
Methods: This is a cross-sectional study which has been done on 300 students of the Maragheh faculty 
of medical sciences at 2014. Data were acquired by researcher- made standardized questionnaires. 
Findings:  Results of the study showed that the highest percent of participants (59.2%) were in the age 
group of 18-20 year old. 6.2% of students have a family history of breast cancer. 69.2% of students 
have an acceptable attitude of risk factors, prevention, and early detection of breast cancer. 90%, 62%, 
and less than 1% of the students have moderate, weak, and high knowledge on breast cancer. 
Conclusion: The knowledge of students in this study was low on breast cancer, so because of 
importance of self-examination and early detection in prevention, it is suggested that effective 
instruction have been implemented in risk groups.  
Key words: knowledge, attitude, behavior, breast cancer 
  
 711 
 
P3-10 
Knowledge and women who are qualified to carry out the CBE 
 Clinical breast Examination  ( in Tabriz health centers in 2014 
1M. Ansari,2 F. Mohammadi,3 doctor N.rahbari  , 4doctor F. Sadeghi, 5Minoo Bardaran 
1Family HealthExpert, university of tabriz ,Tabriz,Iran - M.ansari411@yahoo.com 
2Family HealthExpert, university of tabriz ,Tabriz,Iran 
3DirectorofDepartmentofPopulationandFamilyhealth, university of  
tabriznrf1345@gmail.com                                                        
4Family HealthExpert, university of tabriz ,Tabriz,Iran,frbsadeghi @ yahoo.com  
5Family HealthExpert, university of tabriz , Tabriz,Iran,M.baradaran1345@gmail.Com 
Introduction 
Breast cancer is a disease that annually takes great sacrifices of the disease in 99.5% of women and half 
men ripped seen. 
According to the Ministry of Health Management Center of the incidence of breast cancer among all 
cancers in women in the first place in the statistics of 86, 27.15% have been reported. 
Materials and Methods:  
This cross-sectional study using data from questionnaires completed and analysis is included in the 
software EXCEL. 
Results:Based on these results, the average age is 28 years and 2 percent and 2 percent of teachers and 
96 percent of jobs Arad was home. 16% of the subjects for the clinical assessment of breast health 
houses and health centers were visited by 20 percent of those in the 11 breast cancer symptoms noted in 
24% to about 6% for 3, 6% to 4, 2% 5, 4, 6 and 8 percent to 10 percent, 6 percent, to 11 and% 24 h not 
know the symptoms. 
Conclusion:The results showed that women with information about the study of the possible signs of 
cancer are low and need for education and awareness is required. 
The design and implementation of screening programs and training courses for doctors and nurses 
working in the health care system and the reference system And make specific reference centers for 
clinical trials and symptoms of breast cancer in women over 20 years seems necessary 
Keywords: 
Clinical berest Examination - Breast Cancer 
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Abstract 
Artesunate, a semi-synthetic derivative of artemisinin, isolated from the traditional Chinese herb 
Artemisia annua, is an effective novel antimalarial drug and more recently is used in medications that 
induce tumor cell apoptosis; however the mechanism of action is not clear yet. Thus, the aims of this 
study were to determine whether artesunate could induce the apoptosis of a human breast cancer cell 
line, MCF-7, and to clarify its related mechanism. For this purpose, MCF-7 cells were treated with 
artesunate and then cell viability was measured by MTT assay. Apoptosis detection with Annexin V-
FITC/PI staining was followed by flow cytometry. Furthermore, Caspase-3, -8, and -9 colorimetric 
assay kits were employed to determine caspase protease activity.  MTT assay results demonstrated that 
artesunate significantly inhibits the growth of MCF-7 cells in a dose- and time-dependent manner. In 
addition, based on the findings of Annexin V-FITC/PI staining, the cytotoxicity of artesunate in MCF-7 
cells occurs through apoptosis and by increasing the cellular levels of caspase-3, -8 and -9. Taken 
together, it could be concluded that artesunate effectively induces apoptosis in MCF-7 cells through 
caspase-dependent pathways, so may be a promising candidate for the treatment of breast cancer. 
Keywords: Artesunate, MCF-7 Cells, Breast Cancer, Apoptosis, Caspase 
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Abstract 
BACKGROUND and OBJECTIVE: 
Breast cancer is the most common female cancer worldwide . The lifetime risk of a women being 
diagnosed with breast cancer is approximately 12.5%. For women who carry the deleterious mutation in 
either of the BRCA genes. BRCA1 or BRCA2 , the risk of developing breast or ovarian cancer is 
significantly increased. 
MATERIAL and METHOD:  
To present this review article, researcher used Lifestyle and Breast cancer as key words and searched 
the google scholar, Cochrane library ,Up-to-date and Pub-med sites, and the result was 10 articles, that 
after study all of them carefully we selected 5 of them, and use their data in this article.  
Findings: 
There is some evidence to support a protective role of a healthy body size and of regular physical 
activity among mutation carriers, particularly during adolescence or early adulthood. Factors which 
increase the physiologic expression of the normal copy of the BRCA1 or BRCA2 gene and thereby 
normalize protein levels , contribute to stem cell homeostasis , and/or affect hormone levels, might 
mitigate the effects of an inherited BRCA mutation.    
 Discussion and Conclusions: 
The prospect of changing lifestyle for the purpose of  preventing breast cancer in high-risk women , 
complemented by mechanistic evidence, warrants evaluation in large-scale prospective studies. 
Key words: Lifestyle and Breast Cancer. 
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Abs tract 
With  the  development  of  technologies  such  as  microarrays  and  RNA  deep  sequencing  (RNA-
seq), long  noncoding  RNAs (lncRNAs) have become the focus of cancer investigations. LncRNAs, 
non-protein-coding RNA molecules longer than 200 nucleotides, are dysregulated in many human 
diseases, especially in c ancers. Recent studies have demonstrated that lncRNAs play a key regulatory 
role in gene expression and cancer biology through diverse mechanisms, including chromosome 
remodeling, transcriptional and post-transcriptional modifications. The expression levels of specific 
lncRNAs are attributed to prognosis, metastasis, and recurrence of  cancer. LncRNAs, usually act  
in various biological processes, such as regulation of  alternative splicing of mRNA, protein activity, 
and epigenetic modulation or silencing the microRNAs, via discrete mechanisms. Deregulated levels 
of lncRNAs were shown in diverse tumors, including breast cancer. In this review article, based on 
mentioned findings, we aim to discuss about the potential of lncRNAs in discriminating normal and 
tumor tissue or even the different stages of breast cancer, which makes them clinically  beneficial as 
possible biomarkers in the diagnosis and prognosis or therapeutic targets. 
Ke ywords : Breast neoplasms, Biological  Markers, Long noncoding  RNAs, 
Diagnosis, Prognosis, Epigenesis 
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Abstract 
Breast cancer is the second leading cause of death by cancer in among women. Resistance to therapy is the most 
cause of treatment failure in cancer therapy. Resistance of cancer cells to cytotoxic drugs  may be a result of 
resistance to apopotosis. XIAP (X-Linked Inhibitor of Apoptotic Protein) overexpression can be overcome 
cytotoxic effects of many chemotherapeutic agents in breast cancer by inhibiting apoptosis. 
In this study, XIAP gene was inactivated by RNAi approach in breast cancer cells. Inactivated cells were 
treatmented with chemotherapeutic agents; like etoposide or doxorubicin or taxanes. Cells growth, viability and 
apoptosis studies were performed. 
Findings shows that Reducing XIAP protein expression increases MDA-MB-231 cells susceptibility to taxenes. 
Down-regulation of XIAP also sensitizes MCF-7 breast cancer cells to killing by etoposide and doxorubicin. 
Therefore, downregulation of XIAP increases the effectiveness of chemotherapeutic agents by inducing apoptosis 
in breast cancer cells. 
Key words: Chemotherapy; XIAP; breast cancer 
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Background: Breast cancer remains a leading cause of death from cancer and a scientific challenge for 
the medical community. One critical issue is how to implement an effective preventive strategy. Risk 
factors such as genetic predisposition cannot be modified whereas other factors (unhealthy diet, 
sedentary lifestyle) can be avoided. The Mediterranean diet, the traditional dietary habits of people 
living around the Mediterranean Sea, is a well-known healthy dietary pattern. The target of this study is 
investigation of Mediterranean Diet and other guideline for breast cancer protection. 
 
Methods: We studied recently published (1995-2014) and reviewed articles regarding Mediterranean 
Diet and Breast Cancer. 
Results: 50 studies were found. Many studies suggest Olive oil is an integral ingredient of the 
Mediterranean diet and accumulating evidence suggests that it may have a potential role in lowering the 
risk of breast cancers. The mechanisms by which the cancer-preventing effects of olive oil can be 
performed, however, are not known. Some studies were shown evidence on the benefits of a diet rich in 
fruits, vegetables, legumes, oily fish and vegetable oils for preventing all breast cancer subtypes, and 
particularly triple-negative tumours. Also one study says use of multivitamin-multimineral supplements 
could be inversely associated with mammographic density and may suggest a protective effect against 
breast cancer, whereas high alcohol consumption was associated with increased mammographic 
density.  
Conclusion: High adherence to a Mediterranean Diet is associated with a significant reduction in the 
risk of breast cancer and other types of cancers. 
Keyword: Mediterranean Diet - Breast Cancer 
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Abstract 
Introduction: Breast cancer can be a devastating diagnosis, creating social, emotional, ﬁnancial and 
psychological problems. Social support has been identiﬁed as an important contributor to general well -
being that buffers the impact of stressful experiences, including those related to physical illness. Peer 
support programs are based on the premise that support from others who have been through a similar 
experience can help reduce the negative impacts of this disease. The present study reviews the role of 
peer support on QOL women with breast cancer.  
Methods: A literature search was performed in Pubmed, Scopus and Scirus by key words “Breast cancer”, 
“peer support”, “Quality of life” without time limitation. 
Results: Findings indicated peer-support programs have been found to improve satisfaction with 
medical care; personal relationships and social support, increase a sense of belonging and improve 
mood. One-on-one face-to-face and group Internet peer-support programs should be given priority 
when considering ways to offer peer support. 
Discussion: Peer support results in promotion of quality of life in women with breast cancer. Two 
different theoretical models have been suggested to describe the mechanisms by which peer support 
may increase well-being. The mode l proposes that peer support directly affects health outcomes by 
decreasing feelings of isolation, encouraging health behaviors, promoting positive psychological states 
and providing information. The model 2 suggests that peer support buffers the impact of stress on 
health and improving coping responses and behaviors. Clinicians are urged to consider the study of peer 
support as a factor in quality of life, treatment response and survival studies and determine the best 
ways to offer peer support. 
Key words: Breast cancer, peer support, Quality of life 
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Abstract 
 Genetic mutations in premalignant breast lesions may have a role in malignancy progression or 
influence the behavior of subsequent disease. A point mutation in estrogen receptor-α (ER-α) as A908G 
(Lys303→Arg) was originally involved to hypersensitive to estrogen breast hyperplasia. We detected 
this mutation among Iranian women with invasive breast cancer. A population-based case-control study 
was conducted in 150 newly diagnosed invasive breast cancer and 147 healthy control individuals 
controls to screen for presence of the ER-α A908G mutation by using single-strand conformation 
polymorphism (SSCP) analysis and 33Pcycle DNA sequencing. We detected the 10.7% ER-α A908G 
mutation in the form of heterozygote genotype only among cancer patients (χ2=22.752, P=0.00). 
The allelic frequency of mutant allele AGG in codon 303 was significantly (χ2=29.709, P=0.001) 
higher in patients with the family history of breast cancer (28.9%) than those without the family history 
of breast cancer (1.9%). Our data suggest that ER-α codon 303 mutation is correlated with various 
aspects of breast cancer in Iran. ER-α genotype might represent a surrogate marker for predicting breast 
cancer developing later in life. 
Keywords: Breast cancer, mutation, estrogen receptor, PCR-SSCP, lymph node metastasis 
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ABSTRACT 
Introduction: Studies show that there is an association between obesity risk factors and cancer 
progression. The aim of this study was to investigate the association between pancreatic function 
and genetic markers of obesity in breast cancer. 
Methods: In this review study pancreatic function and genetic markers of obesity have been 
investigated. Moreover, the role of obesity genes in the pancreas function were discussed. Also the 
association between these genes to breast cancer were investigated. 
Results: Genetic factors are substantial determinants of overweight. Some of these genes that involve 
in obesity are FTO, MNX1 and leptin that plays an important roles in the control of food intake, 
energy expenditure, metabolism, and body weight. These factors also have a key role in the regulation 
of glucose homeostasis, even though acts central and peripheral mechanisms 
to modulate glucose metabolism, the pancreatic β-cell of the endocrine pancreas is a critical target of 
these genes actions. There is a link between the fat mass and obesity associated genes and a higher 
incidence of breast cancer. In this paper, an association was shown between genetic marker of obesity 
and breast cancer. 
Conclusion: Based on the findings, genetic marker of obesity have a significant role in pancreatic 
function and progression of breast cancer. Therefore, can be considered as the genes that roles in 
pancreatic development an attractive target for gene therapy of breast cancer. 
Key words: breast cancer, obesity, genetic markers, pancreases 
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Abstract: 
Background: There are over 100 different known cancers that affect humans. Breast cancer is the most 
common malignancy in women worldwide.  
MicroRNAs (miRNAs) are a class of small noncoding RNAs that control gene expression by targeting 
mRNAs. Mir-662 is a tumor-suppressor miRNA proposed as a possible biomarker of invasiveness in 
breast cancer. Although several studies have validated one target of miR-662(ING1 gene), however 
bioinformatics studies are needed to predict comprehensive molecular function of miR-662 in breast 
cancer.  
Objective: Using bioinformatics databases, this study aim to expand current knowledge about 
molecular function of miR-662 in regard to its potential as a predicted biomarker in breast cancer. 
Methods: Validated and predicted targets of miR-662 were regained from miRtarbase and miRwalk 
databases respectively. Expression of retrieved targetome in breast cancer was evaluated in UniGene 
database. At last breast cancer specific targetome were entered into DAVID database for molecular 
pathway enrichment analysis. 
Results: According to our data from KEGG signaling pathways “Cytokine-cytokine receptor 
interaction”, miR-662 may inhibit 11 genes such as EGFR, LTBR and KDR. Researchers have shown 
these genes have multiple effects on breast cancer progression. 
Conclusion: Our data predicts that cytokine-cytokine receptor interaction pathway is a potential target 
for miR-662. MiR-662 may contribute as a tumor-suppressor molecule in breast tumor cells by 
inhibition of some important cytokine mRNAs. 
Key words: Breast cancer, miR-662, signaling pathway, cytokine-cytokine receptor. 
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Abstract 
Introduction: The most of breast masses are not tumorous and mastectomy is not the final breast 
cancer treatment.  Breast cancer could be prevented and treated by early detection. Nuclear medicine 
methods are able to quantify molecular activity and physiological processes within the body, instead of 
anatomical/structural information. Therefore, these methods could detect disease in its earliest stages.  
In this study, the Nuclear Medicine status in breast imaging application and its future direction is 
investigated. 
Methods: A computerized search using the databases PubMED and Science Direct, covering the period 
from 2004 to 2014, was conducted using the following key search terms: “Nuclear Medicine”, “breast 
cancer” and “breast imaging”. In total, 28 relevant papers were reviewed. 
Results and Discussion: It was shown that the accuracy of nuclear medicine breast imaging is 40% to 
60% for small breast abnormalities and is 90% for abnormalities over one centimeter. For a variety of 
indications, nuclear medicine approach is more sensitive than standard X-ray methods and other 
techniques.  
Conclusion: Nuclear medicine is a useful method to evaluate the suspected patients with indeterminate 
(difficult to read) mammograms or physical exams. Scintimammography may help detect additional 
small breast tumors that are not often detectable by other methods. 
Key words: Nuclear Medicine; Breast imaging; Breast cancer. 
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Abstract: 
This study reviewed the literature of Iranians' Knowledge, Attitude, Belief and Practice (KABP) 
about cancer. 61 studies which have published from 2000 to 2014, are retrieved from Iranians' 
scientific databases (Magiran, SID and Medlib) and have been analyzed. Most of these studies 
were conducted on women (82%), especially those who referred to the healthcare centers (31.1 
%), and mainly on breast cancer (n = 40, 65.6 %), in particular, on its screening tests (41%). 
Cervical cancer and other type of cancers studied 16.4 % (n = 10) and 18 % (n = 11) of the total 
volume respectively. These studies were conducted on the staffs and students of medical 
sciences sector (26.2 %), teachers, students and employees of other sectors (18%) and other 
community groups (24.6 %).The authors have mentioned the relationships between the level of 
education, family history of cancer, history of previous education, marital status with KAP of 
cancer; They have reported low level of knowledge (48.8% low, 32.6% medium, 18.6% high), 
high level of attitude (27.6% low, 34.5% medium, 37.9% high) and low level of practice (73.7% 
low, 21.1% medium, 5.3% high) among Iranians about cancer. In any cancer control program, 
this lack of knowledge and practice should be considered along with providing facilities for 
prevention and screening. Doing several comprehensive studies with broader sample volume are 
suggested wherein the factor of beliefs, which not only depends on knowledge and attitudes but 
also influenced by cultural, religious, traditional, and even superstitious issues, should be 
considered. 
Keywords: Knowledge, Attitude, Belief, Practice, Cancer, Iranians 
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Abstract 
Background: Breast cancer is the most common cancer among women Prevention and screening 
programs to reduce morbidity and mortality is  the main component for breast cancer. The purpose of 
this study was to determine the knowledge and practice of women over the age of 18 than  breast cancer 
screening programs. 
Materials and Methods:This cross-sectional, descriptive-analytical study was conducted  descriptive 
study was carried out on 300 urban women over 18 years,  in 2014. The instrument was standardized 
questionnaire interview and Random sampling was done 
Results: 56% of women Breast Cancer knew and 41 % of women believed they knew the importance of 
BSE for early detection of breast cancer. Test results showed, education level, age, family income 
level,with increase women's knowledge and performance in the field, was associated. 
Conclusion: Education and awareness about different methods of breast cancer screening,for promote 
knowledge and good practice, it seems necessary. Increased participation in breast cancer screening 
programs is essential.  
Key words: breast cancer awareness, performance. 
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Purpose: Although mortality rates from breast cancer are declining, many breast cancer patients will 
experience physical and psychological sequelae that affect their everyday lives. The purpose of this 
paper is to report the results of a descriptive study that evaluated the quality of life in this patients. 
Methods: During October-December 2014, A total of 148 women referred to the Cancer Institute; 
Imam Khomeini Medical Center with breast cancer participated in a cross-sectional study.The subjects 
 received EORTC QLQ-C30 instruments and a demographic questionnaire. All data was analyzed using 
SPSS 16 software. 
Result: The mean age was 47.62 years (SD=1.01).The most participant were married(%76.4) and had a 
basic level of education. The total mean score for quality of life was 43.86±2.35 (range; 0 to 100). More 
severe limitations were observed for the emotional and social functioning scales and for the symptom 
subscales of fatigue and insomnia. The highest mean was for the cognitive functioning scale. 
Conclusions: Deficits in emotional and social functioning and specific limitations like fatigue and 
insomnia and financial difficulties are main factors hampering the QOL among braest cancer patients 
and seem to affect predominantly younger patients. 
Keywords: breast cancer,quality of life, EORTC QLQ-C30 
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Abstract 
Attention to Breast Cancer prevalence age and attention to breast Cancer is 1/3 of all Cancers, we 
decided to assay results of screening tests of Breast Cancer in Behbood hospital. For 5000 women of 
clients completed questioner of demographic - Social characteristics and risk factors of BC. Then breast 
s of women was examined by physicians and midwives. If there  
Were abnormal results, Ultra Sonography or Mammography & FNA were ordered. 516 case of left 
Breast mass and 480 case of right breast mass were touched. 759 cases were abnormal in CBE. 40 cases 
of Sonography were abnormal. 183 cases of Mammography were abnormal. One case of FNA was 
Cancer (7.1 %).Occupation, Menopause status, history of doing FNA, 
 Education, Marriage, Age of first pregnancy, and BMI had significant relationship with abnormal 
CBE. Number of Breastfeeding had significant relationship with abnormal Sonography. Menopause 
status, dietary, use of chemical agents,  
And mode of use Lipids had significant relationship with abnormal Mammography (p<0.05).Attention 
to these risk factors, Women should be implementing of Breast Cancer Screening tests more and 
disciplinary, and their Knowledge about Breast Cancer & benefits of screening were increase by public 
IT and correct life style. 
Key Words: Breast Cancer, Screening tests 
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Abstract: 
Breast Cancer is the second most common cancer among women and is the second largest cause of 
death in the world.  Early detection can be very effective and can play an important role for 
treatment. Annually, approximately more than 1,700,000 women worldwide are detected to have this 
disease. There is an increase of around 2% in the breast cancer incidence rate yearly. There are 
several risk factors for Breast Cancer.  Some of them have been proven, some are still having 
controversial reported results and some are almost rejected. Sometimes maternal age at first birth, 
age at marriage and number of children are considered as risk factors. However they sometimes are 
taken as protective measures. In this paper, we proposed a model which can predict the Percentage of 
Suffering for a person having breast cancer. Some of risk factors are modeled and some impact factors 
are chosen for them. In this study, the proposed algorithm is implemented and evaluated using data 
from Breast Cancer Surveillance Consortium (BCSC) in National Cancer Institute. 
Key Words: Breast Cancer, Risk Factor, Data Mining, Screening, EM Algorithm 
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Abstract: 
Background: Prostate cancer and breast cancer are the most common neoplasia in men and women 
respectively. Three main treatments including surgery, chemotherapy and radiation therapy are used to 
treat cancer patients. However, the future of cancer treatment lies in genetic treatment options providing 
with a personalized medicine which will consider specific treatment individually. Nowadays treatment 
options based on the genetic variations occurring in specific individuals are being offered. SNPs are the 
most important biomarker for personalized medicine. 
Micro RNA regulates gene expression at the post-transcriptional level and involves in diverse 
biological and pathological processes including angiogenesis pathways. The miR-196a has been 
experimented in lung, esophageal, gastric and breast cancers. 
Objective: The aim of our study is to expand current knowledge about molecular function of miR-196a 
and its SNP in breast cancer cells by using bioinformatics tools. 
Methods: Validated and predicted targets of miR-196a were obtained from MiRtarbase and MiRwalk 
databases respectively. UniGene and DAVID databases were used for further analysis. MIRSNP 
database predicts single nucleotide polymorphism in miR-196a and its function. 
Results: It is predicted that miR-196a acts as a critical tumor suppressor micro RNA by inhibiting some 
important genes in sustained angiogenesis pathway such as FGFR, STAT3, ERK, ITGA and IκBα. 
Moreover, the stability of stem loop structure of pre-mir-196a is decreased by T allele due to increasing 
gibbs free energy of the structure. As a result, there is a probable association between T allele carriers 
and poor prognostic breast cancer. In other words, T allele may contribute to intensify tumor growth 
and metastasis due to angiogenesis pathway alteration. 
Conclusion: According to our data, miR-196a and its SNP may be involved in breast cancer prognosis 
by altering regulation of angiogenesis and some vital signaling pathways mRNAs. To sum up, T allele 
in this location can have prognostic value for angiogenesis and metastasis phenotypes in patients with 
breast carcinoma. 
Key words: Breast cancer, miR-196a, SNP, agiogenesis, metastasis. 
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Introduction: 
Breast cancer is the most common cancer among women,and every8to10women,someone is 
suffering 
On the basis of data from each of10to15women, there’s someone chanc.age of onset in at least a 
decade younger than developed countries 
Materials and Methods: 
      Paper is intended as an overview of the application of Article27taken from theSIDsite is provided. 
Results: 
1- results of Tabriz University:Only18%of women with breast self-examination,19%clinical breast exam, 
and3%of mammograms performed. 
2- results  of Ardebil university:Breast self-examination of 4% -of clinical examination5%and 
mammography was4%. 
3- results of88years of Kerman University of Medical Sciences:More awareness of the importance of 
participation in screening and early detection of cancer and the most common cause of non-participation 
would not recommend a doctor. 
 
Discussion:. 
1- The emphasis should be on training and facilitated the diagnosis and treatment of breast cancer patients 
to optimize 
2- Early detection of cancerous tumors is associated with better prognosis in breast cancer .therefore it is 
the duty of every physician to possible breast abnormalities detected at an early stage and Diagnostic 
perform certain actions 
 
Keywords: 
Cancer,breast ,screening 
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Abstract 
Background: In many culture, breasts is a symbols of femininity, motherhood, beauty and sexual 
attractiveness that loss and deformity it’s may lead to adversely affect the sexual life. The objective of 
present study was to understanding sexual functioning after mastectomy surgery in breast cancer 
survivor. Material &method: This study was a qualitative design. Semi- structured interview conducted 
with 11 Iranian women surviving breast cancer (mean age 44/5 years; mean age of husbands 47/8 years; 
median length between surgery and interview 2/8 years). Result: Analysis using the Colaizzi method 
revealed four major themes: (1) dyspareunia, (2) hesitation in resuming sex after mastectomy surgery, 
(3) decrease the frequency and quality of sex, and (4) sexual considerateness. Conclusion:  This study 
shows the changes to sexual functioning following mastectomy surgery. In addition, understanding and 
cognition about sexual life among breast cancer survivor will help improve survivor`s sexual wellbeing. 
The finding this study helps to mental healthcare professionals to design appropriate interventions to 
improve survivor`s sexual life. 
Key words: breast cancer, sexual functioning, mastectomy, Iran            
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Abstract: 
Background: MicroRNAs (miRNAs) are endogenous small non-coding RNAs. In animals, miRNAs 
were found to hybridize to 3’ untranslated regions (3’UTRs) and mediate mRNA cleavage or 
translational inhibition. These kinds of RNAs are important class of regulators that were reported to be 
involved in a wide range of biological processes such as cell signaling and cancers. Genetic 
polymorphisms, especially single nucleotide polymorphisms (SNPs) can affect miRNA regulation via 
different molecular mechanisms and associated with various phenotypic differences. First, 
polymorphisms within precursor miRNAs (pre-miRNAs) were found to affect miRNA expression 
possibly via altering pre-miRNA processing. Second, polymorphisms in miRNA target sites had been 
extensively studied and implicated in a variety of human diseases. There are over 100 different types of 
cancer, and each is classified by the type of cell that is initially affected. Breast cancer is a type of 
cancer which malignant cells form in the tissues of the breast. According to the World Health 
Organization, breast cancer is the most common diagnosed cancer in women. 
Objective: the aim of our study is to expand current knowledge about molecular function of miR-499 
and its SNP as a potential biomarker in breast tumor cells by using bioinformatics tools. 
Material and methods: dbSNP in NCBI, miRNASNP, UniGene, KEGG and DAVID databases were 
used for bioinformatics analysis. Validated and predicted targets of miR-146a were obtained from 
miRtarbase and miRwalk databases. Patterns of targetome genes expression in breast tumor and normal 
mammary glands were investigated by Unigene database. DAVID database was used for miR-146a 
enrichment analysis. 
Results and conclusion: Our data manifested KEGG signaling pathways “pathway in cancer” as the 
most statistical relevant pathway with miR-146a targetome. miR-499 in breast tumor cells may target 
angiogenesis related mRNAs such as KITLG, FGF, PDGFR, SOS, STAT3, IKK and iNDS. Stability 
reduction of stem-loop structure of mir-499 due to G allele gains angiogenesis pathway. As a result 
allele G may associate with poor prognosis of breast cancer. To sum up, miR-499 is a potential tumor 
suppressor miRNA which could be used as a worthwhile prognostic biomarker. Allele G in the SNP 
could have prognostic value for breast cancer centers due to its effect on mir-146a stability. The exact 
role of mir-499 and the SNP needs further investigation. 
Key words: Breast cancer, miR-499, SNP, signaling pathway. 
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Abstract: 
Introduction: Silibinin, a natural flavonoid, has many anticancer effects including growth inhibition, 
cell cycle arrest, antiprolifrative effect and apoptosis induction while is well tolerated and largely free 
of any adverse effects. Methods: In the present study, we studied some of silibinin effects on MCF-7 
cells. Cell viability was analyzed by MTT in silibinin treated cells. We investigated effect of silibinin 
on PTEN (phosphatase and tensin homolog) mRNA expression by Real-Time RT-PCR (Reverse 
transcription polymerase chain reaction) technique and cell cycle distribution by flow cytometry. 
Results: Findings of this study showed that silibinin induced dose-dependent cell death in MCF-7 cells. 
Silibinin induced PTEN overexpression and G1 cell cycle arrest. Discussion: These results suggest that 
PTEN overexpression has a role in anticancer mechanisms of silibinin in MCF-7 cells because of 
capacity of PTEN to evoke increases in the expression of the p27/Kip1, cyclin dependent kinase 
inhibitor via its lipid phosphatase and decreases in cyclin D via its protein phosphatase that predisposes 
cell cycle arrest and also PTEN leads to Bad activation that predisposes apoptotic cell death.  
Conclusion: Cell cycle arrest is one of the anti-cancer mechanisms of silibinin in MCF-7 cells that is 
mediated by modulation of some genes including PTEN.  
Keywords: Silibinin, Cell Cycle, PTEN 
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Abstract: 
Breast cancer is the most common form of cancer among women worldwide. Early detection of breast 
cancer can increase treatment options and patients' survivability. Recently, computer-aided detection 
(CAD) systems have been developed to use by less experienced radiologist and to reduce the number of 
false-negative interpretation caused by radiologist distraction and complex architecture. Numbers of 
Recent researches and FDA-approved commercially CAD system were evaluated. This review is based 
on breast density, lesions and their stage using image processing, pattern recognition, and artificial 
intelligence techniques based on the knowledge from too many mammograms which are had been 
interpreted. 
Early detecting Breast cancer in single reading with CAD has better performance compared with double 
reading, although false positive mark increased in dense breast that has a lower false than interpretation 
without CAD. By assessment of different CAD techniques, other modalities like ultrasound imaging are 
suggested to achieve additional information. One solution to improve CAD systems is the development 
of interactive CAD systems that can process only regions of interest. With using more database and 
large number of data we can improve these CAD systems and helps the radiologist in detecting the 
abnormalities in an efficient way in early detecting Breast cancer. 
Key Words: Breast Cancer, Computer aided systems (CAD) 
 
  
 171 
 
P4-11 
An Overview of Breast Cancer Prediction in Early Stage with Analyses of Mammographic  
Images Using by Data mining Techniques and provide a Novel Solution in Screening  
Mahdi Hemmasian-Ettefagh1*, Mohammad-hossein Nadimi-Shahraki2,Mahnaz Etehad-tavakol3 
1Faculty of Computer Engineering, Najafabad branch, Islamic Azad University, Najafabad, Iran  
2 Assistant professor, Department of Computer Engineering, Najafabad branch, Islamic Azad 
University, Najafabad, Iran (nadimi@iaun.ac.ir) 
3 Medical Image and Signal Processing Research Center, Isfahan University of Medical Sciences, 
Isfahan, Iran (m.etehadtavakol@ec.iut.ac.ir) 
*Corresponding Author (mahdi_hemmasian@yahoo.com) 
Abstract: 
Breast cancer is the second leading cause of cancer death in women. Breast cancer prevention and 
early detection can be very effective and saves lives. At present, Mammography is described as the 
gold standard of breast cancer screening. Due to the types of breast tissues and using X-ray with low 
density, the images have a low contrast. It takes 6 to 8 years from the time of first proliferation cells 
to the physician diagnosis in breast cancer development. Consequently, the survivability can be 
increased to 85% by early detection. Hence diagnosis of the disease in early stages is very important. 
In this study, we try to Have an overview on the latest articles and papers about diagnosis of breast 
cancer in early stages using data mining techniques and propose a novel model for screening using 
mammographic Images. 
Key Words: Breast Cancer, Prediction, Data Mining, Mammographic 
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Introduction: triple negative breast cancer (TNBC) refers to any breast cancer that does not express 
the genes for estrogen receptor, progesterone receptor and Her2/neu. The purpose of this study was to 
compare disease-free survival, prognostic factors and site of metastases in patients with triple negative 
breast cancer and other phenotypes. 
Materials and methods: All the patients who were referred to the Breast Cancer Research Center 
between 1376 and 1392, were involved in this cross-sectional study. 
The patients who were negative for estrogen receptor, progesterone receptor and Her2neu were 
categorized in TNBC group and the patients with at least one positive receptor were categorized in 
other phenotypes group. Disease-free survival, prognostic factors and incidence of metastases (bone or 
non-bone) were compared in women with TNBC and other phenotypes. Data were analyzed by SPSS 
21 statistical software with using descriptive and analytical statistics (Cox regression). 
Results: Out of  772 patients with breast cancer, 120 patients (15.5%) had TNBC. The mean age of 
patients with TNBC was 46.3±10.73 and that in patients with other phenotypes was and 47.6±11.18. 
The median of follow-up time was 18.1 months. In this study disease-free survival of all patients was 
0.87; also disease-free survival in TNBC and other phenotypes groups was 0.88. In the group of 
patients with other phenotypes, the tumor size (p=0.01), number of involved lymph nodes (p=0.0001) 
and age (p=0.003) were effective in disease-free survival, but none of these variables were effective in 
the TNBC group (p>0.05). There was no significant difference between the two groups in terms of 
metastases (bone and non-bone)(p>0.05). 
Conclusion: Although previous studies pointed out that the overall survival of TNBC patients is lower, 
but the results of this study showed that there is no significant difference between patients with TNBC 
and patients with other phenotypes in terms of the time of metastases and its site. One of the reasons for 
this could be using different types of treatment especially elimination of hormone therapy and target 
therapy. 
Key words: triple negative breast cancer, metastases, survival 
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Abstract 
The sentinel lymph node biopsy (SLNB) was initially pioneered for staging melanoma in 1994 and it has been 
subsequently validated by several trials, and has become the new standard of care for patients with clinically node 
negative invasive breast cancer. The fo- cussed examination of fewer lymph nodes in addition to improvements in 
histopathological and molecular analysis has increased the rate at which micrometas- tases and isolated tumour 
cells are identified. In this article we review the literature regarding the optimal management of the axilla when the 
SLNB is positive for metastatic disease based on level 1 evidence derived from randomised clinical trials. 
 
 
Key words: Sentinel lymph node biopsy; Early breast cancer; Axillary radiotherapy; Axillary dissection; Evi- dence-
based medicine 
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Abstract 
Background: Since the results from the randomized TARGIT A trial were published, intraoperative 
radiotherapy (IORT) is used  more  often.  IORT can be provided  as accelerated partial breast irradiation (APBI) 
or as a boost.  The definition of suitable patients for IORT as APBI differs between  different  national  societies 
(e.g. ESTRO and ASTRO) and different inclusion criteria of trials and so does the eligibility of patients. This 
analysis identifies eligible patients for IORT according to available consensus statements and inclusion 
criteria of the ongoing TARGIT trials. 
Methods: Between 01/03 – 12/09, 1505 breast cancer cases were treated  at the breast cancer center at the 
University Medical Center Mannheim. Complete data sets for age, stage  (T, N, and M), histology and 
hormone receptor status were available in 1108 cases. Parameters to identify  eligible patients are as follows: 
ESTRO: >50 years, invasive ductal carcinoma/other  favorable histology (IDC), T1-2 (≤3 cm), N0, any hormone  
receptor status, M0; ASTRO: ≥60 years, IDC, T1, N0, positive estrogen hormone  receptor status, M0; TARGIT  E 
“elderly”, risk adapted radiotherapy with IORT followed by external beam radiotherapy in case of risk factors 
in final histopathology, phase II: ≥70 years, IDC, T1, N0, any hormone  receptor  status, M0; TARGIT C 
“consolidation”, risk adapted  radiotherapy, 
phase  IV: ≥50 years, IDC, T1, N0, positive hormone  receptor status, M0; TARGIT BQR “boost quality registry”: 
every age, every histology, T1-2 (max. 3.5 cm), any hormone  receptor status, N0/+, M0/+. 
Results: Out of the 1108 cases, 379 cases (34.2%) were  suitable  for IORT as APBI regarding the ESTRO and  
175 (15.8%) regarding  the ASTRO consensus statements.  82 (7.4%) patients  were eligible  for the TARGIT E 
trial,  258 (23.3%) for the TARGIT C trial  and  671 (60.6%) for the TARGIT BQR registry. According to the 
consensus statements of ASTRO (45.1%)  and  ESTRO (41.4%)  about half of the eligible patients were treated 
with IORT as APBI. From  the eligible patients fulfilling the criteria for IORT boost  (35%) about  one third 
was eventually treated. 
Conclusions:  Patient selection for IORT should  be restrictive.  For IORT as APBI the TARGIT trials  are 
even  more restrictive including patients than the ESTRO and  ASTRO consensus  statements. 
Keywords: Intraoperative radiotherapy, IORT, Breast cancer,  APBI, Boost, Eligibility,  Suitable  patients 
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Abstract 
 
Background: Radiotherapy (RT) improves  overall survival (OS) of breast cancer patients after breast 
conserving surgery and after mastectomy in patients with involved  lymph  nodes (LN). The contribution 
of RT to the regional LN to this survival benefit was poorly understood. Recently, the results of three 
large randomized trials addressing this question have become available. 
Material and methods: The published abstracts (full publication pending) of the MA.20 (n=1832) and the 
EORTC 
22922–10925 (EORTC) (n=4004) trial and the full publication of the French trial (n=1334) were basis of the 
meta-analysis. Main eligibility  criteria were positive axillary LN (all trials), LN negative  disease with high risk for 
recurrence (MA.20), and medial/central  tumor  location (French, EORTC). The MA.20 and the EORTC trial tested 
the effect of additional regional 
RT to the internal mammary (IM) LN and medial supraclavicular (MS) LN, whereas in the French trial all patients 
received RT to the MS-LN and  solely  RT to the IM-LN was randomized. Primary endpoint  was OS. Secondary 
endpoints were disease-free  survival (DFS) and distant metastasis free survival (DMFS). 
Results:  Regional  RT of the MS-LN and the IM-LN  (MA.20  and  EORTC) resulted in a significant 
improvement of OS (Hazard Ratio (HR) 0.85 (95% CL 0.75 - 0.96)). Adding the results of the French trial and 
using the random effects model to respect the different design of the French trial, the effect on OS of regional 
radiotherapy was still significant (HR 0.88 (95% CL 0.80 - 0.97)). The absolute benefits in OS were  1.6% in the 
MA.20 trial at 5 years, 1.6% in the EORTC trial at 10 years, and 3.3% in the French trial at 10 years (not 
significant in single trials). Regional radiotherapy of the MS-LN and the IM-LN (MA.20 and EORTC) was 
associated with a significant improvement of DFS (HR 0.85 (95% CL 0.77 - 0.94)) and DMFS (HR 0.82 (95% CL 
0.73 - 0.92)). The effect sizes were not significantly different between trials for any end point. 
 171 
 
Conclusion: Additional regional radiotherapy to the internal mammary and medial supraclavicular 
lymph nodes statistically significantly improves DFS, DMFS, and overall survival in stage I-III breast 
cancer. 
Keywords: Meta-analysis, Breast cancer, Radiotherapy, Lymph node, Internal mammary, Medial supraclavicular 
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Approximately one-third of all breast cancer patients experience local recurrence of their 
tumor after initial treatment. As initial treatment often employs the use of radiation therapy 
(RT),  the standard of care for local breast cancer recurrence after initial breast conserving 
therapy has traditionally been surgical intervention with mastectomy. However, recent 
attempts to preserve the intact breast after recurrence with local excision have revealed a 
potential need for RT in addition to repeat breast conserving surgery as rates of local failure 
with resection alone remain high. Additionally, local recurrence following initial mastectomy 
and chest wall RT can be treated with reirradiation to increase local control. Repeating RT, 
however, in a previously irradiated area, 
is a complex  treatment strategy, as the clinician must  carefully balance  maximizing  
treatment effectiveness while minimizing 
treatment-related toxicity. As a result, physicians have been hesitant to treat recurrent 
disease with repeat RT with limited data. 
Results from the current literature are promising and current clinical trials are underway to 
explore reirradiation modalities which 
will provide additional information on treatment-related toxicity and outcomes. This paper 
will review the current literature on 
repeat radiation therapy for locally recurrent breast cancer 
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Abstract 
 
Background: We performed this meta-analysis to assess the effectiveness and safety of axillary 
dissection in old women. Methods: The Cochrane Library, PubMed, EMBASE and Chinese 
Biomedical Literature Database were searched and all randomized controlled trials of axillary 
dissection in old women (at least 60 years old) were considered. Meta-analyses were completed using 
RevMan5.1. Results: Three eligible randomized controlled trials (RCTs) including 5,337 patients were 
considered. There was weak evidence in favour of axillary dissection (AD) in old women. The meta-
analysis showed that the overall survival (OS) after 1, 3, 5 and 7 years and the disease free survival 
(DFS) after 1, 3 and 5 year were not statistically significantly different between AD and no AD groups. 
However, there was a difference in the 7 year DFS. Conclusions: Axillary dissection did not provide 
survival benefit to the old women with breast cancer analysed. Therefore, axillary dissection is not well-
indicated in old women with breast cancer. 
 
Keywords: Breast cancer - old women - axillary dissection - meta-analysis - randomized controlled 
trials 
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Vitamin D and Breast Cancer, Is there any association? 
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Background: Vitamin D is one of the fat solution vitamins that play important roles in immunity 
system adjusted, genes expression and antioxidant function. Breast cancer is one of the common cancer 
in women population that has much mortality and debility in every year. Vitamin D deficiency is very 
common in human and the last study of clinical nutrition show that more of disease is relationship 
between vitamin D deficiency and incidence of chronic disease. In this article we review last of clinical 
trial study to investigated between vitamin D and breast cancer. 
Method: This review article is with search in PUBMED motor with keyword “vitamin D” , “25 
hydroxy vitamin D” and “Breast Cancer” between 2008-2014. In this search only articles that were 
“Clinical Trial, were selected and investigated 12 article for this review. 
Result: Results of this article are included: 
Vitamin D and immunity system: 
Function of vitamin D in immunity system and adjusted of immune cell is known and clear. Effect of 
vitamin D in prevention of cancers, autoimmunity disease and allergy is with adjusted of immune 
system. In 3 studies protective effect of vitamin D after treatment of breast cancer with improvement of 
immunity system were shown. 
Vitamin D and adjusted of gene expression of hormone receptor: 
Some of study had shown that vitamin D can play an important role in gene expression and hormone 
receptor; also the control of estrogen receptor was one of function of vitamin D that studies were 
suggested vitamin D supplement in treatment of breast cancer. 
Vitamin D receptor polymorphism in patient with breast cancer: 
One of common status of vitamin D in women with breast cancer is polymorphism of vitamin D 
receptor (VDR) that had observed in some of studies. 
Discussion and Conclusion: 
Vitamin D deficiency is very common in human population that was made elevate of chronic disease 
incidence. Autoimmune disease, allergy and cancer are chronic disease that immune system is involved. 
Last observation has shown that vitamin D play an important role in control of estrogen receptor gene 
expression and insufficient intake of vitamin D or vitamin D receptor polymorphism are common in 
patients with breast cancer that suggested intake of vitamin D food source or supplements for 
prevention of breast cancer. 
Keyword: vitamin D, 25 hydroxy vitamin D, Breast Cancer 
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Background: Breast cancer is by far the most common cancer among women globally. 
Epidemiological evidence suggests that vitamin D from sunlight and diet may be inversely associated 
with breast cancer incidence. 1,25(OH)2D3, the physiologically active metabolite of vitamin D, exerts 
growth regulatory functions by binding to the VDR. 1,25(OH)2D has antiproliferative effects on and 
promotes the differentiation of breast cancer cells. In MCF-7 cells, vitamin D and vitamin D analogs 
have been shown to induce cell cycle arrest and apoptosis, to downregulate estrogen receptor 
expression, to limit responsiveness to the mitogenic effects of 17beta-estradiol, and to limit induction of 
the progesterone receptor.Epidemiologic evidence bearing on the relationship between vitamin D and 
breast cancer risk has come from several sources: ecologic studies, studies of vitamin D in relation to 
breast density, studies of VDR polymorphisms and breast cancer risk. The target of this study is 
investigation risk and incidence of VDR polymorphism in patients with breast cancer. 
Method: We studied recently published (2008-2014) and reviewed articles regarding Vitamin D 
Receptor and breast cancer. 
Results: More reviewed studies says that There is association between vitamin D receptor 
polymorphism and breast cancer. Also, some studies suggest that specific alleles of the VDR gene 
located near the 3' region may identify an increased risk for breast cancer and justify further 
investigation of the role of VDR in breast cancer. One study suggest that breast cancer risk may be 
associated with specific vitamin D-related polymorphisms, particularly CYP24A1. Genetic variation in 
the vitamin D pathway should be considered when designing potential intervention strategies with 
vitamin D supplementation. Some studies suggested that there were no associations between VDR 
BsmI polymorphism andbreast cancer. 
Conclusion: Vitamin D deficiency results of VDR genes polymorphism can be risk factor for breast 
cancer incidence. 
Keyword: Vitamin D Receptor– Breast Cancer 
  
 111 
 
 
P4-15 
Walnut and Breast Cancer  
Zare ommolbanin 
MCS of Midwifery, Department of Nursing and Midwifery, Faculty of Sciences, University of Islamic 
Azad Babol branch.(mahyazare@yahoo.com) 
Abstract 
BACKGROUND and OBJECTIVE: 
Walnuts contain bioactive molecules that may contribute to their beneficial effects , including alpha-
linolenic acid and phytosterols.  
MATERIAL and METHOD:  
To present this review article, researcher used Walnut and breast cancer as key words and searched 
the google scholar, Cochrane library ,Up-to-date and Pub-med sites, and the result was 15 articles, that 
after study all of them carefully we selected 5 of them, and use their data in this article.  
Findings: 
Several studies suggest that regular consumption of nuts, mostly walnuts, may have beneficial effects 
against oxidative stress mediated diseases such as cardiovascular disease and cancer . Walnuts contain 
several phenolic compounds which are thought to contribute to their biological properties. 
 Discussion and Conclusions: 
The results obtained herein strongly indicate that walnut tree constitute an excellent source of effective 
natural antioxidants and chemopreventive agents. 
Key words: Walnut and Breast Cancer. 
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Abstract 
Background: Revolutionary in the strategy of diagnosis and treatment of breast cancer in the last 30 
years,Significantly is contribute to increase the accuracy of diagnosis and quality of care . The aim of 
this study was to review recent studies conducted in the new treatments of breast cancer. 
Materials andMethods: The science direct،google scholar،SIDdatabases were searched. Finally, 31 
article were available was examined for review in the present study. 
Findings :According to the results, the mammography is a best diagnostic method for breast cancer 
screening . Needle biopsy thick With the eliminate many of the problems  diagnostic FNA,  There are 
many benefits for patients. miRNAs as regulators of gene expression, one of the candidates for new 
diagnostic and prognostic markers and therapeutic targets are. With the development of laser 
applications in medicine, can be leads to a damaged tissue temperature higher  than normal. Chance of 
destroying cancer cells at a temperature greater than 42.5 ° C is very high  .  
Conclusion: Based on the results and findings obtained, the new treatment in different ways,Effective 
to improve the quality of life, improve health and reduce morbidity and mortality, and Creation the 
pleasant experience for breast cancer patients,Is effective in the treatment of breast cancer 
Keywords: new treatments, breast cancer 
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 61-6P
زنان جوان مبتلا به سرطان پستان به عنوان استراتژی موثر پرستاری در افزایش کیفیت  مراقبت پرستاری در منزل برای
 زندگی بیمار و خانواده
 فاطمه سمیعی سیبنی، مرضیه خاتونی، زینب علیمرادی ، فرنوش معافی غفاری
و از آنجایی که کیفیت مراقبت از زنان جوان می تواند تاثیر ویژه  منجر به کاهش کیفیت زندگی زنان و خانواده آنها می شودبروز سرطان پستان  مقدمه:
مناسب برای بیمار و ای در کیفیت زندگی بیمار و خانواده داشته باشد، پرستاران با بکار گیری استراتژیهای خانواده محور، می توانند از طریق ایجاد موقعیت 
 تقاء کیفیت زندگی بیمار و خانواده داشته باشند.خانواده جهت مشارکت در فرآیند درمان نقش موثری در ار
 
نواده از آنجایی که زنان به عنوان هسته اصلی خانواده نقش مهمی را ایفا می کنند، سلامت و بیماری آنها می تواند به طور مستقیم سلامت کل خا بحث:
می تواند ماری و درمان، به مشکلات جاری زندگی زنان جوان اضافه شده و و جامعه را نیز تحت تاثیر قرار دهد. با بروز سرطان پستان ،مسائل مربوط به بی
اجتماعی برای –می تواند معضلات اقتصادی و روانی  ، روحی روانی و اجتماعی شود، همچنینیکاهش مراقبت از خود در زمینه های جسم منجر به
مراقبت از زنان مبتلا به سرطان پستان، می تواند بیشتر از مراقبتهای بیمارستانی در مراقبت پرستاری در منزل به عنوان مکمل خانواده نیز ایجاد نماید. 
یمارستانی نیز افزایش کیفیت زندگی بیمار و خانواده اثر بخش باشد. در این شرایط بیماران مراقبتهای ضروری را در منزل دریافت کرده و خطر عفونتهای ب
خانواده علاوه بر دریافت مراقبت، تحت حمایت اعضای خانواده قرار می گیرد.پرستار طی مراقبت در منزل با  کاهش می یابد. همچنین بیمار در محیط گرم
و خانواده  نقش جلب مشارکت بیمار و خانواده می تواند به اهداف بازتوانی سریعتر دست یافته و با افزایش کیفیت مراقبت،  در ارتقاءکیفیت زندگی بیمار 
 ته باشد.تعیین کننده ای داش
علی رغم اهمیت مراقبتهای پرستاری خانواده محور در ارتقاء کیفیت زندگی زنان مبتلا به سرطان و خانواده ، تاکید بر  تیجه گیری و پیشنهادات:
رد، مراقبتهای پرستاری و با توجه به اینکه در کشور ما خانواده جایگاه ویژه ای در حمایت از بیماران دا مشکلات بیماران بیش از خانواده ها می باشد
 خانواده محور از جمله مراقبت پرستاری در منزل می تواند نقش ویژه ای در ارتقاء کیفیت زندگی بیمار و خانواده داشته باشد.
 
 کیفیت زندگی،مراقبت در منزل، پرستاری، سرطان پستانکلمات کلیدی: 
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Background 
Premenopausal women with breast cancer often enter a premature menopause during initial treatment 
of their malignancy, with resulting loss of childbearing capacity, onset of menopausal symptoms, and 
subsequent prolonged exposure to long-term risks of menopause. Adjuvant therapy is believed to 
contribute to this early menopause. 
Methods 
96 menopause women from 5 health center in Shahrekord were recruited for the study in in February 
2014. Using interviewer-administered questionnaires designed to socio demographic information and 
knowledge, attitude and practices of these women towards breast cancer.  
Results 
Study participants had poor knowledge of breast cancer. Mean knowledge score was 32.6%. Practice of 
breast self-examination was low; only 47.2% participants admitted to carrying out the procedure in the 
past year. Only 7.1% study participants had clinical breast examination in the past year. Women with 
higher level of education were significantly more knowledgeable about breast cancer. Participants with 
higher level of education were more likely to practice breast self-examination.  
Conclusion 
The results of this study suggest that menopause women have poor knowledge of breast cancer and 
minority practice BSE and CBE. In addition, education appears to be the major determinant of level of 
knowledge and health behavior among the study participants. We recommend strategies and guidelines 
that will enhance information about breast cancer to all women. 
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Abstract: 
Background: According to the World Health Organization, breast cancer is the most common 
diagnosed cancer in women. MicroRNAs (miRNAs) are causing tremendous excitement in cancer 
research. miRNAs have been shown to regulate oncogenes, tumor suppressors and a number of cancer-
related genes. mir-146a is a tumor suppressor miRNA proposed as a biomarker in breast cancer. 
Objective: the aim of our study is to expand current knowledge about molecular function of miR-146a 
and a potential biomarker in breast tumor cells by using bioinformatics tools. 
Methods: validated and predicted targets of miR-146a were obtained from miRtarbase and miRwalk 
databases. UniGene and DAVID databases were used for further analysis. MIRSNP database predicts 
single nucleotide polymorphism in miR-146a and its function. 
Results: Our data manifested KEGG signaling pathways “pathway in cancer” as the most statistical 
relevant pathway with miR-146a targetome. Interestingly, it revealed that miR-146a inhibit some 
important breast cancer-related pathways such as TGFβRІ, PDGF by targeting some well-known 
oncogenes such as SMAD2/3, SMAD4, PDGFR. rs2910146 is located in mir-146a seed. It is predicted 
that G allele could increase stability of the stem-loop structure of mir-146a. 
Conclusion: According to our data miR-146a may be related to breast cancer through targeting its 
targetome leading to proliferation, invasion, migration and evading apoptosis in breast cancer. 
Therefore hsa-mir-146a is a potential tumor suppressor miRNA which could be used as worthwhile 
prognostic biomarker. Allele G in the SNP could have good prognostic value for breast cancer centers 
due to its effect on mir-146a stability. 
Key words: Breast cancer, miR-146a, SNP, targetome, signaling pathway. 
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A comparison of body image and public health among breast cancer patients with breast evacuation, 
breast keeping and normal people in Tehran 
Abstract 
The present study was conducted aiming to compare public health and body image among breast cancer 
patients with breast evacuation, breast keeping and normal women in Tehran. The method of the 
present study, due to the lack of interference to alter the research variables, was causal comparative. 
The statistical population included all women with breast cancer and normal women in the city of 
Tehran. From these people in each group 80 individuals were selected through available sampling from 
clients of medical centers and special hospitals in Tehran during October 2012 to December 2013. The 
applied instruments were the questionnaires of public health, body image, and marital satisfaction. The 
achieved data were analyzed via one-way ANOVA and Tukey test by SPSS software. The results of the 
analysis showed that there is a significant difference between the mean scores of body image and public 
health in three groups (women with cancer who evacuated their breast, those who didn't and normal 
ones)(p<0.01). Taking the findings of the study, the women with breast cancer suffer from 
psychological problems besides physical problems, the main reason whereof is the very physical 
problems. Therefore these kinds of problems should be attended besides physical treatments. 
Key words: public health, body image, breast cancer. 
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Abstract 
 
Among  the  women  worldwide  breast  cancer  is  one  of  the  widespread  killer  diseases.  Early detection of  
the disease is important in patient survival. The  main  objective  of  this  research  was  to  evaluate    predictive  
ability  of  hidden  markov  model  in  prediction  of  breast  cancer survivability. 
The  breast  cancer  data  set  used  in  this  investigation  were  acquired  of  Health  department  of  Kerman  
province  and includes  the  information  of  900  breast  cancer  patients,  aged  15  to  80  years,  and  its  
associated  risk  factors  among  patients  since  1999  to  2007. Hidden  markov  model  was  made  based  on  a  
set  of  675  patients  information  (75%  of  data)  and  that  was  validate  in  a  test  set  of  225  patients  
information  (25  %  of  data). The  Area  Under  the  ROC  Curve  (AUC),  sensitivity,  specificity  and  
accuracy  used  as  measures  of  validate  of    the  efficiency  of    model. 
The  sensitivity,  specificity,  accuracy  and  the  area  under  the  ROC  curve  of  the  hidden  markov  model  
was  0.989,  0.99,  0.939  and  0.94,  respectively. According  to  the  four  evaluation  criteria,  hidden  markov  
model  had good  performance,  therefore hidden  markov  model  and predict the diagnosis of  breast cancer  is 
recommended. 
 
Keywords:    Hidden markov model (HMM), EM algorithm, Breast cancer, survival 
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Breast Carcinoma Stages Diagnosis by Expression of breast Cancer-Specific Gene1 
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Abstract 
Breast cancer is the most frequent cause of death due to cancers among women. Breast cancer 
development and progression is accompanied by multiple genetic and epigenetic changes that lead to 
qualitative and quantitative alternations in individual gene expression. Breast cancer-specific gene 
)BCSG1(, is highly expressed in a breast cancer tumors and this gene is suggested as a prognosis factor 
in progression of breast cancer. In this study RNA of 50 breast tumors were extracted, which 
pathologically diagnosed, and then expression pattern of BCSG1 in different stages of tumors were 
analyzed by using Real-time PCR. By comparing expression pattern of BCSG1 in different tumor 
tissues, it was demonstrated that BCSG1 expression is directly associated with staging of tumors. Our 
data suggests that up regulated BCSG1 gene expression is potentially involved in the pathogenesis of 
breast cancer and it can be used as a strong prognostic factor in breast cancer. 
Key Words: Breast cancer, BCSG1, Real-time PCR, Gene-expression. 
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The Impact of Intraoperative Radiation Therapy in the Breast Cancer 
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3 Departments of Medical Physics, Faculty of Medicine, Tehran University of Medical Sciences 
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Background: In general External Beam Radiotherapy (EBRT) is regarded as safe for most patients, 
however there are a number of side effects that can limit and in some cases avoid its use in breast 
cancer patients. Intraoperative radiotherapy (IORT) is a guaranteeing methodology for delivering 
accelerated, partial breast irradiation (APBI). For a woman with breast cancer, the prospect of receiving 
radiation therapy in a single dose during surgery, instead of experiencing six weeks of radiation 
medicines, is a welcome one. 
Objective: The aim of this study is assessing the role of intra-operative radiation therapy in the current 
management of breast cancer. 
Results: Restriction of radiation therapy to the tumor bed during surgery may be acceptable for 
selected patients. IORT delivery generally adds around 45 min to the operating room time. The method 
of reasoning for considering IORT in breast malignancy originates the way that around 85% of local 
recurrences show up in the tissue adjacent to the lumpectomy site within 5 years of treatment. For 
surgery alone, the recorded 10-year repeat rate is 10–30%. When postoperative radiotherapy is 
delivered, the local recurrence rate is under 10%. Since most recurrences are near the operative site, 
partial breast irradiation using IORT is an appealing alternative. Condensing the entire therapeutic dose 
into a single fraction, delivering the treatment at the time of lumpectomy in the operating room, and 
with the ability to spare normal surrounding tissue to a greater extent than perhaps any other form of 
APBI, IORT offers numerous potential advantage. 
  
Conclusion: In perspective of the number of publications identified with IORT, improvement and 
usage of randomized clinical trials for most cancer sites ought to be conceivable. Targeted IORT 
allowed the entire dose of radiotherapy to be directed in a single fraction at the time of breast-
conserving surgery, therefore avoiding the need for repeated radiotherapy treatments or placement of 
indwelling radiotherapy devices. Intraoperative radiotherapy in patients with a low risk of recurrence 
could be the only treatment required. In patients with high risk of recurrence, accurate targeting of 
intraoperative radiotherapy might improve on the conventional external-boost treatment.  
Keyword: IORT, Breast Cancer, Radiotherapy 
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Sunlight exposure, vitamin D, and the prevention of breast cancer 
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Introduction: Breast cancer is the most common cancer diagnosed and the second most common cause 
of cancer mortality in women. Vitamin D is one of the critical factors for female reproductive health 
which may have protective activities against many cancer types, including breast cancer. 
Methods: This study was a comprehensive literature review performed through searches in databases 
such as Medline, PubMed, Science Direct, Scopus, and Google Scholar using the terms "Breast Cancer, 
Vitamin D, Sunlight exposure, and Cancer prevention ". 
Findings: According to the study's results vitamin D plays an important role in the prevention of breast 
cancer. Vitamin D plays a role in cell differentiation and may thus protect against breast cancer and its 
deficiency could be correlated by obesity, low levels of dietary intake, lack of chronic (not intermittent) 
sun exposure.  
Conclusions: These findings are discussed that vitamin D intake and sunlight exposure are protective 
factors for breast cancer. Vitamin D supplementation is a low cost, effective, and safe intervention 
strategy for breast cancer prevention. Hence health care providers can play a crucial role in prevention 
of breast cancer and promotion of society health by education of women in field of lifestyle 
modification with emphasis on the nutrition.  
Key words: Breast Cancer, Vitamin D, Sunlight exposure, and Cancer prevention 
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Abstract 
Introduction: Breast cancer is the second most common cancer in the world and the most common 
cancer among women. Pain is a common and often disabling problem in breast cancer patients. 
Estimates indicate that pain is experienced by 25% of newly diagnosed cancer patients and by 60% to 
90% of patients with advanced cancer. Persistent pain after breast cancer treatment is prevalent, and not 
all patients respond sufficiently to pharmacological treatment. Pain is recognized as a multi-
dimensional phenomenon, which includes psychological and social components. American Pain 
Society standards for pain management in cancer recommend both pharmacologic and psychosocial 
approaches. 
Methods: This study was a comprehensive literature review performed through searches in databases 
such as Medline, PubMed, Science Direct, Scopus, and Google Scholar using the terms "Breast Cancer, 
Pain management, Psychological intervention, and Cancer treatment ". 
Findings: Results of studies showed psychological interventions include education (with coping skills 
training), hypnosis, cognitive behavioral approaches, psychosocial supports and relaxation with 
imagery are affective on reducing pain among patients with breast cancer. 
Conclusions: According to efficacy of psychological interventions in reducing breast cancer pain, 
seems multidisciplinary teams are essential in oncology settings to integrate analgesic care and 
expertise in psychological and behavioral interventions in standard care for symptom management, 
including pain. 
Key words: Breast Cancer, Pain management, Psychological intervention, Cancer treatment 
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Abstract 
Leptin plays the role of mitogenic factor in the breast carcinogenesis. Quercetin, a flavonoid that has 
existed in nature. The aim of this study was the investigation of potentiality of Quercetin for inhibition 
of leptin gene expression and secretion, and its link with expression of estrogen receptors. Cytotoxic 
effect of Quercetin on T47D breast cancer cells was investigated by MTT assay test after 24h 
treatments with different concentrations of Quercetin. The levels of leptin, estrogen receptor α and 
estrogen receptor β genes expression was measured by reverse-transcription real-time PCR. The 
amount of secreted leptin in the culture medium was determined by ELISA. Data were statistically 
analyzed by one-way ANOVA test. Quercetin inhibits growth of T47D cells in a time and dose 
dependent manner. There was significant difference between control and treated cells in the levels of 
leptin, estrogen receptor β expression levels and the quantity of secreted leptin was decreased in the 
treated cells in comparison to control cells. In conclusion, Quercetin inhibits the expression and the 
secretion of leptin and in the future it might probably be a drug candidate for breast cancer therapy 
through leptin targeting. 
Keywords: Leptin, Quercetin, Breast cancer, T47D cell line 
  
 134 
 
P5-06 
 
Molecular Mechanisms of Melatonin anti cancer activity in breast cancer mini review article 
Elaheh Nooshinfar , Mohamad Esmail Akbari 
Summery 
Melatonin is a natural  hormone in body that produced mainly by the pineal gland at darkness  
.Melatonin secretion decreases with aging , The researchers  showed  that there is a low incidence of 
breast cancer in  blind women, and an inverse relationship between breast cancer incidence and the 
visual impairment caused  to pay more attention to melatonin as an effective agent duo to breast cancer 
,but why and how melatonin acts? The purpose of this review is orientation with different molecular 
mechanisms of melatonin function in prevention and treatment of breast cancer.  
To open access the articles، we searched valid databases, first we determined mean  key words, then  
identified  equivalent terms  and with use of appropriate operators, the formula was developed . at least, 
we selected  articles about ، molecular action of Melatonin in breast cancer and based on, the review 
was done  .  
The results indicated that melatonin acts as a strong anti oxidant that prevents DNA against free 
radicals  and  carcinogens  also protects it from damage. this hormone  activates  immune system by 
stimulate killer cells . In cellular functions, melatonin effects on breast cancer cells through  MT1 
receptors, the studies indicated that  melatonin decreases  the activity of estrogen receptors , increases  
the transcriptional activity of RAR alpha, inhibits MAPK cell signaling pathways , activates apoptosis 
through increases Bax expression, decreases  the activity of ROR alpha , melatonin through decreases 
in SIRT1(Sirtuin1), activates PER1 and PER2 ,Period genes that produced period circadian protein , 
.melatonin has an anti metastatic effect through inhibit the P38 MAPK signaling pathways, so stop 
proliferation. In addition, telomerase activity is observed in 85%–90% of all cancers, melatonin has  an 
anti telomerase activity., 
Conclusion: duo to the safety of melatonin and the wide molecular actions of it on breast cancer ,it 
seems that  melatonin can be consider in programming and writing the guidelines to prevent and help to 
the treatment of  breast cancer. 
Key words: molecular mechanisms, breast cancer, melatonin  
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 آیا سلامت معنوی برارتقای کیفیت زندگی افراد مبتلا به سرطان پستان تاثیر دارد؟
 زهرا عبادی نژاد؛ دانشجوی کارشناسی ارشد پرستاری کودکان، دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران نویسنده:
. سرطان پستان اولین سرطان در زنان ایرانی است و مهمترین های قلبی عروقی دومین علت مرگ در جوامع انسانی استسرطان بعد از بیماری مقدمه:
ترین عواملی است که کیفیت زندگی افراد مبتلا را تحت تاثیر قرار می دهد. سرطان پستان یکی از مهمعلت مرگ در بین زنان در اثر سرطان می باشد. 
هوم ذهنی، شخصی و وابسته به فرد است که جنبه های غیر مادی انسان معنویت یک مف یکی از راه های ارتقای کیفیت زندگی سلامت معنوی می باشد.
مراقبت معنوی، بخش ضروری در ارائه مداخلات پرستاری بوده و پرستارانی که با بیماران مبتلا به بیماری های مزمن مواجه هستند، را شامل می شود. 
  لازم است توانایی تأمین این نوع مراقبت را داشته باشند
در این مقاله، مرور جامع متون با استفاده از شبکه جهان گستر انجام شد.کلید واژه های مورد استفاده: سلامت معنوی، سرطان پستان و  روش ها: مواد و
کیفیت زندگی بود که در مجلات معتبر موجود در پایگاه داده های ایرانی و بین المللی از جمله 
مورد استفاده قرار  2008-2008و با دو زبان فارسی و انگلیسی از سال  ralohcS elgooG,diS,tceriDecneicS,dembuP,xedeMnarI
 گرفت.
مرور متون نشان داد که بین سلامت معنوی و ارتقای کیفیت زندگی بیماران مبتلا به سرطان پستان تاثیر مثبتی دارد. سلامت معنوی جزء یافته ها: 
ه سرطان من جمله سرطان پستان می باشد. طبق یافته ها افرادی که از سلامت معنوی برخوردار بودند مهمی در ارتقای کیفیت زندگی بیماران مبتلا ب
 احساس بهتری داشتند.
به دنبال تشخیص و درمان بیماران مبتلا به سرطان پستان کیفیت زندگی بیماران دستخوش تغییرات قرار می گیرد. راه های گوناگونی از  نتیجه گیری:
به  وپرستاران می توانند در هر یک از مراحل بیماری درک بهتری از شرایط بیمار مبتلا داشته جمله سلامت معنوی برای ارتقای کیفیت زندگی وجود دارد. 
 تخفیف پیامدهای ناشی از ابتلا به سرطان از جمله کاهش کیفیت زندگی کمک کنند.
 زندگی کیفیت و پستان سرطان معنوی، سلامت کلید واژه ها:
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Breast Cancer and Spiritual Health 
Azam –Shirinabadi Farahani, PhD Candidate in Nursing, Lecturer, Nursing & Midwifery School, 
Shahid  Beheshti University of Medical Sciences 
Email: farahani1381@yahoo.com 
Background & Aim: Breast cancer is the most common type of cancer for women. The purpose of 
this study was to find out the role of spirituality and spiritual well-being in patients with breast 
cancer. 
Material & Methods: Review of literature about breast cancer and spiritual health was performed in 
extensive research library and databases of ISI, Science Direct and PubMed. Regarding the integrity of 
the content a number of papers were selected and the results of these papers were discussed. 
Results: Breast cancer can lead to important mental and physical health problems. Women with breast 
cancer and their family, experience a high degree of stress. A treatment plan should be 
comprehensive and needs to include the spiritual health as well as the physical and psychosocial health 
in patients. Spirituality is an important element in cancer patients and it can help them. 
Conclusion: Spirituality as a psychological resource can support the cancer people. Thus preserve and 
promote the spiritual health in breast cancer people, are one of the main tasks of nurses. 
Keywords: Nurses, Spiritual Health, Breast cancer 
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 معنویت و سرطان پستان   
 فاطمه نیک سرشت؛ دانشجوی کارشناسی ارشد پرستاری کودکان، دانشگاه علوم پزشکی شهید بهشتینویسنده: 
امروزه سرطان پستان، شایع ترین سرطان در زنان ایران و جهان می باشد. این بیماری از همان بدو تشخیص باعث  ترس، نگرانی، اضطراب و  مقدمه:
مان مذهبی را به خطر می اندازد. به دنبال تشخیص بیماری، سؤالات متعددی در زمینه چرایی ابتلا به ناامیدی زیادی  گردیده و اعتماد به نفس و ای
و ممکن است بحران های معنوی زیادی راایجاد کند؛ راهبرد های سازگاری قبلی ناکافی به نظر می رسد نیازهای  بیماری و معنای زندگی مطرح می شود
نویت، به عنوان نظام عقیدتی فرد که بر جستجوی معنا و هدف زندگی تمرکز داشته و در ارتباط با وجودی متعالی می معنوی بیماران بیش تر گردیده و مع
 .دهد قرار توجه مورد نقش معنویت  را در زنان مبتلا به سرطان پستان دارد قصد مقاله نیاباشد، می تواند منبع حمایتی مهمی برای بیمار مبتلا باشد. 
معنویت، زنان  ،سرطان پستان استفاده، مورد یها واژه دیکل .شد گسترانجام جهان شبکه از استفاده با متون جامع مرور مقاله، نیا در:ها روش و مواد
 ecneicS،xedeMnarI، deMbuP جمله، از یالملل نیب و یرانیا یها داده گاهیپا در موجود معتبر مجلات در که بودندمبتلا به سرطان 
 .گرفت قرار جستجو مورد، diS,coDnarI ,narigaM,tceriD
ه به : مرور یافته ها نشان داد که معنویت نقش مؤثری را در سازگاری با بیماری و کاهش مشکلات جسمی و روانی، در زنان مبتلا دارد که با توجیافته ها
 با بیماری و مشکلات ناشی از آن بهره برد. شرایط فرهنگی و مذهبی جامعه ما می توان از معنویت به عنوان راهبردی مناسب برای سازگاری
: مسائل مربوط به معنویت به عنوان مؤلفه ای ضروری در تجربه بیماری های مزمن هم چون بیماری سرطان، به گونه ای کاملا جدی که نتیجه گیری 
قرار گرفته است. از این رو پرداختن به معنویت دارای در  می تواند نگاه زنان مبتلا را نسبت به خود، بیماری و آینده تحت تاثیر قرار دهد، مورد پذیرش
 مسیر بیماری اهمیتی مضاعف، می باشد که بایستی بیش تر مورد توجه قرار گیرد.
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 معنویت و رشد پس از سانحه در زنان مبتلا به سرطان پستان  
 دانشگاه علوم پزشکی شهید بهشتیفائزه ترابی؛ دانشجوی کارشناسی ارشد پرستاری کودکان، نویسنده: 
سرطان پستان، شایع ترین سرطان در زنان ایرانی است. تشخیص سرطان پستان، عامل استرس زای مهمی می باشد، به طوری که این بیماران  مقدمه:
، تجربه تغییر فردی مثبت ناشی از سطوح بالینی آشفتگی شامل اختلال استرس پس از سانحه، افسردگی و اضطراب را گزارش می کنند. رشد پس از آسیب
یر مثبت داشته رویارویی با بحران یا رویداد آسیب زا است. یکی از مداخلاتی که ممکن است بر علائم بیماری و کنار آمدن با بیماری در این بیماران تأث
نقش معنویت را بر رشد پس از  دارد قصد مقاله نیان باشد. باشد، مداخله بر پایه معنویت می باشد. معنویت می تواند منبع حمایتی مهمی برای این بیمارا
 .دهد قرار توجه مورد سانحه در زنان مبتلا به سرطان پستان
معنویت، زنان  ،سرطان پستان استفاده، مورد یها واژه دیکل .شد گسترانجام جهان شبکه از استفاده با متون جامع مرور مقاله، نیا در :ها روش و مواد
 ،deMbuP جمله، از یالملل نیب و یرانیا یها داده گاهیپا در موجود معتبر مجلات در که بودندمبتلا به سرطان و رشد پس از سانحه 
 .گرفت قرار جستجو مورد، diS,coDnarI ,narigaM,tceriD ecneicS،xedeMnarI
 افراد در تیمعنو. دارد وجودمعناداری  مثبت رابطه سانحه در زنان مبتلا به سرطان پستان، رشد پس از و تیمعنو نیب که داد نشان متون مرور: یافته ها
و با پاسخ های  کند یم کمک یشانیپر کاهش و یزندگ به دیجد یمعنا دادن و یماریب با یسازگار جهت در مثبت امدیپ کی حکم در سرطان به مبتلا
 انطباقی تر کنار آمدن، تاب آوری بالاتر در مقابل استرس، جهت گیری خوش بینانه به زندگی در ارتباط می باشد. 
: معنویت بهزیستی را در بیماران مبتلا به سرطان ارتقا می دهد و  نقش حیاتی را در فرآیند رشد پس از آسیب ایفا می کند و باعث یافتن نتیجه گیری 
 یپرستار مراقبت یاجرا منظور به پرستاران توسط  یمعنو مداخلات از استفاده یبرا قیتشو و یمعنو یازهاین از یآگاهنای جدید در زندگی می شود. مع
بیماران مبتلا به . بنابراین با برنامه های درمانی و مراقبتی مبتنی بر معنویت می توان در جهت رشد پس از آسیب در دارد ضرورت درمان نیح در نگر کل
 سرطان پستان گامی موثر برداشت.
 سانحه از پس رشد و سرطان به مبتلا زنان ت،یمعنو پستان، سرطانکلید واژه ها:  
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Abstract 
Sox2 (sex-determining region Y-box protein 2) is a transcription factor involved in the regulation of embryonic 
development and determination of cell fate. Sox2 is essential for self-renewal and pluripotency of embryonic 
stem cells (ESCs), as gene knockdown of Sox2 induces differentiation in ESCs. Sox2 is aberrantly expressed in 
breast and other cancers. 
In breast cancers, 16–30% of the tumors have been reported to express Sox2 detectable by 
immunohistochemistry while adult benign breast tissues show low to no Sox2 expression. Sox2 expression has 
been reported in all 4 majormolecular subtypes of breast cancer. In addition, Sox2 immunoreactivity correlates 
with a worse clinical outcome in breast cancer patients. Sox2 siRNA treatment has been shown to decrease 
proliferation in breast cancer cells, and Sox2 overexpression has been reported to increase in mammosphere 
formation in vitro. Sox2 expression was associated with larger tumor size and positive lymph node status. 
Cancer stem cells (CSCs), are responsible for tumor relapse, metastasis, and chemoresistance. Present 
chemotherapy modalities eliminate the bulk of tumor cells, but cannot eliminate the core of these cancer stem 
cells. Therefore, focusing therapies on cancer stem cells is more effective for the treatment of breast cancer. 
The conformational stability of a protein is defined as the free energy change (ΔGo). The marginal stability of 
proteins makes the use of certain proteins in industrial or pharmaceutical applications difficult, especially when 
the protein is subjected to extremes of temperature and pH, or to destabilizing solvents such as organic solvents.  
The aim of this study was to investigation stability Sox2‚ Under different environmental conditions (such as 
pH‚ polarization‚ surfactant) by various kind of spectroscopic and molecular modeling techniques. 
Our findings suggest that content of the secondary structure, tertiary structure, florophor environment‚ 
hydrophobicity Sox2 changes under different environmental conditions. we concluded that the ionic strength 
changes the protein structure sox2. Been reviewed situations can be used for the design of anti-cancer drugs.
  
Keywords: Sox2, ESC, spectroscopy, protein stability, thermodynamic parameters. 
  
 141 
 
P5-09 
Breast cancer screening barriers from women’s perspective: a systematic review in qualitative 
studies and critical appraisal 
Author name:Zoleykha Asgarlou1,Saber Azami2,Mohammad Arzanlou3 
1 Msc student of midwifery,Faculty of nursing and midwifery,Tabriz university of medicial 
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Abstract: 
Background: The principal aim of the health service providers in the field of breast cancer is to detect 
and treat breast cancer in the appropriatetime.Therefore:, identification of the barriers to screening can 
be very helpful.  
Methods: In this systematic review; some medical related sites were searched using the keywords: 
screening barriers, cancer, qualitative studies, Breast and their Persian equivalents were extracted and 
analyzed using the extraction table. To assess the quality of the studies,  (CASP) tool was used. 
Results: from 2134 found related articles, 21 articles were eventually included in the study. The most 
important barriers in view of 1084 women respectively were: lack of knowledge, access barriers 
(financial, geographical, cultural), fear (of results and pain), performance of service providers, women’s 
beliefs, procrastination of screening, embarrassment, long wait for getting an appointment, language 
problems, and previous negative experiences. Articles’ assessment score was 68.91. 
Conclusion: increasing women’s knowledge, reducing the costs of screening services, screening 
service culture promotion,presentation of less painful methods, change of beliefs of health service 
providers, provision of private environment for service giving, decreasing the waiting time for getting 
an appointment, and providing high quality service and appropriate behavior can be effective ways to 
increase breast cancer screening. 
Keywords: breast cancer, screening, barriers, women’s prospective, qualitative studies 
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The effects of vitamin C administration on conventional treatment in patients with breast cancer: 
A review 
Neda Rezvani1*, Saeed Pirouzpanah2 
1 MSc student of Nutrition, Faculty of Health and Nutrition, Tabriz University of Medical Sciences, 
Tabriz, Iran 
2 Assistant professor, Department of biochemistry and dietetics, Faculty of Health and Nutrition, Tabriz 
University of Medical Sciences, Tabriz, Iran (Pirouzpanahs@tbzmed.ac.ir) 
*Corresponding Author (neda7rezvani@yahoo.com) 
Introduction: Ascorbic acid (AA) readily neutralized reactive oxidant species due to its electron 
donor-acceptor properties. This oxidoreductase activity makes vitamin C related to various cancers 
including breast cancer. Method: This paper was provided as a review by selecting related items which 
published between the years 2000-2014. Documents were collected from databases, PubMed and 
Google Scholar. Results: Results of laboratory and human studies indicated AA had a dual effect on 
breast cancer cells, which probably depended on its blood concentrations. It had an antioxidant action 
in physiologic blood levels. While, in higher concentrations acted as a pro-oxidant agent only in cancer 
cells. Dose and method of administration are factors affecting on plasma levels of vitamin. It seems 
cytotoxic concentrations of vitamin only obtained by intravenous (i.v) administration, not oral intake. 
Generation of hydrogen peroxide (H2O2) was accounted as important mechanisms in vitamin’s pro-
oxidant activity. Impaired antioxidant systems in disease cells caused to the generated H2O2 by AA 
auto-oxidation selectively kill cancer cells. Discussion: i.v use of ascorbic acid is found to create 
cytotoxic blood levels of vitamin. Such finding can suggest a new approach to synergism effect of a 
seemingly antioxidant vitamin with conventional treatments such as chemotherapy. 
Key words: Breast cancer, Ascorbic acid, Conventional treatments 
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 21-6P
 مرور نظام مند راهکارهای مقابله و سازگاری با سرطان پستان
 5، دکتر فرید زایری 2، دکتر محمد هوشیاری  3سیمبر  دکتر معصومه، * 8، دکتر سپیده حاجیان 0عصمت مهرابی 
 0دانشجوی دکتری بهداشت باروری دانشگاه علوم پزشکی شهیدبهشتی، تهران
 8 استادیار، گروه مامایی و بهداشت باروری، دانشگاه علوم پزشکی شهید بهشتی، تهران
 3زشکی شهید بهشتی، تهراندانشیار، گروه مامایی و بهداشت باروری، دانشگاه علوم پ
 2استادیار، گروه رادیوتراپی و انکولوژی، دانشگاه علوم پزشکی شهید بهشتی ، تهران
 5دانشیار، گروه آمار زیستی، دانشگاه علوم پزشکی شهید بهشتی ، تهران
بقاء ناشی از این . باوجود این، توسعه درحال افزایش است. سرطان پستان شایعترین سرطان زنان  می باشد و بروز آن در جهان و بویژه درکشورهای در حالزمینه: 
علی رغم پیشرفت های بدست آمده در درمان سرطان در سالهای اخیر، به دلیل ارتقاء روش های تشخیصی و پیشرفت در درمان این بیماری افزایش یافته، باوجود این، 
) با این بیماری در جهت sroivaheb gnipocیرش این بیماری از سوی بیمار و روشهای مقابله ( این سرطان و افزایش میزان بقاء بیماری، پرداختن به نحوه پذ
 رسیدن به سازگاری، کمتر مورد توجه قرار گرفته است.
 هدف از مطالعه حاضر بررسی شیوه های مقابله ای مبتلایان به سرطان پستان در رسیدن به سازگاری با بیماری می باشد.هدف: 
، yeliW ,tseuqorP ,dem buP ,ralohcs elgooG،xedeM narI ,narigaM ,DISا جستجو در پایگاه های الکترونیک اطلاعاتی بروش کار: 
بوسیله واژه های کلیدی مطالعات مرتبط مورد بررسی قرار گرفت. مطالعه حاضر محدود به مطالعات مرتبط انگلیسی زبان از سال  regnirpS ,divO ,reiveslE
مطالعه از جستجوی اولیه به زبان انگلیسی بدست آمد که در نهایت 330ون و مقالات فارسی بدون محدودیت زمانی و شامل مطالعات کمی و کیفی بودند. تا کن 0008
)  elcitra lanigiroاصیلی(  مقاله به زبان فارسی با در نظر گرفتن معیارهای ورود تحقیق انتخاب شدند. معیارهای ورود شامل مقالات 2مقاله به زبان انگلیسی و  02
ده توسط زنان مبتلا به سرطان بودند که به زبان انگلیسی یا فارسی بوده، روشهای مقابله ای با سرطان پستان را در زنان بررسی کرده و روشهای مقابله ای بکار گرفته ش
 پستان توسط طراحی کمی یا کیفی مورد ارزیابی قرار گرفته شده بود. 
ته ها نشان داد روشهای مقابله ای برای رسیدن به سازگاری با سرطان پستان بر طبق نظریه لازاروس و فولکمن جای داشتند و عمدتا شامل دو دسیافته  نتایج:
ن درمان شده، وجه بیشتر به تلاش برای دریافت اطلاعات راجع به بیماری، مقابله با ناامیدی، معنویت درمانی، ارتباط با همتایا –روشهای مقابله ای مبتنی بر حل مساله 
بودند که در موارد رویکردهای مبتنی  -ترس، انکار، یاس و ناامیدی، افسردگی، انزوا و تسلیم تقدیر شدن -و روشهای مقابله ای مبتنی بر هیجان -اصلاح شیوه زندگی 
ماری و دستیابی به سازگاری را مشکل می سازد. بیشترین رویکردهای اجتنابی بر حل مسئله  منجر به سازگاری و در صورت رفتارهای اجتنابی و هیجان مدار مقابله با بی
 تودرمانی) بروز می نماید.در افراد جوان و واقع در سنین پیش از یائسگی گزارش می شد و مهم ترین نیازهای بیماران در حین روند درمانهای مکمل (شیمی درمانی و پر
مشاوره ای موثر با بیماران از ابتدای تشخیص و پس از اتمام درمان، از مهم ترین نیازهای پنهان بیماران است که باید به  لزوم ارتقاء آگاهی و خدمات: نتیجه گیری
 اندازه درمانهای جراحی و مکمل و درکنار آنها مورد توجه قرار گیرد و قابل دسترس برای همه بیماران مبتلا به این سرطان باشد.
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Futures of Breast Cancer in Iran 
Afsoon Taghavi*,Nahid Nafissi*, Elaheh Nooshinfar* 
* Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran 
In the past 50 years and after the development of new drugs for diseases with high mortality rate such 
as cardiovascular disease, the occurrence rate of cancers was dramatically increased (1). Breast cancer 
is the second (in Iran Breast Cancer is the first) most common cause of death from cancer in women 
with 30-60 years old worldwide with diagnosing over 1.6 million cases annually (2). The most 
important risk factors of Breast Cancer include, mammographic density, age, gender and BRCA1 and 
BRCA2 carrier status (3). Unfortunately, in the last decade, the incidence rate of this cancer has 
increased in Iran with a high mortality rate and occurs in at least 10 years younger women by mean age 
ranging from 47.1 to 48.8 years in comparison to developed countries (3). New cases of breast cancer in 
Tehran were reported 1603, 3946 and 4557 in 2000, 2003 and 2004 respectively. According to 
screening programs, the prevalence rate of breast cancer was reported as 352, 660 and 120 per 100,000 
in Bushehr, Shiraz and Northwest of Tabriz respectively (3). In developed countries, a significant 
decreased in death rate from Breast Cancer were reported because of diagnosis at an earlier time, 
improved surgical and radiotherapy techniques, and enhanced systemic therapies (4). According to 
various guidelines, population based mammography in asymptomatic women is offered for early 
identification of Breast Cancer (5) and lack of national program for screening of women for Breast 
Cancer in Iran is the main cause of increasing clinical Breast Cancer detection and mortality of this type 
of cancer.    
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Breast cancer with Acrometastasis Of hands, two case reports from Ostad Alinasab Hospital in 
Tabriz(north west of Iran).   
Authors:  Alikaram Hedayati Godarzi ,Fatemeh Hedayati , Zahra Mokarram Ghazani. Amir 
Mohammad Hedayati.                                                                                                                 
Corresponding Author : Alikaram Hedayati Godarzi 
Affilliation : professor of medical oncology, Consultant of OstadAlinasab Hospital in Tabriz    E Mail :  
drhedayaty @ yahoo.com 
Bone metastases are frequently seen in patients with malignancies,up to 70% in breast cancer, but 
approximately only %0/1-0/3% of these metastases are located in the hand or foot. In 16%ofpatients, 
acrometastasis is the first manifestation of a malignancy, mimicking a benign condition , the lesion will 
appear similar to that of an infection or inflamation ,and often present with pain, redness or 
discoloration,tenderness , heat , swelling , erythema, or loss of function.The mechanism responsible for 
the deposition of metastatic tumour cells within the hand is unclear, but an increase in blood flow or a 
trauma has been suggested in the past, and more recently, it has been suggested that the chemotactic 
factors (prostaglandins)and angiogenesis and growth factors has anyrols, and most in the dominant 
hand.The most commonly involved bones are the phalanges in the hand and the tarsal bones in the foot. 
Theseacrometastasishave a poor prognosis with a median survival of 6month, and early diagnosis 
isimportant to offer adequate treatment. Amputation, radiotherapy , curettage , cementation , 
chemotherapy , bisphosphonates  , and wide excision are the forms of treatment used most often. 
CASE ONE :The 51 years old woman with 5years past history of right side breast carcinoma ( 
T2N2M0-ER+,PR+,HER2_ ,8course CA/T chemotherapy and 50GY radiation therapy-4years 
tamoxifen therapy (20mg daily), alendronate 70mg weekly , Calcium D(3 tab per day) ) referred for 
pain and redness and inflammatory state in first metacarpal of right hand , and lytic destructive bone 
lesionin the first metacarp… 
CASE TWO: the 32year-old woman referred to our clinic with a two week history of right index finger 
pain,redness,and swelling without any history of trauma.The pain did not respond to NSAIDs ,narcotics 
and antibiotics.Inphysical examination revealed a mass like bone lesion in proximal phalanx of right 
index finger. An X-ray of his right hand lytic and destructive bon lesion in proximal phalanx of the 
right index finger . She subsequently  underwent biopsy of the finger lesion . Pathology from the 
specimen revealed a metastatic adenocarcinoma , most probably from breast or lung (primary lesion 
).CT scan of thorax and abdomen and pelvic was normal  , but in digital mammography and 
sonography of breasts, a 7mm lesion was seen in left breast (outer  upper quadrant ) , and pathology of 
this lesion in biopsy was invasive ductal carcinoma. Acrometastasis in this case is a first presentation of 
breast carcinoma.                                                                                                            
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Introduction :  Breast cancer is one of the most commonly diagnosed types of malignancy during pregnancy 
.Approximately0/2% to 2.6% of all breast cancer occur during pregnancy (BCP ).Many oncologist and 
obstetricians not have experience or only limited exposure to cancers diagnosed during pregnancy. Breast cancer 
during pregnancy has been characterized by more advanced disease stage, poorly differentiated tumors that are 
often estrogen receptor-negative, and delays in diagnosis on the part of patient and physician, assuming breast 
changes are benign or related to pregnancy. Diagnosis was be made by a combination of ultrasonography, 
mammography, and/or MRI, followed by core needle biopsy. Modified radical mastectomy is standard care in 
first trimester, whereas breast- conserving surgery (lumpectomy with lymph node dissection) can be performed 
preferably in the second or third trimester. Radiation therapy is not favored during pregnancy. Tamoxifen  is 
contraindicated during pregnancy and Aromatase inhibitors are not indicated in premenopausal women. 
Chemotherapy is generally contraindicated during first trimester because of the possible damage to 
organogenesis. In the adjuvant and neo-adjuvant and in the advanced/metastatic setting,  Anthracycline - based 
regiments(CA / CAF) remain the best choice, and Docetaxel or Paclitaxel can be administered in pregnancy if 
necessary.  Chemotherapy dosage where equal to those for the nonpregnant patients and were based on body 
surface area. The use of Trastuzumab (Herceptin) and MTX contraindicated during pregnancy /and Lapatinib and 
Bevacizumab cannot be recommended during pregnancy. We review 23cases of breast cancer that diagnosed and 
treated during pregnancy in the north west of Iran (TABRIZ) .                                                                      
Material and Method :  Between  December 1998 to july 2014 , 23patients with breast cancer during pregnancy 
that have been treated as MRM with axillary dissection during pregnancy are referred to our center for adjuvant 
chemotherapy .The mean age of patients was 33/2years (20-47 years). They all received chemotherapy for 4-
6courses in 2th and 3th trimester of pregnancy with CA (in5) or CAF (in 14 ) or TEC (in 4 ) regiment in 1th day 
and  GCSF in 2th to 5th day of each course of chemotherapy. The last course of chemotherapy was at least 3 
weeks before delivery (up to 35th weeks of pregnancy  ) .  Depending on the stage and hormone receptor states of 
tumors, ERT and/or Hormone therapy were given after delivery. The median follow up was 5years (9month to 
12 years)..                                                                                                  Results: The mean age of patients was 
33/2 years.  There was seen 2 patients in stage I and 8 in stage II and 12 in stage III and one in stage IV. Lymph 
node involvement was seen in 68%of cases and greater than 3 lymph nodes in 52% of patients. Vascular and 
lymphatic invasion were seen in 70% of patients. ER was positive in 53% and PR in 45%, Her2 expression in 
43%, P53 in 47%.  Severe grade III/IV hematologic toxic complication of chemotherapy is developed in 4 
patients and neutropenic sepsis in 2cases (with out mortality).All 23 babies were delivered alive and near normal 
without  any malformation, 9 babies with mild low birth weight. Due to 5 years follow up 5 patients were died 
and far metastases and loco regional recurrence are developed in 30% of patients, and 5 years survival  were seen 
in 75% and 5years DFS in 65%  of patients .                                                           
Conclusion:  Breast cancer during pregnancy needs special attention. Delayed diagnosis and its aggressive 
growth behavior  du to biologic effects of pregnancy, diagnostic  and therapeutic limitations during pregnancy 
like impossibility of doing bone scan, radiation and hormone therapy  in all trimesters makes its management 
different somehow difficult. Regarding safety  of FAC or CA or Taxens chemotherapies for mother and fetus 
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from the second trimester of pregnancy ,it is suggested for the patients that need any form of chemotherapy for 
breast cancer during pregnancy .     
Key words: breast cancer, pregnancy, treatment              
  
 141 
 
ROLE OF OVARIAN SLEEP WITH GnRH ANALOGs DURING CHEMOTHERAPY FOR FERTILITY PRESERVATION IN YOUNG 
PATIENT (UP TO 40 YEARS) WITH BREAST CANCER(STUDY OF 54 PATIENTS IN OSTAD ALINASAB HOSPITAL AND OURE 
CLINIC IN TABRIZ)  . 
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Corresponding Author : Alikaram Hedayati Godarzi 
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Background :Breast cancer is the commonest malignant disease in women and up to 20% of this cases in west world (Near 
to 50% Iran ) have less than 50years old ( Pre menopause ). Premature ovarian failure (POF) is a common toxicity of 
chemotherapy. For reproductive age women, a large number of whom have either not contemplated or not completed 
their families, the diagnosis of breast cancer poses fertility concerns. Advances in breast cancer care , including early 
diagnosis and aggressive chemotherapy ,have improved the life expectancy for young women ;and have necessitated an 
increased emphasis on issues of survivorship, including family planning. The reported incidence of amenorrhea after 
systemic therapy for breast cancer varies widely, and is related to age , type, and cumulative dose of administered 
chemotherapy, and reserve of ovaries and probably time of cycles during chemotherapy. The incidence of permanent 
amenorrhea following systemic therapy for breast cancer ranges from 33% to76%.                                                                                          
. 
Methods: Premenopausal patients with age up to 40 years with stage I-III ER/PR_ breast carcinoma to be treated with 
chemotherapy (CA OR TEC) with or without GnRH analogs started 10 day prior to the first chemotherapy dose(q28day up 
to 2weeks after later course of chemotherapy). The primary endpoint is2/5 years POF defined as amenorrhea for the prior 
6months and post –menopausal FSH level .                .                                                                                                                                                     
RESULTS: 54patients with mean age 35years (19-40) , 28 patient in group I ( Cytoxan +Adriamycin orCA +GnRHa) and 26 
patient in group II (TAXENS+EPIRUBICINE+CYCLOPHOFAMID or TEC + GnRHa ) are studied, After 6month of last course of 
chemotherapy normal FSH and menses were seen in 46% and 35% ,and after 12 month in 76% and62% , and after 
18month in86% and 73% and after 24 month in 93% and 85% and after 30 month in96/5% an92%.In control group of 
patient (54cases)normal FSH and menses seen in 31%, 61%,72% 80%, and 84%.After 2/5 years ,premature menopause 
were seen in 3/5% in CA- GnRHa ,7/5%Iin TEC-GnRHa , 16% in control groups.                                                                                                                                                          
. 
CONCLlUSION : Administration of GnRHa analog with chemotherapy was associated with less POF  and premature 
menopause, and we recommended this form of adjuvant therapy in young patients with breast carcinoma.                             
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Molecular Mechanisms of Melatonin anti cancer activity in breast cancer mini review article 
Elaheh Nooshinfar* , Mohamad Esmail Akbari 
Cancer research center Shahid Beheshti ,university of Medical Scienses 
Summery 
Melatonin is a natural hormone in body that produced mainly by the pineal gland at darkness 
.Melatonin secretion decreases with aging, The researchers showed that there is a low incidence of 
breast cancer in blind women, and an inverse relationship between breast cancer incidence and the 
visual impairment caused to pay more attention to melatonin as an effective agent duo to breast cancer, 
but why and how melatonin acts? The purpose of this review is orientation with different molecular 
mechanisms of melatonin function in prevention and treatment of breast cancer.  
To open access the articles، we searched valid databases, first we determined mean key words, then 
identified equivalent terms and with use of appropriate operators, the formula was developed. At least, 
we selected articles about ، molecular action of Melatonin in breast cancer and based on, the review 
was done.  
The results indicated that melatonin acts as a strong anti oxidant that prevents DNA against free 
radicals and carcinogens also protects it from damage. This hormone activates immune system by 
stimulate killer cells. In cellular functions, melatonin effects on breast cancer cells through  MT1 
receptors, the studies indicated that  melatonin decreases  the activity of estrogen receptors , increases  
the transcriptional activity of RAR alpha, inhibits MAPK cell signaling pathways , activates apoptosis 
through increases Bax expression, decreases  the activity of ROR alpha , melatonin through decreases 
in SIRT1(Sirtuin1), activates PER1 and PER2 ,Period genes that produced period circadian protein , 
.melatonin has an anti metastatic effect through inhibit the P38 MAPK signaling pathways, so stop 
proliferation. In addition, telomerase activity is observed in 85%–90% of all cancers, melatonin has  an 
anti telomerase activity., 
Conclusion: duo to the safety of melatonin and the wide molecular actions of it on breast cancer ,it 
seems that  melatonin can be consider in programming and writing the guidelines to prevent and help to 
the treatment of  breast cancer. 
Key words: molecular mechanisms, breast cancer, melatonin  
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Comparison of clinicopathologic appearance and 5years survival of breast cancer in young   (less 
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Abstract  : 
Background:  Up to 7%of breast cancer cases occur in women younger than 40years in west world 
(greater than 25% in IRAN).Studies have suggested an association between breast cancer at a young 
age, poorer outcome, and adverse clinical and pathologic characteristics. It is unclear whether age is an 
independent prognostic factor.                            
Objectives:To characterize the prognostic significance of young age at diagnosis through comparison 
of disease characteristics of young (less than 40 years) and less young (40-50 years old) premenopausal 
patients.                                                                                         
Methods:Consecutive patients with breast cancer up to 50 years old in time of diagnosis, treated in 
Ostad Aalinasab hospital and our provide clinic in north west of IRAN (TABRIZ) between October 
2002-november2o14were identified and their files reviewed(658 patients) .This cohort was identified as 
young (less than 40years old or group I=319 patients) and was compared with a group of less- young 
(40-50 years old or group II=339 ) patients .The clinicopathologic characteristics and survival data were 
compared.                                                
Results: Mean age were 35/2 years in group I (19-39years) and 46years in group II    (40-50years).The 
form of pathology in group I were invasive intra ductal carcinoma in 83% and basal like in 7% and 
invasive intra lobular carcinoma in 8% and other type in 2% of cases, but in group II ,85% invasive 
intra ductal and 5% basal like and 8%intra lobular and 2% other type. In group I , 24%were multifocal 
tumor but 15% in group II .The size of tumor or T in group I were 18% T1 and 47%T2 and 27%T3 and 
8%T4 but in group II , T1 in 28% and T2 in47% and T3 in 20% and  T4 in 5%were seen. Grade of 
tumors in group I were G3 or high grade in 68% and G2 in 19% and G1 in 13%, but in group II , G3 in 
50% and G2 in 35% and G1 in 15%.  Lymphovascular invasion was seen in 63% of group I but in 46% 
of group II. Axillary lymph node involvement was seen in 59% of group I but in 44% of group II. Stage 
of disease in the time of diagnosis group I were (20%stage I, 49%stage II, 21% stage III, 10%in stage 
IV) but in group II (26% stage I , 50% stage II, 16% stage III,8% stage IV ).61% of patients In group I 
and 76% of group II were ER+, 52% of patients in group I and 59% in group II were PR+.Her2 
expression were seen in 31% of group I but in 21% of group II. 30% of patients in group I but 17% in 
group II were triple negative. Median follow up of patients in two groups after treatment was 60 month. 
Five years survival in very young patients was76%.but 84% in group II.                                                                                                         
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Conclusions: young age(less than40 yo) among Iranian women with breast cancer is associated with 
higher stage at diagnosis, adverse pathologic characteristics (high grade, lymphatic and vascular 
invasion, ER negativity, triple negativity, and…) and adverse outcome when compared with less young 
patients (40-50yo), but probably age is not an independent prognostic factor for survival. 
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P5-21 
Evaluation of Silibinin Toxicity on Breast Cancer Cell line MCF-7 
Nasim forghani1*, Hossain faramarzi 2, Arash forghani3 
1. Department of Cell & Molecular Biology, School of Biology, University College of Science, 
University of Tehran 
2. Larestan School Of  Medical Science, Larestan, Iran 
3. Ardabil University of Medical Sciences. Ardabil.Iran 
Introduction: Given the prevalence of breast cancer, Mortality of patients and the public easy access to 
the herbal extract of milk thistle, We decided to examine the effectiveness of this plant on breast cancer 
cell line, MCF-7.Silibinin, a naturally occurring flavonoid antioxidant found in the milk thistle, has 
recently been shown to have potent anti-proliferative effect against various malignant cell lines. 
Materials and methods: In the present study, MCF-7 cells were incubated with various concentrations 
of silibinin for different times and survival rate and proliferation of cells after 12, 24 and 48 hours was 
evaluated by MTT assay. 
Results: The results show that Silibinin have significantly toxic effect on MCF-7 cell line. (P<0.001). 
So that, Silibinin decreases cell viability in a dose and time-dependent manner. 
Concentration 200µl of silibinin and in 48 hours had the best effect on the viability MCF-7 cells. 
Discussion and Conclusion: Considering to Silibinin effect on inhibiting cell growth, it could be 
Effective Preventer factor in the development and progression of cancer. 
Key words: breast cancer, Silibinin, MTT assay 
 
 
 
 
  
 111 
 
P6-01 
Exercise interventions for patients with breast cancer related lymphedema     
Shahram Mohaghegh MD .Sports medicine specialist.Shahid Beheshti university of medical 
sciences,Tehran.Iran 
Soori Mohsen MD.General surgery specialist. Shahid Beheshti university of medical 
sciences,Tehran.Iran 
Maryam Hajian. Community medicine specialist.  
Background and aims: Lymphedema following breast cancer surgery remains a common and feared 
treatment complication. The aim of this study was to find high level evidences(systematic reviews) 
about the role of exercise interventions in prevention and treatment of breast cancer related 
Lymphedema . 
Methods: We searched Pubmed  and Cochrane databases from beginning until 2015-01-01 for English 
language  systematic reviews  related to  Exercise interventions  for  breast cancer related Lymphedema 
.Keywords are  lymphoedema, breast cancer and exercise. 
Results: We found six systematic reviews (one in Cochrane and  five in pubmed database).  The quality 
of the primary RCTs in the included systematic reviews was variable. According  to the findings of 
these reviews , early rather than delayed onset of exercise training did not affect the incidence of 
postoperative lymphoedema, but early introduction of exercises was valuable in avoiding deterioration 
in range of shoulder motion . Strong evidence is now available on the safety of resistance exercise 
without an increase in risk of lymphedema for breast cancer patients. No exacerbation of objectively 
measured or subjectively reported lymphedema symptoms was reported with upper body progressive 
resistance training with or without aerobic training. In one review, it was concluded that the literature 
contains no evidence to suggest the most effective treatment for secondary lymphedema. In other 
review, self instigated therapies such as compression garment wear, exercise and limb elevation yielded 
smaller reductions in arm lymphedema than the more intensive and health professional based therapies, 
such as complex physical therapy, manual lymphatic drainage, pneumatic pump and laser therapy.  
Conclusion:  Although early exercise in the post-operative period may not prevent of postoperative 
lymphoedema, early implementation of exercises for prevention of  loss of shoulder range of motion  is 
important. Further high quality research studies are needed. 
Keywords: are  lymphoedema, breast cancer , exercise 
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 پستان سرطان خطر و ماهی مصرف ارتباط بررسی
 آراء** رزم حکمت*، سمیه انصاری*، لیلا خدیجه
 اهواز. پزشکی علوم دانشگاه، مامایی-پرستاری دانشکده علمی هیئت کارشناس ارشد مامایی ، عضو  *
 دانشگاه علوم پزشکی اهواز. **کارشناس ارشد مامایی،
 09360020090: تماس  شماره .oohay@158831hsمسئول نویسنده الکترونیکی آدرس
 :چکیده
 در ماهی، در موجود 3 -امگا زنجیره  بلند  چرب اسیدهای داشتن علت به ماهی روغن که اند داده نشان زیادی اپیدمیولوژیکی مطالعات: هدف و زمینه 
 خطر و ماهی  مصرف  ارتباط تعیین منظور به که است شاهدی -مورد مطالعه یک حاضر  پژوهش. دهد می کاهش را تومور ایجاد خطر حیوانات برخی
 .است شده  انجام پستان سرطان
 بیمارستان درمانی شیمی مراکز به کننده مراجعه پستان سرطان به مبتلا زن 690 روی بر نگر گذشته تحلیلی صورت به پژوهش این: بررسی روش
.  شد انجام) شاهد( ماموگرافی جهت اهواز شهرستان رادیولوژی مرکز به کننده مراجعه  سالم زن 690 و) مورد( اهواز شهرستان   در شفا و گلستان های
 از   پژوهش در کنندگان شرکت. بود ای تغذیه پرسشنامه و پستان سرطان بر مؤثر  و باروری عوامل پرسشنامه دموگرافیک، پرسشنامه استفاده مورد ابزار
 آماری آزمون از. شدند می مصاحبه  شان بیماری از قبل سال در ماهی مصرف همچنین و پستان سرطان بر مؤثر عوامل لحاظ از  ها پرسشنامه طریق
 تحلیل جهت لجستیک رگرسیون مدل از سپس شد، استفاده سن متغیر بررسی جهت تست ویتنی من آزمون آز و کیفی متغیرهای جهت کای مجذور
 .شد استفاده ها داده نهایی
 03-06 سنی مینیمم و ماکزیمم بود، سال 32/62±6/9  و سال 02/0±  9/0ترتیب به شاهد و مورد گروه دو در سن معیار انحراف و میانگین :ها یافته
 مصرف میزان اما داشت، داری معنی ارتباط پستان سرطان کاهش با ، ) =P0/800(ماهی کنسرو و )=P 0/00(میگو مصرف ، نهایی تحلیل در. بود سال
 نداشت داری معنی تفاوت دریایی و پرورشی ماهی نوع و پخت روش ماهی،
 مصرف ، ماهی متفاوت گونه بررسی در اما ،.نشد یافت ارتباطی پستان سرطان  با ماهی پخت روش ماهی، ،نوع ماهی مصرف مقدار بین :گیری نتیجه
 .داشت ارتباط پستان سرطان کاهش با ماهی کنسرو و میگو
 .ماهی شاهد، -مورد مطالعه پستان، سرطان :کلیدی واژگان
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Induction of apoptosis in human breast cancer cells by Britannin, a sesquiterpene lactone from Inula 
aucheriana 
Faranak Fallahian1*, Maryam Hamzeloo-Moghadam2,3, Mahmoud Aghaei4, Mohammad Hossein 
Abdolmohammadi1 
1Cellular and Molecular Research Center, Qom university of Medical Sciences, Qom, Iran. 
2Traditional Medicine and Materia Medica Research Center, Shahid Beheshti University of Medical Sciences, 
Tehran, Iran. 
3Department of Traditional Pharmacy, School of Traditional Medicine, Shahid Beheshti University of Medical 
Sciences, Tehran, Iran. 
4Department of Clinical Biochemistry, School of Pharmacy & Pharmaceutical Sciences, Isfahan University of 
Medical Sciences, Isfahan, Iran. 
Introduction: Induction of apoptosis in cancer cells can be a promising treatment method in cancer therapy. 
Naturally-derived products had drawn growing attention as agent in cancer therapy. The main target of anti-
cancer drugs may be distinct, but eventually they lead to identical cell death pathway, which is apoptosis. The 
current study was therefore carried out to address the issue if Britannin, a sesquiterpene lactone isolated from 
Astraceae family, is able to induce apoptosis in the breast cancer cell lines MCF-7 and MDA-MB-468. 
Material and Methods: Cell viability was determined using the MTT assay. Annexin-V/propidium iodide (PI) 
staining, Hoechst 33258 staining and caspase-3/9 activity assay was used to indicate that Britannin is able to 
induce apoptosis in MCF-7 and MDA-MB-468 cells. 
Results: we indicated that Britannin have antiproliferative activity on the MCF-7 and MDA-MB-468 human 
breast cancer cells. Annexin-V/propidium iodide (PI) staining, Hoechst 33258 staining and caspase-3/9 activity 
assay confirmed that Britannin is able to induce apoptosis in MCF-7 and MDA-MB-468 cells.  
Conclusion: Taken together, these results suggest that Britannin inhibits growth of MCF-7 and MDA-MB-468 
breast cancer cells and may potentially serve as an agent for breast cancer therapy. 
Key words: Britannin, Sesquiterpene lactone, Apoptosis, Breast cancer cell lines  
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Effect of injecting AuNPs on performance of AccuBoost brachytherapy system in patients with early-stage 
breast cancer using Monte Carlo method 
Poorbaygi, Hosein1; Habibeh Ghasemi Gharneh2; Mohammadi, parivash3; Sarabiasl, Akbar4* 
1Nuclear Science Research School, Nuclear Science and Technology Research Institute, Tehran, Iran 
2Department of Nuclear Engineering, Science and Research Branch, Islamic Azad University, 1477893855, 
Tehran, Iran  
3Physics Department, Faculty of sciences, University of Sistan and Baluchestan, Zahedan, Iran 
4Faculty of Advanced Sciences and Technologies, University of Isfahan, Isfahan, Iran 
(a.sarabiasl@ast.ui.ac.ir) 
Abstract 
Introduction: The AccuBoost system is a novel technology to employs a conventional mammography unit, a 
computed radiography )CR) system, and a 192Ir-HDR brachytherapy source remote afterloading system to 
deliver noninvasive image-guided breast brachytherapy (NIIGBB). This study investigates, for the first time, the 
dose enhancement to breast tumors due to gold nanoparticles (AuNPs) during noninvasive image-guided breast 
brachytherapy. The objective was to determine whether gold nano particles (AuNPs) were appropriate for 
macroscopic dose enhancement (MDE) in AccuBoost system. In order to make this distinction, The MCNPX 
Monte Carlo code was used to simulate this system with AuNPs. 
Materials/Methods: The 192Ir-HDR brachytherapy source and a pair of non-invasive round tungsten applicators 
was positioned on opposite sides of a compressed breast phantom to simulate a clinical geometry. A tumour 
region for a range of depths with a size of 1×1×1 cm3 loaded with AuNPs were simulated inside of ICRU 44 
breast phantom. The dose enhancement factor (DEF) defined as the ratio of the dose with and without AuNPs 
was calculated in the presence of AuNPs with 10, 20 and 30 mg/ml concentrations, separately with sizes of 50, 
100 and 200 nm inside the tumor volume. Then, DEF was averaged over various cubic cells in the tumor on the 
central axis of the beam and the average value was reported. Among the three mentioned concentrations, the 
dose enhancement related to 30 mg/ml is higher. 
Results: In this study, possible tumour dose enhancement by the use of gold nanoparticleswas estimated by 
Monte Carlo calculations. Our preliminary results indicate that major dose enhancement to breasts tumors can 
be achieved using AuNPs. We found a DEF of from 1.3 to 2.79 for 36 number of 192Ir-HDR source beams.The 
effect of AuNP size was not considerable, but the AuNP concentration had a substantial impact on achieved DEF 
in AuNP-based brachytherapy. 
Conclusion: The data demonstrate that the biological effect when irradiating in the presence of 30 mg/ml 
concentration of AuNP is about 30%–180% greater than without AuNP. Meanwhile, without radiation, the 
AuNP showed minimal effect on the cancer cells. These findings provide evidence that AuNP may be employed 
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as radiosensitizers during noninvasive image-guided breast brachytherapy also highlight a potential new 
approach for radiation boosting to breast tumors using AuNPs. 
Key words: AccuBoost brachytherapy, 192Ir-HDR, Breast cancer, AuNPs 
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P6-04 
Comparison of MRI and Pathologic Findings in Patients with Breast Complaints 
Elham Neshan1, Sara Bayesh2, Reza Najibpour2, Atieh Alimohammadi2, Nooshin Rahimi2, Ali farshad 
2,Farzad Tahmasebi-Arashloo2 
1 Department of Radiology, Islamic Azad University, Tehran Medical Sciences Branch, Tehran, Iran  
2 Students’ Research Committee, Islamic Azad University, Tehran Medical Sciences Branch, Tehran, 
Iran  
Introduction: 
Breast cancer is one of the most common cancers among women. The primitive diagnosis of breast 
carcinoma is based on mammography using X-Ray with variable result of 60-90% sensitivity and 10-
40% Specificity. Due to low Specificity, it may lead to unnecessary biopsy. Magnetic resonance 
imaging (MRI) compare to mammography enjoys the most sensitivity and specificity in diagnosing 
cancer pathology. However MRI is not still used as a routine method regarding high cost, limited 
accessibility and other factors. The aim of this study was identifying relationship between MRI and 
pathology results. 
Materials and methods: 
This was a cross-sectional study from January 2009 to 2010 in Athary Radiography center. The patients 
with Breast Imaging-Reporting and Data System (BI-RADS) 3, 4, 5 with no chemotherapy or biopsy 
before MRI were allowed to enter the study. In general 139  pathology from 98 patients were studied. 
Data were analyzed with SPSS 18.0 statistical software. 
Results: 
In pathology study there were 24cases (17.4%) malignant samples and 114 cases (82.6%) benign 
samples. In most of the pathology samples BI-RADS 4 was observed. In analyzing BI-RADS and 
pathology a significant relationship was observed (p=0.5551). There was the most relationship between 
descriptor and pathology of size, shape and internal enhancement. 
Discussion: 
Magnetic resonance imaging (MRI) is a specific non-invasive technique which doesn’t involve any 
radiation exposure and can detect breast lesions sometimes missed by mammography and clinical 
examination at the time of the initial breast-cancer diagnosis with low false positive results. It can be 
useful in gathering more information about suspicious area or already confirmed to be cancerous. 
Conclusion: 
BI-RADS have a high predictive value in diagnosing breast cancer. Span of MRI descriptor diagnosis 
involves abroad field of sensitivity. 
Key word: MRI- Pathology-Breast Cancer-Lesions   
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Evaluation of anti-cancer activity of new COX-2 inhibitors in an invivo model of breast Cancer 
 
Ahoo Afsharinasaba , Khadijeh Moradi b, Seyyedeh Zahra Moosavi a, Hamideh Heidarnezhad c and 
Mona Salimi d,* 
aDepartment of Toxicology & Pharmacology, Pharmaceutical Sciences Branch, Islamic Azad 
University (IAUPS), Tehran, Iran; bDepartment of Biology, Faculty of Science, Kharazmi University, 
Tehran, Iran ; cNational Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran; dDepartment of 
Physiology, Pasteur Institute of Iran, Tehran, Iran 
 
 
Introduction: Breast cancer is the second leading cause of death as a result of cancer among women, 
accounting for approximately 40,000 deaths each year. Current chemotherapy is unable to obtain 
clinical responses in patients with highly invasive metastatic disease. Therefore, there is an essential 
need for more effective approaches to prevention and treatment of breast cancer. An excellent currently 
available model of breast cancer is the BALB/c-derived 4T1 tumor. Cyclooxygenase-2 (COX-2) is a 
rate-limiting enzyme in the synthesis of prostaglandins. It is over-expressed in multiple cancers and has 
been associated with metastasis. In this study, the antitumor growth of celecoxib [a selective 
cyclooxygenase-2 (COX-2) inhibitor] as well as two new COX-2 inhibitor derivatives (A and B) were 
investigated in a murine mammary cancer model. 
Materials and Methods: Mice bearing mammary tumors, developed after inoculation of BALB/c mice 
with a mammary carcinoma cell line (4T1, 5 × 105), were treated with celecoxib and compounds A and 
B  at 20  mg/kg (i.p) five times a week for four weeks. 
Results: Tumor volumes were significantly reduced in mice receiving 20 mg/ Kg of celecoxib and 
compounds A and B after 4 weeks. By the end of the experiment, the average tumor volume in control 
animals was 1002±49.27 mm3, while those for mice receiving celecoxib, compounds A and B were 
183.5±49.50, 475.3±49.50 and 623.6±139.9 mm3, respectively.  
Conclusion: These studies suggest that celecoxib as well as compounds A and B can be good 
candidates for treating breast cancer. However compound A is more effective than compound B.  
Keywords : Breast cancer, Balb/c, COX-2 , 4T1 Cell 
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 سرطان پستانهای آدنوکارسینومای اتیلن گلایکول در مرگ سلولپلی -بررسی عملکرد کمپلکس دارویی پاکلی تاکسل 
 0، محمد احمد راجی0، علیرضا رضائی8، آزاده آصف نژاد0مهران حمیدی
 moc.oohay@18idimahnarheM
 ایران یزد، ، پزشکی مهندسی مهندسی،گروه و فنی دانشکده یزد، تحقیقات و علوم واحد اسلامی، آزاد دانشگاه -0
 ایران ،تهران ، بیومتریال گروه پزشکی، مهندسی دانشکده ، تحقیقات و علوم واحد اسلامی، آزاد دانشگاه -8
 چکیده:
 تاکسول داروی معایب داروهای ضد سرطان است که در مقابل طیف وسیعی از تومورهای انسانی کاربرد دارد. از ازجمله )XTP(پاکلی تاکسل مقدمه:
شود. هدف های آلرژیک شدید پس از تزریق داخل وریدی میواکنشآب اشاره کرد که منجر به  در دارو کم یریپذانحلال و یزگرآب طبیعت  به توانیم
پلی اتیلن  سازگار زیست پلیمری کمپلکس ها:مواد و روش  است. XTPداروی محلول در آب یشپی هاماکرو مولکولاز این مطالعه سنتز 
پروفیل رهایش دارو و مرگ   ،RITFی رسموردبرطراحی و ساخته شد.  شیمیایی روش به XTP سرطان ضد داروی همراه با) GEP(گلایکول
 ) سرطان پستان قرار گرفت.7FCMی آدنوکارسینومای(هاسلول
را تائید کرد. همچنین بازده  XTP شدهفعالهای هیدروکسیل و گروه GEPهای آمینی حضور پیوند بین گروه RITFهای بررسی و بحث: هاافتهی
 هایسیستم در XTP-GEPمحاسبه شد. ارزیابی پروفیل رهایش دارو افزایش پایداری کمپلکس  90/00% ± 8/6شده یطراحانکپسولاسیون سامانه 
آزاد بود که  XTPهای سرطانی مشابه یر کشندگی سلولتأثنیز  7FCMهای سلولی ی را نشان داد. بررسیدوستآباز طریق افزایش  رهش آهسته
 ییر ساختاری دارو در کمپلکس دارویی است. تغعدم دهندهنشان
 های سرطان سینه انسان را دارد.های این پژوهش حاکی از پتانسیل درمانی مناسب برای از بین بردن سلولی یافتهطورکلبه  گیری:بحث و نتیجه
 پستان، سامانه های رهایش دارو تاکسل، سرطان پاکلی گلایکول، دارویی اتیلنپلیکلمات کلیدی: 
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Assessment of flatness and Symmetry of intraoperative radiotherapy beam fields 
by radio chromic EBT-2 films 
Zahra Rahimzadeh Yekta1, Seied rabi Mehdi Mahdavi2 , Hamidreza Mirzaie3,Mohammad Esmaeil Akbari3, Nahid 
Nafisi3 ,Hamid Baghani4, Mostafa Robatjazi 5  
1 Sciences and Research Branch of Tehran, Islamic Azad University, Tehran, Iran 
2 Department of Medical Physics, Iran University of Medical Sciences, Tehran, Iran 
3 Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran 
4 Department of Radiation Medicine, Shahid Beheshti University, Tehran, Iran 
5Department of Medical Physics, Tehran University of medical Science, Tehran, Iran 
Introduction: Symmetry and flatness tests should be done by using suitable 3D motorized water 
phantom or appropriate radio chromic films and slab phantoms. The aim of this work is to check 
symmetry and flatness of Intraoperative Radiotherapy (IORT) fields by using EBT-2 films and beam 
profiles at 6,8,10 and 12 MeV. 
Methods and materials: Four pieces of EBT-2 films cut into 10×12.5 cm2 .Then films were scanned 
before and after irradiation. EBT-2 films put in reference condition (applicator 10 cm and 00 angel) and 
between vertical slab systems. Then, films irradiated in four energies 6, 8, 10, 12 MeV, separately. 
After irradiation, by using MATLAB software and selection of appropriate pixels can draw profiles. 
Flatness aria is in 80% filed size. Flatness and symmetry were obtained by special formulas. For 
assessment of flatness, maximum and minimum dose must be achieved and for analyzing symmetry, 
dose in corresponding points in central axis in profile should be measured.  
Results: Flatness for 6, 8, 10,12MeV energies were measured 3.6, 3.2, 1.7 and 2.9, respectively. Also, 
symmetry measurement in order for above energies were obtained 1, 1, 0.9, and 0.9.  
Conclusion:  absorbed dose variation inside the 80% of the field size (50% isodose) must be less than 
3%. In our results, flatness was acceptable for all energies (just for 6, 8 MeV a little is bigger than 3%).  
Also, maximum absorbed dose between points equidistant from central beam axis, inside the 80% of 
field size must be less or equal 3% and our measurements of symmetries were equal or under 1%.  
Symmetry and flatness of IORT beam fields seems acceptable and reliable for all energies and it is 
appropriate for treatment condition. 
Key words: symmetry, flatness, intraoperative radiotherapy, radio chromic EBT-2 films. 
yekta000066@yahoo.com 
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Title: The role of prolactin and growth hormone in breast cancer . 
Author: saeedeh hosseini , faculty member of shahid beheshti medical 
university.Email:saeedeh38@yahoo.com 
Introduction:  
Much attention has previously been focused on circulating levels of GH/PRL in relation to mammary 
tumor formation. It will review data demonstrating that these ligands also could be produced locally in 
different organs, including the mammary gland and mammary tumors, and suggest that this local 
production may be of importance for pathological conditions. 
Materials and Methods:  
This is review article that were identifical , by computer search of medline (1999-2014)  
Results:  
A crosstalk between GH- and PRL response is possible at multiple levels. In the human, GH can 
activate both the prolactin receptor (PRLR) and the growth hormone receptor (GHR). We have 
demonstrated that activation of the PRLR, but not the GHR, is inducing mammary tumors in transgenic 
mice. Furthermore, the elevated levels of insulin-like growth factor 1 (IGF-I) seen in the GHR 
activating transgenic mice is not sufficient for tumor induction. The induced tumors express 
functionally active prolactin that could be of importance for the tumor formation. Paracrine/aurocrine 
stimulation by PRL may be more important than PRL transported via  the circulation.  
Conclusions: 
In women, the role for stimulation of the PRLR and/or the GHR in mammary tumor formation has not 
been proven although experiments from primates suggest that the PRLR could be of importance. A 
more focused analysis to study local production of GH and/or PRL in relation to mammary tumors in 
women can be very productive. 
Key words: growth hormone, prolactin, breast cancer 
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Abstract 
Salvia officinalis L. (sage) is one of the herbs with anti-proliferative, cytotoxic and anti-carcinogenesis 
effects which turn it into one of the candidates in cancer therapy. In this study, the effects of sage 
hydro alcoholic extract on mouse breast cancer cell line (4T1) were examined. Cultured cells were 
treated with different concentrations (0, 10, 50, 100, 500, 1000 and 10000 μg/ml) of Sage hydro 
alcoholic extract for 24 hours. Cell viability, chromatin condensation and apoptosis induction were 
determined using Neutral Red, Aniline Blue and Acridine Orange/Ethidium Bromide staining, 
respectively. Bax and Bcl2 genes expression were measured using Reverse transcriptase PCR. 
Following treatment with sage extract, decrease in cell viability and increase in chromatin 
condensation were observed in a dose dependent manner. Most cultured cells were in the early 
stages of apoptosis in 50 and 100 μg/ml and in the late stages of apoptosis in 500 μg/ml of the extract. 
While Bax expression was increased with up to 50 μg/ml of sage extract, no significant change was 
observed in the levels of Bcl2 expression. Altogether, these findings demonstrate the cytotoxic and pro-
apoptotic effects of sage hydro alcoholic extract on mouse breast cancer cell line through increase in 
Bax/Bcl2 ratio (apoptotic index). 
 
Keywords: Apoptosis, Cell culture, Mouse breast cancer cells (4T1), Sage (Salvia officinalis L.). 
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Abstract 
Introduction: Physical activity is a well-known modifiable behavior for reducing breast cancer risk in 
postmenopausal women. However the underlying mechanisms are unknown. This study investigated 
how 6 months aerobic physical exercise can change leptin level, as a breast cancer risk factor, in 
postmenopausal women.  
Methods: This study was a randomized controlled trial. The study Participants were ages 50 to 74 years, 
sedentary and postmenopausal that randomly allocated to exercise or control group. Participants in 
intervention group engaged in aerobic exercise for 3 days per week for 6months, at 70-80% of 
maximum heart rate. Blood sampling was taken at baseline and after 6-months. Plasma concentration of 
leptin was assessed using ELIZA kit. Intention-to-treat analyses were performed using independent-
sample T test.  
Result: We had 41 women (19 in control and 22 in exercise group) at baseline and 27 women at 6 
months (14 in control group and 13 in exercise group). Average age and BMI of participants were 
54.5±5.8 and 27.9±3.2 respectively. Plasma leptin decreased 0.6% in exercisers and increased 8.2% in 
controls, although the exercise effect was not statistically significant (p value=0.08).  
Discussion and conclusion: leptin levels slightly decreased in exercisers but increased in control group. 
Thus, regular aerobic exercise might decrease breast cancer risk in postmenopausal women through 
decreased leptin levels. 
 
Key words: aerobic exercise, leptin, postmenopausal, breast cancer 
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ABSTRACT  
 
Introduction: identifying the risk factors for metastasis is major concern for treatment processes of 
cancer patients. Metastasis makes patients frail and increase hazard of death. It also decreases physical 
and psychological quality of life of patients. Aim of this study is determining of prognostic factors for 
metastasis of breast cancer using conditional regression model. 
Materials and Methods: in this survival study, hospital records of 246 women with breast cancer who 
underwent surgery and treatment at hospital Fayyazbakhsh were used. Patients were followed and their 
final situations recorded until 2012 May. Metastasis free survival estimated with Kaplan-Myier method. 
To determine the prognostic factors, a conditional regression model called PWP fitted. All statistical 
analysis was conducted with R software. 
Results: 202 patients (82.1%) were alive until follow up and 44 patients (17.9%) died.54patients 
experience metastasis. 11 patients (4.7%) had two metastases. Most of metastases were shown in bone, 
liver, lung and brain. Median metastasis free survival (MFS) estimated 64 month. One, two and three 
year MFS were 88%, 80.1% and 76.6%, respectively. Lymph node involvement and HER2 were shown 
as prognostic factors for metastasis. Age, Estrogen Receptor, Progesterone Receptor, Grade and tumor 
size variables were not significant (P> 0.05). 
Conclusions: number of lymph nodes involvement as a prognostic factor involve more nodes and 
increase risk of metastasis and death. Thus prognosis and treatment of cancer in early stages increase 
survival of patients.   
 
Keywords: Breast cancer, Metastasis, Metastasis free survival, Conditional model. 
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Abstract 
Background: In many culture, breasts is a symbols of femininity, motherhood, beauty and sexual 
attractiveness that loss and deformity it’s may lead to adversely affect the sexual life. The objective of 
present study was to understanding sexual functioning after mastectomy surgery in breast cancer 
survivor. Material &method: This study was a qualitative design. Semi- structured interview conducted 
with 11 Iranian women surviving breast cancer (mean age 44/5 years; mean age of husbands 47/8 years; 
median length between surgery and interview 2/8 years). Result: Analysis using the Colaizzi method 
revealed four major themes: (1) dyspareunia, (2) hesitation in resuming sex after mastectomy surgery, 
(3) decrease the frequency and quality of sex, and (4) sexual considerateness. Conclusion:  This study 
shows the changes to sexual functioning following mastectomy surgery. In addition, understanding and 
cognition about sexual life among breast cancer survivor will help improve survivor`s sexual wellbeing. 
The finding this study helps to mental healthcare professionals to design appropriate interventions to 
improve survivor`s sexual life. 
Key words: breast cancer, sexual functioning, mastectomy, Iran 
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Introduction: 
Breast cancer incidence is rising worldwide with an increase in aggressive neoplasias in young women. 
Possible factors involved include lifestyle changes, notably diet that is known to make an impact on 
gene transcription. However, among dietary factors, there is sufficient support for only greater body 
weight and alcohol consumption whereas numerous studies revealing an impact of specific diets and 
nutrients on breast cancer risk show conflicting results. Also, little information is available from our 
country.  
 
Result: The diversity of gene expression profiles found in breast cancers indicates that transcription 
control is critical for the outcome of the disease. This suggests the need for studies on nutrients that 
affect epigenetic mechanisms of transcription, such as DNA methylation and post-translational 
modifications of histones. In the present review, a new examination of the relationship between diet and 
breast cancer based on transcription control is proposed in light of epidemiological, animal and clinical 
studies. The mechanisms underlying the impact of diets on breast cancer development and factors that 
impede reaching clear conclusions are discussed. Understanding the interaction between nutrition and 
epigenetics (gene expression control via chromatin structure) is critical in light of the influence of diet 
during early stages of mammary gland development on breast cancer risk, suggesting a persistent effect 
on gene expression as shown by the influence of certain nutrients on DNA methylation.  
 
Conclusion: Successful development of breast cancer prevention strategies will require appropriate 
models, identification of biological markers for rapid assessment of preventive interventions, and 
coordinated worldwide research to discern the effects of diet. 
Keyword: nutrition, breast cancer, incidence 
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Abstract 
 
Background: Breast cancer is the most common cancer among women and one of the leading causes 
of death in the productivity ages. Mammography screening is the main method for the diagnosis of 
breast cancer. While analog mammography counts as the standard method of screening, the digital 
can be an alternative. This review compared the effectiveness and safety of the technologies. 
Method: In order to collect evidence about the effectiveness of analog and digital mammography a 
systematic review of diagnostic accuracy studies within 1990 to March 2014 was conducted. The most 
relevant databases including Abstracts of Reviews of Effects (DARE), NHS Economic Evaluation 
Database (NHS EEDs), Cochrane Database of Systematic Reviews, TRIP, PubMed and Medline. The key 
words included mammography and its roots. After identification of appropriate studies  the quality 
was evaluated with QUADAS and meta-analysis was used for extracted data pooling. 
Results: From 35,284 related study, 166 were selected after after topic review. Then by removing 
duplicates and abstract or full paper review, 13 studies were selected for  analysis. The quality of 9 
studies was good and the rest were at average range. Meta-analysis revealed that the sensitivity of 
analog and digital mammography in women under 50 years were 0.61 and 0.81 respectively. 
Conclusion: Owing to digital mammography’s higher sensitivity and regarding to the increasing 
prevalence of breast cancer in the Iranian women population, especially in 45-50 and higher safety of 
digital mammography, we can recommend it, instead of the analog for the screening and diagnosis of 
breast cancer. 
Key word: Digital mammography, analog mammography, effectiveness, screening, breast cancer 
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Breast Cancer Survivor’s Experiences: A Qualitative Study 
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Background: Living with cancer has somatic and emotional impact on women and cause severe 
complications and challenges in women’s life. 
Aim: The aim of this qualitative study is to explore in-depth recognition of the experience of Iranian 
women living with breast cancer. 
Method: This study was conducted with qualitative approach and content analysis. Women who 
referred to the Center of Omid hospital for receiving chemotherapy due to breast cancer participated in 
the study.  A purposive sampling was conducted. Data collection and in-depth unstructured interviews 
were carried out. Data collection continued until data saturation. All interviews were taped and 
recorded and then constant comparative analysis method was used. The MaxQDA software was 
performed to manage the data.  
Results: Four major core themes explaining the women’s lived experiences arose from the interviews: 
including the "expectations", "change" and "fears". Subthems incuding: need to family support, need to 
social support and spiritual need emerged for expectations; change in role, self perception, values, 
health perception in changes and fear of dying, frustration and losing the family in fears them. 
Conclusion: Awareness of the experiences of women with breast cancer helps them to be able to 
recognize barriers of the coping process in patients.  
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In the past 50 years and after the development of new drugs for diseases with high mortality rate such 
as cardiovascular disease, the occurrence rate of cancers was dramatically increased (1). Breast cancer 
is the second (in Iran Breast Cancer is the first) most common cause of death from cancer in women 
with 30-60 years old worldwide with diagnosing over 1.6 million cases annually (2). The most 
important risk factors of Breast Cancer include, mammographic density, age, gender and BRCA1 and 
BRCA2 carrier status (3). Unfortunately, in the last decade, the incidence rate of this cancer has 
increased in Iran with a high mortality rate and occurs in at least 10 years younger women by mean age 
ranging from 47.1 to 48.8 years in comparisonto developed countries (4). Overall estimated prevalence 
of Breast Cancer among Irainian women is 24 per 100000 (5, 6) and new cases of breast cancer in 
Tehran were reported 1603, 3946 and 4557 in 2000, 2003 and 2004 respectively. According to 
screening programs, the prevalence rate of breast cancer was reported as 28, 16.9, 12.6 and 7.6 per 
100,000 in Golestan province, Kerman, Gilan and Ardebil respectively (5). In developed countries, a 
significant decreased in death rate from Breast Cancer were reported because of diagnosisat an earlier 
time, improvedsurgical and radiotherapytechniques, and enhancedsystemic therapies(7). According to 
various guidelines, population based mammography in asymptomatic women is offered for early 
identification of Breast Cancer (8) and lack of national program for screening of women for Breast 
Cancer in Iran is the main cause of increasing clinical Breast Cancer detection and mortality of this type 
of cancer.  
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Abstract 
Breast cancer is the most common malignancy among Iranian females and more than 36% of the 
tumors occur in women under 40 years old which are frequently triple negative. In comparison with 
other types of breast cancer, patients with triple negative tumors have poor prognosis with less response 
to current therapies. In this study the cytotoxicity of statins were investigated in triple negative MDA-
MB-231 cell line. Hence, MDA-MB-231 cells treated with 0.1 ،1 ،5 ،10 ،25،50 ،100 µmol of 
Simvastatin, Lovastatin and Atorvastatin, separately. Cell death induction was assessed using MTT 
assay after 24 h. EC50 values were estimated using Prism software. All tested statins were able to 
induce cell death in MDA-MB-231 cells but with different EC50. Hence, the highest cell death 
induction was observed in the cells treated with Lovastatin, but a higher concentration of Atorvastatin is 
needed to induce the same amount of cell death. There is an expanding numbers of evidence supporting 
the ability of hydrophobic statins to inhibit the growth of breast cancer cells. It could be concluded that 
statins provoke cell death in triple negative MDA-MB231 cells and might be a new candidates for in 
vivo study of breast cancer treatment.   
Key words: Breast cancer, triple negative breast cancer, cytotoxicity, statins  
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Breast cancer is the second cause of death from cancer among women. It consists of heterogeneous 
group of different tumor subtypes that vary in prognosis and response to therapy. Genetic aproaches 
have provide opportunities in defining the genetic and histological basis of breast cancer, leading to 
classification  and targeted treatment. Despite this, the survival is modest. Cancer is a proteomic disease 
although genomic information illsuatrate the genetic basis of cancer but proteins do all of the work of 
the cell and they are the ultimate effector molecule of cellular functions. The genomic approach has 
some limitations. It does not show posttranslational modification that affects protein function. Currently 
because of rapid development in proteomic technologies with reproducibility and sensitivity, 
proteomics can be applied to extract important biological information to aid in understanding the cancer 
biology. The study of functional proteomics have advantages in related to genomics. At first, it can 
provide high-throughput analysis of  both basal and posttranslational modification of proteins such as 
phosphorylation and glycosylation of  proteins  that are important in carcinogenesis and tumor 
progression of breast cancer.  It can provide study of  protein-protein interactions and identify of hub 
proteins, effector and signaling pathways,  so leads to move from single-marker/single-pathway study 
to global study. Functional pathway-based proteomic biomarkers can provide better classification of 
breast cancer and personalized treatment. For this resean, proteomic technologies like mass 
spectrometry, isotope labeling with amino acids, reverse-phase protein array (RPPA) and tissue 
microarray techniques can use. RPPA-based classification will complement gene expression-based 
classification. It is expected that proteomic approaches can provide opportunities to identify specific 
and sensitive proteins or biomarkers that could be used in clinical applications.  
Key words: Proteomics, Biomarker, Breast Cancer. 
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Abstract  
Among cancer types, breast cancer is the second most common cause of death in women globally. 
Breast cancer involvements are seen more frequently in the left side compared to the right side. We 
aimed to analyze whether the laterality ratio is associated with the disease outcome. 
Recorded data of patients who visited an oncologic clinic in Mashhad in a period of 4 years were 
analyzed and required data including age, gender, involved side, metastasis status, and recurrence were 
extracted. All collected data were analyzed using SPSS version 21. 
The data of 855 patients including 842 females and 13 males were evaluated. Average age of the 
patients was 49.70 ± 0.42 and median was 48 years. In 52.4% and 46.3% of patients, left or right breast 
was involved respectively. 1.3% of patients had both breasts involvement. No significant correlation 
between the involved breast side and either the disease recurrence (p=0.675) or metastasis (p=0.791) 
was identified.  
In contrast to the results of some studies in other populations, our results indicated some of the disease 
outcomes such as recurrence or metastasis were not related to the tumor laterality of the breast cancer in 
our population. 
Keywords: Breast Cancer, Metastasis, Recurrence, laterality 
  
 113 
 
P6 - 20 
Histopathologic Characteristics of Breast Cancer in Patients Treated in a Private Oncologic 
Clinic in Mashhad 
Fatemeh Homaei Shandiz1, Mahdi Rivandi2&3, Fahime Afzal Javan2&3, Sahar Ardalan2, Alireza  
1 Department of Oncology Radiotherapy, Faculty of Medicine , Omid and Qaem Hospital, Mashhad 
University of Medical Sciences, Mashhad, Iran (HomaeeF@mums.ac.ir) 
2 Department of Modern Sciences & Technologies, Faculty of Medicine, Mashhad University of 
Medical Sciences, Mashhad, Iran 
(afzaljf911@mums.ac.ir), (rivandim912@mums.ac.ir), (saardalan2007@yahoo.com) 
3 Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, 
Mashhad, Iran 
4 Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, 
Mashhad, Iran 
*Corresponding Author (PasdarA@mums.ac.ir) 
Abstract 
Breast cancer with over 1,600,000 cases in 2014 alone, is the most globally widespread malignancy in 
women. The purpose of this research is to evaluate several histopathologic characteristics in patients 
diagnosed with breast cancer who visited a private oncologic clinic in Mashhad. 
Medical records of the patients who visited a private oncologic clinic in Mashhad were studied and 
evaluated for demographics and pathological data. Age, gender, breast cancer type, tumor size, stage of 
the disease, and the type of hormone receptors were extracted and analyzed. 
This study was done on 355 patients with an average age of 48.29. 91.8%, 4.2%, 1.7% and 1.4% of 
patients were invasive ductal carcinoma, invasive lobular, medullary carcinoma and comedo carcinoma 
respectively. Most patients, were in stage 3 of the disease (50.8%). Involved lymph nodes were mostly 
2-5.  76.9%, 9%, 5.07%, and 4.78% of patients belonged to (HER2+, PR+, ER+), Her2 Type, (HER2-, 
PR+, ER+), and Triple Negative subgroups respectively. 
This study shows that the leading type of cancer in the target population is invasive ductal carcinoma 
breast cancer type and most patients referred to the clinic were stage 3. Proper education in our 
population for breast cancer awareness and also implementation of the appropriate screening and 
diagnostic methods are essential. 
Keywords: Breast Cancer, Epidemiologic Study, Demographic Study, Invasive Ductal Carcinoma 
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Abstract: 
Introduction: Treatment of breast cancer as the most common cancer in women is one the important 
concerns these days. Selective estrogen receptor modulators and type 2 aromatase inhibitor are used in 
the in the treatment of breast cancer patients. The study was conducted to evaluate the effect of Femara 
(letrozole) and Tamoxifen on serum lipids in early postmenopausal breast cancer patients. 
Methods:  This was a blind randomized clinical trial study which was performed on 84 menopause 
women with early breast cancer. Patients were included in 2009-2012 from Asia, Laleh, Javaheri 
hospitals in Tehran. Patients were randomly divided in Tamoxifen (41 patients) (20 mg/day) and 
Femara (43 patients) (2.5 mg/day) groups. All patients were followed for 12 months. This study was 
approved by research committee of Islamic Azad University, Tehran medical Branch. 
Results: Mean age in Tamoxifen group was 58.48 ± 6.56 years and mean age in Femara group was 
56.18 + 5.86 years (P=0.628). Both medications had reduced serum total cholesterol and serum LDL 
but there was no significant difference between groups (P>0.05). Femara decreased the HDL in 23% 
and tamoxifen decreased it by 3% (P = 0.001).  
 
Conclusion: Our evidence showed that according to Femara properties this drug could be used as an 
alternative option instead of tamoxifen in breast cancer patients. But according to our small sample size 
and short term flow up it seems that more randomized clinical trials are needed to confirm the results of 
this study and evaluate survival in these patients. 
Key words: Breast cancer, Femara, Tamoxifen. 
 
 
Introduction: 
Breast cancer is the most common cancer in women of high-income countries: and over the past 20 to 
30 years, data support a trend of increasing incidence and mortality from breast cancer in lower income 
countries. 
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 Family history of breast cancer and gynecological variables, such as early menarche, late menopause, 
not bearing children, and late first pregnancy are well established risk factors for breast cancer. 
Tamoxifen is a non-steroidal anti-estrogen agent that has already been used as the standard adjuvant 
endocrine therapy for hormone receptor (HR)-positive breast cancer. Previous studies showed that 
tamoxifen can significantly improve progression-free survival (PFS) and overall survival (OS). It 
operates by blocking the estrogen receptors in target tissues and several other biochemical mechanisms, 
such as estrogen agonistic effects on the endometrium and blood lipids as well as bone preservation. 
What is more, tamoxifen is the only choice for endocrine therapy of hormone receptor-positive pre 
menopausal patients. 
Letrozole (Femara) is third generation non-steroidal, reversible aromatase inhibitor currently in use for 
the treatment of advanced and early stage breast cancer in postmenopausal women.  
This study was conducted to evaluate the effect of Letrozole (Femara)  and Tamoxifen on serum lipids 
in early postmenopausal breast cancer patients. 
 
Methods: 
This was a blind randomized clinical trial study which was performed on 84 menopause women with 
early breast cancer. Patients were included in 2009-2012 from Asia, Laleh, Javaheri hospitals in 
Tehran.  
We had included patients who had early postmenopausal breast cancer and we had excluded all patients 
who did not signed Informed consents. 
Patients were randomly divided in Tamoxifen (41 patients) (20 mg/day) and Femara (43 patients) (2.5 
mg/day) groups. 
Blood samples were allowed to clot at 4oC for 2 h, and then centrifuged at 2,000 · g for 10 min. The 
serum was transferred to new tubes for lipid assays. Total serum cholesterol (CH), high-density 
lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol and triglyceride (TG) levels 
were measured. 
 All patients were followed for 12 months. This study was approved by research committee of Islamic 
Azad University, Tehran medical Branch. 
Statistical procedure was done by Statistical Program for Social Sciences software (SPSS) version 18. 
The significance level (p) was set at 0.05. 
 
Results: 
41 patients was included in Tamoxifen  and 43 patients were included in Femara group. Mean age in 
Tamoxifen group was 58.48 ± 6.56 years and mean age in Femara group was 56.18 ± 5.86 years. There 
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was no statistical differences between groups in age (P=0.628).  35 were married and 6 were widow in 
Tamoxifen group. 39 were married and 4 were widow in Femara group. There was no statistical 
differences between groups in marital status(P=0.713). 
Mean serum total cholesterol (TC) was 235.13 ± 24.46, mean high-density lipoprotein (HDL) 
cholesterol was 55.47 ± 12.54, mean low-density lipoprotein (LDL) was  183.32 ± 26.03 and mean 
triglyceride (TG) was 245.36 ± 63.56 in Tamoxifen group at the baseline.  
Mean serum total cholesterol (TC) was 224.13 ± 19.67, mean high-density lipoprotein (HDL) 
cholesterol was 58.34 ± 11.84, mean low-density lipoprotein (LDL) was  171.29 ± 17.63 and mean 
triglyceride (TG) was 236.29 ± 54.27 in Femara group at the baseline.  
There was no difference between groups in their lipid profiles at the baseline (P> 0.05) 
After one year our results showed that mean total cholesterol (TC) was 193.67 ± 23.88, mean high-
density lipoprotein (HDL) cholesterol was 52.38 ± 11.78, mean low-density lipoprotein (LDL) was  
145.45 ± 22.61 and mean triglyceride (TG) was 315.31 ± 43.20 in Tamoxifen group. 
Mean serum total cholesterol (TC) was 182.13 ± 32.25, mean high-density lipoprotein (HDL) 
cholesterol was 46.73 ± 8.76, mean low-density lipoprotein (LDL) was  142.73 ± 18.37 and mean 
triglyceride (TG) was 309.32 ± 34.73 in Femara group. 
Both medications had significantly reduced serum total cholesterol, serum LDL (P<0.05). but there was 
no significant difference between groups (P>0.05).  
Femara decreased the HDL in 23% and tamoxifen decreased it by 3% (P = 0.001). 
 
Discussion:  
Wasan etal in 2012 had reported that Femara had changed the HDL and TG significantly after their 
trial. But there was no difference in LDL and TC. 
Bell et. al had reported in 2009 that Femara had increased LDL significantly after trial but there was no 
significant difference in HDL. 
Goss et.al had reported in 2011 that Femara reduced LDL, TG significantly; TC was reduced after trial 
but there was no statistical difference between groups. HDL was increased but there was no statistical 
difference between groups. 
Lee et.al had reported in 2010 that Tamoxifen had significantly reduced LDL and TC but it had slightly 
reduced HDL. TG was increased significantly in their trial. 
Parkman et.al had reported in 2012 Tamoxifen had significantly reduced LDL, HDL and TC but it had 
slightly increased TG. 
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According to previous studies and our finding there are a lot of controversies about the effect of Femara 
on serum lipid levels but tamoxifen could reduce LDL and TC. Further review and systematic studies 
could demonstrate the effect of these medications on serum lipid profiles. 
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Introduction:Breast cancer is the most common cancer in women and it has a great burden in the 
society. many psychological and social factors could affect these patients and one of the most factors is 
patients perceived social support. This study was designed to evaluate patients social support. 
Methods: This was a case-control study which was done on 140 women who were included in 2011-
2012 from Asia hospital in Tehran. 70 patients had breast cancer and 70 were healthy participants. Age 
was matched between groups. Farsi version of Multidimensional Scale of Perceived Social Support 
(MSPSS-P) questionnaire was used for social support evaluation in participants. 
Results: Mean age in breast cancer group was 52.48 ± 7.25 years and mean age in control group was 
51.37 + 7.46 years (P=0.783). Mean family support score in case group was 18.23 ± 3.12 and in control 
group was 15.48 ± 3.23 (P=0.038). Mean friends support score in case group was 14.87 ± 2.56 and in 
control group was 15.28 ± 2.63 (P=0.648). Mean significant other support score in case group was 
15.58 ± 2.68 and in control group was 14.08 ± 2.52 (P=0.738). 
Conclusion: According to our results patients had a supportive family and this could be because of our 
traditional and religious culture in Iran.  This support could help patients to recover their quality of life. 
Psychological factors should be considered by surgeons during their treatments for women with breast 
cancer. 
Key words: Breast, Cancer, Social support 
 
Introduction: 
Breast cancer, as one of the most common malignant tumors, threatens the health of many women 
worldwide. The diagnosis and treatment for breast cancer in women are less than optimal, and they 
have negative influences on the quality of life. Besides the physical changes, breast cancer can also 
bring about psychological alterations including anxiety, depression, anger, fear, and uncertainty. 
Therefore, in practice, the mental health of breast cancer patients needs much more attention. Hope, 
motivation or energy, encourages patients to realize their goals, and helps patients adapt to the disease 
and improve their physical and mental health. For patients with cancer, hope is regarded as one of the 
most important and effective coping style in overcoming the cancer during treatment. Although 
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researches on the relationships among hope, coping style, and social support in different populations 
with different scales have been conducted in Western populations, there are some differences in the 
Western and Eastern populations that demand further scrutiny before these data being applicable to 
Eastern populations.  
Social support is characterized as any combination of emotional, tangible, appraisal, and informational 
support. Support can be formal, informal, social, professional, structured, or unstructured. It has been 
recognized for many years that social support is an important factor which may affect the general well-
being of individuals living with chronic and life-threatening health conditions like breast cancer. Social 
support can help women with breast cancer to adjust and cope, and can have positive impacts on the 
survivor's health. For an individual who has completed treatment, social support can enhance her 
quality of life and ease her transition into life after treatment. For breast cancer survivors, access to a 
supportive environment can prevent long-term psychological difficulties and benefit her general well-
being. 
This study was designed to evaluate Iranian breast cancer patients social support. 
Methods: 
This was a case-control study which was done on 140 women who were included in 2011-2012 from 
Asia hospital in Tehran. 70 patients had breast cancer and 70 were healthy participants. Age and marital 
status was matched between groups. 
We had included patients with positive breast cancer history how were not under went surgery. 
Informed consents were obtained from all the participants and those who had loss of consciousness 
were excluded. We also had excluded patients who had history of psychological disorders. 
We had used Persian version of Multidimensional Scale of Perceived Social Support (MSPSS-P) 
questionnaire in this study for social support evaluation. 
Persian version of Multidimensional Scale of Perceived Social Support (MSPSS-P) questionnaire had 
12 items and was developed by Zimet et al. It measures the perceived support in 3 subscales from 
family, friends, and significant other (a person with whom one shares a close relationship); each 
subscale contains 4 questions and each question have a score between 0-6. In this test higher scores 
show more perceived support. In Farsi version of MSPSSP, Cronbach's alpha coefficient was found to 
be 0.84 for the whole scale and 0.90, 0.93 and 0.85, respectively for friends, significant others and 
family subscale in patient sample, and 0.92 for the whole scale and 0.89, 0.92 and 0.87, respectively for 
friends, significant others and family subscale in healthy sample. 
This study was approved by research committee of Islamic Azad University, Tehran medical Branch. 
 Results:  
140 participants were included as 2 groups in this study. Mean age in breast cancer group was 52.48 ± 
7.25 years and mean age in control group was 51.37 + 7.46 years (P=0.783). 63 were married and 7 
were widow in both groups (marital status was matched between groups). 
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Education in 46 patients was lower than high school diploma, 19 had high school diploma and 5 
participants education was higher than high school diploma in breast cancer group.  
Education in 51 patients was lower than high school diploma, 13 had high school diploma and 7 
participants education was higher than high school diploma in control group.  There was no statistical 
differences between groups in education (P =0.618).  
Mean family support score in case group was 18.23 ± 3.12 and in control group was 15.48 ± 3.23. 
There was a statistical difference between groups (P=0.038). Mean friends support score in case group 
was 14.87 ± 2.56 and in control group was 15.28 ± 2.63. There was not a statistical difference between 
groups (P=0.648). Mean significant others support score in case group was 15.58 ± 2.68 and in control 
group was 14.08 ± 2.52 . There was not a statistical difference between groups (P=0.738). 
 
Discussion: 
Our results showed that patients family support sub scale was significantly different between groups 
and these patients have a supportive family.  
Yoo et.al had evaluated 110 Chinese participants (55 with breast cancer and 55 healthy individuals) in 
2012. They had evaluated social support, depression and anxiety in these patients. They had reported 
that social support, depression and anxiety was higher in their case group comparing with controls 
(P>0.05). 
They had also divided their case group in to 2 groups according to  patients social support results. They 
had reported that patients who had a better perceived social support  had significantly lower depression 
and anxiety comparing with breast cancer patients who don’t have a good social support. Our results 
are agreed with Yoo findings. We both found that patients with breast cancer had better social support 
comparing with health individuals. 
Kim et.al had evaluated 138 korean patients who had been in cancer treatment at medical clinics in 
2010. They had reported that 47.3% reported having had suicidal thoughts and 16.4% had attempted 
suicide since the diagnosis of cancer. The study participants received most support from family 
members. The suicide attempt group had significantly higher scores according to gender, age, level of 
education, diagnosis, treatment modality, level of activity, caregiver and social support compare to the 
suicide thought group. Suicidal thoughts were negatively related to social support and meaning of life 
was positively associated with social support.  
Den Heijer et. al had evaluated 222 patients with breast cancer in Netherlands in 2011. They had 
reported that perceived support from friends was indirectly associated with breast cancer-specific 
distress. 
Snyder and Pearse had evaluated 70 younger women diagnosed with breast cancer in 201o in USA. 
They had reported that patients had high score in friends and then family support sub scales.  
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According to these western reports breast cancer patients perceived higher supports from their 
friends and family support was in the second rank. But according to eastern reports breast cancer 
patients perceived higher supports from their family. 
This difference could be because of differences in cultures between western and eastern countries.  
According to our results and other eastern reports breast cancer patients perceived higher supports 
from their family. In our study This could be because of our traditional and religious culture in Iran.  
This support could help patients to recover their quality of life. Psychological factors should be 
considered by surgeons during their treatments for women with breast cancer. 
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Introduction: Lactating adenomas are benign breast masses related to physiological changes during 
pregnancy and increased estrogen level. Fibroadenoma and breast cancer are in the differential 
diagnosis of them. The purpose of this study was to evaluate cases of lactating adenoma in Breast 
Cancer Research Center and review of the literature. 
Materials and Methods :All patients between2010-2014 with histological diagnosis of lactating 
adenoma in their biopsy pathology were selected and data were extracted from their medical papers. 
Findings :In this period of time there were a total of 22 patients with pathology of lactating adenoma. 
The mean age was 27+4/6.fourteen patients were breast-feeding, 7 patients were pregnant (second and 
third trimester) and 2 patients had a history of lactation. The chief complaint in 16 patients was mass 
and in 6 patients was pain.Of 15 ultrasound BIRADS Reports, 8 cases were equal to and less than 3 and 
7cases were equal to and greater than 4.The mean size of masses was 4.1 cm (1.8-8 cm). in 15 patients 
core Needle biopsy (CNB)  and  6 patients open biopsy were performed  and 1 vacuum-assisted biopsy 
were done.In 5 patients excisional biopsy were done in the follow up period after CNB that one of them 
was invasive ductal carcinoma and other cases were benign. 
Discussion and Conclusion : Most masses which are diagnosed during pregnancy and lactation are 
benign but they are in differential diagnosis with cancer .lactating adenoma occurs not only during 
breast-feeding but also during pregnancy. Fine needle aspiration is associated with high false positive 
results and biopsy is the standard diagnostic method, especially sono-guided CNB .Most of these 
masses will regress after stopping of breast feeding .surgery can be postponed until that time except for 
suspicious situations. 
Key words: Breast mass, lactating adenoma , pregnancy 
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Abstract 
Background: Recognition of mutations by DNA sequencing can be simplified by scanning methods to 
recognize amplicons which may have mutations. Current scanning methods used for the detection of 
germline sequence variants are difficult as they require post-PCR management. High resolution melting 
(HRM) is a cost-effective quick screening approach, which readily detects heterozygous variants by 
melting curve analysis of PCR products. It is well suited to screening genes such as BRCA1 and 
BRCA2 as germline pathogenic mutations in these genes are always heterozygous. 
Materials & Methods: Assays for the analysis of all coding regions and intron-exon borders of BRCA1 
and BRCA2 were designed, and optimized. A final set of 50 samples which ran under identical 
amplification conditions were chosen for BRCA1 and BRCA2. The most common mutations BRCA1 
(c.3342_3345 delAGAA), BRCA1 (c.5406+1_5406+3 delGTA), BRCA1 ( c.981_982delAT), BRCA2 
(c.3109C.T) were chosen.  
Results: We have done an extensive blinded validation of the protocol with 50 separate patient DNAs. 
All DNAs were analyzed for selected mutations, by HRM technique. According to this result there is no 
variation between HRM and direct sequencing to mutation detect. Prevalence of selected mutations 
were 11.2%, 5.5%, 3.4% and 0% for BRCA1 (c.3342_3345 delAGAA), BRCA1 (c.5406+1_5406+3 
delGTA), BRCA1 ( c.981_982delAT), BRCA2 (c.3109C.T) respectively.  
Conclusion: This is the first HRM attitude to screen the entire coding region of the BRCA1 and 
BRCA2 genes using one set of reaction conditions using specifically designed primers. The parallel 
screening of a relatively large number of samples enables better detection of sequence variants. HRM 
has the advantages of decreasing the necessary sequencing by more than 94%. This evidently reduced 
cost of sequencing will result in BRCA1 and BRCA2 mutation testing becoming accessible to 
individuals who currently do not undergo mutation testing because of the significant costs involved. 
Keywords: High resolution melting (HRM), BRCA1 and BRCA2, mutation  
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Abstract 
Background: Over the last decades, advances in the treatment of women with cancer in reproductive 
age have markedly increased. In addition, in-vitro maturation (IVM) of immature oocytes collected 
from excised ovary has been proposed as an attractive option for fertility preservation.The aim was to 
investigate the developmental competence of immature oocytes retrieved from excised ovarian tissue 
underwent IVM, as a method for fertility preservation.  
Materials and Methods: The excised ovarian tissue and biopsies of the ovarian cortex from 26 cancer 
patients (21- 45 years old), were used. The investigation took place from Dec 2013 to Dec 2014 at Yazd 
institute for reproductive sciences. Ovaries were obtained directly from collaborating hospitals, and 
transported to the IVF center on ice. All visible antral follicles on the biopsies were aspirated. The 
immature oocytes were cultured for 48 h in-house supplemented IVM culture media. Oocyte maturation 
was assessed by the presence of the first polar body. 
Results: 61 immature oocytes were aspirated, of which 18 (29.5%) were degenerated and 
discarded.The remaining 43 (70.5%) healthy oocytes without sign of degeneration underwent IVM 
technology, of which only 30.2% reached viable metaphase II oocytes. The ovarian tissues of 9(34.6%) 
women were lacking oocytes at any stage. There was a positive correlation between the recovered 
number of oocytes and the ovarian volume. 
Conclusions: Oocytes maturation post IVM from unstimulated ovaries showed a good developmental 
competence in cancerous patients. Further studies should be performed to advance the oocyte 
maturation program, such co-culture system, for fertility preservation.  
Key words: Fertility preservation, IVM, Immature oocyte, Ovarian tissue. 
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Abstract 
Introduction: The AccuBoost system is a novel technology to employs a conventional mammography unit, a 
computed radiography )CR) system, and a 192Ir-HDR brachytherapy source remote afterloading system to 
deliver noninvasive image-guided breast brachytherapy (NIIGBB). In this study, for the first time, the dose 
enhancement to the early-stage breast tumors due to gold nanoparticles (AuNPs) during noninvasive image-
guided breast brachytherapy have been investigated. The objective was to determine whether AuNPs were 
appropriate for macroscopic dose enhancement (MDE) in AccuBoost system. In order to make this distinction, 
The MCNP5 Monte Carlo code was used to simulate this system with AuNPs. 
Materials/Methods: The 192Ir-HDR brachytherapy source and a pair of non-invasive round tungsten applicators 
was positioned on opposite sides of a compressed breast phantom to simulate a clinical geometry. A tumor 
region for a range of depths with a size of 1×1×1 cm3 loaded with AuNPs were simulated inside of ICRU 44 
breast phantom. The dose enhancement factor (DEF) defined as the ratio of the dose with and without AuNPs 
was calculated in the presence of AuNPs with 10, 20 and 30 mg/ml concentrations, separately with sizes of 50, 
100 and 200 nm inside the tumor volume. Then, DEF was averaged over various cubic cells in the tumor on the 
central axis of the beam and the average value was reported. Among the three mentioned concentrations, the 
dose enhancement related to 30 mg/ml is higher. 
Results: In this study, possible tumor dose enhancement by the use of gold nanoparticleswas estimated by 
Monte Carlo calculations. Our preliminary results indicate that major dose enhancement to breast tumors can 
be achieved using AuNPs. We found a DEF of from 1.3 to 2.79 for 36 number of 192Ir-HDR source beams.The 
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effect of AuNP size was not considerable, but the AuNP concentration had a substantial impact on achieved DEF 
in AuNP-based brachytherapy. 
Conclusion: The data demonstrate that the biological effect when irradiating in the presence of 30 mg/ml 
concentration of AuNP is about 30%–180% greater than without AuNP. Meanwhile, without radiation, the 
AuNP showed minimal effect on the cancer cells. These findings provide evidence that AuNP may be employed 
as radiosensitizers during noninvasive image-guided breast brachytherapy also highlight a potential new 
approach for radiation boosting to breast tumors using AuNPs. 
Key words: AccuBoost brachytherapy, 192Ir-HDR, Breast cancer, AuNPs 
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Abstract 
Background: Breast cancer is the most common cancer in women. Abortion has been suggested as a 
potential risk factor for breast cancer as it may interrupt the normal cycle of hormones during 
pregnancy. To date, correlation of abortion with the risk of recurrence and tumor size in breast cancer 
patients has not been described in Khorasan population.  
Methods :402 unrelated female breast cancer patients who were referred to the Ghaem Hospital of 
Mashhad University of Medical Sciences were studied during a period of four years. We investigated 
the correlation of abortion with the risk of recurrence and tumor size in these patients.  
Results :The mean age of the patients was 48 ± 0.59 years. Overall, 52.2% of the patients had 
experienced at least one abortion (ranging one to eight). Our results show there is no association 
between abortion and the risk of recurrence in breast cancer patients (p=0.514). We could also find no 
association between abortion and tumor size in breast cancer patients (p=0.21). 
Conclusion: The present results confirm previous reports of no statistically significant correlation 
between abortion and the risk of recurrence as well as tumor size in our breast cancer patients. 
Keywords: breast cancer, abortion, risk of recurrence, tumor size 
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Background. Breast cancer is the second most common form of cancer in women. In spite of 
improvements to surgical and radiotherapy treatment, at least 20% of treated women will continue to be 
diagnosed with breast cancer-related lymphoedema (BCRL) that requires lifelong treatment and 
management. there is growing evidence to support the use of progressive and supervised exercise for 
women with BCRL with adequate warm-up, cool-down, appropriate rests and suitable training of staff. 
This evidence have reported fewer exacerbations of lymphoedema, increased strength, reductions in 
symptoms, and improvements in QOL. In light of this, research into other holistic interventions, 
including yoga, for women with BCRL has been recommended. This practices have been reported to 
improve the psychosocial functioning of women during and after breast cancer treatment and may be 
transferrable to women with BCRL. The aim of this  literature review was to obtain preliminary data to 
determine the effect of yoga on women with BCRL. 
Materials and Methods: Database Browser using ISI and Google Scholar, pubmed, Science direct and 
30 articles in Medline for the period 2000 to 2014 in this area was accessed. Among the found articles, 
articles that met inclusion criteria were selected for the present paper were used. 
Conclusion: The findings of  these studies have shown that Yoga intervention did not exacerbate 
lymphoedema and improved tissue induration of the affected upper arm and the QOL sub-scale of 
symptoms. 
Keywords: Yoga, Breast cancer-related lymphoedema, Symptoms, Quality of life 
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Abstract 
 
The aim of the present study was to investigate the level of  MDA in the serum of patients affected 
with breast cancer. Changes in the levels of malondialdehyde (MDA) as an indicator of lipid 
peroxidation (LPO) is important clinically. So that the assessment of MDA levels is used to diagnose  
pathological conditions, diseases, and cancer. 38 healthy women as control group whit 38 women 
newly diagnosed whit breast cancer were studied as target group.Healthy subjects age 39/61±0/926  
and breast  cancer patients were 40/78±0/847 years old. Blood samples  from both groups were 
collected after overnight fasting and after separating the serum they were kept in -70 until day of 
examination.  In this study serum MDA levels were measured using a chemical method. In this study, a 
significant increase in the levels of malondialdehyde (MDA) as a marker of lipid peroxidation was seen 
in breast cancer patients compared whit control subjects(p<0.05). According to the results of this 
study can be concluded that  there is a direct relationship between serum levels of MDA   with an 
increased risk of breast cancer  and malondialdehyde can be used as a biomarker for the diagnosis of 
breast cancer. 
Keywords: breast cancer- malondialdehyde-lipid peroxidation 
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Abstract 
Breast cancer is the most common cancer among women in the world. In Iran, the incidence of breast 
cancer is on the increase. We studied the association of rs1219648 in FGFR2 and rs1042522 in TP53 
and their interaction in development of early onset sporadic breast cancer in Iranian Azeri population to 
evaluate the proportion of epistatic effect on the risk of breast carcinogenesis.  
We genotyped two polymorphisms (rs1219648 and rs1042522) in 100 women with early onset breast 
cancer and 100 healthy women by PCR-RFLP. Allele frequency differences were tested using chi2-test 
with 95% confident interval. 
Our results indicated statistically significant association (P < 0.05) between rs1219648 and risk of 
breast cancer but rs1042522 was not associated with breast cancer (p> 0.05). We also found that the 
combination of FGFR2 major genotype and TP53 hetero genotype have protective effect against breast 
cancer however the hetero allele of FGFR2 in combination with the minor genotype of TP53 was 
associated with a high risk of breast cancer.  
This study revealed an important crosstalk between two polymorphisms in FGFR2 and TP53 in 
developing breast cancer. These candidates of risk variants can be further evaluated in studies with a 
larger sample size. 
Keywords: early onset breast cancer; FGFR2; TP53; Single nucleotide polymorphism 
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Abstract 
Salvia officinalis L. (sage) is one of the herbs with anti-proliferative, cytotoxic and anti-carcinogenesis 
effects which turn it into one of the candidates in cancer therapy. In this study, the effects of sage hydro 
alcoholic extract on mouse breast cancer cell line (4T1) were examined. Cultured cells were treated 
with different concentrations (0, 10, 50, 100, 500, 1000 and 10000 μg/ml) of Sage hydro alcoholic 
extract for 24 hours. Cell viability, chromatin condensation and apoptosis induction were determined 
using Neutral Red, Aniline Blue and Acridine Orange/Ethidium Bromide staining, respectively. Bax 
and Bcl2 genes expression were measured using Reverse transcriptase PCR. Following treatment with 
sage extract, decrease in cell viability and increase in chromatin condensation were observed in a dose 
dependent manner. Most cultured cells were in the early stages of apoptosis in 50 and 100 μg/ml and in 
the late stages of apoptosis in 500 μg/ml of the extract. While Bax expression was increased with up to 
50 μg/ml of sage extract, no significant change was observed in the levels of Bcl2 expression. 
Altogether, these findings demonstrate the cytotoxic and pro-apoptotic effects of sage hydro alcoholic 
extract on mouse breast cancer cell line through increase in Bax/Bcl2 ratio (apoptotic index). 
 
Keywords: Apoptosis, Cell culture, Mouse breast cancer cells (4T1), Sage (Salvia officinalis L.). 
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Breast Cacer During Pregnancy Can Be Treated as in Nonpregnant Women 
Authors name :  fereshteh choobsaz  
Tehran University of Medical Sciences 
It appears that breast cancer diagnosed during pregnancy can be treated much the same as breast cancer 
diagnosed in nonpregnant women without substantially raising the risks to mother or child, according to 
a study published online August 16 in the Lancet Oncology.  
This conclusion, from an observational study involving 447 European women included in registries of 
cancers diagnosed during pregnancy, must still be validated in other studies. But until then, the current 
evidence indicates that pregnancy outcomes are not significantly different between women who receive 
breast cancer chemotherapy during the second or third trimesters and those who wait until after delivery 
to start treatment. 
In this study, infants exposed to their mothers’ breast cancer chemotherapy while in utero had slightly 
lower birth weights and slightly more complications than those not exposed to chemotherapy, but these 
differences were not clinically significant. 
Breast cancer diagnosed during pregnancy is rare, estimated to occur in less than 1% of breast cancers 
in Europe. But its incidence is increasing in high-income countries due to the trend of women delaying 
childbirth until they are older, when breast cancer is more prevalent. 
The German Breast Group established its Breast Cancer During Pregnancy registry in 2003 and 
expanded it to include cases in the Netherlands, the United Kingdom, Poland, Italy, and the Czech 
Republic in 2009. In the same time period, Belgium also established a registry of all cancers diagnosed 
during pregnancy and colleagues assessed outcomes in 447 cases from these registries in which women 
were diagnosed as having early (413 patients) or metastatic (34 patients) breast cancer while pregnant . 
The median gestational age at diagnosis was 24 weeks (range, 5-40 weeks), and the median age of the 
women was 33 years (range, 22-51 years). 
Data on chemotherapy were available for 368 women. Of these, 197 received chemotherapy while 
pregnant and 171 received it after delivery. 
Overall, 1,187 cycles of chemotherapy were given, and 63% of these were given during pregnancy. The 
women received a median of four cycles (range, one to eight cycles) during pregnancy. 
A total of 90% of those treated during pregnancy received an anthracyline; 8% received a combination 
of cyclophosphamide, methotrexate, and fluorouracil; and 7% received a taxane. None of the women 
received trastuzumab, endocrine therapy, or radiotherapy during pregnancy. 
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Women with early breast cancer who opted for chemotherapy during pregnancy tended to have more 
advanced disease, with more unfavorable tumor stage and nodal status, than did those who chose to 
begin chemotherapy after delivery. After the data were adjusted to account for this difference, the 
researchers found no significant difference between the two groups in disease-free or overall survival. 
The estimated 3-year disease-free survival was 70.2% in women with early disease who underwent 
chemotherapy while pregnant and 74.3% in those who waited until after delivery. Similarly, the 
estimated overall 3-year survival was 84.9% in women with early breast cancer who underwent 
chemotherapy while pregnant and 87.4% in those who delayed chemotherapy until after delivery. 
The estimated 5-year disease-free survival was 61.1% in women who had chemotherapy while pregnant 
and 64.4% in those who waited, and the estimated 5-year overall survival was 77% and 82.4%, 
respectively. 
Data were available for 373 newborns, of whom 203 had been exposed to chemotherapy in utero and 
170 had not. 
Birth weight was slightly lower in the exposed than in the nonexposed infants, but this difference was 
judged to be “clinically irrelevant” because it didn’t affect the health of the babies, and  associates said. 
Moreover, there were no significant differences between the two groups in major birth defects, infant 
height, Apgar scores, hemoglobin concentration, leukocyte counts, thrombocyte counts, or alopecia. 
And there was no significant difference in the proportion of infants discharged with their mothers (34% 
vs. 41%). 
Adverse events occurred more often when chemotherapy was received during pregnancy (15%) than 
when it was delayed (4%). However, this difference was attributed to the higher rates of preterm labor 
and premature rupture of the membrane among exposed pregnancies. “Most complications were 
reported in babies who were delivered prematurely, regardless of exposure to chemotherapy,” the 
investigators said. 
The data were not adequate to determine why women who received chemotherapy had a higher rate of 
preterm delivery. Both physical stress and psychological stress may have played a role, and it is 
possible that women who received chemotherapy were more prone to infections that may have 
triggered labor. In addition, the cytotoxic agents themselves may have hastened labor through some as 
yet unknown mechanism. However, the rate of preeclampsia was similar between the two groups, so 
oxidative stress, which is known to be induced by cytoxic agents, was not responsible. 
Further study of the data being collected in the registries of cancers diagnosed during pregnancy will 
likely shed light on these issues. colleagues are now performing a matched-pair analysis to assess 
whether the prognosis of breast cancer in nonpregnant women differs from that in pregnant women 
when the latter are treated according to current guidelines. 
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Future studies should address not just the toxic effects of chemotherapy during pregnancy but also the 
pharmacokinetics of cytotoxic agents in pregnant women, because the physiological changes of 
pregnancy can greatly affect drug disposition. 
“Whether doses should be increased in this population is uncertain because such increases could result 
in severe thrombocytopenia, neutropenia, and infection, with potentially devastating consequences for 
both mother and baby,” they noted in an editorial comment accompanying  and report . 
More research also is needed to determine whether the slightly increased fetal risks identified and  
colleagues could be minimized with better drug selection and dosing, they added. 
Key word: Breast- cancer – Women - risk- Pregnancy –diagnose 
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Protective impacts of Ziziphus Jujube on biochemical and hematological factors in NMU-induced 
breast cancer in rats 
Dr. Reyhane Hoshyar1, Zabihollah Mohaghegh2, Nihad Torabi3, Aliyeh Abolghasemi2, Iman Nakhei1 
1Department of Biochemistry, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, 
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2 Department of Medical Lab Technology, Birjand University of Medical Sciences, Birjand, Iran. 
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Background: Breast cancer is the most common cancer among women worldwide. Various risk factors 
are for breast cancer such as N-methyl-N-nitrosourea (NMU). On the other hand, herbs for instance 
Ziziphus Jujube have been demonstrated to be a source of anticancer compounds. In this study 
anticancer effects of Z. Jujube on weight, Albumin, Liver enzymes (AST, ALT), albumin, total protein and 
complete blood count (CBC) in NMU induced cancerous rats investigated. 
Methods and materials: NMU (60mg/kg) injected intraperitoneally once a week in during 8-weeks. 
Their weight measured weekly. After observation of first solid tumor, rats daily received Z. jujube 
(400 mg/kg) during 14 days. In the end study the rats anesthetized and blood samples collected from 
heart to assay CBC, liver enzymes, albumin and total protein. 
Result: Our data shown that lower weight of animals in the NMU-treated group then control group. 
The mean body weights of rats receiving 400 mg/kg of Z. jujube did not significantly (P<0.05) differ 
from control group. Biochemical analyses showed that ALT, AST, albumin and total protein levels 
significantly decrease in NMU group whereas normal levels of them seen in Z. jujube group. Also Z. 
jujube exhibited a preventive effect against anaemia, lymphocytosis and neutrophilia compared to 
NMU group. 
Discussion: These findings indicated that Z. jujube moderated clinical sever effects of NMU 
carcinogenesis and could be useful for treatment of mammary tumors in humans. 
 
Key words: Breast cancer- Z. jujube - NMU- ALT-AST-CBC-Albumin 
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Study of epidemiology of Breast Cancer in Maragheh, Iran (2007-2012) 
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Background and Objectives :Breast cancer is one of the most common and important diseases in 
womens. Considering the high prevalence and mortality of breast cancer at early age groups in Iran, it 
seems like necessary to conduct epidemiological studies. The present study was done in a 6 years 
period at Maragheh, Iran. 
Materials and methods: This study is was done based on information collected from Maragheh health 
center registration system on Breast cancer in a period of 6 years, from the January  2007 up to the 
December of 2013. All of the registered patients were included in the study. 
 Results: During the 6 past years 17 patients were diagnosed suffering from Breast cancer, 14 cases 
(82%) by paraclinical  and 3 cases (8%) by clinical criteria, All of the cases (17, 100%) were over 17 
years old. Highest percentage of patients were belong to 2007 (5 cases 29/41%) and the lowest were 
from 2010 and 2013 (1 cases 5/88%). 
Conclusions: There is not a precise statistics on breast cancer prevalence in the country. And some 
experts have been discussing cancer as a tsunami in future years. Annually increasing rate of cancer has 
needs an urgent public interference against cancer progression. 
Keywords: Breast cancer -Epidemiology – Maragheh 
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Article abstract: 
Introduction: Breast cancer is an important issue in chronic disease studies. Breast cancer is the 
most common cancer among women.Life expectancy is long in patients with breast cancer and 
in result they suffer longer from cancer and its complications.Therefore it seems necessary to 
determine QOL and its related-factors in these patients. Objective: The purpose of the study 
isto determine Quality of Life and its related factors among women with breast cancer. 
Methods:This analytical descriptive study was conducted on 150 women with breast cancer 
referred to Educational-therapeutic hospitals in torbat heydarieh in 2012-2013. Data were 
collected by questionnaire including demographics and Health-related Quality of Life 
(WHOQOL-BREF) questionnaires. Data were analyzed using SPSS software version 16, and 
descriptive statistics and t-test, ANOVA, Pearson correlation coefficients and linear regression. 
Results: Findings indicated that samples mean age was 50.67±10.04and mean Health-
relatedQOLscore was 48.65±9.7, physical domain 53.86±12.45, psychological 41.05±12.06, 
social 55.36±10.52 and environment 50.26±9.16. In assessing related factors with quality of life 
using multiple regression indicated significant differences between maritalstatus, occupation, 
type of breast surgery (p<0.05). Conclusion: QOL was lower in psychological health domain 
than other domains. Also, relatedfactors with breast cancer patients' QOL included 
maritalstatus, occupation and surgery type. Therefore paying attention to these factors and 
conducting psychic assessments and psychiatric consultations are important for improvement of 
these patients' QOL.  
 
Keywords: Breast Neoplasm /Quality of Life / Patients,  
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CK19 expression in the peripheral blood of breast cancer patients 
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Abstract  
Background : Circulating tumor cells (CTCs) detection in peripheral blood of epithelial cancer patients 
is a recognized indicator for the presence of primary tumors and/or metastasis. Cytokeratin19 (CK19) 
has been used as a marker for detecting CTCs in blood.  
Methods: A total of 50 blood samples  including  25  healthy and  25 patients with breast cancer were 
tested by flow cytometry to quantify the expression of CK19. Briefly, 1 ml blood and 5 ml RBC lysis 
buffer were mixed and kept on ice for 15 min. Subsequently, the cells were fixed with 4% 
paraformaldehyde for 20 min at room temperature. They were permeabilized with methanol for  30 min  
on ice. Then the cells were incubated with FITC conjugated CK19 antibody or FITC-mouse IgG2a 
isotype antibody as negative control.  
Results: CK19 was positive in the peripheral blood cells of breast cancer patients at stages II to IV, but 
not in the patients at stage I and healthy controls. CK19 was detected in 48% of breast cancer patients. 
The CK19 gene expression in different stages was statistically significant with P Value= 0.037.  
Conclusion: The detection of CK19 in peripheral blood by flow cytometry is a specific and feasible 
method to monitor CTCs in breast cancer patients.  
Keywords: CK19, CTCs, Flow cytometry 
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*Corresponding author (Shiri.I@tak.iums.ac.ir) 
Introduction: The aim of radiotherapy is deliver the desired dose to the target volume and minimizing 
the dose of sensitive tissues to less than the tolerance of the normal tissues to be protected from the 
effects of radiation 
Material and methodes : For practical implementation of techniques, trunk phantom and EDRII film 
manufactured by German Kodak companies are used. For dose-volume curve plotting and data 
extraction we used from MATLAB2012 software. In this study four technic of tangential photon, 
Electron technique with two field of 90 degree, Electron technique with two 45 field of degree and 
electron arc therapy designed by TIGRT software and then been studied. Eventually three of the these 
techniques have been practically implemented on phantom then Information about the design and 
practical implementation of techniques for dose of target volume and 30% of lung volume dose 
compared in dose-volume curve. 
 
Result: The average doses to the target volume for electron technique with field of 90 degrees, the 
highest value of 109.3 percent. In practical dosimetry for tangential photon technique has received 
100% of the target dose of 4500 cGy. 
 
Conclusion: Dose coverage of the target volume in photon technique and the doses delivered to lung 
tissue in electron technique were acceptable. Lung doses from electron technique with 45 degrees field 
is higher than two previous methods, However the doses level for each technique is less than the 
acceptable dose . 
Key word: Radiotherapy, Breast cancer, Mastectomy, EDRII film 
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Abstract 
Breast cancer is a kind of cancer with high mortality among women. With early diagnosis of breast cancer (up to 
five years after cell division) survival will increase from 56% to more than 86%. Therefore, an accurate and 
reliable system is necessary for early diagnosis of benign or malignant tumors. Automatic classification systems 
as a diagnostic tool can reduce the workload of doctors. Intelligent methods to predict Breast cancer survival 
which are used in this study consist of Naïve Bayes, Trees Random Forest, 1NN, AdaBoost, SVM, RBF Network 
and Multilayer Perceptron. In this study 900 patient records are used. These records have been registered at 
Cancer Registry Organization of Kerman Province, in Iran. For evaluate the proposed models, K-fold cross 
validation is used. Seven models of machine learning are compared base on specificity, sensitivity and accuracy. 
The accuracy of the seven models are .95%, .96%, .91%, .94%, .94%, .95% and .95% respectively. Our result 
showed that trees Random Forest model was the best model with the highest level of accuracy. Therefore, Trees 
Random Forest model is recommended to Breast cancer survival. 
Keywords: Breast cancer survival prediction, classification, machine learning models. 
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Abstract 
Background: The use of optical spectroscopy as a powerful device for rapid and non-invasive diagnosis 
of breast cancer was considered. The breast tissue condition can be predicted by using a measuring in 
the vessels optical properties variety, such as absorption, distribution or transmission. 
Methods: In this study blood samples prepared at different concentrations, using a spectrometer 
(USB4000 Fiber Optic Spectrometer, USA) and light source near-infrared provided by the LED 
(Phwee ). Experiment performed using breast phantom accompanied by vessels. 
Results: The change on the absorption amounts in the blood samples with different concentrations of 
hemoglobin was determined. Absorption in blood samples from normal concentration of hemoglobin, 
oxy-hemoglobin were 1.1 and 1.12, respectively. But at two and four times concentrations of 
hemoglobin as abnormal blood, were 1.60 and 1.70, respectively. 
Conclusion: The results absorption values in the normal and oxy- hemoglobin were similar and 
indicating a healthy tissue. In samples with two and four times concentration of hemoglobin, increasing 
on the absorption rate was existed. Thus, an increasing on the amount of blood supply can be predicted 
to cells going to be cancerous. 
Keywords: absorption, hemoglobin, spectrometers, breast cancer 
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Effect of Combine Decongestive Therapy and the quality of life in breast cancer patients  after 
mastectomy 
Marzeih heidari; MSc in occupational therapy, School of Rehabilitation, Tehran University of Medical 
Sciences. Tehran, Iran (Email:heidariot@gmail.com) 
 
Introduction: one of the most effective methods for controlling "lymphedema" is the moving fluid in 
patients with breast cancer following mastectomy.Combine Decongestive Therapy(CDT) is non-
invasive technique and consists of 4 elements (hand massage, aid bandage, member education, sports 
rehabilitation). Our goal is to asses the impact on QOL and functioning of patients with CTD 
techniques. 
Materials&methods: Resources related to the study of internal and external databases were collected 
using relevant keywords. 
Findings: Fold(1989), weiss(2002) in a study reported the greatest improvement in QOL and physical 
aspects. Kim(2008) in the study of women with at least 6 months of chemotherapy and radiotherapy in 
cancer and other surgical treatments for at least 3 months and a maximum of 5 years ago reprted  that 
people's ability to perform activities of daily living and lifting of  arm are affected, Koual(2006) 
mentioned reduction of  pain, swelling, and improving the QOL. Mondry(2008), mullai(2014) showed 
long-term impact of this technique on the QOL of patients. Haghighat(2014) report that patients using 
this technique compared with the this  technique as well as Pressure pump approach showed better 
results. 
Conclusion: This kind of techniques is essential to achieve better health outcomes, reduce 
infection,costs and improve overall QOL for patients. 
Keywords: Combine Decongestive Therapy, quality of life, breast cancer patients 
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Abstract 
 Introduction: Natural compounds, including plants, microorganisms and marine organisms due to its 
anti-cancer properties, have long been considered. Crab shell  have  various antioxidants. The aim of 
the present study was to investigate the effect of crab shell extract on the morphology of breast cancer 
cells (MCF7).  
Materials and methods: Crab shell was prepared and powdered. Then the hydroalcoholic method was 
extracted. MCF7 breast cancer cell line was used in this study. The extract was prepared 5 
concentrations (100, 200, 400, 800 and 1000 μg / ml) and after 24, 48 and 72 hour  induced 
morphological changes were assessed with an inverted microscope.  Effect of different concentrations 
on the percentage of viable cells at these times in terms of quantity were investigated with MTT assay. 
Data were analyzed by ANOVA and P<0.05 was considered significant. 
Results: The results of MTT assay after 72 hour and dose of 1000 μg/ml showed that 50% of cells were 
alive compared to the control group (p<0.001). Cells treated with the extract showed dose and time-
dependent manner morphological changes . So gradually with increasing time and higher doses, 
deformation of cell was much sharper. Inhibition of cell growth, increase the size of the vacuoles, loss 
of cytoplasm and pigmented of nucleus were observed, these changes were not observed in the control 
group or was very small. 
Conclusion: Crab shell extract dose and time-dependent manner inhibited cell growth in breast cancer 
cell line. 
  Keywords: MCF7 cell line, MTT assay, morphological changes 
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Abstract 
Introduction and aim:Breast cancer is the most common cancers among women population and 
adaptive strategies play an important role regarding adjustment to disease and treatment. One of the 
most important needs of breast cancer patients regarding adjustment is information. The aim of this 
study is to investigate the effect of patient_ care giver education on cancer related self efficacy of breast 
cancer patients undergoing chemotherapy. 
Material and Method:This is a controlled randomized clinical trial. 30 patient care giver pair allocated 
randomly to intervention or control group. Intervention group received 2 verbal education sessions 
along with 4 telephones follow up and a written booklet. Education was given to patient and her care 
giver simultaneously.  Control group received routine care only. Post test was taken 6 weeks after the 
pre test in both groups using Cancer related self efficacy scale. Data was analyzed using SPSS software 
version 13. 
Result:Finding showed that patient_ care giver education can improve cancer related self efficacy of 
patients in intervention group rather than control group (p<0.05).  
Discussion and Conclusion:Results of this study confirm our hypothesis that patient_ care giver 
education can increase cancer related self efficacy of patients undergoing chemo therapy. 
Keywords: Breast cancer, Care giver, Self efficacy, Intervention. 
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Introduction 
Self breast examination sick Breast Self examination, awareness of breast health boost Although this 
method is not diagnostic, and as an aid to screening used most breast cancer patients (48%), followed 
by the image border of the breast (41%) are discovered and physical examination by a physician, only 
11 percent of them are identified. 
This study aimed to assess the level of awareness of the importance of breast self-examination qualified 
women and education in Tabriz health centers have been done in  
2014. 
Materials and Methods 
This cross-sectional study using data from the completed questionnaires were entered and analyzed in 
EXCEL software is 
Findings 
The results are the average age is 28 years and% 2 self-employment - %2 of teachers -% 96 was home 
wife. The remaining 19 percent have a college education and 24% of graduate and under graduate 
diploma. 24 percent to to the bigining time- 33 percent since the beginning of the age of onset of breast 
self examination correct answer. 
20% of those in the 11 breast cancer symptoms noted in 24% to 2 - about 6% for 3, 6% to 4, 2% to 5, 
4% to 6 and 8 of the 10 cases, 6% to 11 and% 24 information about no symptoms. 
Conclusion 
Given that 41% of breast cancers are discovered by the patient so that proper protocols and training to 
raise awareness of women over 20 years, for a healthy lifestyle, including the activities physics, 
nutrition body weight and fixing the is. Breast Self Examination, medical examination, mammography 
and early detection are required to care for the looks This requires a comprehensive system of referral 
and referral centers for care and follow-up measures is given. 
Keywords: Breast Self Examination 
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Abstract    
 Background: Breast cancer is the most common malignancy between women in the world and Iran. 
KI67 is a biological marker that is activated in cell proliferation process. In this study we wanted to 
evaluate of the relationship between axillary lymph nodes involvement and Ki67 over expression in 
Breast cancer patients 
Method: In this study, Breast cancer patients admitted to our oncology department , during 2002-2012 
,were evaluated. The Ki67 correlated with age, menopausal status, histologic tumor type, disease stage, 
tumor size, lymph node involvement, hormon receptor (ER, PR), Her2, distant metastasis and the 
overall survival were studied.  
Results: In this study of 2723 cases of female patients with breast cancer were studied, of whom data 
were available for KI67 in 449 of the records. Patients divided into two group as follows: High KI67 
(>=14% ) and Low KI67(<14%). The mean age was 49.3. The most common stag at presentation was 
stage II( 46.8%). In assessing lymph node involvement, 37.9% of patients were N0; 29.3%on N1, 23.1 
on N2 and 9.7on N3. In 66.2% of N0 patients, the 70.9% of N1, 61.7% of N2 and 64.7% of N3; KI67 
rate was high. Although lymph node involvement is associated with KI67, and the relationship of the 
group N1 is the highest, but in this study there is not statistically significant relationship (P-value = 
0.623) in patients with  Her2 positive, patients with high KI67 is significantly more than another group( 
Low KI67) (PV=0.03). On survival analysis performed in patients with Ki67 less than 14% clearly have 
a higher survival rate compared to others. (PV = 0.02). 
Conclusion: The results of this investigation indicate that higher value of KI67 does not accompany 
with the high probability of involving lymph nodes, but due to high level of this factor with decreased  
survival period, we conclude independently to its influence on lymph nodes involvment, this factor can 
play as a prognostic factor and seems determining it at the time of diagnosis,  will be helpful for 
decision of  appropriate treatment . 
Keywords: Breast Cancer, lymph node involvement, KI67  
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Abstract  
Introduction  
Breast cancer is the leading cause of cancer death among women but the potential causes remain 
unclear. Most of the studies have shown the association of reproductive factors with breast cancer risk. 
So the present study was conducted to determine whether induced abortion, as a reproductive factor, is 
risk factor of breast cancer.  
Result  
In the studies reviewed, induced abortion was known as a protective factor and also as a risk factor for 
breast cancer. As risk factor, breasts of women who undergo abortion are exposed to high hormone 
levels typical of early normal pregnancy, but then do not experience the terminal cell differentiation 
that occurs late in a normal pregnancy, so leaving breast tissue immature with more sites for cancer 
initiation and more vulnerable to carcinogens. As protective factor, it shows when the times of induced 
abortion increasing, the non-differentiated cells would be decreasing, and the susceptibility of epithelial 
cells to future carcinogenic stimuli would be decreasing too. It has been found even among BRCA2 
mutation carriers.  
Conclusion 
Due to the presence of conflicted findings and unknown etiology in this domain, further studies are 
required. 
Keywords 
Breast cancer, abortion, risk fact 
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Abstract: 
Breast cancer is considered as a heterogeneous disease, which involves different profile changes in both 
mRNA and micro-RNA (miRNA) expression. In recent years, miRNAs have emerged as key players of 
the carcinogenic process such as tumor initiation, progression and drug resistance. Moreover, these vital 
micro molecules shift from tumor cells to blood stream and due to the high stability of circulating 
miRNAs in serum/plasma, they could be used as signatures of related cancers. Therefore, the aim of 
this study is the evaluation of diagnostic potential of miR-21 oncomir in Iranian Azeri patients of breast 
cancer. 25 fresh tumoral and marginal tissues with plasma of patients and healthy women were 
collected and processed for RNA isolation. Then, quantitative expression of miR-21 was analysed by 
Real-Time PCR in different groups. Our data illustrated that the expression of miR-21 in tumor tissues 
and margins as well as plasma of normal and breast cancer patients are significantly different (P<0.05). 
In conclusion, our work shows that plasma miR-21 could be used as a diagnostic molecular marker for 
invasive ductal carcinomas in a non-invasive manner. However, this claim should be confirmed via 
more related works that are in part under investigation in our lab. 
 Key words: breast cancer, micro RNA, Oncomir, biomarker, Real Time PCR. 
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Abstract: 
Cancer is the most common cause of death. Resistance to conventional anticancer therapies in patients 
with advanced solid tumors has prompted the need of alternative cancer therapies. The cytolethal 
distending toxins (CDTs) were produced by a variety of Gram-negative pathogenic bacteria. The 
mechanism of cytotoxicity of toxin is unique in breaks double-stranded DNA. CDT is the product of a 
three-gene operon (cdtA, cdtB and cdtC). CdtB-associated deoxyribonuclease (DNase) activity is 
responsible for Cdt-induced cell cycle arrest, suggesting that DNase activity is essential for the CDT 
toxicity. Material and methods: DNA encoding the   CdtB was amplified by PCR using specific primers 
with appropriate restriction enzyme sites in their ends. The gene was cloned in the pcDNA 3.1(+)   
vector. Results: The construct was confirmed by colony PCR, restriction analysis and sequencing. 
Conclusion: The gene was cloned in the pcDNA 3.1(+)   vector. CDTs as Biological Tool—Because 
CDTs interfere with the cell cycle control machinery. It is noteworthy that the use of cytotoxic prodrugs 
has been considered in the field of cancer gene therapy therefore the construct include CdtB as a 
biological tool can use against variety of cancers. 
Keywords: 
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Abstract 
The most common cancer among women in the world is breast cancer. In Iran, the incidence of breast 
cancer is increasingly rising and it is among the five most common cancers. Many of natural 
compounds have high chemo-preventive potential which could be sought to be used in drug discovery. 
Many studies have shown the incidence rate of cancers such as breast, colon, and prostate are decreased 
in communities if they would consume cruciferous vegetable.  Sulforaphane is one of the 
isothiocyanates-derived compounds from cruciferous vegetables which bears up such characteristic. 
Sulforaphane is an electrophile compound which has high tendency to react with sulfhydryl. The target 
of this compound is sought to be residues of cysteine of many proteins which control the regulatory 
process of cancer in the cells. The mechanism of sulforaphane is to modify cysteine residues in Keap1 
(kelch-like ECH-associated protein 1) in such way to stabilize Nrf2 (Nuclear factor (erythroid-derived 
2)-like 2). This stabilization would culminate in activating antioxidant response element (ARE) of 
phase 2 enzymes. In this study, the structure of protein of interest, Keap1, and highly similar analogues 
(90%) from PDB and Pubchem websites were respectively downloaded. Then molecular simulation and 
calculation of docking energy (ligand-protein) by Autodock 4.2 was performed to reach sulforaphane-
similar compounds. In this way, a figurative library with around 300 molecules was generated. Finally 
we identified CID:52666086, CID:5076735 and CID:13352380 with the lowest docking energy. The 
aforementioned molecules could be assumed as breast cancer drug candidates. 
Key words: Cancer, Sulforaphane, Drug Design, Molecular Docking 
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Introduction: Folate is one of the water-soluble vitamins. This vitamin functions in cell cycle and gene 
replication and has dragged researcher’s attention to itself. The policy of food enrichment with Acid 
Folic can be beneficial for decrease of nerve tube defect while its enrichment can affect cancer risk, 
especially breast cancer in women population which is the target group of Acid folic supplement intake 
or enriched food with Acid Folic, and this issue has caused Folate Controversy. The aim of this review 
study is investigation of Folate’s role in incidence of breast cancer. 
Method: This review study is based on searching key words of Folic Acid, folate and Breast Cancer in 
PubMed and ISI data bases and selecting cohort studies since 2005 to 2014. Based on this information 8 
articles were surveyed. 
Results: Investigating of these studies indicates that high amount of Folate intake from supplements or 
enriched foods is significantly related to increase the risk of cancer .There was no difference in taking 
folate from supplements or enriched foods. 
Conclusions:  Although Acid Folic supplements and Acid Folic enriched foods caused significant 
decrease in NTD incidence, regarding its role in cell replication, it can be influential in cancer 
risk.According to available evidence concerning folate intake with developing cancer, is a U-shaped 
curve.. Based on these studies, Folate intake less than 150 mcg can be effective in genetic mutations 
and its intake more than 1mg is involved in increased cell replication. 
Key words: Folic acid – Folate – Breast Cancer 
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ABSTRACT:  
This study aims at the identifying relationship between Magnetic resonance imaging (MRI) and 
pathology results among women with breast cancer. The primitive diagnosis of breast carcinoma is 
based on mammography using X-Ray and due to low Specificity; it may lead to unnecessary biopsy. 
MRI compares to mammography enjoys the most sensitivity and specificity in diagnosing cancer 
pathology.  
Materials and methods: 
This was a cross-sectional study from January 2009 to 2010 in Athary Radiography center. The patients 
with Breast Imaging-Reporting and Data System (BI-RADS) 3, 4, 5 with no chemotherapy or biopsy 
before MRI were entered to the study. 139 pathology samples were studied. Data were analyzed with 
SPSS 18.0 statistical software. 
Results: 
There were 24 (17.4%) malignant and 114 (82.6%) benign samples. In most of the pathology samples 
BI-RADS 4 was observed. In analyzing BI-RADS and pathology a significant relationship was observed 
(p=0.5551). There was the most relationship between descriptor and pathology of size, shape and 
internal enhancement. 
Discussion: 
MRI is a specific non-invasive technique which doesn’t involve any radiation exposure and can detect 
breast lesions sometimes missed by mammography and clinical examination with low false positive 
results.  
Conclusion: 
Span of MRI descriptor diagnosis involves abroad field of sensitivity. 
Key word: MRI- Pathology-Breast Cancer-Lesions   
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Introduction: 
Breast ailments including breast cancer occupy the top rank in prevalence amongst other female 
diseases. As a prominent cause of female fatality, breast diseases are of great importance and impose 
personal, familial and social damages. All over the world, the most prevalent cancer-resulting deaths is 
those of breast cancer, that is to say, many women around the world die because of breast cancer.  
Materials and Methods: 
This study conducted an epidemiological comparison of breast cancer cases diagnosed in women by 
scrutinizing Persian and English references available. 
Results: 
Breast cancer is the most prevalent cause of death for women between 35 to 55 years of old. Of every 
one thousand women, one or two women are annually diagnosed to suffer from breast cancer. Indeed, 
from any four cancer-suffering women, one suffers from breast cancer. In the U.S, one out of nine 
women has breast cancer. Recent studies show that Iranian women suffer from breast cancer more than 
from other cancer types. Nearly 5% of breast cancer cases occur genetically and 80% to 90% of them 
are brought about sporadically. Despite the fact that breast cancer is more common among women of 
fifty or above, it may occur at any given age. Comparing past and present statistics indicates a relatively 
fast rise in the number of this ailment among Iranian women. According to the state statistics, one out 
of every ten or every fifteen women suffers from breast cancer in Iran, but the age at which breast 
cancer emerges in Iranian women is the whole one decade earlier than in women of the developed 
countries. Women at any age are exposed to breast cancer. The average diagnosis age of breast cancer 
in western countries and Iran is 56 and 45 years, respectively. The epidemiological study of breast 
cancer shows that 75 percent of breast tumors appear in women of fifty and above and only 5.6 percent 
in those less than 30. And finally, less than one percent of breast cancer cases are diagnosed in women 
younger than 25. After thirty years of age, however, women face a sudden rise in their possibility of 
exposure to breast cancer.  
Discussion and Conclusion: 
Breast cancer is one of the most important factors posing threats to women’s physical, mental and 
social health. That is why breast cancer is placed at a focal point drawing attention of most health 
planners and policy makers. It seems that by 2020, an increase of 26 percent in breast cancer is 
expected, mainly in developing countries. This suggests that lifestyle and environmental factors may 
exert a tremendous influence on emergence of breast cancer. 
Key words: epidemiology, breast, cancer.  
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Background: Breast cancer represents the greatest world incidence of all female malignancies and 
about 1.2 million women suffer from breast cancer in the world every year. Homocysteine, a thiol-
containing amino acid, is produced through the catabolism of the essential amino acid methionine. 
When methionine is in excess, homocysteine is degraded to cysteine through the transsulfuration 
pathway in vitamin B6-dependent reactions. Recently the elevated plasma total homocysteine 
concentration has been concerned as the secondary feature of tumoral proliferation and enhances the 
likelihood of thrombogenesis in cancer patients. The objective of this study was to investigation the 
association betwen homocysteine in breast cancer. 
Methods: We studied recently published (2008-2014) and reviewed articles regarding homocysteine 
and breast cancer. 
Results: 18 studies were found. In vitro studies have shown that homocysteine levels are positively 
associated with proliferation rate of cells in a variety of tumors including breast tumors as well as with 
oxidative damage to cells.  However, recent evidence from in vivo and in vitro studies have suggested 
that cysteine may act as a pro-oxidant agent which causes DNA oxidative damage as a result of the 
overproduction of free radicals and hydrogen peroxide, leading to gene mutation and subsequent cancer 
development. Elevated levels of homocysteine and cysteine are also associated with several metabolic 
disorders including high body mass index, high plasma triglyceride levels, hypertension, and abnormal 
oxidation of low-density lipoproteins, which may lead to the development of several cancers including 
breast cancer. Observational studies assessing the association between circulating homocysteine and 
cysteine and overall breast cancer risk are very limited and findings have been inconsistent. One case-
control study reported a positive association between homocysteine levels and breast cancer risk. 
Conclusion: This studies showing association of hyperhomocysteinemia and hypomethioninemia 
in breast cancer and other studies indicating association of hyperhomocysteinemia with metastasis and 
development of drug resistance in breast cancer cells treated  
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Abstract 
Background: The use of optical spectroscopy as a powerful device for rapid and non-invasive diagnosis of breast cancer was considered. 
The breast tissue condition can be predicted by using a measuring in the vessels optical properties variety, such as absorption, distribution 
or transmission. 
Methods: In this study blood samples prepared at different concentrations, using a spectrometer (USB4000 Fiber Optic 
Spectrometer, USA) and light source near-infrared provided by the LED (Phwee ). Experiment performed using breast phantom 
accompanied by vessels. 
Results: The change on the absorption amounts in the blood samples with different concentrations of hemoglobin was determined. 
Absorption in blood samples from normal concentration of hemoglobin, oxy-hemoglobin were 1.1 and 1.12, respectively. But at two and 
four times concentrations of hemoglobin as abnormal blood, were 1.60 and 1.70, respectively. 
Conclusion: The results absorption values in the normal and oxy- hemoglobin were similar and indicating a healthy tissue. In samples 
with two and four times concentration of hemoglobin, increasing on the absorption rate was existed. Thus, an increasing on the amount of 
blood supply can be predicted to cells going to be cancerous. 
Keywords: absorption, hemoglobin, spectrometers, breast cancer\ 
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Abstract 
Introduction and Objectives: The response of the breast tissue including glandular and fat cells, milk ducats and blood vessels to near-
infrared light source were studied.  Any changes of absorption can be as a prognosis assay in breast tissue.  
Methods: The study was performed on samples of water, milk, fat, oxygenated hemoglobin using a spectrometer (USB4000 Fiber Optic 
Spectrometer, USA) and near-infrared light source from LED (Phwee). The experimental material inserted in to the main and minor 
blood vessels which arranged in the breast phantom. 
Results: A specific change in the optical density of the components of the breast tissue was observed. The absorption values were 
obtained for hemoglobin oxygenation: 1.12, water: 0.7, Milk: 1.07 and fat: 0.8. 
Conclusion: This method can be used to check the different values of accountability, increased hemoglobin levels in cancerous tissue. 
Even breastfeeding mothers suspected to breast cancer can use this invasive and safe method for presentation of distribution of blood 
vessels and milk ducts. 
Keywords: absorption, blood, breast cancer, spectrometers 
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Introduction: Breast cancer is one of the most frequent cancers, and it is the second leading cause of 
cancer deaths in women. Since knowledge, early detection and prevention of breast cancer have had 
important role in reducing the burden of disease, this study aimed to assess the knowledge, attitude and 
practice of female students at the Maragheh faculty of medical sciences on breast cancer.  
Methods: This is a cross-sectional study which has been done on 300 students of the Maragheh faculty 
of medical sciences at 2014. Data were acquired by researcher- made standardized questionnaires. 
Findings:  Results of the study showed that the highest percent of participants (59.2%) were in the age 
group of 18-20 year old. 6.2% of students have a family history of breast cancer. 69.2% of students 
have an acceptable attitude of risk factors, prevention, and early detection of breast cancer. 90%, 62%, 
and less than 1% of the students have moderate, weak, and high knowledge on breast cancer. 
Conclusion: The knowledge of students in this study was low on breast cancer, so because of 
importance of self-examination and early detection in prevention, it is suggested that effective 
instruction have been implemented in risk groups.  
Key words: knowledge, attitude, behavior, breast cancer 
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Introduction 
Women in Iran are at higher risk of breast cancer than other types of cancers. Therefore, preventive 
measures and early diagnosis among the family of the patients can be a starting step. So, the researchers 
conducted the study which resulted in finding 132 women to have educational interventions on them.  
Methodology : After deciding on research group, there was adata analysis using a researcher made 
questionnaire that its validity is proven by authorities and its reliability is calculated by Cronbach 
Alpha, and data analysis was done using the Spss software. 
Results: Women's age average was 37.5. 90% of them believed that having breast history in their 
family can increase the possibility of breast cancer. 50% were aware of suitable age for breast self-
examination. 36% had self-examination of breast and 27% were aware of the suitable age of having 
mammography, and 34% of them had a mammography. The amount of women's awareness of the 
common symptoms of breast cancer was 66% and about the increase of probability of cancer by aging 
this was 55%. They believed that mammography ray is harmful and 40% believed that probability of 
breast cancer among married women is higher. 34% agreed that there is a positive relationship between 
breast cancer and aging. 56% believed that breast cancer will affect the person's whole. 
Conclusion: Despite knowing the risk factors in patients' families, just one third of them perform self-
examination and mammography. This indicates the necessity of having effective educational 
interventions considering altering women's attitudes towards this cancer.  
Keywords: Awareness, Attitude, Performance, Breast Cancer  
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Introduction 
Breast cancer risk in women with a family history is higher. This study aims at inspecting health belief 
models about three behaviors of self-examination of breast, medical examination and mammography in 
patients' families in Arak province. 
Material and methodology 
This study was a cross-sectional one in which132 women over 20 with a family history completed our 
questionnaire. The data were analyzed by t-test and chi-square test.  
Findings 
Data collection was done using a reliable and validated researcher made questionnaire. The results 
indicate that the age average was (37±13) and 89% were educated and 76.5% were married. 36% had 
self-examination and 50% had a medical examination. Just 34% of them had mammography during the 
past three years. The average score for perceived susceptibility was (14±3.2) out of 20, the perceived 
severitywas (8±3) out of 15, perceived barriers (50±14.5) out of 95 and self-efficacy was (24±7) out of 
35. There was a significant relationship between age and marital status with mammography and self-
examination of breast but there was no significant relationship between them with medical examination. 
Conclusion 
Although the risk of breast cancer in patients' families is higher, but the results of this study indicates 
that their eagerness for having mammography is low. And the factors mentioned by them were: 
difficulties in taking an appointment, high expenses, being painful, and being afraid of finding a breast 
cancer tumor. 
Key words: health belief model, Breast cancer, Patients' families 
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Abstract 
Introduction: Physical activity is a well-known modifiable behavior for reducing breast cancer risk in 
postmenopausal women. However the underlying mechanisms are unknown. This study investigated 
how 6 months aerobic physical exercise can change leptin level, as a breast cancer risk factor, in 
postmenopausal women.  
Methods: This study was a randomized controlled trial. The study Participants were ages 50 to 74 
years, sedentary and postmenopausal that randomly allocated to exercise or control group. 
Participants in intervention group engaged in aerobic exercise for 3 days per week for 6months, at 70-
80% of maximum heart rate. Blood sampling was taken at baseline and after 6-months. Plasma 
concentration of leptin was assessed using ELIZA kit. Intention-to-treat analyses were performed using 
independent-sample T test.  
Result: We had 41 women (19 in control and 22 in exercise group) at baseline and 27 women at 6 
months (14 in control group and 13 in exercise group). Average age and BMI of participants were 
54.5±5.8 and 27.9±3.2 respectively. Plasma leptin decreased 0.6% in exercisers and increased 8.2% in 
controls , although the exercise effect was not statistically significant (p value=0.08).  
Discussion and conclusion: leptin levels slightly decreased in exercisers but increased in control group. 
Thus, regular aerobic exercise might decrease breast cancer risk in postmenopausal women through 
decreased leptin levels. 
 
Key words: aerobic exercise, leptin, postmenopausal, breast cancer 
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Abstract 
Introduction: Gene therapy is one of the promising approaches for breast cancer treatment. However, 
nucleic acid based drugs suffer from their poor delivery. Peptide-based nanocarriers have been shown 
to improve delivery of plasmid and SiRNA into living cells. To improve targeting gene delivery to 
breast cancer cells, we have designed a peptide based nanocarrier, by combination of iRGD, as a 
targeting moiety, and MPG H1, as an effective gene delivery carriers.  
Materials and methods: In this study, the coding sequence of this peptide was synthesized by solid 
phase synthesis.After that, this fragment was ligated in pET-28a Plasmid and transformed into E. coli 
BL21. Finally, the purified peptide was characterized by Dynamic light scattering (DLS) analysis and 
gel retardation assay in agarose gel. 
Result: The result of DLS showed that the purified nanocarrier has a mono disperse size distribution 
with a mean hydrodynamic diameter of 30 nm. Gel retardation assay revealed that this peptide 
successfully condensed plasmid included luciferase gene. 
Discussion & conclusion: The physicochemical characteristics of nanocarrier were in principle, well-
suited for cell-targeted, in vivo administered nucleic acid –based drug. Furthermore the presence of an 
iRGD motif in our designed nanoparticle will be ensured specific gene delivery to breast cancer cells.  
Keywords: Breast cancer, Gene therapy, Nanocarrier, Peptide 
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Abstract 
 
Background: Breast cancer is the major cause of cancer-related deaths in women, worldwide. 
Several factors are associated with the development of breast cancer. Amendable factors include diet 
and physical activity and some factors such as race, age, family history and genetics are not 
modifiable. Physical inactivity is associated with obesity breast, colon, kidney, and digestive 
cancer. 
The purpose of this review is to evaluate the effect of physical activity on breast cancer prevention. 
Methods: Eligible studies were identified by searching the following databases: PubMed, Google 
scholar, Science direct and Scopus. The search terms used are Physical Activity, Breast Cancer and 
Cancer Prevention. 
Findings: There is supporting evidence that physical activity is involved in breast 
cancer prevention. 
Proposed mechanisms include multiple biologic pathways such as adiposity, sex hormones, 
inflammation and immune function. In addition, physical activity may reduce risk by modulation 
of adipokines production through reducing fat mass. 
Finally, exercise reduces insulin-like growth factor-I levels and increases insulin sensitivity. 
According to findings, physical activity   may help to protect against breast cancer. 
Conclusion: The evidences are convincing that physical activity is one of the main strategies to 
promote women's health and reduce breast cancer related death. Future research are needed to 
provide more clarity regarding the type, intensity, and timing of activity that relate to breast 
cancer risk reduction and the effects of physical activity on proposed biomarkers to breast cancer 
risk. 
Key Words : Physical Activity ،Breast Cancer ،Prevention 
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Abstract 
Introduction: Breast cancer is one of the significant causes of malignancy and mortality in women. 
Breast cancer is more common in developed countries. It could be the result of earlier detection due to 
screening programs that are performed in developed countries. The aim of this study is evaluation of 
the knowledge, attitudes and perceptions towards breast cancer prevention in pregnant women in 
Sanandaj. 
Methods and Materials: This survey was a descriptive-cross sectional study.  A custom-designed 
questionnaire in persian on knowledge, attitudes and perceptions towards breast cancer prevention was 
prepared and administered to a random sample of 104 pregnant women in 2012   in Besaat hospital in 
Sanandaj. 
Results and discussion: In the collected questionnaire data, all pregnant women were aware about the 
existence of breast cancers. Only 24% and 50% of participants had previously heard about causes and 
risk factors for breast cancer, respectively. Screening methods were familiar for 11% of participants.  
Imaging, self-examining and etc. approaches were considered as a prevention method by 68% of 
sample population. Almost all of them (90%) believed that the medical procedures are the solution 
treatment for breast cancers. 
Conclusion: Proper educational courses to improve breast cancer awareness for women is seems to be 
necessary. 
Key words: Pregnant women; Knowledge and attitudes; Breast cancer. 
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Most of the body normal cells in response to stimulation from inside and outside of the body, growth, 
reproduce and finally die. If the progress happen in a correct and balanced way, body will be healthy 
and functions normally but when equilibrium of that is disturbed because of different reasons, it’s 
the start of difficulties. Among women, breast cancer is the most commonest Couse of death among 
cancers. Bio-drugs like peptides and monoclonal antibodies, are at the highest level of attention and 
hope for control or treatment of the disease. About 20 percent of the patient are overexpressed 
HER2 receptor which is involved in signaling pathways which cause uncontrolled growth and 
reproduction of the cells. Herceptin, a monoclonal antibody is one of the accepted drugs for HER2 
over expressed tumors. Here, we tried to find the most important amino acid sequences of Herceptin, 
which are involved in the interaction. So using ClusPro, we done molecular docking procedure and 
some short time molecular dynamic simulation on the selected complexes. Our results show that the 
extracted peptides could be useful to design more efficient bio- drug in comparison to Herceptin. 
Key words: breast cancer, Her2, Herceptin, molecular dynamic simulation, docking 
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Abstract 
Introduction and Objectives: The response of the breast tissue including glandular and fat cells, milk 
ducats and blood vessels to near-infrared light source were studied.  Any changes of absorption can be 
as a prognosis assay in breast tissue.  
Methods: The study was performed on samples of water, milk, fat, oxygenated hemoglobin using a 
spectrometer (USB4000 Fiber Optic Spectrometer, USA) and near-infrared light source from e LED 
(Phwee). The experimental material inserted in to the main and secondary blood vessels which arranged 
in the breast phantom. 
Results: A specific change in the optical density of the components of the breast tissue was observed. 
The absorption values were obtained for hemoglobin oxygenation: 1.12, water: 0.7, Milk: 1.07 and fat: 
0.8. 
Conclusion: This method can be used to check the different values of accountability, increased 
hemoglobin levels in cancerous tissue. Even breastfeeding mothers suspected to breast cancer can use 
this invasive and safe method for presentation of distribution of blood vessels and milk ducts. 
Keywords: absorption, blood, breast cancer, spectrometers 
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Since current methods for the detection of breast cancer, including personal and clinical examination 
and mammography tests are not able to detect certain and for a definitive diagnosis requires a biopsy, 
switching to modern medical methods such as the use of (Biomarkers) is a necessity. Among the 
benefits of early detection markers in addition to early detection, being inexpensive and safer way 
than the biopsy. Studies have shown that ROR has important role in tumor genesis and metastasis of 
breast cancer. This lncRNA significantly causing aggressive and (Migration) in breast cancer cells. 
It is noteworthy that the ROR is the positive regulator of epithelial to mesenchymal conversion 
(EMT). EMT plays as a key role in the creation of a malignant tumor and it causing loose 
connections between cells. ROR mechanism in this process is miR-205 absorption and it removes 
the inhibitory effect of ZEB 1 and ZEB 2 factors. These factors are involved in the conversion of 
epithelial to mesenchymal tumors and they have overexpressed in breast cancer. The following 
guidelines can be used is Antisense RNA to inhibit ROR or using liposomes containing miR-205 to 
inhibit ROR. 
Key Words: lncRNA ROR in Breast Cancer, mir-205,lncRNA ROR and EMT 
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Introduction:Breast cancer (BC) is the second most common malignant neoplasms after lung cancer in 
the world, with approximately 410 000 cases of death of infected with this disease annually.In recent 
years, different studies have described the role of ischemia modified albumin (IMA) as a new marker 
for diseases related to inflammation. The aim of this study was to evaluate the levels of the novel 
marker ischemia modified albumin(IMA) in patients with breast cancer. 
Materials and Methods: Thirty eight female patients with BC (mean age, 40/78±./847 years) and 
thirty eight age-sex matched healthy persons(mean age 39/61±./926years) were included in this study. 
After samples collection, the serum was separated, and after separating the serum they kept in -70 ° C 
until of day examination. In this study IMA serum levels were measured by chemical methods. 
Results: In this study,levels of the serum IMA were significantly higher in patients with BC compared 
to controls. 
Discussion: According to the result of evaluation  there is a direct relationship between the level of  
serum IMA and breast cancer. IMA is indicated a marker of ischemia and oxidative stress originating as 
a consequence of tissue hypoxia. Ima changes have been seen in a variety of diseases. 
Keywords: Breast cancer, Ischemia modified albumin(IMA), oxidative stress. 
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Introduction:Breast cancer (BC) is the second most common malignant neoplasms after lung cancer in the 
world, with approximately 410 000 cases of death of infected with this disease annually.In recent years, 
different studies have described the role of ischemia modified albumin (IMA) as a new marker for diseases 
related to inflammation. The aim of this study was to evaluate the levels of the novel marker ischemia 
modified albumin(IMA) in patients with breast cancer. 
 
Materials and Methods: Thirty eight female patients with BC (mean age, 40/78±./847 years) and thirty 
eight age-sex matched healthy persons(mean age 39/61±./926years) were included in this study. After 
samples collection, the serum was separated, and after separating the serum they kept in -70 ° C until of 
day examination. In this study IMA serum levels were measured by chemical methods. 
Results: In this study,levels of the serum IMA were significantly higher in patients with BC compared to 
controls. 
Discussion: According to the result of evaluation there is a direct relationship between the level of serum IMA 
and breast cancer. IMA is indicated a marker of ischemia and oxidative stress originating as a consequence of 
tissue hypoxia. Ima changes have been seen in a variety of diseases. 
Keywords: Breast cancer, Ischemia modified albumin(IMA), oxidative stress. 
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Background:Breast Feeding because preventing of the return of menstruation and reduces exposure 
to estrogen, which reduces the risk of breast cancer.The aim of this study was the effect of breast 
feeding and breast cancer incidence in women with breast cancer in Shiraz. 
Methods :This study is a descriptive study, 50 patients with breast cancer participated.  Their adjuvant 
treatments (surgery, chemotherapy, radiotherapy )  had been completed. Age of the patients less 
than 60 years. Demographic questionnaire was used in this study. Data using statistical software spss 
16 and the corresponding tests were analyzed.  
Results:From 50 patients studied, 92% married, mean age 48.48± 8.53 years, 42% diploma, 70% 
housewife and the average number of children (2.59± 1.49) and the average number of months of 
breast feeding them 30.16 ± 25.36. In this study, according to studies in the field, the total duration of  
breast feeding for more than 60 months were found to have a protective effect against breast cancer 
(p <0.001). 
Conclusion:The results show a decrease in the number of months of Breast Feeding is associated with 
increased risk of breast cancer incidence. It seems can be effective to increase awareness of risk 
factors for breast cancer in women and the promotion of breastfeeding. 
 
Key words: Breast cancer, Breast Feeding 
 337 
 
R2-43 
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Background: The aim of this interventional study was to determine the effect of training quality of life 
and coping strategies on functional scale of quality of life in women with breast cancer in Shiraz. 
Methods: In this study, 105 patients with breast cancer participated.  Their adjuvant treatments had 
been completed and they were randomly assigned into two groups. To measure functional scale of the 
quality of life, questionnaire EORTC QLQ-C30, before and two months after intervention were used. 
Then, the experimental group participated in 5 groups in educational programs of quality of life and 
coping strategies  weekly for one month. The results were analyzed by using spss.v.16. 
 
  Results: The mean age of the sample was in the experimental group (48/48± 8/53) and in the control 
group (49/30± 8/71). In terms of marital status, most of participants in the experimental group (92%) 
and the control group (81/8 %) were married and most of them in the experimental group (42%) and 
controls (36/4 %) have diploma. Comparing interventions before and two months after intervention 
revealed significant statistical changes toward increasing symptoms of functional scale of life quality in 
the experimental group as compared to the control group (P<0.001).  
 
Conclusion: Given that the education quality of life and coping strategies is effective on improving the 
quality of life in patients with breast cancer. Therefore, it is suggested this as part of the program 
treatment of patients considered. 
  
Keywords: Breast Cancer, Quality of life ,Coping Strategies 
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Background: Adverse physiological conditions of cancerous patients as well as psychological stress 
associated with it arise from the effect of cancer on the quality of life in these patients. The aim of this 
interventional study was to determine the effect of education on symptomatic scale of quality of life 
in women with breast cancer in Shiraz. 
 
Methods: In this study, 105 patients with breast cancer participated. Their adjuvant treatments had 
been completed and they were randomly assigned into two groups. To measure symptomatic aspects 
of the quality of life, questionnaire EORTC QLQ-C30 (before and two months after intervention) were 
used. Then, the experimental group participated in 5 groups in educational programs of quality of life 
weekly for one month. The data were analyzed using independent t-test, Chi square and repeated 
measurement tests. 
  Results: The mean age of the sample was in the experimental group (48/48± 8/53) and in the control 
group (49/30± 8/71). In terms of marital status, most of participants in the experimental group (92%) 
and the control group (81/8 %) were married and most of them in the experimental group (42%) and 
controls (36/4 %) have diploma. Comparing interventions before and two months after intervention 
revealed significant statistical changes toward decreasing symptoms of symptomatic scale of life 
quality in the experimental group as compared to the control group (P<0.001).  
Conclusion: According to the results of this study, education lead to enhancing life quality and 
decrease other complications in patients with breast cancer. Thus, it is suggested to be considered as 
a part of treatment program in these patients.  
 
Keywords: Education, Quality of Life, Breast Cancer. 
 
 333 
 
 
R3-06 
New methods of treatment for breast cancer 
Arezoo shayan1*, Farkhondeh jamshidi2 , Maryam asadi 3, Sima kiani rad4 ,Shahin tohidi5  
1Faculty of nursing & midwifery, Hamedan University of Medical 
Sciences,hamedan,Iran*(arezoo.shayan2012@yahoo.com)* 
2Instructor of occupational therapy faculty,School ofRehabilitation,Hamadan University of 
Medical Sciences, Hamadan, Iran(farkhondeh.jamshidi@yahoo.com) 
3Master of Science Midwifery(M.asadi59@yahoo.com)  
4Master of Science Midwifery(simagichloo@yahoo.com) 
5Faculty of nursing & midwifery, Hamedan University of Medical 
Sciences,hamedan,Iran(tohidi_sh@yahoo.com) 
Abstract 
Background: Revolutionary in the strategy of diagnosis and treatment of breast cancer in the last 30 
years,Significantly is contribute to increase the accuracy of diagnosis and quality of care . The aim of 
this study was to review recent studies conducted in the new treatments of breast cancer. 
Materials andMethods: The science direct،google scholar،SIDdatabases were searched. Finally, 31 
article were available was examined for review in the present study. 
Findings :According to the results, the mammography is a best diagnostic method for breast cancer 
screening . Needle biopsy thick With the eliminate many of the problems  diagnostic FNA,  There are 
many benefits for patients. miRNAs as regulators of gene expression, one of the candidates for new 
diagnostic and prognostic markers and therapeutic targets are. With the development of laser 
applications in medicine, can be leads to a damaged tissue temperature higher  than normal. Chance of 
destroying cancer cells at a temperature greater than 42.5 ° C is very high  .  
Conclusion: Based on the results and findings obtained, the new treatment in different ways,Effective 
to improve the quality of life, improve health and reduce morbidity and mortality, and Creation the 
pleasant experience for breast cancer patients,Is effective in the treatment of breast cancer 
Keywords: new treatments, breast cancer 
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Abstract 
In recent years, numerous researches on sine oculis homeobox genes have revealed the significant regulatory role 
of them in organogenesis as well as diseases such as tumorigenesis; consequently, it is essential to review the 
biology of Six1 gene. These functions of Six family genes are primarily based on structure as well as regulatory 
role of them in response to external or internal stimuli. An indispensible role of this family involved in 
organogenesis development has been widely demonstrated since expression of Six family lead to a distinct 
increase in development of various organs. In addition to this role Six family proteins can either function as a 
tumorogenesis since they are overexpressed in adult tissues which may lead to metastasis too. This suggests a 
more complicated elements and factors which involve in activating this pathway. This review describes the 
function and mechanisms of Six family in several diseases, including cancer and possible strategies to apply this 
family members for diagnostic, prognostic and therapeutic intentions. 
Key words: Tumorigenesis, Six Family, Diseases. 
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Abstract 
The sentinel lymph node biopsy (SLNB) was initially pioneered for staging melanoma in 1994 and it has been 
subsequently validated by several trials, and has become the new standard of care for patients with clinically node 
negative invasive breast cancer. The fo- cussed examination of fewer lymph nodes in addition to improvements in 
histopathological and molecular analysis has increased the rate at which micrometas- tases and isolated tumour 
cells are identified. In this article we review the literature regarding the optimal management of the axilla when the 
SLNB is positive for metastatic disease based on level 1 evidence derived from randomised clinical trials. 
 
 
Key words: Sentinel lymph node biopsy; Early breast cancer; Axillary radiotherapy; Axillary dissection; Evi- dence-
based medicine 
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Introduction: Radiotherapy plays an important role in the treatment of breast cancer. This technique is 
used of photon and electron beams produced by a linear accelerator to treat breast cancer. The aim of 
this study was to evaluate the effect of radiotherapy in the treatment of breast cancer is the most 
common techniques.  
Material and methodes: The techniques are practical and have been implemented using phantom 
trunk and EDRII films. For these practical Techniques, films were placed between the slice of the 
phantom and were irradiated under selected conditions and after irradiation, the irradiated films in 
various techniques have been appeared under the same conditions with the processor radiology AR 200 
XT. 
Result: Studies show that as a result of using adjacent fields in radiotherapy techniques, Parts of the 
target volume received dose twice or more than the prescribed dose but by the photon dose technique, 
rate of received dose is more uniform and closer to the prescribed dose. 
Keywords: radiotherapy , mastectomy,Breast Cancer 
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Abstract 
Background 
Breast cancer is a major stressor for any woman, there is great variability in women’s emotional 
responses and their ability to mobilize the resources to cope with distress. Complementary medicine 
and yoga is among the most commonly used complementary treatments for breast cancer-related 
impairments. 
 Methods 
This study was a comprehensive literature review performed through searches in databases such as 
Medline, PubMed, Science Direct, Scopus, and Google Scholar using the terms “Breast Cancer, Yoga, 
psychological health, coping skill ". 
Findings 
Previous systematic reviews found favorable effects of yoga interventions on health-related quality of 
life and psychological health in cancer patients and survivors. Yoga is a holistic system of practices that 
aims to create balance in the physical, mental and emotional self. The practices of breathing, meditation 
and relaxation have been reported to improve the psychosocial functioning of women during and after 
breast cancer treatment. Then, the clearly positive effects of yoga on psychological health in breast 
cancer patients should warrant its use in this patient population.  
Conclusions 
Yoga tailored for cancer patients aims to be a gentle practice that appropriately accommodates the 
needs of the patients. For patients, approval from an oncologist is typically needed before beginning the 
practice. 
Key words: Breast Cancer, yoga, psychological health.  
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Background and aim: Because of female students of medical sciences universities, are important 
persons in promoting breast cancer screening practice, this study was conducted to determine 
knowledge, attitude and performance about breast cancer screening among students of Tehran 
University of Medical Sciences, in 2010. 
Method: This cross sectional-analytical study conducted on 415 students of Tehran University of 
Medical Sciences. Data collection tool was questionnaire with four sections consisting of demography 
characteristics and Measurement of Knowledge, attitude and practice. For data analysis descriptive and 
inferential statistics (Pearson, T test, one-way ANOVA and Kruskal-Wallis) were used. 
Findings: The mean age of Participants was 22.3±8.2. Most of participants were professional doctorate 
students (62%). The results showed that most student’s knowledge is insufficient (50.6%) and majority 
participant’s attitude about this issue is positive (96.4%). Practice of students about breast self-exam 
and clinical breast exam was poor (91.1%). The majority of students stated that they have inadequate 
information in this field (62.9%). 
Conclusion: Inadequate knowledge and negative attitudes and poor performance of students of Tehran 
Medical Sciences University, Represents a failure to provide necessary training to them and indicate the 
necessity of training courses about breast cancer and it is screening methods at the University. 
Key words: Knowledge, Attitudes, Performance, Breast Cancer, Tehran University of Medical 
Sciences 
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Background: Beneficial effects of Omega-3 fatty acids are wonderful. Decreases of chronic 
disease include cardiovascular disease and now is breast cancer. The effect of omega-3 fatty acid 
in decreases of breast cancer was observed but the mechanism of this effect is unknown. The 
target of this review is investigated of beneficial effects of omega-3 fatty acids in prevention and 
treatment of breast cancer. 
Method: This review article is with investigated of last studies with searching in PUBMED 
search motor with keywords include “OMEGA-3 FATTY ACIDS” , “EICOSAPENTAENOIC 
ACID” , “DOCOSAHEXAENOIC ACID” and “BREAST CANCER” between 2004 to 2014. 
After filtration and separation, 37 articles are selected.  
Results: The omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid 
(DHA), can reduce metastasis and induce improving in patients with breast caner. The 
mechanisms of this effects are: 
Down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells: in some 
of studies, were observed beneficial effect of omega-3 fatty acid with expression reduction in 
some of metastasis migration receptor (e.g CXCR4 that is a transmembrane G-protein–coupled 
receptor) 
Suppress expression of EZH2 in breast cancer cells: The polycomb group (PcG) protein, 
enhancer of zeste homologue 2 (EZH2), is overexpressed in several human malignancies 
including breast cancer. Aberrant expression of EZH2 has been associated with metastasis and 
poor prognosis in cancer patient. The mechanism of this effect is posttranslationally regulate the 
expression of EZH2 in breast cancer cells. 
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Effect on progestin stimulation of invasive properties in breast cancer: an appropriate 
concentration of the omega-3 fatty acid inhibits progestin stimulation of invasive properties. 
 
 
Inhibition in MDA-MB-231 human breast cancer cells: Omega-3 fatty acids inhibited the growth 
of MDA-MB-231 cells, in addition, EPA and DHA induced apoptosis, as indicated by a loss of 
mitochondrial membrane potential. 
Discussion and Conclusion: Investigation of last studies show that consumption of Omega-3 
fatty acid from supplements or food has beneficial effects in improve and control of breast 
cancer.   
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Predicting  the  survival  in  breast  cancer  using  Hidden  Markov  Model   
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 1Research Center for Modeling in Health, Institute for Futures Studies in Health, Kerman University of 
Medical Sciences, Kerman, Iran 
2Medical Informatics Research Center, Institute for Futures Studies in Health, Kerman University of 
Medical Sciences, Kerman, Iran 
3 Computer Engineering Department, Shahid  Bahonar University, Kerman, Iran 
 
4* Professor of Biostatistics, Research Center for Modeling in Health, Department of Biostatistics and 
Epidemiology, Kerman University of Medical Science, Kerman, Iran 
 
Email addresses: 
madadizadehfarzan@gmail.com, mmontazeri@eng.uk.ac.ir, abahrampour@yahoo.com 
Abstract 
 
Among  the  women  worldwide  breast  cancer  is  one  of  the  widespread  killer  diseases.  Early 
detection of  the disease is important in patient survival. The  main  objective  of  this  research  was  to  
evaluate    predictive  ability  of  hidden  markov  model  in  prediction  of  breast  cancer survivability. 
The  breast  cancer  data  set  used  in  this  investigation  were  acquired  of  Health  department  of  
Kerman  province  and includes  the  information  of  900  breast  cancer  patients,  aged  15  to  80  years,  
and  its  associated  risk  factors  among  patients  since  1999  to  2007. Hidden  markov  model  was  
made  based  on  a  set  of  675  patients  information  (75%  of  data)  and  that  was  validate  in  a  test  
set  of  225  patients  information  (25  %  of  data). The  Area  Under  the  ROC  Curve  (AUC),  
sensitivity,  specificity  and  accuracy  used  as  measures  of  validate  of    the  efficiency  of    model. 
The  sensitivity,  specificity,  accuracy  and  the  area  under  the  ROC  curve  of  the  hidden  markov  
model  was  0.989,  0.99,  0.939  and  0.94,  respectively. According  to  the  four  evaluation  criteria,  
hidden  Markova  model  had good  performance,  therefore hidden  markov  model  and predict the 
diagnosis of  breast cancer  is recommended. 
 
Keywords:    Hidden Markova model (HMM), EM algorithm, Breast cancer, survival 
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Bioinformatics analysis of potential role of miR-520f in patients with breast carcinoma 
Marzieh Mehskat1, Kamran Ghaedi2*, Hamzeh Mesrian Tanha2, Mansoureh Azadeh34, 
Mahboobeh Meshkat1 
 
1 Division of cellular and molecular biology, Department of biology, Nourdanesh University of 
Meymeh, Meymeh, Isfahan, Iran (kimia.biology@gmail.com) 
2 Department of Biology, Faculty of Science, University of Isfahan, Isfahan, Iran 
3 Zistfanavari Novin biotechnology institute, Isfahan, Iran 
4 Islamic Azad University of Najafabad, Najafabad, Isfahan, Iran 
*Corresponding author (kamranghaedi@yahoo.com) 
Abstract: 
Introduction: In 2012, 6.3 million women alive who had been diagnosed with breast cancer in 
the previous five years. MicroRNAs (miRNAs) may act as oncogenes or tumor suppressors, so 
they could be used as a prognostic biomarker. miR-520f was markedly increased in breast 
cancer, HCC and ovarian cancer. miR-520f  do not have any validated target so it is worthwhile 
in research  
Objective: This study aim to expand current knowledge about molecular function of miR-520f 
in regard to its potential as a predicted prognostic biomarker for patients with breast carcinoma. 
Method: With the focus on their bioinformatical aspects, miRbase and miRwalk databases have 
been developed for prediction and validation of miRNA targets. targetome expression in breast 
cancer are evaluated in uniGene database. At last use DAVID database for molecular pathway 
enrichment analysis. 
Results: Among the 2067 predicted targets of mir-520f with 3, 4 and 5 score, 267 genes have 
more than 20 transcripts in breast tumor cell and mammary gland tissue. pathway in cancer as 
the most statistical relevant pathways. 34 genes were identified that probably indicate a role for 
sustained angiogenesis, evading apoptosis and proliferation in breast cancer. 
Discussion: The exact function of miR-520f has not been reported already. Our data suggests 
that miR-520f acts as an oncogenic molecule by targeting some important tumor suppressor 
mRNAs.  In additional, it is demonstrated that miR-520f involved in drug resistance phenotype 
in neuroblastoma. 
Key words: Breast cancer, miR-520f, SNP,signaling pathway. 
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Association between SHBG gene polymorphism (rs 5790) and breast cancer susceptibility 
Nastaran Haghighi 1, Zahra Tahmasebifard* 2, Nahid Nafisi 3 
1- Graduate student in Master of Genetics, Islamic Azad University, Ahar Branch, Ahar, IRAN. 
2- Assistant Professor of Molecular Biology, Islamic Azad University, Roudehen Branch, 
Roudehen, IRAN. 
3- Breast Cancer Surgery Fellowship, Cancer Research Center, Shahid Beheshti University of 
Medical Sciences, Tehran, IRAN. 
Background and Aim: 
Sex hormone binding globulin (SHBG) gene encodes a steroid binding glycoprotein that secreted 
by the liver and participates in the regulation of steroid responses. The encoded protein 
transports androgens and estrogens in the blood. The aim of this study was to evaluate the 
relationship between polymorphisms E326K and the risk of breast cancer. 
Methods:This case - control samples were studied on 79 patients with breast cancer and 79 
healthy control subjects. After sampling and extraction of DNA, genotyping of all samples were 
determined by PCR-RFLP method and the results were statistically analyzed, using SPSS 19 
software.  
Results: The average patients’ ages were 48 ± 8 years and control subjects were 43 ± 6. After 
counting the genotypes, the percentages of their frequencies were determined and observed in 
tumor samples of AA (56.9%), GG (35.4%), AG / GA (7.6%), and in the control samples of AA 
(12.6%), GG (77.2%), AG / GA (10.1%). Statistically, significant relationship was observed 
between the two groups of homozygotes. (P-Value ˂0.05).  
Conclusion:The results show that the E326K polymorphism in exon 8 of SHBG gene is 
associated with risk of breast cancer and may be a factor involved in it. 
Keywords:  
SHBG gene, Polymorphism E326K, RFLP-PCR 
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Association of Breast Cancer Risk with a Common Functional Polymorphisms of fas 1377 
and fas ligand 844. 
Zahra Tahmasebi Fard1*, Nahid Nafisi 2Afsoon Taghavi3 
1- Assistant Professor of Molecular Biology, Islamic Azad University, Roudehen Branch, 
Roudehen, IRAN. 
2- Breast Cancer Surgery Fellowship, Cancer Research Center, Shahid Beheshti University of 
Medical Sciences, Tehran, IRAN. 
3 PhD of Genetics, Cancer Research Center, Shahid Beheshti University of Medical Sciences, 
Tehran, IRAN. 
 
Background and Aim: 
The Fas protein is a member of the TNF-receptor superfamily. Interaction of FAS with Fas 
ligand is critical in triggering apoptosis of some types of cells such as lymphocytes. Alteration 
of the FAS/FAS ligand (FASLG) pathway regulating cell death may lead to cancer development 
such as breast cancer. 
Methods: 
We studied 100 patients and 100 healthy population that their sexes and ages matched case 
subjects with no history of cancer. DNA genomic was extracted from peripheral blood with 
standard protocol. We genotyped the single-nucleotide polymorphisms of FAS -1377 G > A and 
Fas Ligand 844 C˃T, by the PCR-RFLP assay. 
Results: 
The Hardy-Weinberg equilibrium analysis was performed by comparing the observed and 
expected genotypes frequencies in controls using the χ2 test. The results showed that the 
genotypes AA 52%, GG 41%, AG / GA 7% of Fas 1377 G / A in breast cancer cases and 
genotypes AA 34%, GG 47%, AG / GA19% among control group. Statistically, significant 
correlation was observed between the two groups. (P-Value ˃0.01) 
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Conclusion: 
Our study showed that functional FAS -1377 G/A and FASL -844 T/C polymorphisms are 
associated with the risk of breast cancer of Iranian patients, but FASL -844 T/C polymorphisms 
showed a weak correlation. 
Key words: 
Fas 1377, Fas ligand 844, polymorphisms, RFLP-PCR, Breast cancer 
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The effects of vitamin C administration on conventional treatment in patients with breast 
cancer: A review 
Neda Rezvani1*, Saeed Pirouzpanah2 
1 MSc student of Nutrition, Faculty of Health and Nutrition, Tabriz University of Medical 
Sciences, Tabriz, Iran 
2 Assistant professor, Department of biochemistry and dietetics, Faculty of Health and Nutrition, 
Tabriz University of Medical Sciences, Tabriz, Iran (Pirouzpanahs@tbzmed.ac.ir) 
*Corresponding Author (neda7rezvani@yahoo.com) 
Introduction: Ascorbic acid (AA) readily neutralized reactive oxidant species due to its electron 
donor-acceptor properties. This oxidoreductase activity makes vitamin C related to various 
cancers including breast cancer. Method: This paper was provided as a review by selecting 
related items which published between the years 2000-2014. Documents were collected from 
databases, PubMed and Google Scholar. Results: Results of laboratory and human studies 
indicated AA had a dual effect on breast cancer cells, which probably depended on its blood 
concentrations. It had an antioxidant action in physiologic blood levels. While, in higher 
concentrations acted as a pro-oxidant agent only in cancer cells. Dose and method of 
administration are factors affecting on plasma levels of vitamin. It seems cytotoxic 
concentrations of vitamin only obtained by intravenous (i.v) administration, not oral intake. 
Generation of hydrogen peroxide (H2O2) was accounted as important mechanisms in vitamin’s 
pro-oxidant activity. Impaired antioxidant systems in disease cells caused to the generated H2O2 
by AA auto-oxidation selectively kill cancer cells. Discussion: i.v use of ascorbic acid is found to 
create cytotoxic blood levels of vitamin. Such finding can suggest a new approach to synergism 
effect of a seemingly antioxidant vitamin with conventional treatments such as chemotherapy. 
Key words: Breast cancer, Ascorbic acid, Conventional treatments 
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The Effects of vitamin D on breast cancer risk: A review 
Neda Rezvani1*, Azita Hekmatdoost2, Saeed Pirouzpanah3 
1 MSc student of Nutrition, Faculty of Health and Nutrition, Tabriz University of Medical 
Sciences, Tabriz, Iran 
2Assistant professor, Department of Clinical Nutrition & Dietetics, Faculty of Nutrition and food 
sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran 
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3Assistant professor, Department of biochemistry and dietetics, Faculty of Health and Nutrition, 
Tabriz University of Medical Sciences, Tabriz, Iran (Pirouzpanahs@tbzmed.ac.ir) 
*Corresponding Author (neda7rezvani@yahoo.com) 
Introduction: Vitamin D is mainly well known for its classical role in calcium homeostasis and 
bone health. Because its performance is induced by growth hormones-cellular function, it 
probably has some effects on genesis, development, and survival of cancers including breast 
cancer. Method: This paper was provided as a review by selecting related items which published 
between the years 2006-2014. Documents were collected from databases, PubMed and Google 
Scholar. Results: Many epidemiological evidences suggested an inverse association of high 
sunlight exposure, as well as dietary intakes and blood levels of vitamin D with breast cancer 
risk. Modulation of specific gene expression, in tissue specific manner, consequently inhibition 
of cellular proliferation, induction of cell differentiation and apoptosis could be accounted as 
related mechanisms. High dietary intakes of vitamin D were also found to be linked to lower 
breast density. Other proposed mechanisms included increased intracellular calcium 
concentration, inhibition of angiogenesis, suppression of proliferative activity of estrogen and 
insulin-like growth factor-1 (IGF-1) and down-regulation of their receptor levels. Discussion: 
Vitamin D may be related with reduced risk of breast cancer. Such association probably is 
stronger in premenopausal women than in postmenopausal women caused by interactions among 
vitamin D, VDR, estrogen, and IGF-I. 
Key words: Breast cancer, Vitamin D, Calcitriol 
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Expansion and characterization of breast cancer stem cells for the development of BCSC 
targeting therapeutic strategies 
Dehghan Kouhestani Somayeh1, Forouzandeh Moghadam Mehdi1* 
1Department of Medical Biotechnology, School of Medical Sciences, Tarbiat Modares 
University, Tehran, Iran  
 
Introduction: Breast tumors contain a small population of tumor initiating stem-like cells, 
termed breast cancer stem cells (BCSCs) which have been linked to tumor relapse, metastasis, 
and resistance to radio- and chemotherapy. They are distinguished by characteristic markers, 
such as the cell surface antigens CD44high/CD24low and ALDH1 enzymatic activity. Since the 
scarce number of BCSCs severely hampers their isolation and puriﬁcation for further research, it 
is necessary to expand and enrich them in vitro. In the present study, we expanded BCSCs as 
tumorsphere cells from the human breast cancer cell line MCF-7 and characterized them in 
comparison to MCF-7 adhesive cells. 
Materials and methods: Single cell suspensions derived from human breast cancer cell line 
(MCF-7) were seeded in ultra low attachment plates in serum free specific media. The Aldeﬂuor 
assay and immunophenotyping was carried out for ALDH1 functional marker and surface 
antigens expression (CD44high/CD24low).  
Results: we found that BCSCs can expand in serum-free medium as non-adherent spheres of 
cells. Resulting primary tumorsphere after a week (termed T1 tumorspheres) were subjected to 
passaging every 7th day leading to the generation of T2, T3, and T4 tumorspheres. Flow 
cytometry data analysis by means of FlowJo software demonstrated that tumorspheres have 
higher percentage of CD44high/CD24low and ALDH-expressing cells.  
Discussion: The study suggest that BCSCs have a higher proportion in suspension culture as 
tumorsphere and this technique can enrich and expand breast cancer stem cells as 
undifferentiated cells in vitro for further studding the cells behavior. Furthermore, this population 
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would be a suitable in vitro model to develop a new treatment strategy that can effectively 
eliminate the BCSCs that drive tumor growth and recurrence.  
Keywords: Breast cancer, tumorspheres, cancer stem cells, MCF-7  
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Introduction: the prevalence of invasive lobular carcinoma was reported 10-15% of all invasive 
breast carcinomas.Current imaging modalities are not specific for differentiating ILC from other 
invasive breast cancers.This study is a report of patients with invasive lobular carcinoma in 
Breast cancer research center for12 years . 
Methods : In one descriptive study  patient’s physical paper with  diagnosis of ILC from 2001 to 
2013 were evaluated. Information about patients including age , tumor size , mammographic and 
sonographic findings, ER and PR receptors , lymph node status and  history of positive family 
history were analysed in SSPS soft ware. 
Result: from 1380 to 1392 total numbers of invasive cancers were 2206. Among them 83 cases 
had pathology of ILC. (3.7%) 
 Mean age of patients was 49 +11.6 and 53% was premenoposal. Family history of  breast cancer 
was negative in 94%. The most common findings in mammography was speculated mass or ill 
defined  or irregular outline masses. Other findings were focal asymmetry (17%) , 
microcalcifications6.8%, skin changes  6.8% . Mammography was normal in (6.7%). BIRADS 
classifications was equal to 5 in 76.9% , 4 in 14.4% , 3 in 14.3%. 
The most common findings in sonography was  mass in 94% that two of them had regular border 
and other ones had speculated and irregular borders. Posterior shadowing is the next finding.  
BIRADS classifications were equal to 5 in 83.3% , 4 in 11% , 3 in 5.6 %. 
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Mean tumor size was 3.1+-1.8% that(compatible with T2). 
Involvement of axillary lymph nodes was positive in 56%. 
ER and PR were positive in all cases. Incidence of bilateral and multicentric cases were 8.4%. 
Conclusions: Regarding this study ILC had low frequency in all invasive carcinomas and 
bilateral and multicentric cases were  not common .The most common findings in mommogrphy 
was mass and the most common appearance in sonography was irregular  hypoechoic mass with 
or without shadowing. 
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Introduction: 
The cancer is the second leading cause of death in the country. The Breast cancer is the most 
common cancer among Iranian women. The purpose of this study is to determine the incidence 
of breast cancer has been recorded during 2011 to 2013 in the area recorded by Iran University 
of Medical Sciences. 
Materials and Methods: 
Recorded Cases of cancer diagnosed in the pathology labs under covered by Iran University of 
Medical Sciences were over a period of three years (2011-2013) and registered in a Iran Cancer 
Registry (ICR) Software, then the output data analyzed by Microsoft ®  Excel® program. 
Results: 
The number of cancers diagnosed by pathology labs in the years 2011, 2012 and 2013 were 
18330- 21830- 23203, respectively, of the Breast cancer was the most in three years, 19%, 19% 
and 20%, respectively, colorectal cancer was the second (Per three years 11%). Skin cancer was 
ranked third in 2011 and 2012 with 8% and 10% of stomach cancer was ranked third in 2013 
with 7%.  
Conclusion: 
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Given the importance of early detection of breast cancer, it is recommended to be educated in the 
prevention and early diagnosis of cancer in patients at risk 
Keywords: 
Cancer, pathology, breast cancer 
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 پیشگیری از سرطان سینهخودمدیریتی در نوجوانان جهت 
فاطمه علایی کرهرودی: دانشجوی دکترای تخصصی پرستاری و مربی هیئت علمی دانشکده پرستاری و مامایی شهید بهشتی  
  moc.oohay@eealaf
 
بهداشتی وخود مدیریتی در بکارگیری اقدامات پیشگیری کننده سرطان سینه در نوجوانان نادر و قابل پیشگیری است. رعایت نکات مقدمه:  
 منجر به حفظ سلامتی نوجوانان در رابطه با پیشگیری از سرطان سینه می شود.
سالگی) همراه با تظاهر سایر صفات ثانویه جنسی 2-30تشکیل می شود. رشد بافت در نوجوانی ( بافت سینه در هفته پنجم جنینی محتوی: 
د. موارد رشد پاتولوژیک سلول های نسج سینه در کودکان و نوجوانان نادر است. اما علیرغم شیوع و بروز کم آن حائز اهمیت می انجام می شو
 به باشد. نوجوانان می توانند با رعایت نکات بهداشتی از جمله داشتن فعالیت کافی، عدم استفاده از تغذیه نامناسب و خود آزمایی سینه ابتلا
 خود مدیریت کنند.  سرطان را در
، بسیاری از مواد مصرفی آرایشی نامطمئن و مصرف بی رویه آن ها می تواند روی تولید استروژن تاثیر نامطلوب داشته و بی توجهی به این امر
جوانان بالا می سالگی شدت افزایش دهد. مصرف غذاهای پر کالری احتمال بروز سرطان سینه را در نو 58خطر ابتلا به سرطان سینه را تا سن 
برد. غذاهای پر چرب و پر کربوهیدرات در افزایش تکثیر سلول های سرطانی در نسج سینه نقش دارد. تحرک داشتن کافی و منظم نیز عامل 
 58نها طوری که اگر زنان از دوران نوجوانی به طور مرتب ورزش کنند، احتمال ابتلا به سرطان پستان در آمهم دیگری در این زمینه است. به
درصد کمتر می شود. آگاهی از این عوامل خطر و یادگیری روش صحیح خودآزمایی سینه به نوجوانان کمک می کند که عوامل خطر را در خود 
 به مدیریت کنند و این وظیفه اعضای تیم سلامت است که این آگاهی ها را در اختیار نوجوانان قرار دهند و به آنان در امر خودمدیریتی مربوط
 سرطان سینه یاری برسانند.
 در صورت خودمدیریتی نوجوانان در امر پیشگیری از سرطان سینه احتمال بروز خطر در این مورد کاهش می یابد.نتیجه گیری: 
 پیشگیری، سرطان سینه، خودمدیریتی، نوجوانان واژه های کلیدی:
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 به فرزندم درباره سرطان پستان چه بگویم؟
 انصاری؛ دانشجوی دکترای پرستاری، دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران مژگان نویسنده:
 moc.liamg@10irasnanagjomایمیل: 
ه با ابتلا به سرطان نه تنها بر بیمار مبتلا  بلکه بر خانواده آنان تاثیرات بسیاری بر جای می گذارد. در این میان برای پدر و یا مادری ک مقدمه:
 ه شده اند، صحبت با فرزندان در ارتباط با تشخیص سرطان یک چالش بزرگ به شمار می آید. سرطان مواج
این مقاله با مطالعات کتابخانه ای و رجوع به مقالات معتبر موجود و در دسترس و نیزموتورهای جستجو و پایگاههای معتبر موجود  روش کار: 
 در شبکه انجام شده است. 
بیمار مبتلا تغییرات روانی اجتماعی بسیاری بر اعضاء خانواده خصوصا برکودکان میگذارد. پاسخ های کودکان در  سرطان علاوه بریافته :  
خانواده براساس سن آنان و شرایط حاکم بر خانواده متفاوت می باشد. بر اساس تحقیقات افراد مبتلا به سرطان عنوان می کنند که برقراری 
به بر این مشکلات نقش مهمی را ایفا می نماید. واکنش اغلب کودکان به صورت عدم قطعیت، ترس، احساس ارتباط در خانواده به منظور غل
ه گناه و اضطراب می باشد و این بر عهده والدین و تیم چند رشته ای درمان می باشد که شرایط موجود را مدیریت نمایند. مادر در خانواده ب
ی باشد و اکنون به دنبال سرطان،  این تکیه گاه مورد تهدید قرار گرفته است. چنانچه مادری قصد عنوان یک تکیه گاه برای دنیای کودکان م
دارد تا با کودک خویش صحبت نماید بهتر است تاآنجا که امکان دارد دیدی باز نسبت به موضوع داشته باشد هرچند این موضوع سخت به نظر 
با فرزندش صحبت نماید؟ باید به خاطر داشت که با آغاز شرایط  جدید در خانواده و عدم توجه  می رسد، بایستی از ابتدا تصمیم بگیرد که چگونه
ر وبه والدین و ایجاد فاصله بین کودک و والدین، کودکان نیز مانند بزرگسالان فاصله های ایجاد شده بین خود و والدینشان را به شیوه های دیگ
ده در این زمینه عبارتند از: فرزند خویش را تشویق به صحبت کنید، واز او بخواهید تا ازشما سوال اشتباه پرخواهند نمود. راهکارهای توصیه ش
نماید، صادقانه به او پاسخ دهید، متناسب با سن و فهم کودک خویش با او صحبت کنید، جوابهای واقع بینانه به سوالات کمک میکند که ترس 
ختیار کودک خویش قرار دهید، اگر بخاطر درمان چند روزی در منزل نیستید، اگر موهایتان را از های او کم شوند، اطلاعات قابل درک را در ا
مین دست داده اید، یا سینه خویش را تحت جراحی از دست داده اید، اجازه دهید که فرزندتان بداند که چه اتفاقاتی در جریان می باشد. با معل
ز وقایع پیش آمده برایشان بگویید قطعا در سازگاری و پذیرش شرایط موجود به کودک شما کمک فرزند خویش می توانید در ارتباط باشید و ا
انواده خواهند نمود. اگر چه، چگونگی برخورد خانواده با بحران ایجاد شده به نحوه برخورد خانواده با مشکلات قبل ازوقوع بیماری بر میگردد. خ
به سادگی به اشتراک می گذارند قادرند تا به راحتی درباره تاثیر سرطان بر افراد صحبت نمایند اما  هایی که ارتباط باز دارند و احساساتشان را
 گروهی که مشکلات و مسائل خویش را به تنهایی حل می نمایند در مواجهه با سرطان در خانواده دچار گرفتاری خواهندشد.  
  753
 
 
 
 
 
بلکه بر اعضاء خانواده بیمار نیز می باشد. بیماری منجر به تغییر در خانواده می  تشخیص سرطان نه تنها بربیمار و زندگی وی عواقبنتایج:   
 شود. والدین می توانند با ارتباطات صحیح از زمان تشخیص و در فرایند درمان این نگرانی ها را کاهش دهند.  
 سرطان سینه، والدین مبتلا به سرطان، خانواده واژه های کلیدی:
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 بیماران مبتلا به سرطان پستان از نیازهای مراقبتی بیماران تبیین ادراک
 5، موسی سجادی 3، سیروس مومن زاده2،  فرح لطفی کاشانی3،  ، محمد اسماعیل اکبری 8، مریم رسولی0طاهره السادات خوش نظر
 
سرطان پستان تاثیر بسزایی بر کیفیت زندگی بیماران داشته و سبب  بروز علایمی در ابعاد جسمی، روانی، اجتماعی و معنوی بیماران  مقدمه :
مع می گردد. پژوهش فوق با هدف تبیین ادراک بیماران مبتلا به سرطان پستان از نیازهای مراقبتی در زنان مراجعه کننده به مرکز تحقیقات جا
 جام گرفت.سرطان ان
زن مبتلا به سرطان  6شامل شد. مشارکت کنندگان انجام محتوا تحلیل شیوه از بهره گیری با و کیفی رویکرد با مطالعه این روش بررسی: 
 از بعد گرفتند.  قرار ساختارمند نیمه و چهره به چهره مصاحبه های مورد و شدند مطالعه وارد هدفمند نمونه گیری روش به بودند که پستان
 مورد معنایی شباهت های ابتدا در گردید. استخراج طبقات و گرفتند قرار بازنگری مورد و شدند پیاده سازی مصاحبه ها ه ها، تمام داد گردآوری
 گرفتند. قرار طبقه یک در مرتبط زیرطبقات مجدد بازنگری در سپس و شدند مشخص زیرطبقات گرفت  و قرار بازنگری
  ) طبقه0سال بود. در طول تجزیه و تحلیل داده ها، دو مضمون اصلی پدیدار شد:  22/3) ± 6/ 22میانگین سنی شرکت کنندگان ( یافته ها:
جهت کاهش اضطراب و افسردگی پس از تشخیص  حمایتی رفتار با زیر طبقه اجتماعی-) طبقه نیاز روانی8نیازجسمی با زیرطبقه تسکین درد و 
 بیماری می باشد.
یافته های این مطالعه به تیم مراقبتی در جهت درک و شناخت بیشتر نیازهای مراقبتی بیماران مبتلا به سرطان پستان و نیز  جه گیری:نتی 
 ارائه راهکار های موثر در جهت ارتقای سلامت آنان یاری می رساند.
 : سرطان پستان، تحلیل محتوا، نیاز مراقبتیکلمات کلیدی
                                                          
 . دانشجوی دکترای دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران   1
 moc.liamg@razanhsohk.hnپست الکترونیک: 
 . دانشیاردانشگاه علوم پزشکی شهید بهشتی، تهران، ایران 2
 
 .استاد مرکز تحقیقات سرطان ،دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران 3
 دانشیار دانشگاه آزاد اسلامی، رودهن، ایران 4
 . استادیار، دانشگاه علوم پزشکی گناباد، ایران 5
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 یماری در زنان مبتلا به سرطان پستان و عوامل مرتبط با آنعدم قطعیت در ب 61-3R
 2، حمید علوی مجد3، عباس عباس زاده8*، مریم رسولی0موسی سجادی
سرطان بیماری مزمنی است که اثرات منفی زیادی بر زندگی بیماران دارد. سرطان پستان شایع ترین سرطان در بین زنان در  مقدمه و هدف: 
تمامی جوامع است. عدم قطعیت در بیماری یکی از تجارب بیماران مبتلا به سرطان است که می تواند موجب کاهش کیفیت زندگی و سازگاری 
ام این مطالعه بررسی میزان عدم قطعیت در بیماری و ارتباط آن با برخی متغیرهای بالینی و جمعیت  شناسی در با بیماری شود. هدف از انج
 بیماران مبتلا به سرطان پستان بود. 
بیمار زن مبتلا به سرطان پستان مراجعه کننده به دو مرکز ارجاع مهم  080همبستگی و مقطعی در مورد  -این مطالعه توصیفیروش ها: 
انجام شد. داده ها توسط پرسش نامه ویژگی های جمعیت شناسی و بالینی  8930طان در تهران( بیمارستان طالقانی و امام خمینی) در سال سر
که روایی و پایایی آن تایید شده است، گردآوری شد. داده ها با استفاده از نرم افزار  "عدم قطعیت در بیماری"بیماران، و نسخه فارسی مقیاس 
 توسط آزمون های آماری ضریب همبستگی پیرسون، اسپیرمن، کای اسکوئر، تی مستقل و آنالیز واریانس  تحلیل گردید. 08نسخه  SSPS
بود. بین سطح  22/0) 00/6سال و امتیاز عدم قطعیت در بیماری آنها( 62/0)00/2نتایج مطالعه نشان داد میانگین سنی بیماران ( نتایج:
قوی  )، سابقه تشخیص بیماری با بعد پیچیدگی عدم قطعیت یک رابطه معنی دار =r -0/25 , <p0/000بیماری( تحصیلات و عدم قطعیت در
). همچنین بین متغیر های شغل،محل سکونت و متاستاز با ععدم قطعیت درک شده رابطه وجود =r -0/68 , =p0/300و معکوس وجود داشت(
 د فرزندان با عدم قطعیت در بیماری رابطه معنی داری وجود نداشت.  داشت. اما بین سن بیماران، وضعیت تاهل و تعدا
                                                          
 جراحی، دانشکده پرستاری و مامایی ، دانشگاه علوم پزشکی گناباد، گناباد، ایران. -روه پرستاری داخلیاستادیار،گ 1
 دانشیار، گروه پرستاری کودکان،دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی شهید بهشتی،تهران، ایران. نویسنده مسؤل:  2
روبروی بیمارستان قلب شهیدرجایی ، گروه  -تقاطع ولی عصر و اتوبان نیایش -از میر داماد بالاتر -خیابان ولی عصر -تهرانپستی:   آدرس    
 پرستاری ، دانشکده پرستاری و مامایی دانشگاه علوم پزشکی شهید بهشتی
 121-12521277ر:  نماب    121-28655377تلفن:     moc.liamg@m.iluossaRپست الکترونیک:
 استاد،گروه پرستاری، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی شهید بهشتی،تهران، ایران. 6
 دانشیار،گروه آمار حیاتی، دانشکده پیراپزشکی، دانشگاه علوم پزشکی شهید بهشتی،تهران، ایران. 4
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بیماران مبتلا به سرطان پستان در حد نسبتا بالایی عدم قطعیت در بیماری را تجربه می کنند. بررسی عدم قطعیت در این  نتیجه گیری:
تواند منجر به کاهش عدم قطعیت در بیماری و در نتیجه ارتقای بیماران و انجام مداخلات و استفاده از استراتژی های موثر توسط پرستاران می 
 کیفیت زندگی و سازگاری آنها با بیماری شود.
 عدم قطعیت در بیماری، سرطان، سرطان پستان، ایران. کلید واژه ها:
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R3-08 
Heavy Metals Contamination of Milk and Dairy Products and Risk of Cancers 
S. Esmaeili1,2, H. Davoodi*2,3  
 
1 Department of Food Technology Research, National Nutrition and Food Technology 
Research Institute, Faculty of Nutrition Sciences, Food Science and Technology, Shahid 
Beheshti University of Medical Sciences, P.O. Box 19395-4741, Tehran, Iran. 
2 Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran  
3 Department of Clinical nutrition and Dietetic, National Nutrition and Food Technology 
Research Institute, Faculty of Nutrition Sciences, Food Science and Technology, Shahid 
Beheshti University of Medical Sciences, P.O. Box 19395-4741, Tehran, Iran. 
 
Milk and milk products are recognized as functional foods which their uses have a direct and 
significant effect on health outcomes and their consumption correlate with a reduced risk of 
numerous cancers. On the other hand, growing environmental pollutant resulted from the 
increase of industrial, agricultural and urban emissions caused milk and dairy products contain 
different amounts of toxic contaminants such as heavy metals which induce risk of cancers. Milk 
and dairy products become contaminated with heavy metals through water or manufacturing and 
packaging processes. Elements such as chromium and nickel release from stainless steel dairy 
equipment or tin may enter milk through direct contact with soldered cans. Some Heavy metals 
are not expected to have any direct contact with milk and milk products except in accidental 
cases such as cadmium, lead, mercury, and arsenic. For these elements, the main pathway of 
contamination is through the ingestion of contaminated feed and water by milk-producing 
animals. The carcinogenicity of arsenic, chromium, and nickel has been established. Many 
previous studies have proven that long-term, even with low-level, exposure to inorganic arsenic 
is related to increased risk of the lung, skin, bladder, pancreatic and hematopoietic cancers. 
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Because of milk and dairy products can contribute a large fraction of the intake of trace and toxic 
elements by the wide consumption in the human diet, especially in early childhood, control of 
these elements in dairy products is extremely required. So, determination of the residual 
concentrations of metals in milk products could represent the safety and hygienic status of the 
theses products. Moreover could be ‘‘indirect indicator’’ of the degree of environmental 
pollution of the region of milk is produced. Therefore, monitoring heavy metal contamination 
and using different technics for reducing of them in these products is an effective way to prevent 
cancers in society. 
  
 363 
 
 
 
 
 
R3-07 
Effectiveness of Group Training Based on Acceptance and Commitment Therapy on 
Anxiety and Depression of Women with Breast Cancer 
Sahar Mohabat-Bahar1, Fatemeh Maleki-Rizi2, Mohammad Esmaiel Akbari 3, Mohammad 
Moradi-joo 3 
1. Allame Tabatabai University. Faculty of Psychology and Educational Sciences, Tehran, Iran 
2. Alzahra University. Faculty of Psychology and Educational Sciences, Tehran, Iran 
3. Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran 
 
 
Abstract 
Background Breast cancer is the most common cancer in women that as a sudden event has 
profound effects on all aspects of patient's lives. Psychosocial interventions may play important 
roles in reducing anxiety and depression among breast-cancer survivors. Therefore, group 
training based on acceptance and commitment therapy may help women to cope better with their 
condition, and decrease their anxiety and depression. 
Methods: In an experimental study, 30 patients with breast cancer were selected by convenience 
sampling method and randomly assigned to 2 experimental and control groups. The experimental 
group attended acceptance and commitment training classes for 8 weeks continuously (each class 
lasting 90 minutes). Participants in both the experimental and control groups completed Beck 
Anxiety Inventory (BAI) and Beck Depression Inventory (BHI-) as a pretest and posttest. 
Analysis of Covariance was used as the statistical method. 
Results: In acceptance and commitment group training, anxiety and depression were 
significantly decreased (p<0/05). These changes were not observed in the control group. 
Conclusions: The results showed that group training based on acceptance and commitment 
therapy is an effective method in reducing anxiety and depression. Hence psychological 
interventions can be used to reduce psychological difficulties of women with breast cancer. 
Keywords: Breast Cancer; Treatment based on acceptance and commitment; anxiety; depression 
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افزایش کیفیت زندگی زنان مبتلا به سرطان اثربخشی آموزش گروهی ذهن آگاهی و درمان مبتنی بر پذیرش و تعهد بر 
 پستان
 سحر محبت بهار، فاطمه ملکی، دکتر محمد اسماعیل اکبری، محمد مرادی جو
 کارشناس ارشد روانشناسی، دانشگاه علامه طباطبایی، تهران .0
 کارشناس ارشد مشاوره، دانشگاه الزهرا،  تهران .8
 تی، تهرانمرکز تحقیقات سرطان، دانشگاه علوم پزشکی شهید بهش .3
 moc.liamg@oojidaromمرکز تحقیقات سرطان، دانشگاه علوم پزشکی شهید بهشتی،  تهران  :نویسنده مسئول  .2
 
 چکیده
سرطان پستان از شایع ترین سرطان در زنان است که تأثیرات عمیقی را بر سلامت روانی و اجتماعی زنان مبتلا به سرطان پستان به  مقدمه:
جای می نهد. هدف پژوهش حاضر تعیین اثربخشی آموزش گروهی درمان مبتنی بر پذیرش و تعهد بر کیفیت زندگی زنان مبتلا به سرطان 
 پستان بود.
نفر از زنان مبتلا به سرطان  03روش تحقیق از نوع نیمه آزمایشی با پیش آزمون، پس آزمون با گروه گواه بود. بدین منظور  روش بررسی:
نفر) 50نفر) و کنترل ( 50پستان بیمارستان شهدای تجریش به شیوه نمونه گیری در دسترس انتخاب و به طور تصادفی در دو گروه آزمایشی (
دقیقه ای برنامه آموزش گروهی درمان مبتنی بر پذیرش و تعهد برای گروه آزمایش، در  09جلسه  2نی ها، ضمن اجرای جای گرفتند. همه آزمود
 دو مرحله پیش آزمون و پس آزمون با استفاده از پرسشنامه کیفیت زندگی مورد بررسی قرار گرفتند. داده های بدست آمده با استفاده از روش
 تجزیه و تحلیل قرار گرفت. آماری تحلیل کوواریانس مورد
یافته های حاصل از تحلیل کوواریانس نشان داد که برنامه درمانی کیفیت زندگی را در گروه آزمایش افزایش داده است. درحالیکه این ها:  یافته
زندگی را در گروه آزمایش ). به عبارت دیگر این مداخله توانسته میزان کیفیت 50/0<pاختلاف معنادار درباره گروه کنترل مشاهده نشد. (
 افزایش دهد.
: از این رو می توان نتیجه گرفت که مداخلات روانشناختی از جمله آموزش گروهی درمان مبتنی بر پذیرش و تعهد، می توانند به گیری نتیجه
 عنوان یک روش مؤثر به منظور افزایش کیفیت زندگی زنان مبتلا به سرطان پستان به کار گرفته شوند.
 سرطان پستان، درمان مبتنی بر پذیرش و تعهد، کیفیت زندگی های کلیدی: واژه
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ی کش بر بهبود تصویر تن و بهزیستی مرحله 7رفتاری مبتنی بر الگویی _بررسی اثربخشی درمان شناختی 
 شناختی زنان مبتلابه سرطان پستان روان
 3، فرح لطفی کاشانی8، حمید پورشریفی0بیتا باوادی
تغییر در تصویر ذهنی از جسم  در حال حاضر یکی از انواع شایعترین سرطان که زنان با آن مواجه هستند سرطان پستان است. وهدف:مقدمه 
ه درنتیجه بیماری، جراحی یا درمان، اسکارهای دردناک، ریزش مو، تغییر وزن، منوپوز زودرس وعدم ایفای نقش در محیط خانواده و کار منجر ب
رفتاری مبتنی بر -گردد لذا این پژوهش با هدف تعیین اثربخشی درمان شناختیشناختی فرد میاجتماعی وتاثیر بر بهزیستی روان مشکلات روانی
 مرحله ای کش بر بهبود تصویر تن و بهزیستی روانشناختی زنان مبتلا به سرطان پستان انجام گردیده است.2الگوی 
زن ماستکتومی شده و تحت  03ی نیمه تجربی، شامل دو گروه مداخله و شاهد است؛ که بر روی این پژوهش مطالعه :روش بررسی
صورت آسان گیری بهکننده به مرکز تحقیقات سرطان دانشگاه علوم پزشکی شهید بهشتی در تهران انجام شد. نمونهدرمانی مراجعهشیمی
رفتاری شرکت _جلسه درمان شناختی  2در  نفر) 50ادفی بوده است. در طی این پژوهش گروه مداخله (صورت تصها بهوجایگزنی افراد در گروه
در سطح آمار توصیفی و sspsافزار منظور دستیابی به نتایج از نرماند. ابزار گردآوری اطلاعات در طی این پژوهش پرسشنامه بوده است و بهکرده
 .آمار استنباطی از روش تحلیل کوواریانس چندمتغیری استفاده گردید از میانگین و انحراف معیار و در سطح
شناختی در گروه مداخله قبل و بعد از نتایج حاصل از این پژوهش نشان می دهدکه میانگین نمره تصویر بدنی و بهزیستی روان  یافته ها:
 .)50/0<p( معناداری داشته است درمان تفاوت آماری
ین ویژگی افراد دارای سرطان پستان داشتن یک تصویر منفی از جسم خود بوده است که متعاقبا کیفیت عملکرد مهم تر بحث ونتیجه گیری:
ی کش مرحله 2رفتاری الگویی _درمانی مبتنی بر روش شناختیاجتماعی وبهزیستی روانشناختی فرد مختل میشود، لذا انجام روان–روانی 
 گردد.صورت گروهی برای این بیماران توصیه میبه
 رفتاری -تصویر تن، بهزیستی روانشناختی، درمان شناختی سرطان پستان، گان کلیدی: واژه
                                                          
 علوم و تحقیقات تهران،  کارشناس ارشد روانشناسی بالینی دانشگاه آزاد اسلامی واحد 1 
 moc.oohay@ohcysp.atibنوسنده مسئول:    
 استادیار دانشگاه تبریز 2 
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Abstract 
The incidence of breast cancer in Iran is less than western countries but it occurs about a decade earlier 
than well developed countries. In comparison with other types of breast cancer, patients with triple 
negative tumors have poor prognosis with less response to current therapies. Here, we investigated the 
cytotoxic effect of three synthetic benzoxaloyl coumarins in triple-negative breast cancer cell line MDA-
MB231. Three derivatives of benzoxaloyl coumarin were synthesized.  MDA-MB231 cells were treated 
with concentration of 5, 25, 50, 100 and 150µM of benzoxaloyl coumarins for 72 hours, separately. Cell 
viability was assessed using MTT assay, analyzed by GraphPad Prism software and EC50 values were 
calculated. All three benzoxaloyl coumarin derivatives induced significant cell death in the treated MDA-
MB-231 cells. Results showed that the Benzoxazole coumarins induce a significant cell death in the 
MDA-MB-231 cells. So far, the cell death induction of benzoxaloyl coumarins in triple negative breast 
cancer cells has not been reported. But, growth inhibitory effects of other coumarins in lung and breast 
cancer cell lines (such as MCF7) were reported.  It could be concluded that benzoxaloyl coumarins 
possess cell death induction activity and might be new candidates in drug design for triple negative breast 
cancer.  
Keywords : Breast cancer, cytotoxicity, triple-negative breast cancer ، benzoxaloyl coumarins  
 367 
 
 
 
 
 
R3-04 
The association between Vitamin D status and risk of breast cancer: a case-
control study 
Jamshidi Naeini Y1, Abdollahi M2, Ajami M3, Akbari ME4, Davoodi H5  
1 M.Sc in Nutrition Sciences, Faculty of Nutrition Sciences and Food 
Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran 
2 Associate  Prof. (in Research), Dept. of Nutrition Research, National Nutrition 
and Food Technology Research Institute, Faculty of Nutrition Sciences and Food 
Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran 
3 Assistant Prof, Dept. of Food and Nutrition Policy and Planning Research, 
National Nutrition and Food Technology Research Institute, Faculty of Nutrition 
Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, 
Tehran, Iran 
4 Cancer Research Center, Shahid Beheshti University of Medical Sciences, 
Tehran, Iran 
5 Corresponding author: Assistant Prof, Dept. of Clinical Nutrition and Dietetic, 
National Nutrition and Food Technology Research Institute, Faculty of Nutrition 
Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, 
Tehran, Iran  
 
Background: Increase in the incidence of breast cancer during the 4 past decades 
has made it the most prevalent cancer among the Iranian women. Some of current 
evidence support the association between vitamin D status and breast cancer 
development. Although the role of vitamin D in breast cancer incidence and outcomes 
is controversial. Results from some studies support the inverse association between 
vitamin D intake or serum concentration and risk of breast cancer. Therefore, 
considering the conflicting results of previous studies and high prevalence and rising 
incidence of breast cancer and high prevalence of vitamin D deficiency in Iran, this 
case-control study aimed to investigate the relationship between intake and serum 
concentration of vitamin D and risk of breast cancer. 
Methods and Materials: A total of 135 incident breast cancer cases in the 
Cancer Research Center of Shahid Beheshti university of medical sciences were 
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matched with 135 controls by age and menopausal status. Information on the risk 
factors of breast cancer was collected to assess the role of confounding factors in the 
relationship between vitamin D and breast cancer. A 168-item food frequency 
questionnaire was filled by interviews for every participants to assess dietary intake of 
vitamin D and some other dietary factors. To determine the vitamin D content of foods 
we used the USDA nutrient database. For analyzing  the food frequency questionnaires 
we used the food composition table for the comprehensive plan for assessment of 
nutrient intakes in 1381-83. 5 mL blood samples were collected from all participants to 
measure serum 25(OH)D using ELISA method. 
Results: Dietary intake of vitamin D was inversely associated with risk of breast 
cancer so that the odds ration of the forth quartile of dietary vitamin D intake compared 
to the first was 0.392 (P=0.008). After adjusting for the confounding factors this 
inverse association remained significant and the risk of developing breast cancer for 
those in the forth quartile was 2.6 times lower compared to those in the first quartile. 
When the participants were stratified by menopausal status the inverse association 
remained marginnaly significant in premenopausal women but not in postmenopausal 
participants. Women who were in the forth quartile of serum 25(OH)D level had 3 
times lower risk of developing breast cancer compared to women in the first quartile. 
In adjusted model the inverse relationship between serum 25(OH)D concentration and 
risk of breast cancer remained significant OR(95% CI)=0.269(0.122-0.593). in the 
stratified model the inverse association was only seen in premenopausal women 
OR(95% CI)=0.25(0.094-0.687).  
Conclusion: Results from this case-control study support the protective effect of 
higher serum concentration of 25(OH)D against breast cancer. Moreover, dietary but 
not total intake of vitamin D was associated with decreased risk of breast cancer. 
Key words: Breast cancer, Vitamin D, 25(OH)D 
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Background :Breast cancer is the commonest malignant disease in women and up to 20% of this 
cases in west world (Near to 50% Iran ) have less than 50years old ( Pre menopause ). Premature 
ovarian failure (POF) is a common toxicity of chemotherapy. For reproductive age women, a 
large number of whom have either not contemplated or not completed their families, the 
diagnosis of breast cancer poses fertility concerns. Advances in breast cancer care , including 
early diagnosis and aggressive chemotherapy ,have improved the life expectancy for young 
women ;and have necessitated an increased emphasis on issues of survivorship, including family 
planning. The reported incidence of amenorrhea after systemic therapy for breast cancer varies 
widely, and is related to age , type, and cumulative dose of administered chemotherapy, and 
reserve of ovaries and probably time of cycles during chemotherapy. The incidence of permanent 
amenorrhea following systemic therapy for breast cancer ranges from 33% to76%.                                                                                           
Methods: Premenopausal patients with age up to 40 years with stage I-III ER/PR_ breast 
carcinoma to be treated with chemotherapy (CA OR TEC) with or without GnRH analogs started 
10 day prior to the first chemotherapy dose(q28day up to 2weeks after later course of 
chemotherapy). The primary endpoint is2/5 years POF defined as amenorrhea for the prior 
6months and post –menopausal FSH level .                .                                                                                                                                                     
RESULTS: 54patients with mean age 35years (19-40) , 28 patient in group I ( Cytoxan 
+Adriamycin orCA +GnRHa) and 26 patient in group II 
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(TAXENS+EPIRUBICINE+CYCLOPHOFAMID or TEC + GnRHa ) are studied, After 6month 
of last course of chemotherapy normal FSH and menses were seen in 46% and 35% ,and after 12 
month in 76% and62% , and after 18month in86% and 73% and after 24 month in 93% and 85% 
and after 30 month in96/5% an92%.In control group of patient (54cases)normal FSH and menses 
seen in 31%, 61%,72% 80%, and 84%.After 2/5 years ,premature menopause were seen in 3/5% 
in CA- GnRHa ,7/5%Iin TEC-GnRHa , 16% in control groups.    
CONCLlUSION : Administration of GnRHa analog with chemotherapy was associated with less 
POF  and premature menopause, and we recommended this form of adjuvant therapy in young 
patients with breast carcinoma. 
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Background: Increase in the incidence of breast cancer during the 4 past decades 
has made it the most prevalent cancer among the Iranian women. Some of current 
evidence support the association between vitamin D status and breast cancer 
development. Although the role of vitamin D in breast cancer incidence and outcomes 
is controversial. Results from some studies support the inverse association between 
vitamin D intake or serum concentration and risk of breast cancer. Therefore, 
considering the conflicting results of previous studies and high prevalence and rising 
incidence of breast cancer and high prevalence of vitamin D deficiency in Iran, this 
case-control study aimed to investigate the relationship between intake and serum 
concentration of vitamin D and risk of breast cancer. 
Methods and Materials: A total of 135 incident breast cancer cases in the 
Cancer Research Center of Shahid Beheshti university of medical sciences were 
matched with 135 controls by age and menopausal status. Information on the risk 
factors of breast cancer was collected to assess the role of confounding factors in the 
relationship between vitamin D and breast cancer. A 168-item food frequency 
questionnaire was filled by interviews for every participants to assess dietary intake of 
vitamin D and some other dietary factors. To determine the vitamin D content of foods 
we used the USDA nutrient database. For analyzing  the food frequency questionnaires 
we used the food composition table for the comprehensive plan for assessment of 
nutrient intakes in 1381-83. 5 mL blood samples were collected from all participants to 
measure serum 25(OH)D using ELISA method. 
Results: Dietary intake of vitamin D was inversely associated with risk of breast 
cancer so that the odds ration of the forth quartile of dietary vitamin D intake compared 
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to the first was 0.392 (P=0.008). After adjusting for the confounding factors this 
inverse association remained significant and the risk of developing breast cancer for 
those in the forth quartile was 2.6 times lower compared to those in the first quartile. 
When the participants were stratified by menopausal status the inverse association 
remained marginnaly significant in premenopausal women but not in postmenopausal 
participants. Women who were in the forth quartile of serum 25(OH)D level had 3 
times lower risk of developing breast cancer compared to women in the first quartile. 
In adjusted model the inverse relationship between serum 25(OH)D concentration and 
risk of breast cancer remained significant OR(95% CI)=0.269(0.122-0.593). in the 
stratified model the inverse association was only seen in premenopausal women 
OR(95% CI)=0.25(0.094-0.687).  
Conclusion: Results from this case-control study support the protective effect of 
higher serum concentration of 25(OH)D against breast cancer. Moreover, dietary but 
not total intake of vitamin D was associated with decreased risk of breast cancer. 
Key words: Breast cancer, Vitamin D, 25(OH)D 
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Abstract 
Background: Breast cancer is the most common cancer among women and one of the leading 
causes of death in the productivity ages. Mammography screening is the main method for the 
diagnosis of breast cancer. While analog mammography counts as the standard method of 
screening, the digital can be an alternative. This review compared the effectiveness and safety 
of the technologies. 
Method: In order to collect evidence about the effectiveness of analog and digital 
mammography a systematic review of diagnostic accuracy studies within 1990 to March 2014 
was conducted. The most relevant databases including Abstracts of Reviews of Effects (DARE), 
NHS Economic Evaluation Database (NHS EEDs), Cochrane Database of Systematic Reviews, 
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TRIP, PubMed and Medline. The key words included mammography and its roots. After 
identification of appropriate studies  the quality was evaluated with QUADAS and meta-analysis 
was used for extracted data pooling. 
Results: From 35,284 related study, 166 were selected after after topic review. Then by 
removing duplicates and abstract or full paper review, 13 studies were selected for  analysis. 
The quality of 9 studies was good and the rest were at average range. Meta-analysis revealed 
that the sensitivity of analog and digital mammography in women under 50 years were 0.61 
and 0.81 respectively. 
Conclusion: Owing to digital mammography’s higher sensitivity and regarding to the increasing 
prevalence of breast cancer in the Iranian women population, especially in 45-50 and higher 
safety of digital mammography, we can recommend it, instead of the analog for the screening 
and diagnosis of breast cancer. 
Key word: Digital mammography, analog mammography, effectiveness, screening, breast 
cancer 
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Abstract: 
Back ground: Changing to a health-promoting lifestyle is crucial to cancer survivors, both for promoting 
their health status and  for refusing of the diseases and heightening the survival. 
Purpose: The purpose of this study was to investigate the association among depression, social support 
and health-promoting behaviors in breast cancer survivors. 
Method: A cross sectional design was performed. The data were collected by questionnaires from a 
convenience sample of 158 breast cancer survivors in Urmia in 2014. The data were analyzed 
implementing descriptive statistics, t-tests, one-way ANOVA, Pearson’s correlation coefficients. 
Results: The mean age of the samples was 45.15 (SD=6.25), ranging from 32 to 66. The mean score for 
social support and depression was 68.59 (SD=12.32) and 16.18 (SD=9.66) respectively. The mean score 
for health-promoting lifestyle was 145.23 (SD=32.23). Among the six domains of a health promoting 
lifestyle, spiritual growth had the highest score (27.93,SD=2.68), while physical activity showed the 
lowest (21.01,SD=2.11). Significant positive relationships were found among social 
support(r=0.6023,p<0.0001), depression  (r=-0.5113p<0.0001), and health-promoting lifestyle. 
Conclusion: The findings of this study will accelerate the accessing to the healthy lifestyle in breast 
cancer survivors who are willing to pursue health promotion h behavior. 
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Abstract 
Background: Recent attempts have done specifically target superantigens towards tumors and 
for the preclinical treatment of a variety of tumors by means of tumor-targeted superantigens 
(TTS) strategy. In this study we explored the antitumor potency of TTS strategy by fusing the 
third loop of transforming growth factor α (TGFαL3) genetically to staphylococcal enterotoxin 
type B and investigated the possibility of the therapeutic application of TGFαL3-SEB as a new 
antitumor candidate in mice bearing breast cancer. 
Methods: Antitumor effect of TGFαL3-SEB in mice bearing breast cancer was examined by 
intravenous or intratumoral injection. Tumors size volume, long term survival and cytokine 
production were determined.  
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Results: In the i.t (TGFαL3-SEB)-injected group of mice, reduction of tumor volume and long 
term survival showed significant differences compared with mice in the i.v. (TGFαL3-SEB)-
injected group. Surprisingly, four of eleven mice were cleared thoroughly in 20-25 days after i.t. 
administration of TGFaL3-SEB fusion protein.  
Conclusion: TGFaL3-SEB can effectively inhibit the growth of breast tumors by increased 
cytotoxic T-cell activity, cytokine levels and necrosis induction in mice bearing breast tumor. So 
these results indicate that TGFαL3-SEB might be a promising antitumor candidate for cancer 
immunotherapy. 
Keywords: Breast Cancer, Immunotherapy, Staphylococal Enterotoxin type B, Transforming 
Growth Factor α 
 
 
